Trait_category,Trait,Protein,Protein_definition,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PLA2G7,Platelet-activating factor acetylhydrolase,42610,0.103886502431388,0.00311296291853063,0.0977850951110676,0.109987909751708,1.1808720787894e-234
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LDLR,Low-density lipoprotein receptor,42643,0.119111001743809,0.00489038650830159,0.109525844187537,0.12869615930008,2.93440393339952e-128
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FGFBP1,Fibroblast growth factor-binding protein 1,42678,0.0730362493249095,0.00317153093914523,0.0668200486841849,0.0792524499656342,3.94740019706494e-115
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FGFBP3,Fibroblast growth factor-binding protein 3,40482,0.0731368769579124,0.00354567829961584,0.0661873474906654,0.0800864064251595,7.9880402387574e-93
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PLTP,Phospholipid transfer protein,42751,-0.0703028448760121,0.00344482404419987,-0.0770547000026439,-0.0635509897493804,3.29585990846174e-91
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TFPI,Tissue factor pathway inhibitor,42617,0.0554496438585436,0.00298900276856592,0.0495911984321544,0.0613080892849328,7.06332988259871e-76
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PLA2G10,Group 10 secretory phospholipase A2,42494,-0.0907908087316239,0.00570192459621987,-0.101966580940215,-0.0796150365230329,1.46453162240929e-56
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FST,Follistatin,42653,0.0732427652122573,0.00476478278860244,0.0639037909465966,0.0825817394779181,7.12677551396549e-53
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",42793,0.0423500694861349,0.00283601466251457,0.0367914807476063,0.0479086582246634,5.0094491168765e-50
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LGALS9,Galectin-9,42619,0.0461296567698332,0.00312669129503777,0.0400013418315591,0.0522579717081072,7.04823165842467e-49
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IGFBP1,Insulin-like growth factor-binding protein 1,42769,0.168465553333304,0.01164417287716,0.14564297449407,0.191288132172538,4.33521702195767e-47
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,APCS,Serum amyloid P-component,40418,0.0467478703733984,0.00331283245950629,0.040254718752766,0.0532410219940307,7.83018215886421e-45
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CCL23,C-C motif chemokine 23,42675,0.0559759740868965,0.00407152077694906,0.0479957933640763,0.0639561548097166,1.01394705183404e-42
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CFP,Properdin,40538,0.0294336650836468,0.00216423783317362,0.0251917589306265,0.0336755712366671,8.50865644528131e-42
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,C4BPB,C4b-binding protein beta chain,42678,0.0530016560273201,0.00392110405368259,0.0453162920821022,0.060687019972538,2.30711195099815e-41
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LGALS1,Galectin-1,42635,0.0457617160540192,0.00340778383343662,0.0390824597404835,0.052440972367555,7.5383513406307e-41
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,40538,0.0332630801711785,0.00248696263831028,0.0283886334000904,0.0381375269422667,1.71493068236306e-40
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ANGPTL4,Angiopoietin-related protein 4,42653,0.0576611605786951,0.00435706671672799,0.0491213098139082,0.0662010113434819,9.89382667141039e-40
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GIP,Gastric inhibitory polypeptide,40222,-0.074083230491861,0.00569107786268004,-0.0852377431027139,-0.0629287178810081,1.86917694571763e-38
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FGA,Fibrinogen alpha chain,40283,0.0381911015510451,0.00301419427540072,0.0322832807712597,0.0440989223308305,1.54463100980777e-36
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD72,B-cell differentiation antigen CD72,40282,0.0535326530828411,0.0043163525364122,0.0450726021114732,0.061992704054209,4.33816507807863e-35
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BPIFA2,BPI fold-containing family A member 2,39837,-0.135437454344666,0.0110015755695,-0.157000542460886,-0.113874366228446,1.36284479899579e-34
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LTA4H,Leukotriene A-4 hydrolase,42720,0.0692497812301457,0.005699375618097,0.0580790050186756,0.0804205574416159,8.56020353412557e-34
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CCL22,C-C motif chemokine 22,42508,0.0624127265783299,0.00515479561125353,0.052309327180273,0.0725161259763869,1.44310945468304e-33
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CFH,Complement factor H,39955,0.027032418680655,0.00223141502791535,0.0226588452259409,0.0314059921353691,1.46347199479565e-33
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PAMR1,Inactive serine protease PAMR1,42610,0.0312942603664636,0.00259981549666437,0.0261986219930014,0.0363898987399258,3.36192867610178e-33
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SNCA,Alpha-synuclein,40282,0.134118142333519,0.0111974149065566,0.112171209116668,0.15606507555037,7.42374342442424e-33
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",40481,0.106677298174355,0.00891345238043167,0.089206931508709,0.124147664840001,8.24264972568259e-33
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",40222,0.105652839922555,0.00888443100215902,0.0882393551583232,0.123066324686787,2.05701749933217e-32
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CXCL10,C-X-C motif chemokine 10,42675,0.0772311172479556,0.00657549511859751,0.0643431468155045,0.0901190876804067,1.0654727816244e-31
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MTIF3,"Translation initiation factor IF-3, mitochondrial",40448,0.099511429498191,0.00852369409260277,0.0828049890766896,0.116217869919692,2.60121216552141e-31
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,INHBB,Inhibin beta B chain,40282,0.0620862700044454,0.0053233571363293,0.05165249001724,0.0725200499916508,2.99784793513921e-31
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,42688,0.0477893650439713,0.00410725240351049,0.0397391503330907,0.0558395797548518,3.8363053185793e-31
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD14,Monocyte differentiation antigen CD14,42415,0.0471608848392152,0.0040763736435957,0.0391711924977676,0.0551505771806628,8.29417069461185e-31
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,APOA1,Apolipoprotein A-I,40538,-0.0309363335254557,0.00268903475271001,-0.0362068416407674,-0.0256658254101441,1.84463049491275e-30
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,42637,0.0402950609072701,0.0035063183539795,0.0334226769334703,0.0471674448810699,2.00429598067921e-30
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AGRN,Agrin,42675,0.0406101950291279,0.00353829318573877,0.0336751403850799,0.0475452496731759,2.37221759539887e-30
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD4,T-cell surface glycoprotein CD4,42569,0.034172066024233,0.00301268590965196,0.0282672016413152,0.0400769304071509,1.10127663497047e-29
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,P4HB,Protein disulfide-isomerase,42562,0.0421331602794963,0.00372211333107391,0.0348378181505915,0.0494285024084012,1.42927428723906e-29
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PYY,Peptide YY,40115,-0.112998478359492,0.00998621781911623,-0.132571465284959,-0.0934254914340239,1.60625559068041e-29
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TNFSF10,Tumor necrosis factor ligand superfamily member 10,42753,0.0280298212984198,0.00248449649187874,0.0231602081743375,0.0328994344225021,2.17978530536637e-29
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ANGPTL2,Angiopoietin-related protein 2,42639,0.0435004375748395,0.00390206199040375,0.0358523960736482,0.0511484790760309,9.78032528977221e-29
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NRP2,Neuropilin-2,42610,0.0311839309787758,0.00279861961547394,0.0256986365324469,0.0366692254251047,1.03987765771624e-28
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",40448,0.112908783326252,0.0101501875846095,0.093014415660417,0.132803150992086,1.3540265768728e-28
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FXN,"Frataxin, mitochondrial",42720,0.0791345421077324,0.00711801821708232,0.065183226402251,0.0930858578132137,1.37156709624213e-28
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,C3,Complement C3,39988,0.0502007158913903,0.00458711215209789,0.0412099760732784,0.0591914557095021,9.94308613175161e-28
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",40448,0.10825060735239,0.00991442486812035,0.0888183346108745,0.127682880093906,1.29342687822913e-27
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MARCO,Macrophage receptor MARCO,42635,0.0278328424741803,0.00255642724570433,0.0228222450725998,0.0328434398757608,1.72391199565035e-27
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CCL7,C-C motif chemokine 7,42593,0.0616936965495242,0.00574929543270005,0.0504250775014321,0.0729623155976163,9.38557717573982e-27
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LAG3,Lymphocyte activation gene 3 protein,42586,0.0428578504904101,0.0040066396889848,0.0350048366999999,0.0507108642808203,1.35041063829437e-26
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,42610,0.0369402580345349,0.00346800237366135,0.0301429733821586,0.0437375426869111,2.18152654640357e-26
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,42710,0.0534669832482238,0.0050389847021534,0.0435905732320032,0.0633433932644445,3.37044839454081e-26
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TRIAP1,TP53-regulated inhibitor of apoptosis 1,42720,0.0632529537571618,0.00596842066588147,0.0515548492520341,0.0749510582622894,3.8570254010323e-26
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CXCL13,C-X-C motif chemokine 13,42710,0.0645716984333206,0.00609591480107416,0.0526237054232152,0.0765196914434259,4.08148928018859e-26
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TREML2,Trem-like transcript 2 protein,42610,0.0357312595063687,0.00338910209899841,0.0290886193923319,0.0423738996204056,6.90985871101331e-26
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MMP12,Macrophage metalloelastase,42591,0.0574225399507258,0.00546461948041448,0.0467118857691135,0.0681331941323382,9.98555999694565e-26
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TMPRSS15,Enteropeptidase,42586,-0.0927867127147714,0.00888327844948044,-0.110197938475753,-0.0753754869537897,1.93236383345935e-25
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,40282,0.0440097337985896,0.00422924860652613,0.0357204065297984,0.0522990610673808,3.04069251794731e-25
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FCRL1,Fc receptor-like protein 1,42635,0.0476146427481713,0.00458386296726483,0.0386302713323323,0.0565990141640104,3.52189265041657e-25
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TMSB10,Thymosin beta-10,42610,0.0746351361621684,0.00720436719691272,0.0605145764562194,0.0887556958681173,4.69970714587707e-25
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DPY30,Protein dpy-30 homolog,42650,0.0606552733849563,0.00585713642832124,0.0491752859854467,0.0721352607844659,4.89142033804414e-25
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BPIFB1,BPI fold-containing family B member 1,42572,-0.0630648084659127,0.00609451487115932,-0.075010057613385,-0.0511195593184405,5.32047477986454e-25
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MAMDC4,Apical endosomal glycoprotein,40450,-0.0553329657014075,0.00535180930281238,-0.0658225119349198,-0.0448434194678953,6.06192355650749e-25
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GOLM2,Protein GOLM2,42710,0.0231559593848492,0.00224537779399575,0.0187550189086175,0.0275568998610808,7.63054841826445e-25
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EFNA1,Ephrin-A1,42589,0.0304553226873437,0.00295718703689567,0.0246592360950282,0.0362514092796592,8.83111440631646e-25
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CFHR5,Complement factor H-related protein 5,40381,0.0422389622028764,0.0041329647100278,0.0341383513712219,0.0503395730345308,2.06495941010146e-24
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TGFBI,Transforming growth factor-beta-induced protein ig-h3,42581,0.0268717917742706,0.00263883232395504,0.0216996804193187,0.0320439031292225,2.88868010065121e-24
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CRIP2,Cysteine-rich protein 2,42494,0.0362538965226137,0.00356199536686322,0.0292723856035618,0.0432354074416656,3.05124410694825e-24
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SEMA4D,Semaphorin-4D,42710,0.029594380569294,0.00290826977929126,0.0238941718018831,0.0352945893367049,3.10504744649206e-24
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,42710,0.0461887649127067,0.00454107616948572,0.0372882556205146,0.0550892742048987,3.25458276278106e-24
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RELT,Tumor necrosis factor receptor superfamily member 19L,42610,0.0305634302626897,0.00300523180766749,0.0246731759196614,0.0364536846057179,3.30126282164473e-24
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SERPINA3,Alpha-1-antichymotrypsin,40501,0.0150524220121618,0.00148239088919804,0.0121469358693337,0.01795790815499,4.02952398464691e-24
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,C1S,Complement C1s subcomponent,40538,0.0205754467214213,0.00202702450773988,0.0166024786862512,0.0245484147565915,4.17574202569521e-24
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CLEC4G,C-type lectin domain family 4 member G,42593,0.0326020700085179,0.00322292655288104,0.0262851339648711,0.0389190060521648,5.73946641466154e-24
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,COL18A1,Collagen alpha-1(XVIII) chain,42691,0.0238191808803928,0.002362657542885,0.0191883720963382,0.0284499896644474,8.09728218697705e-24
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HHEX,Hematopoietically-expressed homeobox protein HHEX,40482,0.073490396586305,0.00731290423797409,0.0591571042798758,0.0878236888927342,1.16196121030521e-23
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",40222,0.0746068053737322,0.00743928672170411,0.0600258033991921,0.0891878073482722,1.43757549018697e-23
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NUDT16,U8 snoRNA-decapping enzyme,40428,0.0843348235379584,0.00840976792644598,0.0678516784021243,0.100817968673793,1.43955382116715e-23
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ASGR2,Asialoglycoprotein receptor 2,40531,0.0263174143143504,0.00263200254636242,0.0211586893234801,0.0314761393052207,1.92485073822574e-23
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GCG,Pro-glucagon,42345,-0.122760656684724,0.0122930104334636,-0.146854957134313,-0.0986663562351351,2.12183390140342e-23
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NUCB2,Nucleobindin-2,42682,0.0356470040416787,0.00359398449472862,0.0286027944320106,0.0426912136513468,4.14939971771366e-23
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NPDC1,Neural proliferation differentiation and control protein 1,42635,0.0335190637649929,0.00338178396635946,0.0268907671909283,0.0401473603390574,4.44540797362496e-23
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MRC1,Macrophage mannose receptor 1,40531,0.0282370500909885,0.00285466768837321,0.022641901421777,0.0338321987602,5.61218203488693e-23
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,C2,Complement C2,42662,0.0219549132268866,0.00223479338552654,0.0175747181912546,0.0263351082625186,1.05648998449567e-22
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CXCL11,C-X-C motif chemokine 11,42710,0.0763013476531361,0.00777355351167309,0.0610651827702569,0.0915375125360154,1.14951975679887e-22
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SIGLEC8,Sialic acid-binding Ig-like lectin 8,40222,0.0435924221360765,0.0044459419015287,0.0348783760090803,0.0523064682630728,1.32544612713952e-22
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TNF,Tumor necrosis factor,42338,0.0367233204622163,0.00375142500350121,0.0293705274553539,0.0440761134690787,1.49657317867374e-22
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,C1RL,Complement C1r subcomponent-like protein,40518,0.0189258067143438,0.00193315912134222,0.0151368148365131,0.0227147985921746,1.52568740266257e-22
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",42369,0.0682041735593957,0.00697213013202602,0.0545387985006247,0.0818695486181667,1.59863924082509e-22
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",42586,0.0653090676644975,0.00668546505678653,0.0522055561531959,0.0784125791757991,1.82127160458005e-22
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,C9,Complement component C9,40531,0.0505203957634661,0.00517604838952956,0.0403753409199881,0.060665450606944,2.03971925982791e-22
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CCL18,C-C motif chemokine 18,42476,0.0662753705934277,0.00679264241719313,0.0529617914557291,0.0795889497311262,2.04888094289583e-22
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SERPINF2,Alpha-2-antiplasmin,40316,0.0127710103584024,0.00131691201603337,0.010189862806977,0.0153521579098278,3.77375983897847e-22
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ALPI,Intestinal-type alkaline phosphatase,40198,-0.118584179214889,0.0122438117218739,-0.142582050189761,-0.0945863082400158,4.26828976461389e-22
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LONP1,"Lon protease homolog, mitochondrial",40222,0.0815472065998855,0.00843451038800162,0.0650155662394023,0.0980788469603687,5.02866175241224e-22
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LPA,Apolipoprotein(a),40323,0.171353131937467,0.0177556765770624,0.136552005846424,0.206154258028509,5.95579536753219e-22
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CA6,Carbonic anhydrase 6,42580,-0.0587090683476357,0.00610016884481895,-0.0706653992834808,-0.0467527374117905,7.44002622062894e-22
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DLL1,Delta-like protein 1,42678,0.029516226489715,0.00307579413234078,0.0234876699903271,0.0355447829891029,9.7239702711693e-22
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,42586,0.0413570722871157,0.00432105305208288,0.0328878083050332,0.0498263362691981,1.24088389795711e-21
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MSR1,Macrophage scavenger receptor types I and II,42710,0.0429850056521212,0.0044931963071153,0.0341783408901752,0.0517916704140672,1.29227171189372e-21
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ACOT13,Acyl-coenzyme A thioesterase 13,40448,0.105379897407095,0.0110127027874867,0.0837949999436209,0.126964794870569,1.30512395640515e-21
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SFRP1,Secreted frizzled-related protein 1,42456,0.041202631494485,0.00430778712119912,0.0327593687369347,0.0496458942520352,1.3213117714688e-21
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ICAM1,Intercellular adhesion molecule 1,42594,0.0271013175773452,0.00284744599131745,0.021520323434363,0.0326823117203274,2.06770590044037e-21
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GP1BA,Platelet glycoprotein Ib alpha chain,42582,0.0305888182727609,0.00321660134317095,0.0242842796401458,0.036893356905376,2.23420480849833e-21
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CST3,Cystatin-C,42658,0.0278513513529429,0.00294675707319653,0.0220757074894777,0.0336269952164081,3.88281908342796e-21
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CIRBP,Cold-inducible RNA-binding protein,40448,0.0872212652709744,0.0092279984932045,0.0691343882242935,0.105308142317655,3.98825793563892e-21
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MIA,Melanoma-derived growth regulatory protein,42678,0.0347546525775314,0.00368159717576062,0.0275387221130406,0.0419705830420222,4.3263132196909e-21
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD59,CD59 glycoprotein,42129,0.0230219395442347,0.00244052794261945,0.0182385047767006,0.0278053743117688,4.64891176942955e-21
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EPCAM,Epithelial cell adhesion molecule,42615,-0.0907128841301828,0.00964422071640644,-0.109615556734339,-0.0718102115260261,5.98232191700932e-21
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,40222,0.0482922999450764,0.00513282950788505,0.0382319541096217,0.0583526457805311,6.02840011408618e-21
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RARRES2,Retinoic acid receptor responder protein 2,42704,0.0428590524192184,0.00457780406335848,0.0338865564550358,0.051831548383401,9.01221209794272e-21
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MYDGF,Myeloid-derived growth factor,40510,0.0892050158726821,0.00953742004972326,0.0705116725752245,0.10789835917014,1.01036646272828e-20
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FLT4,Vascular endothelial growth factor receptor 3,42678,0.0300785335628243,0.00321870501255007,0.0237698717382261,0.0363871953874224,1.06203656430766e-20
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TXNDC5,Thioredoxin domain-containing protein 5,42710,0.0606683334862192,0.00650321495079545,0.0479220321826601,0.0734146347897783,1.2329447147551e-20
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KLK14,Kallikrein-14,42720,0.0428265451761443,0.00460524773677311,0.033800259612069,0.0518528307402196,1.62430431629988e-20
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CRYBB1,Beta-crystallin B1,40510,0.0576646671868617,0.00620349570589857,0.0455058156033005,0.0698235187704229,1.7328149559755e-20
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TGFA,Protransforming growth factor alpha,42593,0.0428993583502881,0.00462048803554744,0.0338432018006152,0.0519555148999611,1.86949995921584e-20
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LY9,T-lymphocyte surface antigen Ly-9,42442,0.0277525634073647,0.00298915483889498,0.0218938199231305,0.0336113068915988,1.87558463402122e-20
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NCAN,Neurocan core protein,42710,0.0342761057796035,0.0037081717711317,0.0270080891081853,0.0415441224510216,2.74015909796532e-20
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CANT1,Soluble calcium-activated nucleotidase 1,42579,0.0184420577184203,0.00199632241437582,0.0145292657862437,0.0223548496505969,2.88446604377392e-20
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AIFM1,"Apoptosis-inducing factor 1, mitochondrial",42569,0.094381431344402,0.0102225314730261,0.0743452696572708,0.114417593031533,3.031039448736e-20
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,42356,0.0498357284667703,0.00540029685992709,0.0392511466213132,0.0604203103122274,3.16305762646301e-20
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PDCD1,Programmed cell death protein 1,42688,0.040534589477245,0.00439903139012785,0.0319124879525945,0.0491566910018956,3.58551820820913e-20
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL18,Interleukin-18,42565,0.0416400226534858,0.00452292884058652,0.0327750821259362,0.0505049631810354,3.86619481983299e-20
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CDHR5,Cadherin-related family member 5,42635,0.0347424905163757,0.00377499714264691,0.0273434961167878,0.0421414849159636,3.97635682035075e-20
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PPP3R1,Calcineurin subunit B type 1,42494,0.0358611683056842,0.00389933495971148,0.0282184717846497,0.0435038648267186,4.23174234476275e-20
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL2RA,Interleukin-2 receptor subunit alpha,42516,0.0373698633364993,0.00406945801664279,0.0293937256238794,0.0453460010491192,4.80300430562672e-20
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,42586,0.0300010431915465,0.00326913655104016,0.0235935355515077,0.0364085508315852,5.07067121507008e-20
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD83,CD83 antigen,42593,0.0315667048020847,0.00344287217694948,0.0248186753352637,0.0383147342689057,5.4757366347213e-20
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PTPRS,Receptor-type tyrosine-protein phosphatase S,42793,0.0221829634091111,0.00242240562766895,0.01743504837888,0.0269308784393422,6.0646570096133e-20
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MPI,Mannose-6-phosphate isomerase,42586,0.075187933931532,0.00821705095200717,0.0590825140655979,0.091293353797466,6.49193420044357e-20
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,B4GAT1,"Beta-1,4-glucuronyltransferase 1",42610,0.0211917727606449,0.00231759454495917,0.016649287452525,0.0257342580687649,6.88183580817044e-20
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MTDH,Protein LYRIC,40198,0.0834123409568278,0.00913030906556287,0.0655169351883246,0.101307746725331,7.63091941648914e-20
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,40510,0.0540376442668119,0.00591626454920999,0.0424417657503603,0.0656335227832634,7.73929762402732e-20
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CRELD2,Protein disulfide isomerase CRELD2,42653,0.046050174983457,0.00504501994887911,0.0361619358836539,0.0559384140832601,7.96930781287381e-20
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DPT,Dermatopontin,42793,0.022505351142632,0.00246700801186801,0.0176700154393707,0.0273406868458933,8.35667237143855e-20
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SDC1,Syndecan-1,42635,0.0361896928626886,0.0039707465274528,0.0284070296688811,0.043972356056496,9.04365460600206e-20
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,METAP1D,"Methionine aminopeptidase 1D, mitochondrial",42593,0.072116845300169,0.0079335414236395,0.0565671041098356,0.0876665864905024,1.12655824620056e-19
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CCL27,C-C motif chemokine 27,42635,0.0520759767013129,0.00574188204777849,0.0408218878876671,0.0633300655149587,1.35946336427589e-19
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SMOC1,SPARC-related modular calcium-binding protein 1,42720,0.0289550286624714,0.00319331749295618,0.0226961263762773,0.0352139309486655,1.38482116103556e-19
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL17RB,Interleukin-17 receptor B,42415,0.0470724540745521,0.00519621122074461,0.0368878800818926,0.0572570280672115,1.49920354997971e-19
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ORM1,Alpha-1-acid glycoprotein 1,40482,0.0176891510940522,0.00195821701804279,0.0138510457386883,0.021527256449416,1.93604776059358e-19
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,40448,0.102775734110027,0.0113938143587212,0.0804438579669332,0.12510761025312,2.17899681921583e-19
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NOTCH1,Neurogenic locus notch homolog protein 1,42793,0.0140271235014194,0.00155657914666149,0.0109762283739629,0.0170780186288759,2.30010093539047e-19
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CNPY4,Protein canopy homolog 4,42586,0.0648538627259576,0.00719781289417335,0.0507461494533778,0.0789615759985374,2.33156566728673e-19
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NOS3,"Nitric oxide synthase, endothelial",42310,0.0479443958069818,0.00533910985296307,0.0374797404951742,0.0584090511187894,3.07698457369213e-19
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL16,Pro-interleukin-16,42753,0.0361110707293541,0.00402178841003233,0.0282283654456907,0.0439937760130175,3.09185449424611e-19
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CCL3,C-C motif chemokine 3,42593,0.0501297393070379,0.00559690681890422,0.0391598019419856,0.0610996766720902,3.78209154470468e-19
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TNFSF12,Tumor necrosis factor ligand superfamily member 12,42753,0.0245680587488306,0.00274751625260937,0.0191829268937162,0.0299531906039449,4.31393183509918e-19
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FABP4,"Fatty acid-binding protein, adipocyte",42793,0.044484514045083,0.00499386436027124,0.0346965398989514,0.0542724881912147,5.8568287379295e-19
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DAB2,Disabled homolog 2,42720,0.0945112110689547,0.0106108906897211,0.0737138653171014,0.115308556820808,5.90448533849425e-19
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KLK10,Kallikrein-10,42635,0.0353446297033025,0.00397037089408344,0.027562702750899,0.0431265566557061,6.17431427665043e-19
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CFI,Complement factor I,40538,0.0169711360828287,0.00190681582917777,0.0132337770576402,0.0207084951080171,6.41658482439051e-19
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PTN,Pleiotrophin,42356,0.0426995697706363,0.004829639631673,0.0332334760925572,0.0521656634487154,1.06660902003227e-18
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SOST,Sclerostin,42612,0.0335070317395609,0.00379817491302173,0.0260626089100383,0.0409514545690835,1.26311079341542e-18
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CFB,Complement factor B,40343,0.0277985739603551,0.00315806023544877,0.0216087758988755,0.0339883720218347,1.53624286077442e-18
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,42688,0.0321800612288267,0.00365731503028699,0.0250117237694642,0.0393483986881892,1.54873142963674e-18
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TINAGL1,Tubulointerstitial nephritis antigen-like,42606,0.0191328457245329,0.00217578966512043,0.0148682979808968,0.0233973934681689,1.62432481536702e-18
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FCER2,Low affinity immunoglobulin epsilon Fc receptor,42610,0.0463608289492855,0.00527421674053213,0.0360233641378425,0.0566982937607284,1.67434337464573e-18
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NAGK,N-acetyl-D-glucosamine kinase,40208,0.047587126563566,0.0054191821488299,0.0369655295518594,0.0582087235752726,1.85574767933322e-18
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HCLS1,Hematopoietic lineage cell-specific protein,42753,0.0469408882410655,0.00535307160308956,0.03644886789901,0.057432908583121,2.01572056097528e-18
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GBP1,Guanylate-binding protein 1,40465,0.0559927850654233,0.0063851802609557,0.0434778317539502,0.0685077383768965,2.05771343799403e-18
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CLEC11A,C-type lectin domain family 11 member A,42591,0.0418693272334811,0.00478795656876869,0.0324849323586945,0.0512537221082678,2.49955491914833e-18
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SELL,L-selectin,40538,0.0203099241328615,0.00233142828334159,0.015740324697512,0.024879523568211,3.41803116529662e-18
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RILPL2,RILP-like protein 2,40510,0.0819983237382557,0.00941404797262971,0.0635467897119014,0.10044985776461,3.45396208022448e-18
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SYAP1,Synapse-associated protein 1,40282,0.0486293494169868,0.00558482108138276,0.0376831000974766,0.0595755987364971,3.54900138380017e-18
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IST1,IST1 homolog,40374,0.0834707129938024,0.00960356262607975,0.0646477302466861,0.102293695740919,4.06997889235676e-18
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TPD52L2,Tumor protein D54,40282,0.0905204275718316,0.0104437518488853,0.0700506739480163,0.110990181195647,5.03384141412783e-18
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SIGLEC10,Sialic acid-binding Ig-like lectin 10,42593,0.0298176377067727,0.00344208448079848,0.0230711521244077,0.0365641232891377,5.13124182675722e-18
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD22,B-cell receptor CD22,42753,0.0368050202043333,0.00425147496435018,0.0284721292742069,0.0451379111344597,5.38456496230952e-18
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FOLR2,Folate receptor beta,42710,0.0250133715763737,0.00289041331058171,0.0193481614876335,0.0306785816651138,5.53357746762624e-18
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ITGA5,Integrin alpha-5,42610,0.0210925770393802,0.00243998625628773,0.0163102039770563,0.0258749501017042,6.00856540059212e-18
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD300LF,CMRF35-like molecule 1,42720,0.0512915671498283,0.00595143390191671,0.0396267567020715,0.062956377597585,7.5391544738163e-18
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD300E,CMRF35-like molecule 2,42676,0.0363457671261302,0.00422450398714524,0.0280657393113256,0.0446257949409349,8.5747821730901e-18
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD163,Scavenger receptor cysteine-rich type 1 protein M130,42688,0.0361928028962893,0.00422544518627842,0.0279109303311836,0.044474675461395,1.19230780097856e-17
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,42736,0.0290019210113583,0.00338917542553391,0.0223591371773119,0.0356447048454048,1.27949354714766e-17
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",40222,0.0213967709400887,0.00250362828902639,0.016489659493597,0.0263038823865804,1.43824752667051e-17
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CR1,Complement receptor type 1,40508,0.0301707276022773,0.00353386010509352,0.023244361796294,0.0370970934082606,1.54507683414425e-17
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RTBDN,Retbindin,42586,0.0248593317451323,0.00291584642557913,0.0191442727509972,0.0305743907392674,1.68173542393185e-17
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HYOU1,Hypoxia up-regulated protein 1,42793,0.0191967082100367,0.00225278364892671,0.0147812522581404,0.0236121641619331,1.7418969592149e-17
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FDX2,"Ferredoxin-2, mitochondrial",40115,0.0470754186962959,0.00552699988865389,0.0362424989145343,0.0579083384780575,1.84647496113307e-17
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,VASP,Vasodilator-stimulated phosphoprotein,40531,0.0598681584527929,0.00703085738034456,0.0460876779873176,0.0736486389182683,1.87474305371245e-17
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CCN5,CCN family member 5,42610,0.032071610948903,0.00377063544303504,0.0246811654805544,0.0394620564172517,1.99586746594555e-17
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FABP5,Fatty acid-binding protein 5,42677,0.055957136052693,0.0065814439422611,0.0430575059258612,0.0688567661795247,2.05329424606884e-17
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PENK,Proenkephalin-A,40282,0.0272242036362002,0.00320262198865974,0.0209470645384271,0.0335013427339733,2.12758896896797e-17
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL13RA1,Interleukin-13 receptor subunit alpha-1,42447,0.0181364649406251,0.0021348357671244,0.0139521868370613,0.0223207430441889,2.179699465392e-17
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PPIB,Peptidyl-prolyl cis-trans isomerase B,42655,0.0768682737692737,0.00906044007486977,0.059109811222529,0.0946267363160185,2.40224675080987e-17
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SIGLEC1,Sialoadhesin,42675,0.0357925811451573,0.00421985033026891,0.0275216744978303,0.0440634877924844,2.44311767450177e-17
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CHRDL1,Chordin-like protein 1,42653,0.0267552125923318,0.00315665708553463,0.020568164704684,0.0329422604799797,2.57538623034329e-17
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MET,Hepatocyte growth factor receptor,42653,0.0164179688173035,0.00194012597418258,0.0126153219079057,0.0202206157267014,2.88966395799468e-17
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SPINK2,Serine protease inhibitor Kazal-type 2,40282,0.0311652980852483,0.00368800507043986,0.0239368081471862,0.0383937880233104,3.264226320348e-17
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ADA2,Adenosine deaminase 2,42571,0.0366227296914858,0.00433983063898757,0.0281166616390701,0.0451287977439014,3.53459635873665e-17
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ECHS1,"Enoyl-CoA hydratase, mitochondrial",40222,0.0793466260881516,0.00944267636206446,0.0608389804185052,0.0978542717577979,4.88686482189355e-17
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TIMP3,Metalloproteinase inhibitor 3,42675,0.106457614754442,0.0126769031007828,0.0816108846769075,0.131304344831976,5.00170805722017e-17
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MCFD2,Multiple coagulation factor deficiency protein 2,42564,0.0354356195853042,0.00422030757166816,0.0271638167448346,0.0437074224257738,5.06136023699192e-17
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MDK,Midkine,42637,0.0418228828073262,0.00498243270217044,0.0320573147110721,0.0515884509035802,5.16196603556839e-17
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RLN2,Prorelaxin H2,40256,0.0408837128498866,0.00487700787603268,0.0313247774128625,0.0504426482869106,5.78667370435707e-17
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL6R,Interleukin-6 receptor subunit alpha,42581,0.0278667325781139,0.00332832713247038,0.021343211398472,0.0343902537577558,6.19213492068241e-17
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HPCAL1,Hippocalcin-like protein 1,42753,0.0589606532411438,0.00705425070158013,0.0451343218660467,0.0727869846162409,6.98505736968846e-17
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,40170,0.0320420140621381,0.00383388465624331,0.0245276001359012,0.039556427988375,7.17318972583925e-17
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DIPK2B,Divergent protein kinase domain 2B,40282,0.0227498605571923,0.00273047565315495,0.0173981282770086,0.028101592837376,8.89736702405214e-17
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TFPI2,Tissue factor pathway inhibitor 2,42634,0.0306732208588523,0.00368260661315241,0.0234553118970736,0.037891129820631,8.9202848473721e-17
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CTSF,Cathepsin F,42678,-0.0322251517495372,0.00387120406914721,-0.0398127117250657,-0.0246375917740087,9.29172249230344e-17
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,42648,0.0174120434699751,0.00209605461289553,0.0133037764286998,0.0215203105112503,1.07422514554279e-16
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,42610,0.0310641279983567,0.00374253288337491,0.0237287635469419,0.0383994924497716,1.1371182358423e-16
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,VAMP8,Vesicle-associated membrane protein 8,40198,0.0709984225872574,0.00856869125504099,0.054203787727377,0.0877930574471377,1.30929056125015e-16
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",40222,0.0559095100306305,0.00675187755269013,0.0426758300273579,0.0691431900339032,1.36715255310732e-16
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,40282,0.0241942820854801,0.00292811034206076,0.018455185815041,0.0299333783559192,1.5852693133308e-16
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD5,T-cell surface glycoprotein CD5,42705,0.0290712675779573,0.00351944459389908,0.0221731561739151,0.0359693789819995,1.58881008660554e-16
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TPK1,Thiamin pyrophosphokinase 1,40510,0.0220234470838077,0.00266820290378118,0.0167937693923966,0.0272531247752189,1.70104186505386e-16
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD5L,CD5 antigen-like,40478,0.0384364134019172,0.00466571507174656,0.029291611861294,0.0475812149425405,1.94336714349629e-16
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MINK1,Misshapen-like kinase 1,40482,0.0741121914378339,0.00900419841969259,0.0564639625352365,0.0917604203404314,2.06310617343919e-16
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,STXBP1,Syntaxin-binding protein 1,40481,0.0614970832424347,0.00747242225631268,0.0468511356200619,0.0761430308648076,2.07989836274418e-16
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,YTHDF3,YTH domain-containing family protein 3,42369,0.067902739500257,0.00825861304924133,0.051715857923744,0.08408962107677,2.18664932760688e-16
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PLA2G2A,"Phospholipase A2, membrane associated",42601,0.0457916528847954,0.00557037541604515,0.0348737170693469,0.0567095887002439,2.21032362071848e-16
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BID,BH3-interacting domain death agonist,42593,0.0536540981663997,0.00653230252801448,0.0408507852114913,0.0664574111213081,2.34082953289529e-16
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ABHD14B,Protein ABHD14B,42459,0.0454967696627272,0.00554710519032105,0.0346244434896979,0.0563690958357564,2.58269918634505e-16
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,40448,0.0708774264739606,0.00864277569659028,0.0539375861086437,0.0878172668392775,2.64771856968544e-16
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MAX,Protein max,42310,0.0834840050863625,0.0102061479672353,0.0634799550705814,0.103488055102144,3.10396678628152e-16
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DNAJA2,DnaJ homolog subfamily A member 2,42720,0.0644481838457211,0.00789052698245383,0.0489827509601116,0.0799136167313306,3.41755840440461e-16
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FCN2,Ficolin-2,42596,0.0327274934444952,0.00400699408437443,0.0248737850391213,0.040581201849869,3.42586365735756e-16
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,40481,0.0663519935973715,0.00813492846754589,0.0504075338009815,0.0822964533937614,3.81572435796123e-16
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BPIFB2,BPI fold-containing family B member 2,40472,0.0546999757047605,0.00670780282268558,0.0415526821722968,0.0678472692372243,3.87148269198065e-16
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CXCL3,C-X-C motif chemokine 3,42619,0.0739486685463894,0.00907145457298171,0.0561686175833453,0.0917287195094336,3.90132592400904e-16
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ATP5IF1,"ATPase inhibitor, mitochondrial",42675,0.0869404046154549,0.0106666787274368,0.0660337143096788,0.107847094921231,3.93687506461891e-16
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,40282,0.049672822922351,0.00609435716472491,0.0377278828794902,0.0616177629652118,4.00955496717381e-16
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NPL,N-acetylneuraminate lyase,40510,0.036138423670709,0.0044350721803074,0.0274456821973065,0.0448311651441115,4.07763229045622e-16
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HGF,Hepatocyte growth factor,42753,0.0276264582765424,0.0033934339736462,0.0209753276881959,0.034277588864889,4.25487390082595e-16
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DPEP2,Dipeptidase 2,42586,0.02348103532258,0.00288563512395195,0.0178251904796342,0.0291368801655259,4.39927039787385e-16
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,42637,0.0252087530466492,0.00310613127758682,0.019120735742579,0.0312967703507193,5.24260720673699e-16
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GFAP,Glial fibrillary acidic protein,42325,0.0387683004400927,0.00477898432733397,0.0294014911585182,0.0481351097216673,5.40824558227744e-16
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,42494,0.0358816375282263,0.0044245805124801,0.0272094597237653,0.0445538153326873,5.52023570302546e-16
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SLAMF8,SLAM family member 8,42345,0.043732194045806,0.00540647075726871,0.0331355113615593,0.0543288767300527,6.54747364348688e-16
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PDIA4,Protein disulfide-isomerase A4,40526,0.0470464073442362,0.00582144340868098,0.0356363782632215,0.0584564364252509,7.04222885364525e-16
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,VASN,Vasorin,42448,0.0217212626224623,0.00268888914294522,0.0164510399022896,0.0269914853426349,7.14088660696736e-16
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GLRX5,"Glutaredoxin-related protein 5, mitochondrial",40282,0.0694367990596707,0.0086103816636398,0.0525604509989367,0.0863131471204047,8.12240970733774e-16
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD80,T-lymphocyte activation antigen CD80,40510,0.0273646732749064,0.00340283210554576,0.0206951223480367,0.034034224201776,9.73904635144585e-16
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD274,Programmed cell death 1 ligand 1,42494,0.0274398567778357,0.00341576151366848,0.0207449642110455,0.0341347493446259,1.02827731972374e-15
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DTX3,Probable E3 ubiquitin-protein ligase DTX3,42586,0.0196634203086453,0.00244826900597471,0.0148648130569348,0.0244620275603557,1.04236998680912e-15
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,COL15A1,Collagen alpha-1(XV) chain,40526,0.0219435716248823,0.00273226406724669,0.0165883340530788,0.0272988091966858,1.05997215909201e-15
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",42586,0.0276625843831088,0.00344604536546691,0.0209083354667937,0.0344168332994239,1.07865429595661e-15
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD300A,CMRF35-like molecule 8,40282,0.0244308479231186,0.0030495725898899,0.0184536856469343,0.0304080101993028,1.24925525269586e-15
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LATS1,Serine/threonine-protein kinase LATS1,40198,0.065543049252931,0.00821942149336942,0.049432983125927,0.0816531153799351,1.68592901877416e-15
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MZB1,Marginal zone B- and B1-cell-specific protein,42659,0.0411714208424696,0.00516722917309836,0.0310436516631968,0.0512991900217424,1.74448569551429e-15
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,42369,0.0336347396928642,0.0042282436001048,0.0253473822366588,0.0419220971490696,1.94033178775508e-15
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,42586,0.0293645817801979,0.00369725825727335,0.0221179555959421,0.0366112079644536,2.14290339964355e-15
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RSPO3,R-spondin-3,42720,0.0230731443200374,0.00290598229485902,0.0173774190221137,0.0287688696179611,2.18259923514703e-15
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SCRN1,Secernin-1,42593,0.042723591969633,0.00538218457716744,0.0321745101983848,0.0532726737408812,2.21793961574898e-15
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MESD,LRP chaperone MESD,42610,0.0928796200185561,0.0117075124899696,0.0699328955382156,0.115826344498896,2.30162210518955e-15
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SCG2,Secretogranin-2,42635,-0.0264783383592341,0.00333928882137701,-0.033023344449133,-0.0199333322693352,2.37629435806166e-15
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GNLY,Granulysin,42610,0.0414655774578043,0.00522998317528487,0.031214810434246,0.0517163444813627,2.39383874366158e-15
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HAVCR2,Hepatitis A virus cellular receptor 2,42610,0.0284123950046933,0.00359011400619491,0.0213757715525512,0.0354490184568353,2.68570588972014e-15
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RNASE4,Ribonuclease 4,40168,0.0226703033604726,0.00286418228867906,0.0170565060746616,0.0282841006462835,2.7082410716371e-15
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DNM1,Dynamin-1,40448,0.0876609847806044,0.0111024122973128,0.0659002566778714,0.109421712883337,3.1556185556023e-15
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CDH17,Cadherin-17,42635,-0.0536048536376109,0.00679576056075282,-0.0669245443366864,-0.0402851629385354,3.30719627698602e-15
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,APOF,Apolipoprotein F,40531,0.0183715802129636,0.00232922018868051,0.0138063086431498,0.0229368517827774,3.36743467820945e-15
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,42793,0.0211003868317002,0.00267790303104077,0.0158516968908603,0.0263490767725401,3.53712163956812e-15
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CPB2,Carboxypeptidase B2,40515,0.017034933685993,0.00216661592325843,0.0127883664764065,0.0212815008955796,4.10807647200651e-15
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL18BP,Interleukin-18-binding protein,42688,0.024778061907283,0.00315981473180478,0.0185848250329456,0.0309712987816203,4.78026909480762e-15
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CA14,Carbonic anhydrase 14,42720,0.027552341857301,0.00351585812385675,0.0206612599345418,0.0344434237800602,4.97377927221533e-15
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CCL17,C-C motif chemokine 17,42603,0.0698957419508885,0.0089298902573038,0.0523931570465731,0.0873983268552039,5.36253494197763e-15
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TIA1,Nucleolysin TIA-1 isoform p40,42189,0.0921832936034466,0.0117784900830303,0.0690974530407073,0.115269134166186,5.4071046572295e-15
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SIRT2,NAD-dependent protein deacetylase sirtuin-2,42586,0.0668247853976441,0.00854962142459824,0.0500675274054315,0.0835820433898566,5.85314419033979e-15
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SHISA5,Protein shisa-5,40526,0.0212305981194028,0.00271590657781775,0.01590742122688,0.0265537750119256,5.88206705478862e-15
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SEPTIN9,Septin-9,42586,0.0216937813642454,0.0027785092380032,0.0162479032577591,0.0271396594707317,6.25499061186108e-15
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SDHB,Succinate dehydrogenase,40448,0.0505188854241008,0.00647793267157004,0.0378221373878235,0.0632156334603781,6.81138087522297e-15
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",42678,-0.0267009107564697,0.0034290873020495,-0.0334219218684868,-0.0199798996444527,7.38444449549623e-15
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PHACTR2,Phosphatase and actin regulator 2,40481,0.0856227637854661,0.0110260488689214,0.0640117080023802,0.107233819568552,8.83543700817175e-15
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RBP5,Retinol-binding protein 5,42586,0.0421884775082615,0.00544045845289476,0.0315251789405878,0.0528517760759353,9.5017153722457e-15
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CFHR4,Complement factor H-related protein 4,40508,0.0565473534364675,0.00729484382634508,0.0422494595368312,0.0708452473361039,9.84408361112755e-15
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ERP29,Endoplasmic reticulum resident protein 29,40282,0.0893918813427445,0.0115406809627383,0.0667721466557775,0.112011616029711,1.03253215139171e-14
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HLA_E,,42593,0.0232702659099922,0.00300708969036619,0.0173763701168745,0.0291641617031099,1.07802118759392e-14
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GGH,Gamma-glutamyl hydrolase,42436,0.0258176593049632,0.00334151714575136,0.0192682856992906,0.0323670329106359,1.1863692904955e-14
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MOG,Myelin-oligodendrocyte glycoprotein,42720,0.0255602929827366,0.00331918788343094,0.0190546847312119,0.0320659012342612,1.44621310093815e-14
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FABP6,Gastrotropin,42333,0.044231666970251,0.00574464519036519,0.0329721623971353,0.0554911715433668,1.46190664143205e-14
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LRRC25,Leucine-rich repeat-containing protein 25,42586,0.0295275829029313,0.00383580899187032,0.0220093972788655,0.0370457685269971,1.48014301111334e-14
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PROC,Vitamin K-dependent protein C,42662,0.0188229121855169,0.00245064651264012,0.0140196450207423,0.0236261793502916,1.68990834347007e-14
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CFD,Complement factor D,40538,0.0157294782918598,0.00205032986809163,0.0117108317504002,0.0197481248333194,1.83644604402839e-14
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,B2M,Beta-2-microglobulin,40538,0.0235321666358078,0.00306886805496995,0.0175171852480667,0.0295471480235489,1.88923008475586e-14
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,42720,0.0257283149667551,0.00335937395950357,0.0191439420061281,0.0323126879273821,2.00606468134666e-14
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PODXL2,Podocalyxin-like protein 2,42678,0.0211972112530811,0.00276876461522555,0.015770432607239,0.0266239898989231,2.05090801189383e-14
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL12A_IL12B,Interleukin-12,42586,0.0612606115555765,0.00800285743908658,0.0455750109749668,0.0769462121361862,2.06770898281827e-14
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,C8B,Complement component C8 beta chain,40538,0.0227294474270136,0.00296911453455517,0.0169099829392855,0.0285489119147417,2.08511892307602e-14
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,COLEC12,Collectin-12,42617,0.020922166380565,0.00273406345658582,0.0155634020056568,0.0262809307554733,2.10676478476761e-14
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,STC1,Stanniocalcin-1,42710,0.0337136242201971,0.00440615266647766,0.0250775649939009,0.0423496834464934,2.1208554698649e-14
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SEZ6L,Seizure 6-like protein,42678,0.0209812230468822,0.00274687930537622,0.0155973396083448,0.0263651064854195,2.35083200187532e-14
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CMC1,COX assembly mitochondrial protein homolog,40510,0.0671895912234732,0.00879998682974127,0.0499416170371803,0.0844375654097661,2.43622841333823e-14
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GM2A,Ganglioside GM2 activator,40269,0.0305010271718237,0.00399514961252733,0.0226705339312702,0.0383315204123773,2.45312519150019e-14
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GCC1,GRIP and coiled-coil domain-containing protein 1,40482,0.079522189351493,0.0104226157407273,0.0590938624996675,0.0999505162033184,2.5407982095183e-14
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,40510,0.0669739242136603,0.00877975066112609,0.0497656129178532,0.0841822355094674,2.57080923894543e-14
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,40481,0.0737056272268598,0.0096629507064596,0.054766243842199,0.0926450106115206,2.58272942705182e-14
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CXCL17,C-X-C motif chemokine 17,42753,0.030142844538429,0.00395824847013551,0.0223846775369634,0.0379010115398946,2.806749611953e-14
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TAFA5,Chemokine-like protein TAFA-5,42586,0.0287175468788038,0.00377131767895899,0.0213257642280441,0.0361093295295634,2.81923684388411e-14
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FRZB,Secreted frizzled-related protein 3,42453,0.0185196769130884,0.00243268841008783,0.0137516076293163,0.0232877461968606,2.86226161432548e-14
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,QPCT,Glutaminyl-peptide cyclotransferase,42680,0.0202470591049809,0.00266321117827731,0.0150271651955574,0.0254669530144045,3.09625591727884e-14
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL1RL2,Interleukin-1 receptor-like 2,42369,0.0286203692151414,0.00376699079518991,0.0212370672565692,0.0360036711737136,3.21817106318241e-14
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ZFYVE19,Abscission/NoCut checkpoint regulator,40448,0.0666140806819839,0.00878832434831109,0.0493889649592941,0.0838391964046736,3.73157934674392e-14
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AK2,"Adenylate kinase 2, mitochondrial",40482,0.0776943088034841,0.0102583049732449,0.057588031055924,0.0978005865510441,3.90760718363089e-14
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ECI2,Enoyl-CoA delta isomerase 2,40115,0.0456114155919641,0.00602259720483992,0.0338071250704779,0.0574157061134504,3.92996495397175e-14
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RGCC,Regulator of cell cycle RGCC,40481,0.0554539400546865,0.00733590248350739,0.041075571187012,0.069832308922361,4.36784391948474e-14
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL1RN,Interleukin-1 receptor antagonist protein,42584,0.0400466471241281,0.00530566048139829,0.0296475525805875,0.0504457416676688,4.7084077307742e-14
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,VWC2,Brorin,42455,0.0303159186157193,0.00401699415109153,0.0224426100795799,0.0381892271518587,4.74717672562631e-14
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RSPO1,R-spondin-1,42494,0.0250063702183313,0.00331376897131325,0.0185113830345573,0.0315013574021053,4.77227815445682e-14
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",42586,0.0250421100316031,0.00332131004914648,0.018532342335276,0.0315518777279302,5.00819231520238e-14
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL1B,Interleukin-1 beta,42292,0.0419293438606215,0.00556111655042916,0.0310295554217803,0.0528291322994627,5.01878786579551e-14
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LGMN,Legumain,42675,0.0262464275451586,0.00348200715316922,0.0194216935249469,0.0330711615653702,5.08704030973843e-14
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,C5,Complement C5,40538,0.0110757003396605,0.00147126848003832,0.00819201411878541,0.0139593865605356,5.54286083142821e-14
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PRKG1,cGMP-dependent protein kinase 1,40282,0.0912874412328438,0.012133701264458,0.0675053867545062,0.115069495711181,5.7471460017416e-14
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DDC,Aromatic-L-amino-acid decarboxylase,42612,-0.0349030419637484,0.00464308203533739,-0.0440034827530097,-0.0258026011744871,5.949986933048e-14
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SERPINH1,Serpin H1,40301,0.0944165598069072,0.0125598406739715,0.0697992720859231,0.119033847527891,6.02059952633649e-14
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FGFBP2,Fibroblast growth factor-binding protein 2,40526,-0.0376797671220149,0.00501304085725825,-0.0475053272022411,-0.0278542070417887,6.05712196361531e-14
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MANF,Mesencephalic astrocyte-derived neurotrophic factor,42675,0.0860088096492908,0.0114813630776177,0.06350533801716,0.108512281281421,7.25067487434085e-14
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IDO1,"Indoleamine 2,3-dioxygenase 1",40222,0.0470369808565322,0.00628220735403345,0.0347238544426266,0.0593501072704378,7.56491680267775e-14
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PDCD5,Programmed cell death protein 5,42710,0.0419578102898675,0.00560534525516482,0.0309713335897445,0.0529442869899906,7.57826793657205e-14
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PPY,Pancreatic prohormone,42599,-0.0757017633436765,0.0101228030680217,-0.0955424573569991,-0.055861069330354,7.99402117932082e-14
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GZMA,Granzyme A,42753,0.0258863662609518,0.00346684413167605,0.0190913517628668,0.0326813807590369,8.7153442815971e-14
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD300C,CMRF35-like molecule 6,42710,0.0262052315602387,0.00351113193998841,0.0193234129578614,0.0330870501626159,8.94187170222064e-14
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CCL20,C-C motif chemokine 20,42753,0.0667142855825012,0.00895095383440853,0.0491704160670605,0.0842581550979419,9.65330939648671e-14
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,STX8,Syntaxin-8,42593,0.0346941672843524,0.00465515701389586,0.0255700595371165,0.0438182750315882,9.69441589356196e-14
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CTSL,Cathepsin L1,42635,0.0180298077493337,0.00242328055385904,0.01328017786377,0.0227794376348974,1.06591600231545e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,APOA4,Apolipoprotein A-IV,40538,-0.0262499481548391,0.00352818280223546,-0.0331651864472206,-0.0193347098624576,1.07893890317148e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NIT2,Omega-amidase NIT2,40461,0.0528737511704745,0.00711047886358803,0.038937212597842,0.066810289743107,1.11282901998351e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PDAP1,28 kDa heat- and acid-stable phosphoprotein,40510,0.0703672957840218,0.00946392761722531,0.0518179976542601,0.0889165939137834,1.11850623501567e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GRN,Progranulin,42551,0.0178339260309664,0.00239930347318963,0.0131312912235147,0.0225365608384181,1.12650759032168e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CCL8,C-C motif chemokine 8,42705,0.0438282380592926,0.00589842832205314,0.0322673185480684,0.0553891575705167,1.14684901316844e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GYS1,"Glycogen [starch] synthase, muscle",42356,0.0668449176549812,0.00900091001676542,0.0492031340221209,0.0844867012878414,1.18401265001611e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CXCL9,C-X-C motif chemokine 9,42675,0.0490119830017609,0.00662061426781874,0.0360355790368361,0.0619883869666856,1.41098240778154e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PGD,"6-phosphogluconate dehydrogenase, decarboxylating",40510,0.0379291455729395,0.0051230666219417,0.0278879349939338,0.0479703561519452,1.41945123809224e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SF3B4,Splicing factor 3B subunit 4,42586,0.0523781293256008,0.00709867848593065,0.0384647194931767,0.0662915391580249,1.69410734581828e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,40448,0.0993179009314294,0.0134609573168026,0.0729344245904964,0.125701377272362,1.71710510266862e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CDH2,Cadherin-2,42635,0.0255593248988852,0.00346541838457934,0.0187671048651097,0.0323515449326607,1.73265632162391e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DNAJB6,DnaJ homolog subfamily B member 6,40182,0.0601699300339686,0.00816147932261249,0.0441734305616481,0.0761664295062891,1.79594426578865e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GP5,Platelet glycoprotein V,40282,0.0260131675778152,0.00353260815854236,0.0190892555870721,0.0329370795685582,1.91523040953225e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ACRBP,Acrosin-binding protein,40450,0.0281386484935399,0.00382636344403213,0.0206389761432369,0.0356383208438429,2.0588999010114e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PPM1F,Protein phosphatase 1F,40510,0.0371555636763437,0.00507088365178089,0.0272166317188531,0.0470944956338342,2.50933392682184e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NPC2,NPC intracellular cholesterol transporter 2,40366,0.0244684821012215,0.00333992948324699,0.0179222203140574,0.0310147438883857,2.53371988640017e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NME3,Nucleoside diphosphate kinase 3,42637,0.0171511315427225,0.00234223314780048,0.0125603545730335,0.0217419085124114,2.57126365269798e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PDIA3,Protein disulfide-isomerase A3,40282,0.0176701294741767,0.00242046555998261,0.0129260169766108,0.0224142419717426,3.06777460129877e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CYTL1,Cytokine-like protein 1,40526,0.018216102123231,0.00249665402398648,0.0133226602362175,0.0231095440102445,3.15763633642205e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CETN3,Centrin-3,40448,0.053790738467383,0.007372499514417,0.0393406394191257,0.0682408375156403,3.1607484398505e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NID1,Nidogen-1,42651,0.0273157633117968,0.00374635929906959,0.0199728990856204,0.0346586275379732,3.24158199421579e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DTYMK,Thymidylate kinase,40510,0.0481592171312372,0.00661199404164646,0.0351997088096101,0.0611187254528643,3.46577000456167e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SCARB2,Lysosome membrane protein 2,42301,0.0248579306307649,0.00341467974030686,0.0181651583397635,0.0315507029217664,3.53563219255344e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AP3B1,AP-3 complex subunit beta-1,40448,0.0540573333214816,0.00744107577166077,0.0394728248090265,0.0686418418339367,3.98517880049142e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PROS1,Vitamin K-dependent protein S,40538,0.0185313423721654,0.00255132296679582,0.0135307493572456,0.0235319353870852,4.02133461250442e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,YAP1,Transcriptional coactivator YAP1,40482,0.0203696646518238,0.00280723980258863,0.01486747463875,0.0258718546648975,4.24477829925669e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD244,Natural killer cell receptor 2B4,42753,0.0193770444260105,0.00267333126061905,0.0141373151551972,0.0246167736968238,4.44940155565019e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CLEC4A,C-type lectin domain family 4 member A,42593,-0.0248425863561408,0.00343080447933257,-0.0315669631356326,-0.0181182095766489,4.69544262958083e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SDC4,Syndecan-4,42635,0.033218513193074,0.00460087765717312,0.0242007929850147,0.0422362334011334,5.47652163892296e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CLSTN3,Calsyntenin-3,40482,0.0216041174318236,0.00299248563007176,0.0157388455968829,0.0274693892667642,5.55493252627834e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SEC31A,Protein transport protein Sec31A,40222,0.0538825222145616,0.00746347177980023,0.0392541175261532,0.0685109269029701,5.56133120710463e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,42612,0.0799720435482826,0.0110823929968987,0.0582505532743611,0.101693533822204,5.63583574612154e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,UBXN1,UBX domain-containing protein 1,40282,0.0481584273043614,0.00667302260248659,0.0350793030034876,0.0612375516052351,5.6668144300862e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CDC26,Anaphase-promoting complex subunit CDC26,40427,0.0486189266157392,0.00674027471020213,0.0354079881837431,0.0618298650477354,5.8169864364865e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LYN,Tyrosine-protein kinase Lyn,42586,0.0589206995866691,0.00817145105472401,0.04290465551941,0.0749367436539281,5.8713372173434e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD28,T-cell-specific surface glycoprotein CD28,42345,0.0267280983565578,0.00370937714883989,0.0194577191448316,0.0339984775682839,6.09610033965157e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,42442,0.0339393962079008,0.00471386497773542,0.0247002208515394,0.0431785715642622,6.35017450591688e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AHSG,Alpha-2-HS-glycoprotein,40531,0.0190851730851352,0.00265357362259745,0.0138841687848443,0.0242861773854262,6.77451045023706e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,OGN,Mimecan,42610,0.0311506025949514,0.0043328883841414,0.0226581413620343,0.0396430638278686,6.8550808282448e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CSTB,Cystatin-B,42436,0.0298619187682787,0.0041545785282334,0.0217189448529412,0.0380048926836162,6.94154020933891e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FLI1,Friend leukemia integration 1 transcription factor,42345,0.0768379010665302,0.0106950669172384,0.055875569908743,0.0978002322243173,7.11256864847518e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL6,Interleukin-6,42586,0.0540080955207018,0.00752071589855952,0.0392674923595251,0.0687486986818784,7.2725366410292e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NCR1,Natural cytotoxicity triggering receptor 1,42565,0.0271421654806578,0.00377978443176469,0.019733787994399,0.0345505429669166,7.2926197855404e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DBI,Acyl-CoA-binding protein,42561,0.0534204087069725,0.00744025177832442,0.0388375152214566,0.0680033021924883,7.34376866498841e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,42753,0.0684227563738229,0.00954043601863795,0.0497235017772925,0.0871220109703533,7.7815403833421e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,OTUD7B,OTU domain-containing protein 7B,40481,0.0432087205987256,0.00602713753563459,0.0313955310288818,0.0550219101685694,8.02491462579266e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,STK11,Serine/threonine-protein kinase STK11,42356,0.0505427687418367,0.00705558995105416,0.0367138124377705,0.0643717250459028,8.28210253509652e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,STX7,Syntaxin-7,40198,0.0349774283458233,0.00488306730416138,0.025406616429667,0.0445482402619796,8.39709211641503e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BLNK,B-cell linker protein,40198,0.0285343959880895,0.00398525019898707,0.0207233055980748,0.0363454863781042,8.58219464891199e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IFNLR1,Interferon lambda receptor 1,42593,0.0253818994128263,0.00354824462901876,0.0184273399399495,0.032336458885703,8.90708542724985e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CRIM1,Cysteine-rich motor neuron 1 protein,42675,0.0144597735012437,0.00202600001015576,0.0104888134813385,0.018430733521149,1.001911516641e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PON2,Serum paraoxonase/arylesterase 2,42356,0.0242965742886364,0.00341736064489083,0.0175985474246504,0.0309946011526224,1.22252992160993e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,42680,0.0208713293097851,0.00293632266936514,0.0151161368778294,0.0266265217417407,1.23672132663763e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TNFSF14,Tumor necrosis factor ligand superfamily member 14,42494,0.039844112618785,0.00561267475348943,0.0288432701019457,0.0508449551356243,1.32083861663113e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RBM17,Splicing factor 45,40481,0.0527851463155358,0.00743477513664012,0.0382129870477212,0.0673573055833505,1.32475367030107e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ICAM3,Intercellular adhesion molecule 3,42793,0.0186579770008718,0.00262901402262886,0.0135051095165193,0.0238108444852244,1.33860225405735e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,USO1,General vesicular transport factor p115,42586,0.062136811839313,0.00875807627152053,0.0449709823471328,0.0793026413314933,1.36048344613148e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,42672,0.0224973961283373,0.00317424599682387,0.0162758739745625,0.0287189182821121,1.43370701214491e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LRG1,Leucine-rich alpha-2-glycoprotein,40538,0.0184944560328733,0.00261151843064593,0.0133758799088072,0.0236130321569393,1.50623822168033e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SEMA3F,Semaphorin-3F,42635,0.0187320858452408,0.00264787352994398,0.0135422537265506,0.023921917963931,1.57539695195421e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IFNGR2,Interferon gamma receptor 2,42494,-0.0359666664909486,0.00508418101221885,-0.0459316612748975,-0.0260016717069997,1.57799540600927e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NT5E,5'-nucleotidase,42678,0.0390951185022363,0.0055290595681949,0.0282581617485742,0.0499320752558983,1.61576609207852e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CTF1,Cardiotrophin-1,42356,0.0578670726577614,0.00819187667243612,0.0418109943797866,0.0739231509357362,1.69961289755937e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PTGES2,Prostaglandin E synthase 2,40101,0.03751415916216,0.005310618699747,0.0271053465106559,0.0479229718136641,1.71648626356538e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CCL26,C-C motif chemokine 26,42593,0.0642074011010823,0.00909967503397443,0.0463720380344925,0.0820427641676722,1.79771737507417e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TBCA,Tubulin-specific chaperone A,40282,0.0582813020496527,0.00826974319188189,0.0420726053935642,0.0744899987057412,1.92926844937532e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ASAH1,Acid ceramidase,40418,0.0313891111636012,0.00445542512842233,0.0226564779118934,0.040121744415309,1.96117077254052e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BST2,Bone marrow stromal antigen 2,42710,0.0351723615605835,0.00499672376228507,0.0253787829865048,0.0449659401346623,2.02841751386352e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,42678,0.0655366997533071,0.00931498486699692,0.0472793294139931,0.083794070092621,2.07950130004932e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CCN1,CCN family member 1,42568,0.0504616401021034,0.00717507518099911,0.0363984927473451,0.0645247874568617,2.12102491093774e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LCN2,Neutrophil gelatinase-associated lipocalin,42239,0.0277140732382576,0.0039412932383822,0.0199891384910285,0.0354390079854867,2.14163492361813e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TXNDC15,Thioredoxin domain-containing protein 15,42678,0.018897518541035,0.00269588801274225,0.0136135780360601,0.0241814590460098,2.50086160560259e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BLMH,Bleomycin hydrolase,42793,0.0213853748979631,0.00305340426711871,0.0154007025344104,0.0273700472615158,2.60851114023323e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD27,CD27 antigen,42678,0.0303425607793272,0.00433486880879743,0.0218462179140842,0.0388389036445701,2.68736666617161e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,42610,0.0220531515152916,0.00315803558257341,0.0158634017734477,0.0282429012571355,3.02143860667138e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CDCP1,CUB domain-containing protein 1,42494,0.0370219481903048,0.00530333886639605,0.0266274040121686,0.0474164923684411,3.07261102951665e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ESYT2,Extended synaptotagmin-2,40482,0.0557930413577573,0.00800160285974448,0.0401098997526581,0.0714761829628565,3.28197939564223e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",42475,0.0647626154773153,0.00929254345461011,0.0465492303062794,0.0829760006483511,3.33529136248368e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KIFBP,KIF-binding protein,42586,0.0552664143928505,0.00795188938824547,0.0396807111918894,0.0708521175938116,3.81923327716582e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LTBP3,Latent-transforming growth factor beta-binding protein 3,42345,0.035374689716554,0.00509319969872316,0.0253920183070566,0.0453573611260514,3.94923607274648e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,42652,0.0333936453952938,0.00481112514484087,0.0239638401114057,0.0428234506791819,4.07390194832537e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PLAT,Tissue-type plasminogen activator,42759,0.0341523413597763,0.00492104114176824,0.0245071007219105,0.0437975819976421,4.09719034289083e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CTSS,Cathepsin S,39872,0.0165805981036479,0.00238934661577764,0.0118974787367237,0.0212637174705721,4.16640096223005e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CDNF,Cerebral dopamine neurotrophic factor,42586,0.0227918415964509,0.00328778318208255,0.0163477865595691,0.0292358966333327,4.33071043980477e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LZTFL1,Leucine zipper transcription factor-like protein 1,40282,0.0480178357411803,0.00692607673841084,0.034442725333895,0.0615929461484656,4.35194881662476e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PLAU,Urokinase-type plasminogen activator,42610,0.0199553742569205,0.00288166130344813,0.0143073181021622,0.0256034304116788,4.5596908817359e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,WFDC2,WAP four-disulfide core domain protein 2,41947,0.0296511733230929,0.00428562658183481,0.0212513452226966,0.0380510014234891,4.77416791504332e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,42745,0.0272737626081782,0.00394748751109676,0.0195366870864285,0.0350108381299278,5.0935611740692e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ARHGEF1,Rho guanine nucleotide exchange factor 1,40482,0.0604086025724079,0.00874181355731245,0.0432746480000755,0.0775425571447403,5.09654483968603e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,F2R,Proteinase-activated receptor 1,42653,0.0376465520797425,0.00545302647347302,0.0269586201917354,0.0483344839677497,5.290257029124e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NOMO1,Nodal modulator 1,42610,0.0155697325467251,0.00225564532105725,0.0111486677174529,0.0199907973759973,5.33679379509089e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CSF1,Macrophage colony-stimulating factor 1,42675,0.0187646322545983,0.00272091912381788,0.0134316307719153,0.0240976337372813,5.57011997725967e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,42688,0.0299054320067859,0.00433833679458934,0.0214022918893908,0.038408572124181,5.69372989218856e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,40481,0.0325538021667366,0.00472232456063988,0.0232980460278824,0.0418095583055908,5.73004257372558e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CLEC6A,C-type lectin domain family 6 member A,42345,0.032048042972895,0.00464975268659653,0.0229345277071658,0.0411615582386242,5.7352466793976e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TIMP1,Metalloproteinase inhibitor 1,42500,0.0196846747853505,0.00285771045139204,0.0140835623006221,0.0252857872700789,5.90140491479003e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ADGRF5,Adhesion G protein-coupled receptor F5,40510,0.0190338210089394,0.00277232230921448,0.013600069282879,0.0244675727349998,6.96485653579644e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PSAP,Prosaposin,40439,0.0194124150383784,0.00282796276384121,0.0138696080212497,0.0249552220555072,7.02602147606346e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GGCT,Gamma-glutamylcyclotransferase,40499,0.0318423431512669,0.00464098207528379,0.0227460182837107,0.0409386680188232,7.18916073918127e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CASC3,Protein CASC3,40181,0.0280360242546542,0.00408912816416331,0.0200213330528941,0.0360507154564142,7.44914420154894e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,39939,0.0712632993213618,0.0103975788593803,0.0508840447569764,0.0916425538857473,7.5835609335835e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TALDO1,Transaldolase,40498,0.0293581660085005,0.00428680465931724,0.0209560288762387,0.0377603031407622,7.85011885043968e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",40482,0.064492951935655,0.00944783259709366,0.0459752000453514,0.0830107038259586,9.16530209819286e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MAP2,Microtubule-associated protein 2,40482,0.0307495084324434,0.00452417385941205,0.0218821276679957,0.039616889196891,1.12426430751025e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,YARS1,"Tyrosine--tRNA ligase, cytoplasmic",40448,0.0962394929656909,0.0141796585259043,0.0684473622549186,0.124031623676463,1.20116771026434e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SCAMP3,Secretory carrier-associated membrane protein 3,42586,0.0558504521617585,0.00823230340178127,0.0397151374942672,0.0719857668292498,1.21548098611361e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LPL,Lipoprotein lipase,42635,-0.03083424509625,0.00454671321919684,-0.0397458030058758,-0.0219226871866241,1.23771443502735e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,40222,-0.0245584690308053,0.00362469409283681,-0.0316628694527654,-0.0174540686088452,1.30454273458146e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,42369,0.0304831600209474,0.00450533378827834,0.0216527057959219,0.039313614245973,1.37971502810858e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CLUL1,Clusterin-like protein 1,42620,-0.0296404469413595,0.00438173324669641,-0.0382286441048845,-0.0210522497778346,1.39264698994221e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,42635,0.0324416580254284,0.00480138991503673,0.0230309337919564,0.0418523822589004,1.46961414636951e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PLAUR,Urokinase plasminogen activator surface receptor,42546,0.0185458774064165,0.00274594813773269,0.0131638190564605,0.0239279357563726,1.4987366237094e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LAMA4,Laminin subunit alpha-4,42675,0.0218270400367957,0.00323453619899818,0.0154873490867593,0.0281667309868322,1.55890896367352e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD63,CD63 antigen,42474,0.0335104850523574,0.0049719577327757,0.023765447896117,0.0432555222085978,1.65041172360999e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,40450,0.0539231778137355,0.00799946792254324,0.0382442206855508,0.0696021349419203,1.65165746171092e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL12B,Interleukin-12 subunit beta,42753,0.0373297132179661,0.00554120582185478,0.0264689498071307,0.0481904766288015,1.68503278538426e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HNMT,Histamine N-methyltransferase,42438,0.0315168273743281,0.00467858426525765,0.0223468022144231,0.0406868525342331,1.69062549525862e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD48,CD48 antigen,42653,0.0204259007253183,0.00303240207822137,0.0144823926520044,0.0263694087986321,1.69558332976092e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PLSCR3,Phospholipid scramblase 3,40456,0.0380063245988764,0.00564174913024045,0.0269484963036051,0.0490641528941477,1.70013642105948e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MSRA,Mitochondrial peptide methionine sulfoxide reductase,42678,0.0471427925409571,0.00700353458731835,0.0334158647498131,0.0608697203321011,1.74970566771291e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL15,Interleukin-15,42593,-0.0218011003438344,0.00324111792034211,-0.028153691467705,-0.0154485092199639,1.8095230071097e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",40526,0.0414598117467442,0.00616284471342264,0.0293806361084358,0.0535389873850525,1.81062862564981e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ARSB,Arylsulfatase B,42586,0.0360006359600327,0.00535965722094139,0.0254957078069876,0.0465055641130779,1.93038511409412e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ERBB3,Receptor tyrosine-protein kinase erbB-3,42585,0.0124248637721059,0.00185120735155397,0.0087964973630601,0.0160532301811517,2.00027903472728e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TWF2,Twinfilin-2,40526,0.0541497614634454,0.00806880626957153,0.0383349011750852,0.0699646217518056,2.02514423455647e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FADD,FAS-associated death domain protein,42635,0.0493426833589246,0.00736193967849271,0.0349132815890789,0.0637720851287703,2.13196124613739e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD46,Membrane cofactor protein,42579,0.0189493078573456,0.00282769148352062,0.0134070325496452,0.024491583165046,2.14789602327707e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ANXA3,Annexin A3,42680,0.0453116025558574,0.00676809023792592,0.0320461456895226,0.0585770594221922,2.24377354722238e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RGS10,Regulator of G-protein signaling 10,40481,0.038736388062073,0.00578703900770531,0.0273937916069706,0.0500789845171754,2.27995820272592e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CA13,Carbonic anhydrase 13,42482,0.06709203782874,0.0100280236316,0.047437111510804,0.086746964146676,2.31390550792896e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GPI,Glucose-6-phosphate isomerase,40531,0.0306453020220759,0.00458393501442535,0.0216607893938022,0.0396298146503496,2.41156757907678e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SAMD9L,Sterile alpha motif domain-containing protein 9-like,42593,0.046333245795457,0.00693336588322216,0.0327438486643416,0.0599226429265724,2.43940161890253e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CXCL12,Stromal cell-derived factor 1,42369,0.0262767252408382,0.00393399225473146,0.0185661004215645,0.0339873500601118,2.49546269653732e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SCARF1,Scavenger receptor class F member 1,42793,0.027246214393922,0.00407971909185753,0.0192499649738813,0.0352424638139628,2.50857759856059e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RAB2B,Ras-related protein Rab-2B,40450,0.0394255963339339,0.00590868579581424,0.027844572174138,0.0510066204937299,2.63318138548998e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PTGDS,Prostaglandin-H2 D-isomerase,42554,0.0213069256283118,0.00319648682861964,0.0150418114442173,0.0275720398124063,2.7368681963139e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ERP44,Endoplasmic reticulum resident protein 44,42568,0.0165863875163687,0.00248865651034607,0.0117086207560904,0.021464154276647,2.75420779119317e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MPHOSPH8,M-phase phosphoprotein 8,42356,0.0489260454307566,0.00734671632120641,0.034526481441192,0.0633256094203211,2.85515972944861e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,VSIG4,V-set and immunoglobulin domain-containing protein 4,42590,0.0284070613867878,0.00428041472869542,0.0200174485185448,0.0367966742550309,3.33528949427841e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NMI,N-myc-interactor,40420,0.0467461157704769,0.00704488352643061,0.0329381440586729,0.0605540874822809,3.38357243819469e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SCGN,Secretagogin,42369,-0.0293524747469218,0.0044255009659859,-0.0380264566402542,-0.0206784928535894,3.42752825583984e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BCAN,Brevican core protein,42494,0.0224368519529005,0.00338419141816448,0.0158038367732981,0.0290698671325029,3.48879042148058e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GRSF1,G-rich sequence factor 1,40013,0.0521864567667306,0.00789336961277576,0.0367154523256901,0.0676574612077711,3.98555417641883e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PZP,Pregnancy zone protein,40538,0.0329500266306972,0.00498518467309627,0.0231790646714285,0.0427209885899658,4.02663440333541e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RNASE6,Ribonuclease K6,40467,0.0220184687162694,0.00333193952000505,0.0154878672570595,0.0285490701754793,4.06274730349046e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RBPMS2,RNA-binding protein with multiple splicing 2,40222,0.0658412564871911,0.00996902501051517,0.0463019674665814,0.0853805455078009,4.16975219156742e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NACC1,Nucleus accumbens-associated protein 1,40450,0.0355618351641843,0.00538649708570718,0.0250043008761982,0.0461193694521704,4.23798449900754e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PRDX5,"Peroxiredoxin-5, mitochondrial",42753,0.0424386697897238,0.00644067127028946,0.0298149540999565,0.0550623854794912,4.5863028464392e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ACAN,Aggrecan core protein,42487,0.0178863862107923,0.00271519242235642,0.0125646090629737,0.0232081633586109,4.6406757446862e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,STXBP3,Syntaxin-binding protein 3,42345,0.0278375199282042,0.0042273070380253,0.0195519981336746,0.0361230417227338,4.71644418536317e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,S100A11,Protein S100-A11,42530,0.0292770238637984,0.00445182242304333,0.0205514519146335,0.0380025958129633,4.99893619144029e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LEFTY2,Left-right determination factor 2,42688,0.032049405361342,0.00487481495231664,0.0224947680548013,0.0416040426678826,5.06171679330293e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL12RB1,Interleukin-12 receptor subunit beta-1,42369,0.0249948111568944,0.00380318731361117,0.0175405640222165,0.0324490582915723,5.14881202657447e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RETN,Resistin,42597,0.0277812669332796,0.00422871746843943,0.0194929806951383,0.0360695531714209,5.22900751934089e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DAG1,Dystroglycan,42675,0.0293071386324019,0.00446915710594539,0.020547590704749,0.0380666865600549,5.66570301574345e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SEMA7A,Semaphorin-7A,42759,0.018234020833266,0.00278123256684155,0.0127828050022566,0.0236852366642755,5.7234155453729e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,42494,0.0604479059909733,0.00922331690598783,0.0423702048552371,0.0785256071267094,5.81532552326368e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GLOD4,Glyoxalase domain-containing protein 4,42601,0.0222765810176871,0.00340466884681463,0.0156034300779305,0.0289497319574438,6.25076191209171e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MEP1A,Meprin A subunit alpha,40448,-0.0461983931530585,0.00706880941543889,-0.0600532596073188,-0.0323435266987983,6.61248670998381e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LACTB2,Endoribonuclease LACTB2,42635,0.0414264417476905,0.00634286399621171,0.0289944283151156,0.0538584551802655,6.75969343271235e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PDLIM7,PDZ and LIM domain protein 7,42675,0.0785426539150227,0.0120334410861654,0.0549571093861385,0.102128198443907,6.9485665549402e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CASP8,Caspase-8,42673,0.0390081181884708,0.00598032239699038,0.0272866862903697,0.050729550086572,7.14956201293982e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PILRA,Paired immunoglobulin-like type 2 receptor alpha,42610,0.0274494885132741,0.00420968016218983,0.019198515395382,0.0357004616311661,7.25516948998021e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GORASP2,Golgi reassembly-stacking protein 2,40448,0.0298540388428964,0.00457812462807489,0.0208809145718696,0.0388271631139232,7.28218962929586e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IGFBP4,Insulin-like growth factor-binding protein 4,42407,0.0305682608613992,0.00468933376824586,0.0213771666756373,0.039759355047161,7.35058591975502e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,COCH,Cochlin,40510,0.029797076703494,0.0045715781511864,0.0208367835271686,0.0387573698798193,7.4330536241997e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,VASH1,Tubulinyl-Tyr carboxypeptidase 1,42593,0.0516343658479268,0.00792728255730218,0.0360968920356145,0.0671718396602391,7.60400043769922e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PEBP1,Phosphatidylethanolamine-binding protein 1,42610,0.0359735849403542,0.00552930777031082,0.025136141710545,0.0468110281701634,7.99261445394281e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,40282,0.0534895565334451,0.00823368623450297,0.0373515315138193,0.0696275815530709,8.57717315058865e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AHNAK,Neuroblast differentiation-associated protein AHNAK,40222,0.0202172150701313,0.00311242260818869,0.0141168667580815,0.0263175633821811,8.62332768144614e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NT5C1A,Cytosolic 5'-nucleotidase 1A,40482,0.0204330174410875,0.0031466985574227,0.014265488268539,0.026600546613636,8.73983560294829e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ELAC1,Zinc phosphodiesterase ELAC protein 1,40481,0.053721382166869,0.00827642065572718,0.0374995976816437,0.0699431666520942,8.89044165757668e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HSPA1A,Heat shock 70 kDa protein 1A,42657,0.0442409689258013,0.00682052284014594,0.0308727441591152,0.0576091936924873,9.09544842129736e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MERTK,Tyrosine-protein kinase Mer,42753,0.0161929135172698,0.00249726138054215,0.0112982812114072,0.0210875458231324,9.22525456759701e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CALB2,Calretinin,42310,0.0202809729297795,0.0031341528411411,0.0141380333611429,0.026423912498416,1.00844616271225e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LGALS7_LGALS7B,Galectin-7,42523,0.0273768448756412,0.00423280067797687,0.0190805555468065,0.0356731342044758,1.02920601903897e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GMFG,Glia maturation factor gamma,40510,0.0450122706558971,0.00695868748466823,0.0313732431859474,0.0586512981258468,1.03062122949863e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CERT,Ceramide transfer protein,42310,0.0385533716051658,0.00596209158469351,0.0268676720991665,0.0502390711111651,1.03910845918355e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SEZ6L2,Seizure 6-like protein 2,42586,0.014999166385541,0.00232303061516679,0.0104460263798141,0.0195523063912679,1.10685159751719e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LMNB2,Lamin-B2,40482,0.018066593180521,0.00279927502127323,0.0125800141388254,0.0235531722222165,1.13380022376763e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SLC39A5,Zinc transporter ZIP5,42593,-0.0338341100654822,0.00524548939745858,-0.044115269284501,-0.0235529508464633,1.15588731913213e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ASPSCR1,Tether containing UBX domain for GLUT4,40481,0.0420998531937047,0.00653487331256345,0.0292915015010804,0.0549082048863291,1.22434275428562e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD79B,B-cell antigen receptor complex-associated protein beta chain,42753,0.0301639992083357,0.00468506237183817,0.0209812769595329,0.0393467214571385,1.24860078520254e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DXO,Decapping and exoribonuclease protein,40482,0.0286202103480946,0.00444637130631674,0.0199053225877138,0.0373350981084754,1.2700123261954e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ANXA11,Annexin A11,42569,0.0417616109622702,0.00648905822881078,0.0290430568338011,0.0544801650907394,1.27099065216502e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HPSE,Heparanase,40407,0.0586957474510631,0.00912375180435313,0.040813193914531,0.0765783009875952,1.29956162642142e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TRIM58,E3 ubiquitin-protein ligase TRIM58,40450,0.0549278114740058,0.0085419074184569,0.0381856729338303,0.0716699500141813,1.32429627325807e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FAM172A,Cotranscriptional regulator FAM172A,40222,0.0380623271958543,0.0059367027470196,0.0264263898116958,0.0496982645800127,1.50122619434291e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,42635,0.0518169073317435,0.0080862129361113,0.0359679299769653,0.0676658846865216,1.52302288567449e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PPP1R2,Protein phosphatase inhibitor 2,42635,0.049115822421549,0.00766606336764789,0.0340903382209591,0.0641413066221389,1.53441931032678e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MMP7,Matrilysin,42332,0.031614303865836,0.00493514229431551,0.0219414249689776,0.0412871827626944,1.54524081784382e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CXCL1,Growth-regulated alpha protein,42606,0.0596867161208477,0.00932384708316559,0.0414119758378432,0.0779614564038523,1.58967663918173e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,STAT2,Signal transducer and activator of transcription 2,40198,0.0474248058167763,0.00740971987632838,0.0329017548591726,0.0619478567743799,1.61325850291047e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LBP,Lipopolysaccharide-binding protein,42688,0.0367260109849186,0.00574365721011774,0.0254684428530879,0.0479835791167494,1.66721094723257e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,40115,0.0423284348118557,0.00662204109905568,0.0293492342577066,0.0553076353660048,1.70347871884344e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CEP20,Centrosomal protein 20,42345,0.0465489388860237,0.00728565302623613,0.0322690589546008,0.0608288188174465,1.72461618945592e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LCAT,Phosphatidylcholine-sterol acyltransferase,40531,0.0138394710454114,0.00216668719805021,0.00959276413723295,0.0180861779535898,1.75348516339989e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TST,Thiosulfate sulfurtransferase,42276,0.0464433091645524,0.00727834000710772,0.0321777627506213,0.0607088555784835,1.81830153104976e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PHLDB1,Pleckstrin homology-like domain family B member 1,40448,0.0327543590163365,0.00513450353117927,0.0226907320952252,0.0428179859374479,1.84921609110967e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PTPRC,Receptor-type tyrosine-protein phosphatase C,40526,0.014488312832647,0.00227258318486912,0.0100340497903035,0.0189425758749904,1.89749348432402e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ATRN,"Attractin, Isoform 2",40538,0.0104204986326714,0.00163637897572759,0.00721319584024533,0.0136278014250975,1.98880816198243e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MIF,Macrophage migration inhibitory factor,42585,0.0420115586814847,0.00659859369737566,0.0290783150346284,0.054944802328341,1.99383134340313e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KDR,Vascular endothelial growth factor receptor 2,42678,0.0153379928420175,0.00241198487569678,0.0106105024856518,0.0200654831983832,2.09517696724565e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LAT,Linker for activation of T-cells family member 1,42753,0.0465962197801817,0.00733482301703781,0.0322199666667876,0.0609724728935758,2.18269673879053e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,OSCAR,Osteoclast-associated immunoglobulin-like receptor,42637,0.0216230636951952,0.00340754179820876,0.014944281770706,0.0283018456196843,2.2859484242695e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AKT2,RAC-beta serine/threonine-protein kinase,40481,0.077620358722869,0.0122445173351424,0.0536211047459899,0.101619612699748,2.39783747643283e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LTBR,Tumor necrosis factor receptor superfamily member 3,42565,0.0187271641788561,0.0029566128018969,0.0129322030871381,0.024522125270574,2.46545843920715e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RP2,Protein XRP2,42586,0.02594731319542,0.00409688639900035,0.0179174158533794,0.0339772105374607,2.47444069180068e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TOMM20,Mitochondrial import receptor subunit TOM20 homolog,40510,0.0479622788899053,0.00757641655670765,0.0331125024387584,0.0628120553410523,2.5366513975839e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HSPB1,Heat shock protein beta-1,42447,0.0417503627043785,0.00659694107182242,0.0288203582036066,0.0546803672051505,2.55121050743733e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GBP2,Guanylate-binding protein 2,42369,0.0375745725491986,0.00594204919385826,0.0259281561292364,0.0492209889691608,2.6395356296549e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PAM,Peptidyl-glycine alpha-amidating monooxygenase,42721,0.017558646361808,0.00277683512914094,0.0121160495086918,0.0230012432149242,2.64154284280148e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SIRPB1,Signal-regulatory protein beta-1,42599,0.0297554729255696,0.00471103431047611,0.0205218456770364,0.0389891001741027,2.76676482109929e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,42710,0.0290770200474184,0.00460488673477193,0.0200514420472654,0.0381025980475713,2.79726270077016e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SFTPA2,Pulmonary surfactant-associated protein A2,42345,0.0322220057714205,0.00510297357490444,0.0222201775646078,0.0422238339782332,2.80009443194416e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SERPINI1,Neuroserpin,40266,0.0186903696860919,0.00296258570613413,0.012883701702069,0.0244970376701148,2.91934866513549e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PKD2,Polycystin-2,40115,0.0359598479941635,0.00570010201192164,0.0247876480507971,0.04713204793753,2.92406795766177e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,YWHAQ,14-3-3 protein theta,40282,0.0452311232698258,0.00717338214404884,0.0311712942674901,0.0592909522721615,2.98361378230228e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DCTD,Deoxycytidylate deaminase,40282,0.0578352015754342,0.00917930602939701,0.0398437617578161,0.0758266413930523,3.07723445012298e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FHIT,Bis(5'-adenosyl)-triphosphatase,42310,0.0448590545834734,0.00713312775328577,0.0308781241870333,0.0588399849799136,3.30011136622583e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TMEM106A,Transmembrane protein 106A,40450,0.0429427191231489,0.00683689899316813,0.0295423970965394,0.0563430411497585,3.48758126944629e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CIAPIN1,Anamorsin,42678,0.0379404570873653,0.00604899540645816,0.0260844260907074,0.0497964880840233,3.66872757133967e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PLG,Plasminogen,40284,0.013143367415715,0.00209652470762382,0.00903417898877231,0.0172525558426577,3.76584894066574e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AP1G2,AP-1 complex subunit gamma-like 2,40450,0.048303662609763,0.00770521608823196,0.0332014390768284,0.0634058861426977,3.7678014454532e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HS1BP3,HCLS1-binding protein 3,40222,0.054036566050527,0.00861992498731038,0.0371415130753986,0.0709316190256553,3.7744230910609e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AGR2,Anterior gradient protein 2 homolog,42214,-0.0621598409206384,0.00991901061099645,-0.0816011017181915,-0.0427185801230854,3.80314921028966e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CDKN2D,Cyclin-dependent kinase 4 inhibitor D,42586,0.0568686070269549,0.00907684353192597,0.03907799370438,0.0746592203495298,3.8364701499434e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HARS1,"Histidine--tRNA ligase, cytoplasmic",42610,0.0466238122343489,0.00744233000836381,0.0320368454179558,0.061210779050742,3.85005716242673e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SNAP29,Synaptosomal-associated protein 29,42678,0.0556964933547289,0.00889374997649981,0.0382647434007892,0.0731282433086685,3.90525266067078e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SIAE,Sialate O-acetylesterase,42645,0.0280389211782641,0.00447793285465594,0.0192621727831385,0.0368156695733897,3.92692377897197e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,COL6A3,Collagen alpha-3(VI) chain,42793,0.0231843468836597,0.00370972885046743,0.0159132783367436,0.0304554154305759,4.23768425171242e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IGFBP6,Insulin-like growth factor-binding protein 6,42594,0.019807351903011,0.00316968995304126,0.0135947595950501,0.0260199442109718,4.25633515724188e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BTN3A2,Butyrophilin subfamily 3 member A2,42593,0.0237368450546645,0.00380235985989807,0.0162842197292643,0.0311894703800647,4.43163891610883e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CACYBP,Calcyclin-binding protein,40266,0.0621525222551122,0.00995581377428701,0.0426391272575097,0.0816659172527147,4.45435339927907e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,OPTC,Opticin,42586,0.028289164404473,0.00453431420283163,0.019401908566923,0.037176420242023,4.53905994832479e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FCRL5,Fc receptor-like protein 5,42610,0.0359631720493509,0.00576724225661792,0.0246593772263797,0.047266966872322,4.63057841550611e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EEF1D,Elongation factor 1-delta,40510,0.0554950107034258,0.00889840484087737,0.0380541372153062,0.0729358841915455,4.63391036994026e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,B4GALT1,"Beta-1,4-galactosyltransferase 1",42675,0.0172314179393765,0.00276385307720619,0.0118142659080524,0.0226485699707006,4.66550941198682e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PAXX,Protein PAXX,40282,0.0276789918730587,0.00444077607897549,0.0189750707582668,0.0363829129878507,4.74456917393838e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",40481,0.0441758737774382,0.00708768044786596,0.0302840200996209,0.0580677274552555,4.74608684056432e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NUDT5,ADP-sugar pyrophosphatase,42610,0.0306763620330875,0.0049238182772956,0.0210256782095882,0.0403270458565869,4.79769840057961e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CKAP4,Cytoskeleton-associated protein 4,42712,0.0176253681848479,0.00283063142521243,0.0120773305914316,0.0231734057782643,4.90596762429648e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SOD2,"Superoxide dismutase [Mn], mitochondrial",42610,0.0229716142688996,0.00368960812701082,0.0157399823399584,0.0302032461978408,4.9266044473973e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD40,Tumor necrosis factor receptor superfamily member 5,42619,0.0298942259077316,0.00480390355992587,0.0204785749302769,0.0393098768851863,5.025484426825e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NCK2,Cytoplasmic protein NCK2,42675,0.0632446638227305,0.0101840941302927,0.0432838393273568,0.0832054883181042,5.44914804395403e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AIF1,Allograft inflammatory factor 1,42345,0.0315189827335566,0.00508144797015439,0.021559344712054,0.0414786207550592,5.71456008094994e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,VEGFB,Vascular endothelial growth factor B,40198,0.0179404160680718,0.00289419170011277,0.0122678003358507,0.0236130318002928,5.89459217717214e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CPA2,Carboxypeptidase A2,42669,-0.0399507023683558,0.00644779523906262,-0.0525883810369186,-0.0273130236997931,5.95927980008402e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD302,CD302 antigen,42586,0.0194202601527974,0.00313535846486756,0.0132749575616569,0.0255655627439378,6.03908210667989e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BCL2L1,Bcl-2-like protein 1,40482,0.0596880819977573,0.00964186091054554,0.0407900346130881,0.0785861293824266,6.2050028761613e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DEFA1_DEFA1B,Neutrophil defensin 1,42350,0.0331912945916362,0.00536858137248123,0.0226688751015729,0.0437137140816994,6.49571530147954e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CRTAM,Cytotoxic and regulatory T-cell molecule,42494,0.0314364446146668,0.00508523552004736,0.021469382995374,0.0414035062339596,6.51842258001023e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SBSN,Suprabasin,40510,0.0211327906001257,0.00342018934858442,0.0144292194769002,0.0278363617233512,6.67953770229721e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SIGLEC7,Sialic acid-binding Ig-like lectin 7,42635,0.016669873310871,0.00270011087687548,0.011377655992195,0.0219620906295469,6.85978468452873e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,VAV3,Guanine nucleotide exchange factor VAV3,40135,0.0595040054694575,0.0096376164711966,0.0406142771859121,0.0783937337530028,6.88830844973104e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PARK7,Parkinson disease protein 7,42610,0.0311521904540574,0.00504965676632869,0.0212548631920532,0.0410495177160617,7.06228926952993e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,THPO,Thrombopoietin,42356,0.0234592073780159,0.00380749534977632,0.0159965164924543,0.0309218982635775,7.42435286400348e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FCRL2,Fc receptor-like protein 2,42680,0.0317044576750124,0.00514761493216267,0.0216151324079735,0.0417937829420512,7.52581209859983e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,METAP2,Methionine aminopeptidase 2,42688,0.0341267694101414,0.00555096028187337,0.0232468872576696,0.0450066515626132,8.07270544723584e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CLC,Galectin-10,42610,0.0396027802322764,0.00644170981152054,0.0269770290016961,0.0522285314628566,8.07583213086126e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SPOCK1,Testican-1,42494,0.0154628409516813,0.00251699400878141,0.0105295326944697,0.0203961492088929,8.3090020091987e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GRPEL1,"GrpE protein homolog 1, mitochondrial",42586,0.0355498872008002,0.00579097734863226,0.024199571597481,0.0469002028041194,8.54736487309161e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SERPINB6,Serpin B6,42678,0.0346102301517212,0.0056393451711594,0.0235571136162487,0.0456633466871936,8.62995221579152e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TMED8,Protein TMED8,40448,0.0610139213709485,0.00994022464304962,0.0415310810705713,0.0804967616713258,8.63355830822437e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ANXA4,Annexin A4,42583,0.0427700676820634,0.00697038170478135,0.029108119540692,0.0564320158234349,8.70266591107368e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LETM1,Mitochondrial proton/calcium exchanger protein,40481,0.0317429924002398,0.00517270226713971,0.021604495956646,0.0418814888438337,8.71139436127644e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GPA33,Cell surface A33 antigen,42586,-0.0833433034085684,0.0135935366172327,-0.109986635178345,-0.0566999716387924,8.97273604913317e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PMVK,Phosphomevalonate kinase,42302,0.0645853621045639,0.0105369926969795,0.0439328564184841,0.0852378677906436,9.07460486346e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PARP1,Poly [ADP-ribose] polymerase 1,42593,0.0346941633055244,0.00566958140782609,0.0235817837461853,0.0458065428648636,9.65758920933467e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ARFIP1,Arfaptin-1,40481,0.0407960013641714,0.00666645157024784,0.0277297562864857,0.0538622464418572,9.69238036633059e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,40282,0.0358563904244632,0.00586000982106352,0.0243707711751787,0.0473420096737477,9.74485530344527e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,40510,0.0442364905183737,0.00723194542307341,0.0300618774891498,0.0584111035475975,9.86152917142186e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DRG2,Developmentally-regulated GTP-binding protein 2,42586,0.0334638941921561,0.00547789269218571,0.0227272245154721,0.0442005638688401,1.03099855312174e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",42345,0.0460559200100576,0.00755761037223086,0.0312430036804851,0.0608688363396301,1.13215880849209e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,C1R,Complement C1r subcomponent,40538,0.0115795083655051,0.00190049282377023,0.00785454243091546,0.0153044743000948,1.14481592114812e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HBEGF,Proheparin-binding EGF-like growth factor,42673,0.0430808396901785,0.00708521971249368,0.0291938090536909,0.0569678703266661,1.23136247441719e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CTSB,Cathepsin B,42658,0.0319066779868722,0.00525735979395279,0.0216022527907247,0.0422111031830196,1.32202151812168e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,42345,0.0456308157094611,0.00753095063577956,0.0308701524633331,0.060391478955589,1.4062109365085e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AHCY,Adenosylhomocysteinase,42635,0.0396888562234369,0.00655281078360402,0.026845347087573,0.0525323653593008,1.42589221501103e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EIF4E,Eukaryotic translation initiation factor 4E,40198,0.0532008647316505,0.00879207872395874,0.0359683904326914,0.0704333390306097,1.48635562862551e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EFNA4,Ephrin-A4,42474,0.0200693274861605,0.00331834627535883,0.0135653687864572,0.0265732861858638,1.50602130709794e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,APPL2,DCC-interacting protein 13-beta,40282,0.0655154488227615,0.0108322080619086,0.0442843210214205,0.0867465766241025,1.51188067675118e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GHRL,Appetite-regulating hormone,42635,0.050155804385966,0.00829733840502807,0.033893021112111,0.066418587659821,1.53549914407176e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SPRY2,Protein sprouty homolog 2,42369,0.0541915565864106,0.00896694856782185,0.0366163373934798,0.0717667757793415,1.54898118599925e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CCL24,C-C motif chemokine 24,42653,0.0487709361606269,0.00808428685824981,0.0329257339184572,0.0646161384027965,1.65363665380942e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HTRA2,"Serine protease HTRA2, mitochondrial",42678,0.0356729805155232,0.00591399922530641,0.0240815420339227,0.0472644189971238,1.66226399521449e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SNX15,Sorting nexin-15,40282,0.0319608899395141,0.00530035793288192,0.0215721883910655,0.0423495914879626,1.69236296478672e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,STX4,Syntaxin-4,42586,0.034948666788629,0.00579727584090663,0.023586006140452,0.046311327436806,1.69877399364608e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RAB11FIP3,Rab11 family-interacting protein 3,40510,0.0626153359202282,0.0103864299802458,0.0422579331589465,0.0829727386815099,1.70572913664171e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FBLN2,Fibulin-2,40526,0.0192134229075073,0.00319132951026007,0.0129584170673976,0.025468428747617,1.79256212400273e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MASP1,Mannan-binding lectin serine protease 1,42475,0.0137364222581021,0.00228483072300167,0.00925815404101886,0.0182146904751854,1.88044557746308e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CLIP2,CAP-Gly domain-containing linker protein 2,42593,0.0649748910299883,0.0108076111157196,0.0437919732431778,0.0861578088167988,1.88061863183907e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DTD1,D-aminoacyl-tRNA deacylase 1,40282,0.0505594213604167,0.0084112479664524,0.03407337534617,0.0670454673746634,1.90266069633409e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GIPC3,PDZ domain-containing protein GIPC3,40448,0.0569079106080081,0.00947547531690733,0.0383359789868698,0.0754798422291465,1.9625888427993e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MFGE8,Lactadherin,42610,-0.0255225853563975,0.00425489649614382,-0.0338621824888394,-0.0171829882239557,2.04394405064471e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DNM3,Dynamin-3,40481,0.0320447373666494,0.00535235440263307,0.0215541227374885,0.0425353519958102,2.20200295481305e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AKT3,RAC-gamma serine/threonine-protein kinase,42296,0.0330626453453317,0.00552521651729718,0.0222332209714292,0.0438920697192342,2.23469175153638e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LCP1,Plastin-2,40526,0.0280340078672538,0.00468505908127651,0.0188512920679518,0.0372167236665557,2.24712987569892e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SLA2,Src-like-adapter 2,40481,0.0604499314961469,0.0101058079086796,0.0406425479951348,0.080257314997159,2.27511413518116e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FABP3,"Fatty acid-binding protein, heart",40510,0.0306604642125898,0.00512788169277667,0.0206098160947475,0.0407111123304321,2.3105008885867e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FABP2,"Fatty acid-binding protein, intestinal",42635,0.0462337834683282,0.00773423118921463,0.0310746903374676,0.0613928765991889,2.31883896951279e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GSR,"Glutathione reductase, mitochondrial",40489,0.0131504117772637,0.00220120049480007,0.00883605880745554,0.0174647647470718,2.38191290752385e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NUMB,Protein numb homolog,40198,0.0478883488225757,0.00801574770715858,0.0321774833165449,0.0635992143286066,2.38256294955094e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ACVRL1,Serine/threonine-protein kinase receptor R3,42474,0.0155742921203153,0.00260796219060086,0.0104626862267376,0.020685898013893,2.4060857063223e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PTPRR,Receptor-type tyrosine-protein phosphatase R,40482,0.0220063239950753,0.00368835609417169,0.0147771460504988,0.0292355019396518,2.49774593494296e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GGACT,Gamma-glutamylaminecyclotransferase,40510,0.040747490044164,0.00684284276051539,0.0273355182335538,0.0541594618547741,2.68188121843153e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SNX9,Sorting nexin-9,42635,0.0388727868495899,0.00653382220530555,0.0260664953271911,0.0516790783719888,2.7569961256588e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RWDD1,RWD domain-containing protein 1,42710,0.0364434214560565,0.0061258296205914,0.0244367953996973,0.0484500475124156,2.7621796462905e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ADGRE1,Adhesion G protein-coupled receptor E1,40448,0.0326693108634114,0.00549232999814293,0.0219043440670512,0.0434342776597715,2.79220131602665e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ABL1,Tyrosine-protein kinase ABL1,42586,0.0387318853871446,0.00651251950662394,0.0259673471541617,0.0514964236201275,2.79401233215e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,C1QL2,Complement C1q-like protein 2,40198,0.0256326844431408,0.00431543835871921,0.0171744252600512,0.0340909436262305,2.9406723470374e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TIE1,Tyrosine-protein kinase receptor Tie-1,42793,0.0238906161065211,0.00402314788268849,0.0160052462564517,0.0317759859565906,2.95037014677171e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FXYD5,FXYD domain-containing ion transport regulator 5,42369,0.0381526707018216,0.00643065603738356,0.0255485848685498,0.0507567565350933,3.05032985538497e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",40510,0.0420768244303958,0.00709515871014627,0.0281703133585091,0.0559833355022825,3.11109650626969e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GFRA1,GDNF family receptor alpha-1,42688,0.0171961200367535,0.00290258339107388,0.0115070565902487,0.0228851834832583,3.2103797312926e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NARS1,"Asparagine--tRNA ligase, cytoplasmic",40481,0.0274238194968685,0.00462841066924021,0.0183521345851577,0.0364955044085793,3.21209571586169e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,STAB2,Stabilin-2,40526,0.0161874228439404,0.00273339432219786,0.0108299699724326,0.0215448757154482,3.27088816547161e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NEXN,Nexilin,40531,0.0398757695458191,0.00673548811776016,0.0266742128350092,0.053077326256629,3.3076660918579e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ALCAM,CD166 antigen,42793,0.0113692841436069,0.0019212634780132,0.00760360772670099,0.0151349605605128,3.34516891137204e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,VPS4B,Vacuolar protein sorting-associated protein 4B,40450,0.0542884524280998,0.00917872436117264,0.0362981526802014,0.0722787521759982,3.42361891314798e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ENAH,Protein enabled homolog,42369,0.0272453806073135,0.00461556226316448,0.0181988785715111,0.0362918826431159,3.6586794955485e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PCDH9,Protocadherin-9,40448,0.0198687197277867,0.00336623490221397,0.0132708993194473,0.0264665401361261,3.68679930229875e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,40510,0.0363115085571345,0.00615579399045236,0.0242461523358479,0.0483768647784211,3.76738298481549e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",40482,0.0240932123933753,0.00408600884231892,0.0160846350624302,0.0321017897243204,3.81892214012947e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SWAP70,Switch-associated protein 70,40448,0.0205201136310874,0.00348196212339963,0.0136954678692241,0.0273447593929506,3.895005214521e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MPO,Myeloperoxidase,42610,0.0267358045247138,0.00454468025170051,0.0178282312313808,0.0356433778180468,4.12799826043475e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,STK4,Serine/threonine-protein kinase 4,42635,0.0491404485099729,0.00835893049152259,0.0327569447465886,0.0655239522733572,4.23064971110824e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,42666,0.0634515519164249,0.0108184201053712,0.0422474485098973,0.0846556553229525,4.59277648811447e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FCAR,Immunoglobulin alpha Fc receptor,42593,0.027949248218083,0.0047662043883436,0.0186074876169296,0.0372910088192365,4.62363214204983e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,INPP1,Inositol polyphosphate 1-phosphatase,42586,0.0302363532383687,0.00516408854461125,0.0201147396909306,0.0403579667858067,4.87839769994769e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KIAA0319,Dyslexia-associated protein KIAA0319,40482,0.0179411931472,0.00306438983927822,0.0119349890622147,0.0239473972321854,4.91074037552181e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FGFR2,Fibroblast growth factor receptor 2,42678,0.0127947079888231,0.00218615773878596,0.00850983882080263,0.0170795771568436,4.95190173480005e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ELOA,Elongin-A,42586,0.0305749489159489,0.00522706650376369,0.0203298985685721,0.0408199992633257,5.050143643299e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CDHR2,Cadherin-related family member 2,42586,0.0402887566443653,0.00688817282250108,0.0267879379122632,0.0537895753764675,5.06152852481258e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NAA80,N-alpha-acetyltransferase 80,40181,0.0687210327659764,0.0117558644521729,0.0456795384397174,0.0917625270922353,5.18851746200264e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PLA2G4A,Cytosolic phospholipase A2,42675,0.0492900905310592,0.00844406263139152,0.0327397277735318,0.0658404532885866,5.4290674579068e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",40481,0.0440218853369822,0.00754142162275132,0.0292406989563896,0.0588030717175748,5.44989600775607e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TCL1A,T-cell leukemia/lymphoma protein 1A,42489,0.0575653458221932,0.0098759165451992,0.0382085493936027,0.0769221422507836,5.71013847742164e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MEGF9,Multiple epidermal growth factor-like domains protein 9,42759,0.0109767482399515,0.00188320103384831,0.00728567421360877,0.0146678222662942,5.7105995131097e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FUS,RNA-binding protein FUS,42335,0.0226116003842987,0.00388066809521357,0.0150054909176801,0.0302177098509173,5.78490782381324e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BRK1,Protein BRICK1,42310,0.0256236895062104,0.00439817769429732,0.0170032612253876,0.0342441177870331,5.81114220585492e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RBP2,Retinol-binding protein 2,42586,0.0440069402183181,0.00755419142050647,0.0292007250341254,0.0588131554025108,5.82500995463635e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,STIP1,Stress-induced-phosphoprotein 1,42585,0.0366956817492594,0.00630218817457025,0.0243433929271017,0.0490479705714171,5.92361865697176e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,WASHC3,WASH complex subunit 3,40482,0.0423925980069895,0.00728302106133962,0.0281178767267639,0.0566673192872152,6.01809580846587e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,OSMR,Oncostatin-M-specific receptor subunit beta,42704,0.0115034823875212,0.00197663963924772,0.00762926869459566,0.0153776960804467,6.02845689539243e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CYB5R2,NADH-cytochrome b5 reductase 2,40328,0.031708556313245,0.00545004093284296,0.0210264760848728,0.0423906365416172,6.11818761048753e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KLRD1,Natural killer cells antigen CD94,42753,0.026726185116801,0.00459794117722659,0.0177142204094368,0.0357381498241651,6.28776615527437e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HMOX2,Heme oxygenase 2,42310,0.0259349109723084,0.00446260865489818,0.017188198008708,0.0346816239359089,6.3315526848149e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CXCL6,C-X-C motif chemokine 6,42753,0.0433410771497051,0.00746199610833852,0.0287155647773616,0.0579665895220487,6.45480503753759e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MYCBP2,E3 ubiquitin-protein ligase MYCBP2,40481,0.0378937028964861,0.00652445756993483,0.0251057660594138,0.0506816397335583,6.49501912183835e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MGMT,Methylated-DNA--protein-cysteine methyltransferase,42593,0.067733075265397,0.0116640725916824,0.0448714929856995,0.0905946575450946,6.50508321387751e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ERBIN,Erbin,42586,0.0576238505140586,0.00993009252206865,0.038160869170804,0.0770868318573131,6.66316839337735e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,OLR1,Oxidized low-density lipoprotein receptor 1,42520,0.0327886094276431,0.0056538017385595,0.0217071580200665,0.0438700608352197,6.80657787781239e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NT5C3A,Cytosolic 5'-nucleotidase 3A,42569,0.0489931944590099,0.00845318723385521,0.0324249474806537,0.0655614414373661,6.95189007485363e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MED18,Mediator of RNA polymerase II transcription subunit 18,42345,0.0426582248054746,0.00736307766498191,0.0282265925821101,0.0570898570288392,7.0499568862046e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SCGB1A1,Uteroglobin,42645,0.031568739810906,0.00545317076353951,0.0208805251143686,0.0422569545074434,7.23603088942092e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PRELP,Prolargin,42617,0.0137803289248424,0.00238177737652854,0.00911204526684642,0.0184486125828383,7.3807421730501e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,40510,0.0226121314965613,0.0039185256013645,0.0149318213178868,0.0302924416752357,8.10762051315432e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,APOL1,Apolipoprotein L1,40531,0.0328611912154069,0.00569539405098807,0.0216982188754703,0.0440241635553435,8.14510789001992e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EGLN1,Egl nine homolog 1,42593,0.0311046111285413,0.0054014801099975,0.0205177101129462,0.0416915121441364,8.6708851580714e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,QDPR,Dihydropteridine reductase,42580,0.0238487001319758,0.00414168900953153,0.015730989673294,0.0319664105906576,8.68790786316357e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PI3,Elafin,42445,0.0320154676890191,0.00556348184449503,0.0211110432738088,0.0429198921042294,8.87827070400154e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,S100G,Protein S100-G,40481,0.0271298801958892,0.00472027679858832,0.0178781376706561,0.0363816227211223,9.29077089841555e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,OTUD6B,Deubiquitinase OTUD6B,40448,0.0327454593418857,0.0057029373179899,0.0215677021986255,0.0439232164851459,9.60658289371102e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PCYT2,Ethanolamine-phosphate cytidylyltransferase,40448,0.0424430785335834,0.00739804005281455,0.0279429200300669,0.0569432370370999,9.88121722765145e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DNAJC6,Putative tyrosine-protein phosphatase auxilin,40222,0.046892161230545,0.00819321324493602,0.0308334632704704,0.0629508591906196,1.07202976605466e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DNAJB1,DnaJ homolog subfamily B member 1,42586,0.0482437599115624,0.00843393042329768,0.0317132562818989,0.0647742635412258,1.08674720589471e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CXCL5,C-X-C motif chemokine 5,42604,0.0631787569029346,0.0110461612961482,0.0415282807624841,0.0848292330433851,1.09104724546223e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TOP2B,DNA topoisomerase 2-beta,40198,0.0443948141583537,0.00776091909449915,0.0291834127331353,0.059606215583572,1.09106818129277e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD160,CD160 antigen,42753,0.027430257342188,0.00479753304397124,0.0180270925760044,0.0368334221083717,1.1033258078359e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KYAT1,Kynurenine--oxoglutarate transaminase 1,42619,0.0315217094066981,0.00552508792354557,0.0206925370765488,0.0423508817368474,1.1866282627156e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PGLYRP1,Peptidoglycan recognition protein 1,42736,0.0237554794196616,0.0041652105444201,0.0155916667525982,0.031919292086725,1.19960297550983e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RGMB,RGM domain family member B,42710,0.0158812540293677,0.00278519225989533,0.0104222771999728,0.0213402308587625,1.20865081207991e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DDX58,Antiviral innate immune response receptor RIG-I,42345,0.0314808949313356,0.00552561343047626,0.0206506926076021,0.0423110972550691,1.24353321153123e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,42593,0.0663160716410823,0.0116435444369963,0.0434947245445695,0.0891374187375951,1.25579115060013e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PPP1R9B,Neurabin-2,42753,0.0519041079431034,0.00911888974387216,0.034031084045114,0.0697771318410929,1.2821094732941e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CLTA,Clathrin light chain A,42356,0.0264745664257525,0.00465885106714486,0.0173432183341486,0.0356059145173564,1.35445084815252e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL10RB,Interleukin-10 receptor subunit beta,42675,0.0167131394979575,0.00294181884558386,0.0109471745606131,0.0224791044353018,1.36497740298145e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ANGPTL7,Angiopoietin-related protein 7,42720,-0.0201901296433076,0.00355396740312999,-0.0271559057534423,-0.0132243535331728,1.3665985172511e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",42458,0.0230443873946779,0.00406398353614698,0.0150789796638298,0.031009795125526,1.45442159047301e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SPINT1,Kunitz-type protease inhibitor 1,42564,0.0145137986925507,0.0025596677927094,0.0094968498188403,0.0195307475662611,1.45592470333489e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SERPINC1,Antithrombin-III,40515,0.00815966482174454,0.0014390902617855,0.00533904790864496,0.0109802817348441,1.4627894564004e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DBNL,Drebrin-like protein,42675,0.0505720000659788,0.00892592783690154,0.0330771815056517,0.0680668186263058,1.49385175064822e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CCL5,C-C motif chemokine 5,42688,0.0550146968865186,0.00971046232908246,0.0359821907215169,0.0740472030515202,1.49585850372425e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LGALS8,Galectin-8,42710,0.0330338865618626,0.0058312430749249,0.0216046501350099,0.0444631229887154,1.50039030731535e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AKR1B1,Aldo-keto reductase family 1 member B1,42345,0.0408067771285496,0.00720717921212132,0.0266807058727918,0.0549328483843074,1.52782847523195e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CRADD,Death domain-containing protein CRADD,42475,0.0412239774252016,0.00728253469483321,0.0269502094233285,0.0554977454270747,1.53909948202939e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SELP,P-selectin,42688,0.030890524479028,0.00545795643469656,0.0201929298670228,0.0415881190910333,1.54703209834036e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD99L2,CD99 antigen-like protein 2,42610,0.0134029625019327,0.00236840179335909,0.00876089498694891,0.0180450300169166,1.55305987009248e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BAP18,Chromatin complexes subunit BAP18,40482,0.0373616160144671,0.00660180171468884,0.024422084653677,0.0503011473752572,1.5568973081083e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD86,T-lymphocyte activation antigen CD86,40448,0.0168061396697551,0.00297017236032383,0.0109846018435204,0.0226276774959898,1.56609534250652e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ST13,Hsc70-interacting protein,40282,0.0311587639310852,0.00551076364647423,0.0203576671839957,0.0419598606781747,1.6047785453804e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,A1BG,Alpha-1B-glycoprotein,40538,0.00938042359228104,0.00166133960889311,0.00612419795885055,0.0126366492257115,1.6787556053075e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TBCC,Tubulin-specific chaperone C,42494,0.0440726731694594,0.00780726194449932,0.0287704397582407,0.0593749065806781,1.68473265507956e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CLU,Clusterin,40538,0.0174202527466278,0.0030871171614821,0.0113695031101229,0.0234710023831327,1.71230583799487e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FETUB,Fetuin-B,42662,0.0176845052170611,0.00314052358694669,0.0115290789866456,0.0238399314474766,1.82676619768434e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CRKL,Crk-like protein,42635,0.05738339941231,0.0101923079632022,0.0374064758044337,0.0773603230201863,1.83743543060389e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MATN2,Matrilin-2,42637,0.0162597651243116,0.00289265568549374,0.0105901599807439,0.0219293702678794,1.9357453091002e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DKK1,Dickkopf-related protein 1,42710,0.0321505211127831,0.00572062503071937,0.0209380960525731,0.0433629461729931,1.94612780154924e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GIGYF2,GRB10-interacting GYF protein 2,40481,0.0411177704468369,0.00732857379889179,0.026753765801009,0.0554817750926648,2.0636367881714e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NUDC,Nuclear migration protein nudC,42753,0.0338223693578019,0.00604103586230225,0.0219819390676895,0.0456627996479144,2.20069454995404e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PCBP2,Poly(rC)-binding protein 2,40481,0.0392648473951376,0.00701475129171551,0.0255159348633752,0.0530137599269,2.2258125293214e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FLT1,Vascular endothelial growth factor receptor 1,42558,0.0118502127124941,0.00211766795298714,0.00769958352463928,0.0160008419003489,2.23822990458704e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,42544,0.0154959712320342,0.00277115772155661,0.0100645020977833,0.0209274403662852,2.29037488997031e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ARHGAP45,Rho GTPase-activating protein 45,40282,0.0449428371935953,0.008040778740846,0.0291829108615371,0.0607027635256534,2.33288052836817e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TYMP,Thymidine phosphorylase,42562,0.0354574970666805,0.00635284054507152,0.0230059295983403,0.0479090645350207,2.43286622873496e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FN1,Fibronectin,40538,0.0145281074854323,0.00260297113605021,0.00942628405877392,0.0196299309120907,2.44130683847593e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,APRT,Adenine phosphoribosyltransferase,42479,0.0257485226527935,0.00461704643731686,0.0166991116356524,0.0347979336699346,2.49709085240592e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IGBP1,Immunoglobulin-binding protein 1,40481,0.0331425244628829,0.0059437531667939,0.0214927682559668,0.0447922806697989,2.51732155296854e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CC2D1A,Coiled-coil and C2 domain-containing protein 1A,42494,0.0395505874470436,0.00709829968643418,0.0256379200616326,0.0534632548324546,2.5695995178632e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IMPA1,Inositol monophosphatase 1,42494,0.0328331210424811,0.00589980625735669,0.021269500778062,0.0443967413069002,2.67039372722568e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,42617,0.0218081596795785,0.0039200027980693,0.0141249541953627,0.0294913651637944,2.69781432242355e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ROBO1,Roundabout homolog 1,42637,0.0133387000882472,0.002397722515819,0.00863916395724198,0.0180382362192525,2.70130943210513e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TACC3,Transforming acidic coiled-coil-containing protein 3,42586,0.0625509129716365,0.0112490575905647,0.0405027600941298,0.0845990658491433,2.74077450751467e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NOTCH2,Neurogenic locus notch homolog protein 2,40526,0.0115303476341886,0.00207497563646685,0.00746339538671359,0.0155972998816636,2.80877351275747e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GMPR2,GMP reductase 2,40282,0.0365462074128105,0.00657674413059149,0.0236557889168511,0.0494366259087698,2.80974782830405e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LAT2,Linker for activation of T-cells family member 2,42586,0.0667820561217069,0.0120210265297427,0.0432208441234113,0.0903432681200025,2.82198809348555e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FABP1,"Fatty acid-binding protein, liver",42617,0.0510974952814208,0.00921856146479064,0.0330291148104311,0.0691658757524104,3.03126039338586e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KITLG,Kit ligand,42635,-0.0203294618211166,0.00366971558190651,-0.0275221043616534,-0.0131368192805799,3.08521312541016e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LY6D,Lymphocyte antigen 6D,42547,0.02211723422114,0.00399445736417012,0.0142880977873666,0.0299463706549135,3.13539553886799e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SEMA4C,Semaphorin-4C,42586,0.0150715625084844,0.0027231212015148,0.00973424495351534,0.0204088800634534,3.17684393538888e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ENO1,Alpha-enolase,42587,0.0425852733328668,0.00769581600752201,0.0275014739581236,0.0576690727076099,3.19684238258864e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FKBPL,FK506-binding protein-like,40448,0.0315397691562963,0.00570695932262472,0.0203541288839519,0.0427254094286408,3.33870413326842e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,42494,0.0316243045698371,0.00572419581078506,0.0204048807806984,0.0428437283589758,3.36304245404406e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,USP8,Ubiquitin carboxyl-terminal hydrolase 8,42356,0.0508066290739598,0.0092010312208905,0.0327726078810144,0.0688406502669052,3.41823755420547e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD300LG,CMRF35-like molecule 9,42610,-0.0207312875513335,0.00375485846017662,-0.0280908101332797,-0.0133717649693874,3.42967380359437e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SNAP25,Synaptosomal-associated protein 25,40135,0.0255034889978558,0.00462531358858207,0.0164378743642349,0.0345691036314767,3.58949120618925e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",42593,0.0512299006011002,0.00929438736541098,0.0330129013648947,0.0694468998373057,3.61504544404997e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DNAJB14,DnaJ homolog subfamily B member 14,40448,0.0340284589643016,0.00617340240203517,0.0219285902563126,0.0461283276722905,3.6237641695143e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RNASE3,Eosinophil cationic protein,42577,0.0591461277217279,0.0107426218136095,0.0380905889670533,0.0802016664764025,3.74384712932517e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SERPINA7,Thyroxine-binding globulin,40538,0.00995164595592664,0.00180773338084901,0.00640848852946259,0.0134948033823907,3.77111917674443e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ATP6V1G1,V-type proton ATPase subunit G 1,40222,0.0387925696065747,0.00705129264620962,0.0249720360200039,0.0526131031931456,3.85017432399811e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SRPK2,SRSF protein kinase 2,42593,0.0445791725885688,0.0081112551599205,0.0286811124751246,0.060477232702013,3.95680955076163e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TDRKH,Tudor and KH domain-containing protein,42310,0.0453232997637134,0.00824956615062692,0.0291541501084847,0.0614924494189422,4.00206454141334e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SNCG,Gamma-synuclein,42494,0.0368525544590994,0.00672100808059469,0.0236793786211338,0.050025730297065,4.25348490980176e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,42494,0.0498473775039134,0.00909209739112362,0.0320268666173111,0.0676678883905157,4.2701635828162e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KIT,Mast/stem cell growth factor receptor Kit,42662,0.0161477620817494,0.00294651549652698,0.0103725917085566,0.0219229324549423,4.32260879531275e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GP6,Platelet glycoprotein VI,42589,0.0464847290831793,0.00848308995596026,0.0298578727694972,0.0631115853968614,4.3376275618389e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HDGFL2,Hepatoma-derived growth factor-related protein 2,40482,0.0339194355937933,0.00618957089914295,0.0217878766314731,0.0460509945561135,4.34227942345743e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AXL,Tyrosine-protein kinase receptor UFO,42688,0.0148501274040153,0.00271101763679262,0.00953653283590174,0.0201637219721288,4.38619618201259e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,42494,0.0416360140068501,0.00760269925386486,0.026734723469275,0.0565373045444253,4.41752940595299e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CSF1R,Macrophage colony-stimulating factor 1 receptor,40531,0.0218047322297897,0.00398358894246015,0.0139968979025679,0.0296125665570116,4.50268396440615e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TBCB,Tubulin-folding cofactor B,42494,0.0530460388894516,0.00969272799857475,0.0340482920122451,0.0720437857666581,4.51086677105156e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ATOX1,Copper transport protein ATOX1,42678,0.0371601943453609,0.00679264898572321,0.0238466023333434,0.0504737863573784,4.56388223872523e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,VCAM1,Vascular cell adhesion protein 1,42662,0.0149692962636158,0.00273672417412843,0.00960531688232412,0.0203332756449076,4.58618472165646e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,OCLN,Occludin,40481,0.0240244141115921,0.00439584958352331,0.0154085489278864,0.0326402792952978,4.72080650401039e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LRRC59,Leucine-rich repeat-containing protein 59,40510,0.0258780075664104,0.00473702653278022,0.0165934355621612,0.0351625795706596,4.78271374733799e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TEK,Angiopoietin-1 receptor,42678,0.0117284185544726,0.00214913652769304,0.00751611096019422,0.0159407261487509,4.92050834166046e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BTN2A1,Butyrophilin subfamily 2 member A1,42675,0.014955292054887,0.00274236643064568,0.00958025385082143,0.0203303302589525,5.02790519878409e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ASGR1,Asialoglycoprotein receptor 1,42494,0.0162282946878545,0.00297625549963344,0.0103948339085729,0.022061755467136,5.05281006783521e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PILRB,Paired immunoglobulin-like type 2 receptor beta,42635,0.0310728741299431,0.00569885715397391,0.0199031141081543,0.042242634151732,5.05508583926941e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SERPING1,Plasma protease C1 inhibitor,40515,0.00976795145160764,0.00179137306085207,0.00625686025233759,0.0132790426508777,5.06316011041909e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",40222,0.0258855955829592,0.00475010754559428,0.0165753847935944,0.035195806372324,5.16052506308955e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,F11,Coagulation factor XI,40382,0.0160640265543351,0.002947857580342,0.0102862256968648,0.0218418274118054,5.16142750772568e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL7,Interleukin-7,42593,0.03366485519289,0.00618383225725825,0.0215445439686638,0.0457851664171162,5.30110539819719e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CCDC134,Coiled-coil domain-containing protein 134,40450,0.0259326074932273,0.00476472822246,0.0165937401772057,0.0352714748092489,5.36033076161384e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GSTT2B,Glutathione S-transferase theta-2B,40482,0.127406896862224,0.0234242026627639,0.0814954596432067,0.173318334081241,5.46630814332327e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LBR,Delta(14)-sterol reductase LBR,42710,0.0351947433505498,0.00648513660309155,0.0224838756084904,0.0479056110926093,5.83019364245365e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SPART,Spartin,40282,0.0406012706377955,0.00748083001477311,0.0259388438088402,0.0552636974667508,5.83930459733639e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ITGAL,Integrin alpha-L,40198,0.0236452380127283,0.00435676957872674,0.0151059696384239,0.0321845063870327,5.8446120957251e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,THBD,Thrombomodulin,42635,0.0160274117886863,0.00295397561357391,0.0102376195860814,0.0218172039912912,5.87249410167316e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SULT2A1,Bile salt sulfotransferase,42593,0.0296673430435507,0.00546995454703483,0.0189462321313624,0.040388453955739,5.93938322566435e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ITGB1BP2,Integrin beta-1-binding protein 2,42356,0.0579132645853461,0.010683862456753,0.0369728941701103,0.078853635000582,6.04363227436281e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TXNDC9,Thioredoxin domain-containing protein 9,40482,0.0278026055977175,0.00512903644401688,0.0177496941674445,0.0378555170279906,6.06117974163683e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CRHBP,Corticotropin-releasing factor-binding protein,42617,0.0144947663662713,0.0026752028100156,0.00925136885864068,0.0197381638739018,6.1242941405237e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PECR,Peroxisomal trans-2-enoyl-CoA reductase,40222,0.0149795468355405,0.00276457740880855,0.0095609751142757,0.0203981185568052,6.14045901943957e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HEPH,Hephaestin,40510,-0.0139914663746261,0.00258722818342344,-0.0190624336141361,-0.00892049913511618,6.50657717787962e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,40188,0.0185642382571427,0.00343549619652791,0.011830665711948,0.0252978108023374,6.66594631481929e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,42585,0.0320163066078163,0.00592847597920938,0.0203964936885659,0.0436361195270667,6.76172651333492e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CAPG,Macrophage-capping protein,42460,0.0308767935025383,0.00571988715434653,0.0196658146800191,0.0420877723250575,6.84911957796132e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CHMP1A,Charged multivesicular body protein 1a,42494,0.0414704224418521,0.00768615392778288,0.0264055607433976,0.0565352841403065,6.95146723386239e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PRG2,Bone marrow proteoglycan,40526,0.0278486437865745,0.00516219540269879,0.0177307407972849,0.0379665467758642,7.00078543953772e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,XG,Glycoprotein Xg,42733,0.0181824602854387,0.00337236221686408,0.0115726303403851,0.0247922902304923,7.10010080325326e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PTPN6,Tyrosine-protein phosphatase non-receptor type 6,42653,0.0465340705335551,0.00863294852589171,0.0296134914228073,0.0634546496443028,7.15314523016063e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,40448,0.0336018151962228,0.00623801798220127,0.0213752999511083,0.0458283304413373,7.32421182557721e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IGFBP3,Insulin-like growth factor-binding protein 3,42688,0.0166888650100744,0.00309909913831919,0.0106146306989688,0.02276309932118,7.36299244815608e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TSHB,Thyrotropin subunit beta,42635,0.0417144651013253,0.00775708749343187,0.0265105736141988,0.0569183565884517,7.67508936906041e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SOD1,Superoxide dismutase [Cu-Zn],42364,0.0251619631270177,0.00468279512773755,0.0159836846766521,0.0343402415773833,7.86339671814721e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TREML1,Trem-like transcript 1 protein,40531,0.0275651646481327,0.00513289963754625,0.017504681358542,0.0376256479377233,8.01627186744924e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TP53I3,Quinone oxidoreductase PIG3,40057,0.0278759258632928,0.00519375383563646,0.0176961683454454,0.0380556833811403,8.16131507812171e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EIF4B,Eukaryotic translation initiation factor 4B,42494,0.0300562603615741,0.00560111026935207,0.0190780842336441,0.0410344364895042,8.17950125640197e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PROK1,Prokineticin-1,42593,0.0289683877512324,0.00540051720187262,0.018383374035562,0.0395534014669027,8.27505066689466e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DIABLO,"Diablo homolog, mitochondrial",42602,0.0568594345444134,0.0106115356709904,0.0360608246292722,0.0776580444595547,8.54139275183761e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,JPT2,Jupiter microtubule associated homolog 2,40448,0.0453731852995791,0.00847143570883113,0.0287691713102701,0.0619771992888881,8.67504802983096e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TNFSF8,Tumor necrosis factor ligand superfamily member 8,40526,0.0193487641182694,0.00361387759972623,0.0122655640228059,0.0264319642137328,8.77026915675251e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,42345,0.0346602480456821,0.00648653070928331,0.0219466478554868,0.0473738482358774,9.27314376660342e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,VEGFC,Vascular endothelial growth factor C,42678,0.0289129285170634,0.00542107483600113,0.0182876218385011,0.0395382351956256,9.79305625060917e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TBC1D23,TBC1 domain family member 23,42586,0.0464747350198982,0.00872044693489992,0.0293826590274943,0.063566811012302,1.00136284661933e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LAP3,Cytosol aminopeptidase,42369,0.0252166213458987,0.00473252537885899,0.015940871603335,0.0344923710884623,1.00733084590481e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NSFL1C,NSFL1 cofactor p47,42710,0.0336664566423588,0.00632045029669904,0.0212783740608287,0.0460545392238889,1.01677088422862e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DOK2,Docking protein 2,42635,0.0623643863182965,0.0117190647070146,0.039395019492548,0.0853337531440451,1.04500250217236e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EREG,Proepiregulin,42475,0.0416548871154636,0.00783682966436194,0.0262947009733142,0.057015073257613,1.08220928075065e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LAMP3,Lysosome-associated membrane glycoprotein 3,42745,0.0272790075727416,0.00513247579480225,0.0172193550149292,0.037338660130554,1.08359918991051e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TCOF1,Treacle protein,40510,0.0166887356548214,0.00314559608081123,0.0105233673364314,0.0228541039732114,1.14530296272598e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RRAS,Ras-related protein R-Ras,40181,0.0669500106490638,0.0126397166566512,0.0421761660020275,0.0917238552961001,1.20128866389287e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RNASE1,Ribonuclease pancreatic,40531,0.0137156204544953,0.00259107331658094,0.00863711675399663,0.0187941241549939,1.22296501008378e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EHD3,EH domain-containing protein 3,40222,0.0604967632107585,0.0114339667631289,0.0380861883550259,0.0829073380664911,1.24002091094211e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CPXM2,Inactive carboxypeptidase-like protein X2,40510,0.0138241234105224,0.0026133296109127,0.00870199737313349,0.0189462494479113,1.24700578743597e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DCTPP1,dCTP pyrophosphatase 1,42635,0.0163802069804876,0.003099125564526,0.0103059208740167,0.0224544930869586,1.2737219638106e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DTNB,Dystrobrevin beta,40429,0.0220935160706814,0.00417968615316413,0.0139013312104797,0.0302857009308831,1.27413726966929e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,42710,0.0368871795506218,0.00697996733555456,0.0232064435729349,0.0505679155283088,1.27853535715715e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HSDL2,Hydroxysteroid dehydrogenase-like protein 2,40222,0.0252687432110493,0.00478313287523505,0.0158938027755886,0.03464368364651,1.2958778226661e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GRAP2,GRB2-related adapter protein 2,42635,0.0653160169581776,0.0123783970812703,0.0410543586788877,0.0895776752374675,1.33637815302262e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,40282,0.0216228862962722,0.00410292061101913,0.0135811618986747,0.0296646106938697,1.38893335632544e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KLKB1,Plasma kallikrein,40292,0.012687539910783,0.00240763127595312,0.00796858260991488,0.0174064972116511,1.39194554475855e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SIGLEC6,Sialic acid-binding Ig-like lectin 6,42720,0.0176420578264339,0.00334916753273033,0.0110776894622825,0.0242064261905854,1.40342748129185e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SMOC2,SPARC-related modular calcium-binding protein 2,42675,0.020265169387854,0.00384771538333137,0.0127236472365245,0.0278066915391834,1.4095305664838e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PPL,Periplakin,40198,0.0171608223015113,0.00326049381411297,0.0107702544258499,0.0235513901771728,1.44187692923891e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SORT1,Sortilin,42612,0.0189724799511312,0.00360605249448779,0.0119046170619352,0.0260403428403273,1.4525147973087e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,42593,0.0507130748494675,0.00964045952560426,0.0318177741792831,0.0696083755196518,1.45923278102642e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MDH1,"Malate dehydrogenase, cytoplasmic",40480,0.0204104177925548,0.00388104900331764,0.0128035617460522,0.0280172738390574,1.47493655585321e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD40LG,CD40 ligand,42753,0.0397513907411152,0.00756550270095345,0.0249230054472464,0.054579776034984,1.50842946838228e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",40407,0.0557279702515669,0.0106139735466253,0.0349245821001813,0.0765313584029524,1.54516617864316e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FAM3B,Protein FAM3B,42586,-0.0180810529648671,0.00345128104187616,-0.0248455638069444,-0.0113165421227899,1.63951309846672e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CALCB,Calcitonin gene-related peptide 2,40482,0.0210038796088562,0.00400906101724099,0.0131461200150638,0.0288616392026485,1.64266983905402e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NUB1,NEDD8 ultimate buster 1,42593,0.0423525431307053,0.00808560451777708,0.0265047582758622,0.0582003279855484,1.64768833263197e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,WARS,"Tryptophan--tRNA ligase, cytoplasmic",42610,0.0199178510335557,0.00380276666988472,0.0124644283605817,0.0273712737065298,1.65025834829319e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,WNT9A,Protein Wnt-9a,42369,0.0152272384059672,0.00290732832791313,0.00952887488325751,0.020925601928677,1.65240492736347e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CXCL16,C-X-C motif chemokine 16,42777,0.0122139020809237,0.0023333365882896,0.00764056236787608,0.0167872417939713,1.67877370898946e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CRLF1,Cytokine receptor-like factor 1,42675,0.0128656284566913,0.00245795787191313,0.00804803102774154,0.017683225885641,1.68120101777175e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LTBP2,Latent-transforming growth factor beta-binding protein 2,42793,0.0168474213471492,0.00321902660714341,0.0105381291971481,0.0231567134971503,1.68621234067735e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SCPEP1,Retinoid-inducible serine carboxypeptidase,40168,0.0251135042799703,0.00480052904030813,0.0157044673609664,0.0345225411989743,1.71328310858596e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EHBP1,EH domain-binding protein 1,40510,0.0378023879123851,0.0072291218159495,0.0236333091531241,0.0519714666716462,1.73299793276506e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ACYP1,Acylphosphatase-1,40249,0.0334487160009525,0.00640474217451619,0.0208954213389008,0.0460020106630043,1.79739054128482e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,42494,0.0222005809207887,0.00425158498700262,0.0138674743462636,0.0305336874953138,1.79942910694105e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SERPINB1,Leukocyte elastase inhibitor,42568,0.045076726076055,0.00864498603681097,0.0281325534439055,0.0620208987082045,1.87360098290373e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SERPIND1,Heparin cofactor 2,40515,0.0143039955418304,0.00274511112192618,0.00892357774285512,0.0196844133408057,1.91421209570004e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CDC37,Hsp90 co-chaperone Cdc37,42678,0.0423513518997772,0.00814457288484026,0.0263879890454903,0.0583147147540641,2.02261341513256e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SMAD1,Mothers against decapentaplegic homolog 1,42345,0.0411902608178349,0.00792397202694773,0.0256592756450173,0.0567212459906524,2.04260809110141e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IPCEF1,Interactor protein for cytohesin exchange factors 1,42474,0.0449912113162995,0.00866361085366583,0.0280105340431145,0.0619718885894845,2.09850263083636e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MENT,Protein MENT,40282,-0.0117874893433241,0.0022696349861644,-0.0162359739162063,-0.00733900477044183,2.0996642074527e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BAG4,BAG family molecular chaperone regulator 4,40198,0.024823151188682,0.00477975289542022,0.0154548355136584,0.0341914668637056,2.10180781274878e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FAM20A,Pseudokinase FAM20A,40510,0.0143023815658642,0.00275641830203313,0.00889980169387923,0.0197049614378491,2.15367912541778e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BMPER,BMP-binding endothelial regulator protein,40282,0.0117705286399349,0.00227214121777145,0.00731713185310283,0.0162239254267669,2.25335687099207e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PTPRF,Receptor-type tyrosine-protein phosphatase F,42793,0.0146432515757994,0.00283198219190726,0.00909256647966116,0.0201939366719376,2.36563588179056e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SCGB3A1,Secretoglobin family 3A member 1,40282,-0.0135424757857002,0.00262062912720916,-0.0186789088750302,-0.00840604269637029,2.41186656876772e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",40510,0.0153126169100308,0.00296360567904191,0.00950394977910867,0.021121284040953,2.42077039581594e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,UNC5D,Netrin receptor UNC5D,40198,0.0132386722711825,0.00256305943889684,0.00821507577094471,0.0182622687714203,2.4440416264585e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PDGFB,Platelet-derived growth factor subunit B,42675,0.0429792779965685,0.00833055089348942,0.0266513982453292,0.0593071577478078,2.51479013594002e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MITD1,MIT domain-containing protein 1,42494,0.0480951338761799,0.00932344369224618,0.0298211842393774,0.0663690835129824,2.52494165448904e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CDKN1A,Cyclin-dependent kinase inhibitor 1,42586,0.0525549325547959,0.0101905003470131,0.0325815518746503,0.0725283132349416,2.54181829731527e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AMIGO2,Amphoterin-induced protein 2,42586,0.0118227452977866,0.00229664639519869,0.00732131836319717,0.0163241722323761,2.67250054769688e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,40282,0.029046638808885,0.0056433135171513,0.0179857443152684,0.0401075333025015,2.69088700676546e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CLPS,Colipase,42589,0.0366831535071692,0.00712979852131778,0.0227087484053864,0.0506575586089521,2.71232750176257e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,OGFR,Opioid growth factor receptor,42586,0.016316246350611,0.00317469291507514,0.0100938482370637,0.0225386444641583,2.7938937148516e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LGALS3,Galectin-3,42668,0.0150133452368618,0.00292502833650681,0.00928028969730845,0.0207464007764151,2.89562994721489e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EVI5,Ecotropic viral integration site 5 protein homolog,40198,0.0445324427954312,0.00867942822364986,0.0275207634770774,0.0615441221137849,2.93423898076379e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PLPBP,Pyridoxal phosphate homeostasis protein,42635,0.0334303456193335,0.00651797229531632,0.0206551199205135,0.0462055713181535,2.95418699463041e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",40510,0.044635513052617,0.00870705972909821,0.0275696759835845,0.0617013501216495,3.00276808608799e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CCL14,C-C motif chemokine 14,42617,0.0202157122242657,0.0039464602518811,0.0124806501305787,0.0279507743179526,3.05703914549843e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,40181,0.0275998638287873,0.00539311652336399,0.0170293554429939,0.0381703722145807,3.14661013960598e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TNC,Tenascin,42688,0.0241889614129271,0.00472817555523833,0.01492173732466,0.0334561855011943,3.16502071047539e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EDA2R,Tumor necrosis factor receptor superfamily member 27,42720,0.0205751250174848,0.00402483547724909,0.0126864474820766,0.028463802552893,3.2304629048783e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LTA,Lymphotoxin-alpha,42593,0.0203577014336304,0.00398729922823775,0.0125425949462844,0.0281728079209764,3.34203355474006e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AFAP1,Actin filament-associated protein 1,40282,0.0415348027522418,0.00814105666907522,0.0255783316808544,0.0574912738236293,3.41835145721236e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GZMH,Granzyme H,42356,0.0387294048374362,0.00759860285535376,0.0238361432409428,0.0536226664339295,3.50027983896031e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TXNRD1,"Thioredoxin reductase 1, cytoplasmic",42610,0.022440806562018,0.00441478725696086,0.0137878235383747,0.0310937895856613,3.76322201114008e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,40115,0.020116786313124,0.0039623116435013,0.0123506554918615,0.0278829171343866,3.89693182152142e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NADK,NAD kinase,42635,0.0271048555309672,0.00534570247608532,0.0166272786778399,0.0375824323840944,4.02260822274793e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL15RA,Interleukin-15 receptor subunit alpha,42369,0.0179449858024075,0.00354222945556815,0.0110022160694939,0.024887755535321,4.11727919199533e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PRSS8,Prostasin,42567,-0.0207271924135502,0.00409870857889299,-0.0287606612281805,-0.01269372359892,4.31528737450905e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KLK6,Kallikrein-6,42655,0.0156829947866058,0.00310666310173162,0.00959393510721183,0.0217720544659998,4.51865002558085e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SCRG1,Scrapie-responsive protein 1,40510,0.0140847735523701,0.00278987918779271,0.00861661034429635,0.0195529367604438,4.52162332907597e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PRKAB1,5'-AMP-activated protein kinase subunit beta-1,42369,0.0261777043455866,0.00519092755494697,0.0160034863378906,0.0363519223532827,4.64448890233711e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,40510,0.0163784113143426,0.00325489448149376,0.00999881813061478,0.0227580044980703,4.93017123013269e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,40481,0.0395029073097178,0.00785291107996288,0.0241112015929905,0.054894613026445,4.97110510839216e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DAAM1,Disheveled-associated activator of morphogenesis 1,40282,0.0408955354625069,0.00813647032530922,0.0249480536249009,0.056843017300113,5.08100569710055e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,42650,0.0285620814166749,0.0056870975248682,0.0174153702679332,0.0397087925654166,5.17211530997146e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,COX6B1,Cytochrome c oxidase subunit 6B1,40510,0.0160397830464227,0.00319374148070566,0.00978004974423965,0.0222995163486058,5.18470023382988e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MAGED1,Melanoma-associated antigen D1,42345,0.0237019267541978,0.0047197948059719,0.0144511289344929,0.0329527245739028,5.18567107940969e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SUGT1,Protein SGT1 homolog,42345,0.0391572286656195,0.0078091338251537,0.0238513263683182,0.0544631309629208,5.39242640217893e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,40301,0.0186954812380811,0.0037338165029264,0.0113772008923453,0.0260137615838168,5.61132743865714e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,42720,0.0130404009731586,0.00260575218033583,0.00793312669970036,0.0181476752466168,5.67208165308454e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AAMDC,Mth938 domain-containing protein,40222,0.0259294089252984,0.00518270008566033,0.0157713167574042,0.0360875010931927,5.72944135674471e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DNMBP,Dynamin-binding protein,42494,0.0292327540428685,0.00584424600868233,0.0177780318658512,0.0406874762198859,5.74708620008295e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CRYZL1,Quinone oxidoreductase-like protein 1,40222,0.0445985161653663,0.00892592733321521,0.0271036985922645,0.0620933337384682,5.92714524578693e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD70,CD70 antigen,42593,0.0211245190858419,0.00423225348601899,0.0128293022532446,0.0294197359184391,6.0722118879784e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NECTIN4,Nectin-4,42678,0.0168804120187828,0.00338341942492124,0.0102489099459371,0.0235119140916284,6.13987583692825e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ZNRF4,E3 ubiquitin-protein ligase ZNRF4,40450,0.026880729857914,0.00539594164028188,0.0163046842429615,0.0374567754728664,6.39784741648077e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DNAJC9,DnaJ homolog subfamily C member 9,40448,0.0372750228675611,0.00748381070574837,0.0226067538842943,0.0519432918508279,6.42771078037325e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MAPK9,Mitogen-activated protein kinase 9,42593,0.0204326954998064,0.00410857822492264,0.012379882178958,0.0284855088206548,6.6679348808064e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,42345,0.0211527080777597,0.00425435462487722,0.0128141730130003,0.029491243142519,6.70964486953982e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CCL4,C-C motif chemokine 4,42641,0.03319886440413,0.00668193162106944,0.0201022784268339,0.0462954503814261,6.83187590414164e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LSP1,Lymphocyte-specific protein 1,42593,0.0192506072497317,0.00387590908058,0.0116538254517949,0.0268473890476685,6.89290205104788e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AGRP,Agouti-related protein,42753,0.0249892967824818,0.00504740874554275,0.015096375641218,0.0348822179237455,7.47532379484653e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CORO1A,Coronin-1A,42352,0.0429901142478541,0.00868821309840921,0.025961216574972,0.0600190119207361,7.58696439888304e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ENO2,Gamma-enolase,42710,0.0310101849496524,0.00628938292998432,0.0186829944068831,0.0433373754924217,8.29673980628951e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DYNLT1,Dynein light chain Tctex-type 1,40181,0.0387420533205373,0.0078637030465921,0.0233291953492168,0.0541549112918578,8.4852006848632e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,STAT5B,Signal transducer and activator of transcription 5B,42586,0.0657079961638748,0.0133426306071469,0.0395564401738668,0.0918595521538827,8.55126400371111e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NRGN,Neurogranin,40531,0.0436969868618971,0.008873938636795,0.0263040671337789,0.0610899065900153,8.59033315995088e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CR2,Complement receptor type 2,42688,0.023088656203943,0.00468954481621418,0.0138971483641632,0.0322801640437227,8.6044995394675e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,42345,0.031215926591913,0.00634108774255251,0.01878739461651,0.0436444585673159,8.63481062675273e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PALM,Paralemmin-1,40383,0.0151631293440716,0.0030845111577282,0.00911748747492431,0.0212087712132189,8.96325083191737e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SKAP2,Src kinase-associated phosphoprotein 2,42675,0.0498667760198211,0.0101523783687495,0.0299681144170721,0.0697654376225701,9.12877624688881e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,COMMD1,COMM domain-containing protein 1,40222,0.0289162530693143,0.0058874929874153,0.0173767668139803,0.0404557393246482,9.16926497339062e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL7R,Interleukin-7 receptor subunit alpha,42610,-0.025277478183096,0.0051483589812731,-0.0353682617863913,-0.0151866945798007,9.22362586933983e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,40464,0.038477592622549,0.00784103216374778,0.0231091695816034,0.0538460156634947,9.36736940344686e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MCEMP1,Mast cell-expressed membrane protein 1,40198,0.0435652616250354,0.00888735254206433,0.0261460506425893,0.0609844726074815,9.6249688642216e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GDNF,Glial cell line-derived neurotrophic factor,42310,0.0183179650292253,0.00373725889280749,0.0109929375993227,0.025642992459128,9.62725400206327e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SUGP1,SURP and G-patch domain-containing protein 1,40448,0.0190829362977964,0.00389531064376098,0.0114481274360249,0.0267177451595679,9.76909628522738e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CEP43,Centrosomal protein 43,42254,0.0329592660972261,0.00674260768249445,0.019743755039537,0.0461747771549153,1.02967676695939e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MAPKAPK2,MAP kinase-activated protein kinase 2,40301,0.0351874712098278,0.00720876056942516,0.0210583004937545,0.0493166419259011,1.06903736669228e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PMM2,Phosphomannomutase 2,40115,0.0286932277753107,0.00588162913910079,0.0171652346626731,0.0402212208879482,1.08432766357234e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,42356,0.0151126809229925,0.00309926365362955,0.00903812416187854,0.0211872376841064,1.09403118316769e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TREM2,Triggering receptor expressed on myeloid cells 2,42617,0.0249070868320737,0.00511338394946373,0.0148848542911248,0.0349293193730226,1.1232423643069e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,S100A14,Protein S100-A14,40481,-0.0261289523559816,0.00536637666649321,-0.0366470506223083,-0.0156108540896549,1.1367789518046e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CASP1,Caspase-1,42310,0.0329387268316825,0.0067688145646609,0.0196718502849471,0.0462056033784179,1.15059896264725e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RAD23B,UV excision repair protein RAD23 homolog B,42345,0.0221564582590642,0.00455849554421727,0.0132218069923984,0.0310911095257301,1.1845594157234e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DUSP13,Dual specificity protein phosphatase 13 isoform A,40450,0.0199746651786163,0.00411101050252008,0.011917084593677,0.0280322457635557,1.19678814280109e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GPC5,Glypican-5,42494,0.0266894310405092,0.00549664110188493,0.0159160144808147,0.0374628476002036,1.21394293180358e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LDLRAP1,Low density lipoprotein receptor adapter protein 1,40481,0.0460137934751279,0.0094786969924352,0.0274355473699549,0.0645920395803009,1.22343198580777e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SLITRK2,SLIT and NTRK-like protein 2,42720,0.0188187382534503,0.00388179680103712,0.0112104165234175,0.026427059983483,1.2613317400383e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ESAM,Endothelial cell-selective adhesion molecule,42793,0.0153577517970447,0.00317239340883534,0.00913986071572748,0.021575642878362,1.30567037129968e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PDGFC,Platelet-derived growth factor C,42345,0.0134546992636825,0.00278568948118186,0.00799474788056605,0.0189146506467989,1.38116582783286e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CASP2,Caspase-2,42593,0.0316512103606434,0.00655578796288542,0.0188018659533879,0.0445005547678988,1.39448135839236e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,42310,0.0521550835078486,0.0108084881036739,0.0309704468246478,0.0733397201910493,1.41308251622494e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,THY1,Thy-1 membrane glycoprotein,42710,0.0141768844764212,0.00294695485798682,0.00840085295476699,0.0199529159980753,1.52034253536984e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SMAD5,Mothers against decapentaplegic homolog 5,42586,0.00942376175274865,0.00195908101451123,0.00558396296430664,0.0132635605411907,1.52347557814712e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ICA1,Islet cell autoantigen 1,42369,0.0368799138759402,0.00767006902957189,0.0218465785779793,0.0519132491739011,1.53909787533094e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ZBTB17,Zinc finger and BTB domain-containing protein 17,42356,0.0198085438596974,0.00412714274470277,0.01171934408008,0.0278977436393148,1.60747297542041e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TBL1X,F-box-like/WD repeat-containing protein TBL1X,42345,0.0394700608430266,0.00823014511529976,0.0233389764170391,0.0556011452690141,1.63810128606212e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PSIP1,PC4 and SFRS1-interacting protein,42593,0.0300580885653404,0.00626892730996602,0.017770991037807,0.0423451860928738,1.64609352639098e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CGREF1,Cell growth regulator with EF hand domain protein 1,42635,-0.0203006419033355,0.00424216936465727,-0.0286152938580638,-0.0119859899486073,1.72428959492957e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CASP7,Caspase-7,40482,0.0388959865872049,0.00813739990819537,0.0229466827671419,0.0548452904072678,1.77592465063678e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,42345,0.0316132210475336,0.00662009474999414,0.0186378353375451,0.0445886067575221,1.81336170045243e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CASP3,Caspase-3,42793,0.0403232364425855,0.00845297005446451,0.023755415135835,0.0568910577493359,1.85858434078497e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ARF6,ADP-ribosylation factor 6,40448,0.0498117512448898,0.0104411212720018,0.0293471535517662,0.0702763489380133,1.85867368092107e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CFHR2,Complement factor H-related protein 2,40450,0.0269623236919931,0.005659250750898,0.015870192220233,0.0380544551637532,1.91886056543294e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DSCAM,Down syndrome cell adhesion molecule,40481,0.0168385611994454,0.00353828960400528,0.00990351357559509,0.0237736088232958,1.97012309757685e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PDLIM5,PDZ and LIM domain protein 5,40481,0.0540787898433453,0.011375375365115,0.0317830541277199,0.0763745255589708,2.01873239898063e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,42593,0.046448132358182,0.00977484312308794,0.0272894398369297,0.0656068248794344,2.03703857486085e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,STK24,Serine/threonine-protein kinase 24,42310,0.0284760526601774,0.00600006415836763,0.0167159269097768,0.0402361784105779,2.09712839596241e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SLC51B,Organic solute transporter subunit beta,40115,-0.0358731761660687,0.00756181642097634,-0.0506943363511823,-0.021052015980955,2.12205074185241e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IGSF8,Immunoglobulin superfamily member 8,42635,0.0141942543482185,0.00299415255531309,0.00832571533980488,0.0200627933566322,2.1521002700937e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",40282,0.0479114146791555,0.0101215911465378,0.0280730960319414,0.0677497333263696,2.23317706605815e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ATG16L1,Autophagy-related protein 16-1,40448,0.0389021597939165,0.00822637194901701,0.0227784707738432,0.0550258488139899,2.28416758600891e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MBL2,Mannose-binding protein C,40378,0.0504112904192809,0.0106658001568974,0.029506322111762,0.0713162587267998,2.31274063730349e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RNASEH2A,Ribonuclease H2 subunit A,40481,0.0221153495222262,0.00468067422978993,0.0129412280318379,0.0312894710126145,2.33097161150254e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PSMG3,Proteasome assembly chaperone 3,42593,0.0235247292139963,0.00499166765364486,0.0137410606128524,0.0333083978151403,2.46794199307719e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KCTD5,BTB/POZ domain-containing protein KCTD5,40289,0.0203599573213818,0.00432054854687947,0.011891682169498,0.0288282324732655,2.47846566675954e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,WDR46,WD repeat-containing protein 46,40450,0.0165391879063784,0.00351285522430508,0.00965399166674046,0.0234243841460164,2.5291027977472e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SYTL4,Synaptotagmin-like protein 4,40510,0.0338120344022364,0.00718682230035295,0.0197258626935446,0.0478982061109282,2.57216197966654e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GNPDA2,Glucosamine-6-phosphate isomerase 2,40282,0.016833838724453,0.00358066601157004,0.00981573334177573,0.0238519441071303,2.61606544623769e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SETMAR,Histone-lysine N-methyltransferase SETMAR,42458,0.013697341097741,0.00291396916481662,0.00798596153470043,0.0194087206607816,2.62035266151779e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TTF2,Transcription termination factor 2,40181,0.0224707982918086,0.00478243944610694,0.013097216977439,0.0318443796061782,2.65122121466905e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SYT1,Synaptotagmin-1,40482,0.0194552804942763,0.00414357943394286,0.0113338648037483,0.0275766961848043,2.6937288687225e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PALM2,Paralemmin-2,40482,0.0172724028672834,0.00368380732527737,0.0100521405097397,0.024492665224827,2.78117112614216e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,39982,0.0225899537639719,0.00481827505551998,0.0131461346551527,0.032033772872791,2.78737643464261e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IFNL1,Interferon lambda-1,42310,0.0210252426305798,0.00448662747671769,0.0122314527762131,0.0298190324849465,2.81120051680167e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ITGA11,Integrin alpha-11,42593,-0.0155405666146518,0.00331671963787021,-0.0220413371048774,-0.00903979612442619,2.81992441187673e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TIGAR,"Fructose-2,6-bisphosphatase TIGAR",42291,0.0214932149794337,0.00458968593571223,0.0124974305454378,0.0304889994134297,2.85631899774813e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TARBP2,RISC-loading complex subunit TARBP2,42310,0.0356520988277493,0.00761461640415199,0.0207274506756113,0.0505767469798872,2.86850773481707e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EPHB6,Ephrin type-B receptor 6,42475,0.0153432152890277,0.00328351827394432,0.00890751947209684,0.0217789111059586,3.00042869775392e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,VPS53,Vacuolar protein sorting-associated protein 53 homolog,42586,0.0349146987866643,0.00747382170057818,0.0202660082535311,0.0495633893197976,3.0177149989852e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HIP1R,Huntingtin-interacting protein 1-related protein,40448,0.0203533472217096,0.00435686910142896,0.0118138837829089,0.0288928106605104,3.02393352259256e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DLG4,Disks large homolog 4,40482,0.0318155151626677,0.00682010690992198,0.0184481056192207,0.0451829247061148,3.12225385510744e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SMAD2,Mothers against decapentaplegic homolog 2,40450,0.0315053404663791,0.00675652953213268,0.0182625425833991,0.0447481383493592,3.15297791521204e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,XIAP,E3 ubiquitin-protein ligase XIAP,40198,0.0258896505269455,0.0055534733638284,0.0150048427338418,0.0367744583200491,3.17010539105162e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TSPYL1,Testis-specific Y-encoded-like protein 1,40198,0.0183381786713998,0.00394083179991829,0.01061414834356,0.0260622089992397,3.30353047730647e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SERPINA5,Plasma serine protease inhibitor,40386,0.0143112859321044,0.00307800100219939,0.00827840396779356,0.0203441678964152,3.36483311222703e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SEMA3G,Semaphorin-3G,40282,0.0203974667223861,0.00439116244295122,0.0117907883342017,0.0290041451105705,3.43792840319191e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KYNU,Kynureninase,42753,0.0201408440381847,0.00433791096018529,0.0116385385562215,0.0286431495201479,3.46638320122969e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ACE2,Angiotensin-converting enzyme 2,42356,-0.0243172058536495,0.00524706103326426,-0.0346014454788474,-0.0140329662284515,3.61335424656724e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MLN,Promotilin,42593,0.0400813177602597,0.0086571761065702,0.0231132525913821,0.0570493829291373,3.69390520020077e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GOT1,"Aspartate aminotransferase, cytoplasmic",40526,0.0185554378088489,0.0040125013113299,0.0106909352386422,0.0264199403790555,3.79828640831213e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SRP14,Signal recognition particle 14 kDa protein,42586,0.026731901199173,0.00578198854551523,0.0153992036499632,0.0380645987483829,3.81202563575584e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ICAM5,Intercellular adhesion molecule 5,42635,0.0207037735369221,0.00448905751554005,0.0119052208064635,0.0295023262673806,4.02388893130623e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL18R1,Interleukin-18 receptor 1,42753,0.0148418498399222,0.0032210661793732,0.00852856012835077,0.0211551395514937,4.10769976454337e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NELL2,Protein kinase C-binding protein NELL2,42675,0.0130430303150912,0.00283464914807068,0.00748711798487269,0.0185989426453098,4.23719119219502e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,THTPA,Thiamine-triphosphatase,40435,0.0394871013537366,0.00858166600547211,0.0226670359830113,0.0563071667244619,4.24389096754712e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BIRC2,Baculoviral IAP repeat-containing protein 2,42345,0.0280891530189737,0.00610751871996513,0.0161184163278421,0.0400598897101054,4.28257136901655e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FAM13A,Protein FAM13A,40448,0.0301669411208869,0.00656056467049604,0.0173082343667146,0.0430256478750591,4.30753830416643e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,OSM,Oncostatin-M,42533,0.0314105142257884,0.00683651255235045,0.0180109496231815,0.0448100788283953,4.37714120853979e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SMNDC1,Survival of motor neuron-related-splicing factor 30,40448,0.0266441520269207,0.00579874717893563,0.0152786075562068,0.0380096964976345,4.37847767612653e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SLAMF6,SLAM family member 6,42345,0.0174007809438302,0.00379431098836319,0.0099639314066383,0.024837630481022,4.55946948857815e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD1C,T-cell surface glycoprotein CD1c,42678,0.0113018033149146,0.00246715128392143,0.00646618679842858,0.0161374198314006,4.67100385751056e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,42657,-0.0291761268635406,0.00636966110972392,-0.0416606626385995,-0.0166915910884817,4.68064109611546e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CLEC4D,C-type lectin domain family 4 member D,42593,0.0278286969043191,0.00608076417606317,0.0159103991192352,0.0397469946894029,4.77037620512277e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HEG1,Protein HEG homolog 1,40282,0.0120751909125756,0.00263940333967753,0.00690196036680768,0.0172484214583436,4.81456161871929e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GPR37,Prosaposin receptor GPR37,42356,0.0305092245288361,0.00667211834371812,0.0174318725751486,0.0435865764825236,4.85997709638659e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,40481,0.0479456141557798,0.0104849734564147,0.0273950661812069,0.0684961621303527,4.86385283878045e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PLXNB3,Plexin-B3,42596,0.0208826660972648,0.00456936822742163,0.0119267043715184,0.0298386278230112,4.91745902232922e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,42657,0.0228643967695791,0.00500714450515085,0.0130503935394834,0.0326783999996747,5.00678764551739e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SKAP1,Src kinase-associated phosphoprotein 1,42475,0.0327455810771848,0.00717562388414706,0.0186813582642566,0.0468098038901131,5.07715757212674e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BAX,Apoptosis regulator BAX,42291,0.0396322045492547,0.00868619829648495,0.0226072558881442,0.0566571532103652,5.09674895802718e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD55,Complement decay-accelerating factor,42200,0.0121862313292868,0.00267138164120499,0.006950323312525,0.0174221393460485,5.11876787970874e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD93,Complement component C1q receptor,42140,0.0144042933643612,0.00315923061286753,0.00821220136314081,0.0205963853655815,5.17626329435901e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CDC42BPB,Serine/threonine-protein kinase MRCK beta,40448,0.0455881183445378,0.0100084080978214,0.025971638472808,0.0652045982162677,5.29407366787367e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CCL13,C-C motif chemokine 13,42733,0.0306958116432619,0.00674165789168146,0.0174821621755663,0.0439094611109576,5.33080661489365e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PPCDC,Phosphopantothenoylcysteine decarboxylase,42710,0.0204821436266427,0.00450069802919075,0.0116607754894288,0.0293035117638566,5.38872208595048e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PNMA1,Paraneoplastic antigen Ma1,40222,0.0247681192506716,0.00544491432647912,0.0140960871707725,0.0354401513305707,5.45145170789434e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PAK4,Serine/threonine-protein kinase PAK 4,42310,0.0269404968779311,0.00592658792737619,0.0153243845402737,0.0385566092155884,5.52423680272529e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MXRA8,Matrix remodeling-associated protein 8,40282,-0.0138714587824942,0.00305184645477025,-0.0198530778338439,-0.00788983973114455,5.54460693005207e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RILP,Rab-interacting lysosomal protein,42673,0.0263759530200754,0.00580745896903624,0.0149933334407644,0.0377585725993864,5.62763898793318e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SIT1,Signaling threshold-regulating transmembrane adapter 1,42369,0.0247105389294324,0.00544127007527026,0.0140456495819027,0.0353754282769621,5.6399440017527e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FARSA,Phenylalanine--tRNA ligase alpha subunit,40181,0.0307446991958078,0.00678038461147676,0.0174551453573133,0.0440342530343022,5.83899912787298e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PVALB,Parvalbumin alpha,42653,0.0486616172674818,0.0107427510277258,0.0276058252531392,0.0697174092818244,5.95706472720298e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FYB1,FYN-binding protein 1,42589,0.0405176173970529,0.00895236954547312,0.0229709730879255,0.0580642617061802,6.06540277764746e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,40282,0.0219836850589144,0.0048590629068671,0.0124599217614549,0.0315074483563739,6.12359232330694e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KLK4,Kallikrein-4,42720,0.0281397507065518,0.00622498530212504,0.0159387795143867,0.0403407218987169,6.22313206185306e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CLEC1B,C-type lectin domain family 1 member B,42710,0.0418720645367219,0.00928261374121927,0.0236781416039321,0.0600659874695116,6.51260032028889e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ACP5,Tartrate-resistant acid phosphatase type 5,42710,0.0138933979437661,0.00308457019326069,0.00784764036497511,0.019939155522557,6.71941644358553e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RTN4R,Reticulon-4 receptor,42720,0.0151473535264089,0.00336311870016847,0.00855564087407868,0.0217390661787391,6.72568505137502e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GDF15,Growth/differentiation factor 15,42793,0.0203713710287936,0.00452585920404366,0.011500686988868,0.0292420550687192,6.81622038006401e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CSF3,Granulocyte colony-stimulating factor,42369,0.0214981407342701,0.00478369790496597,0.0121220928405368,0.0308741886280034,7.04791833015362e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,40450,0.0150840430095775,0.00336003628646613,0.00849837188810391,0.0216697141310511,7.21846669074548e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ANXA2,Annexin A2,40053,0.0317793373432029,0.00708651246492873,0.0178897729119426,0.0456689017744633,7.38412509049416e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RBP7,Retinoid-binding protein 7,40448,0.0263198893551442,0.00587256198089047,0.0148096678725989,0.0378301108376895,7.47327538139848e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IGF2R,Cation-independent mannose-6-phosphate receptor,42610,0.0101980664226552,0.00227607412568823,0.00573696113630628,0.0146591717090041,7.50663312519831e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BCHE,Cholinesterase,40345,0.0122226269401201,0.00272851561827845,0.00687473632829436,0.0175705175519459,7.55311756468364e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,STAMBP,STAM-binding protein,42475,0.0275459498493844,0.0061521929256097,0.0154876517151894,0.0396042479835794,7.61801860065147e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SDK2,Protein sidekick-2,40282,0.0177445424500694,0.00396447405117029,0.00997417330977568,0.0255149115903632,7.68532916494276e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TSC22D1,TSC22 domain family protein 1,40481,0.028449377942175,0.006357670473253,0.0159883438145991,0.0409104120697509,7.72273183903534e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GAL,Galanin peptides,42675,-0.0281329218959752,0.00628788468008658,-0.0404571758689449,-0.0158086679230055,7.73448632823538e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GUSB,Beta-glucuronidase,42710,0.0264362810763861,0.00591197226098041,0.0148488154448645,0.0380237467079077,7.82501212849952e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NEFL,Neurofilament light polypeptide,42261,0.020211629722738,0.00453157547020482,0.0113297418011366,0.0290935176443395,8.25753226424739e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TSPAN8,Tetraspanin-8,40448,-0.0446529641215824,0.0100253945626726,-0.0643027374644207,-0.0250031907787441,8.51035428375925e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,XCL1,Lymphotactin,42720,0.0244165364050043,0.00548848372114924,0.0136591083115518,0.0351739644984568,8.70871455627049e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LMNB1,Lamin-B1,40433,0.0260150806985792,0.00584954072520771,0.0145499808771721,0.0374801805199863,8.77620336352063e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HLA_A,,40481,0.0144443441540499,0.00324887422621212,0.00807655067067416,0.0208121376374257,8.83383448344542e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EFCAB14,EF-hand calcium-binding domain-containing protein 14,40448,0.0127316398902032,0.0028645331410605,0.00711715493372459,0.0183461248466817,8.89070697384345e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MAMDC2,MAM domain-containing protein 2,40510,0.0158625336800677,0.00357264525349571,0.00886014898321613,0.0228649183769193,9.08125733495481e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,42494,0.0158361673095817,0.00356704163797336,0.00884476569915395,0.0228275689200095,9.08605195725585e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,40222,0.0330116070391744,0.00743567759629469,0.0184376789504368,0.047585535127912,9.09924588928055e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,40198,0.034592812137039,0.0077924320348939,0.019319645348647,0.049865978925431,9.11380164170258e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CCN2,CCN family member 2,42623,0.0238491653295472,0.00537878449198581,0.013306747725255,0.0343915829338394,9.32642713970423e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RNF41,E3 ubiquitin-protein ligase NRDP1,42345,0.0285073060873705,0.00643220301476115,0.0159001881784387,0.0411144239963024,9.41333392456401e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,F2,Prothrombin,40538,0.00644841883322253,0.00145502291729424,0.00359657391532582,0.00930026375111924,9.43121993961719e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DFFA,DNA fragmentation factor subunit alpha,42753,0.0288371008064168,0.0065113710755903,0.0160748134982598,0.0415993881145738,9.55317023791185e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IRAK4,Interleukin-1 receptor-associated kinase 4,42593,0.0447520137937162,0.0101070821951796,0.0249421326911641,0.0645618948962683,9.5957972989497e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KIF1C,Kinesin-like protein KIF1C,40115,0.0156019087987541,0.00352440109063459,0.00869408266111027,0.0225097349363978,9.65583635532683e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NPPC,C-type natriuretic peptide,42593,0.0216449857520997,0.00489434381501736,0.0120520718746657,0.0312378996295337,9.8357121044509e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,INSR,Insulin receptor,40198,0.00750819848111676,0.00170112701167486,0.00417398953823405,0.0108424074239995,1.02604997857497e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NECAP2,Adaptin ear-binding coat-associated protein 2,40115,0.0296124655859322,0.00671254710721861,0.0164558732557837,0.0427690579160806,1.03635797623291e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TCN2,Transcobalamin-2,42770,0.0133177723926265,0.00301925747865237,0.00740002773446784,0.0192355170507851,1.03713626869107e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MRPL46,"39S ribosomal protein L46, mitochondrial",42310,0.0121035050766074,0.00274935649283135,0.00671476635065795,0.0174922438025568,1.07953984764021e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RASSF2,Ras association domain-containing protein 2,42345,0.0243997230449585,0.00554438112034386,0.0135327360490846,0.0352667100408325,1.08701054442793e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IFNGR1,Interferon gamma receptor 1,42675,0.00943069507825676,0.00214389913391087,0.00522865277579145,0.0136327373807221,1.09659697318775e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IMMT,MICOS complex subunit MIC60,40450,0.0194371584416672,0.00441845018109807,0.010776996086715,0.0280973207966194,1.09705312269393e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CDH15,Cadherin-15,42691,-0.026809807930749,0.00609536042593348,-0.0387567143655786,-0.0148629014959193,1.09889084859151e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD7,T-cell antigen CD7,40165,0.0192010057637755,0.0043748692307678,0.0106262620714706,0.0277757494560804,1.14973457801507e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],42586,0.0239576014134492,0.00546201494758606,0.0132520521161805,0.0346631507107179,1.16218056756831e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL17D,Interleukin-17D,42369,0.0147520223634833,0.00337301661902645,0.00814090979019143,0.0213631349367751,1.23186491974999e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AK1,Adenylate kinase isoenzyme 1,42635,0.0269227231776046,0.0061577166316583,0.0148535985795543,0.0389918477756549,1.23929445338903e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PRAP1,Proline-rich acidic protein 1,40526,-0.0176938327620566,0.00404738028510323,-0.025626698120859,-0.00976096740325432,1.2439600598838e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MMP8,Neutrophil collagenase,42680,0.031213811076766,0.00714087294806757,0.0172177000985536,0.0452099220549785,1.24520086098094e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,REG3A,Regenerating islet-derived protein 3-alpha,42793,0.027971007316615,0.00639970643081548,0.0154275827122167,0.0405144319210134,1.24784571934136e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ITGA6,Integrin alpha-6,42593,0.0216374425046941,0.00496409611163615,0.0119078141258873,0.031367070883501,1.31759291376039e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MFAP5,Microfibrillar-associated protein 5,42793,0.0175097579720042,0.00401764635913164,0.00963517110810614,0.0253843448359022,1.32091049774318e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CMIP,C-Maf-inducing protein,40450,0.0351649457072321,0.00807944983184643,0.0193292240368131,0.0510006673776511,1.35847632598784e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ATXN2,Ataxin-2,40135,0.0469572493012516,0.0108009963069366,0.025787296539656,0.0681272020628473,1.38947829905853e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NECTIN2,Nectin-2,42612,0.0133950031747259,0.00308603985392026,0.00734636506104216,0.0194436412884096,1.43189841986651e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PRRT3,Proline-rich transmembrane protein 3,40222,0.0169677528102034,0.00391585550331746,0.00929267602370114,0.0246428295967056,1.48333379932218e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IGFBP7,Insulin-like growth factor-binding protein 7,42793,0.013315349173558,0.00307616029334155,0.00728607499860854,0.0193446233485074,1.51159330553739e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CLEC4C,C-type lectin domain family 4 member C,42593,0.0202897551647573,0.00468961165832468,0.0110981163144409,0.0294813940150737,1.52572393470148e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GP1BB,Platelet glycoprotein Ib beta chain,40115,0.0292224668652465,0.00675739240744346,0.0159779777466573,0.0424669559838357,1.54222353358874e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,WIF1,Wnt inhibitory factor 1,42720,0.0145961563920254,0.0033755119891833,0.00798015289322609,0.0212121598908246,1.54230563388449e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,40482,0.0168149060121615,0.00389170767615408,0.00918715896689954,0.0244426530574235,1.56865135117898e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",40481,0.0334590409331131,0.00775272027126517,0.0182637092014334,0.0486543726647929,1.60394938023038e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SRC,Proto-oncogene tyrosine-protein kinase Src,42663,0.050011491498792,0.0115935923735209,0.0272880504466909,0.0727349325508931,1.61675075805514e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,OBP2B,Odorant-binding protein 2b,42461,0.0258887903051714,0.00600502239843823,0.0141189464042325,0.0376586342061104,1.6355035847259e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,42457,0.0146250342756416,0.00339528073500749,0.00797028403502691,0.0212797845162563,1.66328454072618e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AKT1S1,Proline-rich AKT1 substrate 1,42310,0.0279732652529964,0.00649854104826163,0.0152361247984037,0.0407104057075892,1.68543212235387e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CASP10,Caspase-10,42310,0.0300481415029535,0.00698209104102086,0.0163632430625526,0.0437330399433544,1.69261800736327e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,S100A4,Protein S100-A4,42678,0.0239104688423096,0.00556023175909063,0.013012414594492,0.0348085230901272,1.71793670600966e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NBL1,Neuroblastoma suppressor of tumorigenicity 1,42678,0.0118514439161262,0.00276038289813676,0.00644109343577817,0.0172617943964743,1.77182667540049e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MARS1,"Methionine--tRNA ligase, cytoplasmic",40266,0.03560828600122,0.00829548437845602,0.0193491366194462,0.0518674353829938,1.78183659779381e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SUSD1,Sushi domain-containing protein 1,42356,0.020650568921228,0.00481394456447762,0.0112152375748519,0.0300859002676042,1.8015932368999e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ATP6AP2,Renin receptor,42345,0.0169073023496376,0.00394273458303671,0.00917954256688564,0.0246350621323895,1.81397659331962e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GZMB,Granzyme B,42593,0.0278191146724099,0.00648742581304043,0.0151037600788507,0.0405344692659692,1.81421130239211e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ATXN2L,Ataxin-2-like protein,40481,0.020175721256258,0.00470686420203452,0.0109502674202703,0.0294011750922457,1.83061134962932e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CHMP6,Charged multivesicular body protein 6,40510,0.0233927941385735,0.00545761179071329,0.0126958750287755,0.0340897132483716,1.83202930117118e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,40448,0.0214223179181935,0.0049978873628097,0.0116264586870864,0.0312181771493005,1.83206878762863e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SERPINB8,Serpin B8,42753,0.0241615629549003,0.00563894268686648,0.013109235288642,0.0352138906211586,1.84191314263124e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DNAJB2,DnaJ homolog subfamily B member 2,40282,0.0225359009932963,0.00526372324984339,0.0122190034236032,0.0328527985629893,1.87316183599255e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,40301,0.0439330936529493,0.0102652045157153,0.0238132928021473,0.0640528945037513,1.88624260473266e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ASPN,Asporin,40510,0.0117626189374114,0.00274965969034367,0.00637328594433783,0.017151951930485,1.90261656275677e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ARHGAP25,Rho GTPase-activating protein 25,42345,0.0247799065363513,0.00579599357375224,0.0134197591317969,0.0361400539409057,1.92182157901449e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,42612,0.0135925551090261,0.00318292028869626,0.00735403134318145,0.0198310788748708,1.9640654782133e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AP2B1,AP-2 complex subunit beta,40181,0.0201324800851821,0.00471845137881005,0.0108843153827144,0.0293806447876498,1.99998080468946e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SCG3,Secretogranin-3,42637,0.0142708577841641,0.00334525921092605,0.00771414973074905,0.0208275658375792,2.003749448586e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KIF22,Kinesin-like protein KIF22,40115,0.0521452350596761,0.012235436261942,0.0281637799862699,0.0761266901330824,2.04470120780692e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PRTG,Protogenin,42720,-0.0103712610449173,0.00243635843394881,-0.0151465235754569,-0.00559599851437759,2.08706758814351e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,42494,0.0161642783121564,0.00379963197999582,0.00871699963136456,0.0236115569929482,2.11261867579318e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CRELD1,Protein disulfide isomerase CRELD1,40282,0.0157374162894572,0.0037015772514471,0.00848232487662093,0.0229925077022935,2.14041341091724e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IRAK1,Interleukin-1 receptor-associated kinase 1,42369,0.0282094402788064,0.00664089294026816,0.0151932901158809,0.041225590441732,2.17325218988385e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CREG1,Protein CREG1,42444,0.0160011877409982,0.00377001756794023,0.00861195330783539,0.0233904221741611,2.20742737168489e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",42586,0.0182139535529338,0.00429646100383995,0.00979288998540754,0.0266350171204601,2.25728874245447e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RAB10,Ras-related protein Rab-10,40510,0.02211360203673,0.00521640180725531,0.0118894544945095,0.0323377495789504,2.2605350880125e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",42345,0.0337029180947881,0.00795916805605105,0.018102948704928,0.0493028874846481,2.30640943988038e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SH3BP1,SH3 domain-binding protein 1,40448,0.0197782559415048,0.00467128516123014,0.0106225370254937,0.0289339748575158,2.31386911519807e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RAB27B,Ras-related protein Rab-27B,40510,0.0339682174978993,0.00802572037290069,0.018237805567014,0.0496986294287847,2.33014152216752e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TP53,Cellular tumor antigen p53,42345,0.017765569520687,0.00420082842895004,0.0095319457999449,0.025999193241429,2.36253682129284e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SCGB3A2,Secretoglobin family 3A member 2,42653,-0.0358736830198486,0.0085028362965472,-0.0525392421610811,-0.0192081238786161,2.46967582547884e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,VCAN,Versican core protein,42710,0.0125946824829655,0.00299143089829433,0.00673147792230864,0.0184578870436224,2.56734788131342e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IGLC2,Immunoglobulin lambda constant 2,40518,0.0104406934655135,0.00248144565046593,0.00557705999060031,0.0153043269404267,2.60196453198863e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,40301,0.0373629853791714,0.00888542549240561,0.0199475514140564,0.0547784193442864,2.63159068655788e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SLITRK1,SLIT and NTRK-like protein 1,40198,0.0135161361120609,0.00321496305427622,0.0072148085256795,0.0198174636984423,2.64155928549878e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SERPINA6,Corticosteroid-binding globulin,40538,0.00646349258859235,0.00153792083360621,0.00344916775472418,0.00947781742246051,2.6571497802061e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DBN1,Drebrin,40198,0.0205175794570195,0.00488366053797858,0.0109456048025815,0.0300895541114575,2.67514557826222e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,42720,0.0143206350301018,0.00341007797825537,0.00763688219272127,0.0210043878674823,2.69213466916246e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,42678,0.0151330587356946,0.00360828259484537,0.00806082484979767,0.0222052926215915,2.75856005793982e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CHM,Rab proteins geranylgeranyltransferase component A 1,40181,0.024955090866292,0.00595058252752477,0.0132919491123435,0.0366182326202405,2.76566768182394e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,S100A12,Protein S100-A12,42433,0.0308416700997744,0.00735877546438455,0.0164184701895807,0.0452648700099681,2.79356372621713e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LY96,Lymphocyte antigen 96,42494,0.0146283038596115,0.00349368586635304,0.00778067956155952,0.0214759281576635,2.84399384248732e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",40208,0.0325219075237745,0.00778110020812538,0.0172709511158488,0.0477728639317003,2.94275004873234e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PLA2G15,Phospholipase A2 group XV,42678,0.0108741009946497,0.00260264801869141,0.0057729108780145,0.0159752911112848,2.95817364449138e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",40222,0.0180507963081083,0.00432078490503222,0.00958205789424514,0.0265195347219714,2.96784251952878e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TREH,Trehalase,40526,-0.030263002233817,0.00724796213504086,-0.044469008018497,-0.0160569964491369,2.99713129555439e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GFRA2,GDNF family receptor alpha-2,42586,0.00870952106735415,0.00208609079836777,0.00462078310255331,0.012798259032155,2.99812660483817e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,VAMP5,Vesicle-associated membrane protein 5,42356,0.0226704594656402,0.00543316084172853,0.0120214642158523,0.0333194547154282,3.03064202464139e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DSC2,Desmocollin-2,42487,0.0144746696023948,0.00347035090025765,0.00767278183788978,0.0212765573668998,3.05254357892967e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ZBP1,Z-DNA-binding protein 1,40198,0.0163248613272818,0.00391685721478124,0.00864782118631056,0.024001901468253,3.09842796914617e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TMPRSS11D,Transmembrane protease serine 11D,40469,0.0166743662786431,0.00400490446451975,0.00882475352818444,0.0245239790291018,3.1575514655948e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DDT,D-dopachrome decarboxylase,40526,0.0168800907936199,0.00405477164306254,0.00893273837321729,0.0248274432140225,3.16390222343999e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ANPEP,Aminopeptidase N,42665,0.0112689076968837,0.00271697294872214,0.00594364071738825,0.0165941746763791,3.3804386030859e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SPON1,Spondin-1,42637,0.0137480351821484,0.00331857281138208,0.0072436324718395,0.0202524378924572,3.45257121291109e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SPP1,Osteopontin,42770,0.0191405736843253,0.00462449593501979,0.0100765616516865,0.0282045857169641,3.5099951802253e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TNFAIP2,Tumor necrosis factor alpha-induced protein 2,40448,0.0186356558783131,0.00450286294012085,0.00981004451567621,0.02746126724095,3.51939686278483e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NMT1,Glycylpeptide N-tetradecanoyltransferase 1,40481,0.0267768957834658,0.00647145512149075,0.0140928437453439,0.0394609478215877,3.53360121148274e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SMAD3,Mothers against decapentaplegic homolog 3,40450,0.0208704930141674,0.00504572364715718,0.0109808746657393,0.0307601113625955,3.55556028344008e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD84,SLAM family member 5,42593,0.0126592717513922,0.00306108955644537,0.0066595362207593,0.0186590072820252,3.56273056696648e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MGLL,Monoglyceride lipase,42653,0.0345547754184363,0.00836431957951361,0.0181607090425896,0.050948841794283,3.63037426563669e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SARG,Specifically androgen-regulated gene protein,40455,0.0436921654148756,0.0105762093743685,0.0229627950411133,0.0644215357886379,3.6352333034921e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,40450,0.0433898998658016,0.0105074684770336,0.0227952616508157,0.0639845380807875,3.66282509453463e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PF4,Platelet factor 4,40462,0.0395777973091852,0.00959358539477037,0.0207743699354353,0.0583812246829351,3.72679309474016e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SLMAP,Sarcolemmal membrane-associated protein,40448,0.0331936993653149,0.0080541411086228,0.0174075827924142,0.0489798159382156,3.79406295544181e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SNX2,Sorting nexin-2,40450,0.033059147270708,0.00803566381441275,0.017309246194459,0.048809048346957,3.91539221732064e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ZNRD2,Protein ZNRD2,40448,0.0279749127451286,0.0068047688445436,0.0146375658098232,0.0413122596804341,3.9661775289039e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NFASC,Neurofascin,42753,-0.0116547067117923,0.00283664166736108,-0.0172145243798201,-0.00609488904376462,4.00354794609863e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NPTXR,Neuronal pentraxin receptor,42635,0.0136663280877304,0.00332702732436549,0.00714535453197406,0.0201873016434868,4.02039063465055e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SV2A,Synaptic vesicle glycoprotein 2A,40181,0.025145086673753,0.00612375115893966,0.0131425344022313,0.0371476389452747,4.05207628931889e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,40301,0.044724894016807,0.0109092140008142,0.023342834575211,0.0661069534584029,4.16566596432463e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TFRC,Transferrin receptor protein 1,42672,0.0151837283214682,0.00370422671768141,0.00792344395481264,0.0224440126881238,4.17320321405462e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ESM1,Endothelial cell-specific molecule 1,42617,0.0137656758568861,0.00335918593006821,0.00718167143395243,0.0203496802798198,4.19329250234665e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HSBP1,Heat shock factor-binding protein 1,40222,0.037897776602929,0.00924848647751816,0.0197707431069934,0.0560248100988646,4.20211950710234e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PTPRK,Receptor-type tyrosine-protein phosphatase kappa,40448,0.00861006984406982,0.0021072220257477,0.00447991467360432,0.0127402250145353,4.41953357357724e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GTPBP2,GTP-binding protein 2,40181,0.0321689641430944,0.00787741965602568,0.016729221617284,0.0476087066689047,4.46398286373261e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,VEGFA,Vascular endothelial growth factor A,42715,0.0233145376212418,0.00571361113293554,0.0121158598006881,0.0345132154417954,4.51919264098008e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BSG,Basigin,42745,0.00867051501513999,0.00212663465281334,0.00450231109562585,0.0128387189346541,4.58600925393621e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,APP,Amyloid-beta precursor protein,42591,0.0263878778888503,0.00648459769958685,0.01367806639766,0.0390976893800405,4.74217222672167e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ABRAXAS2,BRISC complex subunit Abraxas 2,40115,0.0264694308349268,0.00651344787419806,0.0137030730014986,0.039235788668355,4.86156370572078e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,42610,0.0119508549975454,0.00294199058232968,0.00618455345617922,0.0177171565389116,4.88959734146654e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,STX16,Syntaxin-16,42345,0.0229457572206927,0.00565244752397703,0.0118669600736978,0.0340245543676877,4.94758071238912e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TIGIT,T-cell immunoreceptor with Ig and ITIM domains,40301,0.0147824892406824,0.00364326778722246,0.00764168437772637,0.0219232941036384,4.99443529037555e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ENSA,Alpha-endosulfine,40450,0.0210893046897634,0.00520013006822419,0.010897049756044,0.0312815596234828,5.03570290287001e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD74,HLA class II histocompatibility antigen gamma chain,42710,0.0140716986329239,0.00347228075685529,0.00726602834948748,0.0208773689163602,5.09391456805534e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NINJ1,Ninjurin-1,42345,0.0213960266061315,0.00528457713983983,0.0110382554120454,0.0317537978002175,5.17830177103669e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PEAR1,Platelet endothelial aggregation receptor 1,42793,0.00901308098110126,0.00222634065650044,0.0046494532943604,0.0133767086678421,5.18582568234166e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,40282,0.0279215464372647,0.00690451911377656,0.0143886889742626,0.0414544039002667,5.29133487192479e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,42777,0.011316906094573,0.00279931767474667,0.00583024345206956,0.0168035687370765,5.31222406278924e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,COPB2,Coatomer subunit beta',40115,0.0171825656871655,0.0042500468654749,0.00885247383083471,0.0255126575434963,5.31538802590258e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CNTNAP2,Contactin-associated protein-like 2,42593,0.0165344862403439,0.004091200267024,0.00851573371697686,0.024553238763711,5.34126004883842e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BOC,Brother of CDO,42356,-0.00927477427796463,0.00229502924671818,-0.0137730316015323,-0.00477651695439699,5.34705803785289e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CCDC80,Coiled-coil domain-containing protein 80,42635,0.0148485645963222,0.00368037319894831,0.00763503312638352,0.0220620960662609,5.50151062207722e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CA4,Carbonic anhydrase 4,42793,0.00950792812459215,0.00235830563112371,0.00488564908758968,0.0141302071615946,5.5682104973759e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DRAXIN,Draxin,42494,0.0172904074768708,0.00429022838279544,0.00888155984659171,0.0256992551071498,5.60436663644933e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HNRNPK,Heterogeneous nuclear ribonucleoprotein K,42306,0.0306143990157002,0.00761735081112368,0.0156843914258978,0.0455444066055026,5.87636140202469e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SH2D1A,SH2 domain-containing protein 1A,42593,0.0226214787929548,0.00562897718833418,0.0115886835038198,0.0336542740820898,5.88264238166457e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EGFR,Epidermal growth factor receptor,42793,0.00639714570110298,0.00159390600706536,0.00327308992725487,0.00952120147495109,6.01450589972658e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,F9,Coagulation factor IX,42662,0.00707941004935144,0.00176389457129047,0.00362217668962212,0.0105366434090808,6.01460440981811e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GSN,Gelsolin,40487,0.00764146359904191,0.00190424886175554,0.00390913583000106,0.0113737913680828,6.03773774063609e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DNPEP,Aspartyl aminopeptidase,40482,0.0223496393043518,0.00557409126755105,0.0114244204199517,0.0332748581887518,6.12241827747551e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TACSTD2,Tumor-associated calcium signal transducer 2,40979,-0.0124679023885936,0.00311422128187667,-0.0185717761010719,-0.00636402867611534,6.27847220864146e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CDK5RAP3,CDK5 regulatory subunit-associated protein 3,40481,0.0226979945229989,0.00567482090452888,0.0115753455501223,0.0338206434958755,6.38076651702215e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CEP170,Centrosomal protein of 170 kDa,40222,0.0301267524145736,0.00753225710058836,0.0153635284974204,0.0448899763317268,6.38373824523396e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PSME1,Proteasome activator complex subunit 1,42479,0.0144550686453154,0.00362150749786393,0.00735691394950214,0.0215532233411287,6.60232436986747e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PPBP,Platelet basic protein,40470,0.0328332112002291,0.00822662463206804,0.0167090269213757,0.0489573954790824,6.61863198937885e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EGF,Pro-epidermal growth factor,42596,0.039923362559771,0.0100090762325935,0.0203055731438876,0.0595411519756543,6.67848499590396e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ULBP2,UL16-binding protein 2,42494,0.0155858319942306,0.00391034693234498,0.00792155200683448,0.0232501119816268,6.7614305698302e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,USP25,Ubiquitin carboxyl-terminal hydrolase 25,40450,0.0277801689048437,0.00697063270481486,0.0141177288034066,0.0414426090062808,6.78156771729844e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BECN1,Beclin-1,40222,0.0232803144735114,0.00584155592172487,0.0118308648669306,0.0347297640800921,6.78307114281608e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MYH9,Myosin-9,40526,0.0442477896837865,0.0111564315624492,0.022381183821386,0.066114395546187,7.35002945811977e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,42753,0.0160761771398413,0.00406153065358761,0.00811557705880954,0.024036777220873,7.59154601786698e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SHMT1,"Serine hydroxymethyltransferase, cytosolic",42653,0.0327849737146972,0.00828937450191629,0.0165377996909413,0.0490321477384531,7.69074477681579e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SFTPA1,Pulmonary surfactant-associated protein A1,42345,0.0223240906776856,0.00564572724553824,0.0112584652764307,0.0333897160789406,7.72074129343531e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,UROD,Uroporphyrinogen decarboxylase,40282,0.0266067399126921,0.00673636469403639,0.0134034651123807,0.0398100147130034,7.87276480836541e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PDGFA,Platelet-derived growth factor subunit A,42793,0.0276177620869043,0.0069929604782637,0.0139115595495075,0.0413239646243012,7.87535284703329e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FSTL3,Follistatin-related protein 3,42573,0.0130801203270104,0.00331286774673495,0.00658689954340989,0.0195733411106109,7.91186812150758e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ASRGL1,Isoaspartyl peptidase/L-asparaginase,40222,0.0392141188095918,0.00993441444288446,0.0197426665015382,0.0586855711176453,7.95280605124644e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GIT1,ARF GTPase-activating protein GIT1,40198,0.0372635732777526,0.0094477262350189,0.0187460298571156,0.0557811166983897,8.05688126432672e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,42494,0.020526321606856,0.00520634654503658,0.0103218823785843,0.0307307608351277,8.10302373072006e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SH3GLB2,Endophilin-B2,40482,0.0256133829209647,0.0064971736264314,0.0128789226131591,0.0383478432287702,8.1213203472874e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SUSD4,Sushi domain-containing protein 4,40450,0.0161774798993646,0.00411486139183679,0.00811235157136446,0.0242426082273647,8.49316131260255e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,40510,-0.0109202902980416,0.00277863426966161,-0.0163664134665784,-0.00547416712950487,8.54184364004452e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SLAMF7,SLAM family member 7,42593,0.0228428196289496,0.00581677133244247,0.0114419478173624,0.0342436914405369,8.64207235960085e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ANG,Angiogenin,42617,0.01286903506904,0.00328135815325351,0.00643757308866313,0.0193004970494169,8.83043746735096e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,40482,0.0179846571935117,0.00458682651602501,0.00899447722210265,0.0269748371649207,8.87269641428908e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,OPHN1,Oligophrenin-1,40482,0.040792355039507,0.0104046196502852,0.0203993005249479,0.061185409554066,8.88508107442702e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TOR1AIP1,Torsin-1A-interacting protein 1,40222,0.0199826474395969,0.00510024377211798,0.00998616964624568,0.0299791252329482,8.98334899602296e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,42617,0.0112438352344573,0.00287078130980644,0.00561710386723671,0.016870566601678,9.02338187826712e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PGF,Placenta growth factor,42753,0.010180475352202,0.00259934856528224,0.0050857521642488,0.0152751985401552,9.02658467504705e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CTSE,Cathepsin E,40282,-0.0196625141199749,0.00502184303499455,-0.0295053264685642,-0.00981970177138558,9.07956611895033e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,STX6,Syntaxin-6,42345,0.0252980201189983,0.00646346491070185,0.0126296288940226,0.0379664113439739,9.12361141105432e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EDF1,Endothelial differentiation-related factor 1,40481,0.0255855240028427,0.00654670805395934,0.0127539762170824,0.038417071788603,9.35484176197882e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ARL13B,ADP-ribosylation factor-like protein 13B,40115,0.0263637905980727,0.00675140015921089,0.0131310462860193,0.039596534910126,9.48172890511406e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AIF1L,Allograft inflammatory factor 1-like,40222,0.0212791206253774,0.00545021378223109,0.0105967016122045,0.0319615396385503,9.50721101026261e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,VPS28,Vacuolar protein sorting-associated protein 28 homolog,40301,0.0249725495384434,0.00642157908044058,0.0123862545407799,0.0375588445361069,0.000101307666733954
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DNAJC21,DnaJ homolog subfamily C member 21,40482,0.014514289369725,0.00373739670272599,0.00718899183238202,0.0218395869070679,0.000103538245817874
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RGMA,Repulsive guidance molecule A,42710,-0.0121686672881148,0.00313543786863475,-0.0183141255106389,-0.00602320906559065,0.000104517402934203
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SNRPB2,U2 small nuclear ribonucleoprotein B'',40482,0.0163676621492942,0.00421765563301152,0.00810105710859159,0.0246342671899967,0.000104727590364937
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KLB,Beta-klotho,42310,-0.0283013804816099,0.00730329180425462,-0.042615832417949,-0.0139869285452708,0.000107075866194066
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HSD17B3,Testosterone 17-beta-dehydrogenase 3,40115,0.0186640444325764,0.00481910907973969,0.00921859063628659,0.0281094982288662,0.000108164639352556
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,OGA,Protein O-GlcNAcase,40448,0.0264377264542629,0.00682839060240575,0.0130540808735476,0.0398213720349781,0.000108673959349531
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AFP,Alpha-fetoprotein,42458,0.0252246505509607,0.00654897529869468,0.0123886589655192,0.0380606421364023,0.000117855114758829
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ELOB,Elongin-B,40115,0.0151298514591647,0.00393172201521402,0.00742367630934517,0.0228360266089841,0.000119691442955385
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LAMP2,Lysosome-associated membrane glycoprotein 2,42237,0.0074252020037154,0.00193716844819799,0.00362835184524734,0.0112220521621835,0.000127174976693014
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RPE,Ribulose-phosphate 3-epimerase,40301,0.0261747200158423,0.00682946438105612,0.0127889698289723,0.0395604702027123,0.000127486446372986
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DGKA,Diacylglycerol kinase alpha,40198,0.0204456328522347,0.00533809042665404,0.00998297561599277,0.0309082900884766,0.000128781496391499
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MMP9,Matrix metalloproteinase-9,42593,0.0225112339995855,0.0058786261741542,0.0109891266982433,0.0340333413009277,0.00012907474694811
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PRG3,Proteoglycan 3,40526,0.0186356210392969,0.00487251827425144,0.0090854852217641,0.0281857568568298,0.000131666303992895
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CRYM,Ketimine reductase mu-crystallin,40135,0.0283259768144486,0.00740845291953631,0.0138054090921575,0.0428465445367398,0.000132318064131234
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IGF1R,Insulin-like growth factor 1 receptor,42586,0.00812952616563545,0.00212707695606016,0.00396045533175754,0.0122985969995134,0.000133013570420103
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GAS6,Growth arrest-specific protein 6,42717,-0.00946714991478696,0.00247736024328039,-0.0143227759916165,-0.0046115238379574,0.000133254289169877
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DCTN6,Dynactin subunit 6,42310,0.0267839503908286,0.0070119155794045,0.0130405958551957,0.0405273049264614,0.000134188305714099
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PLEKHO1,Pleckstrin homology domain-containing family O member 1,40482,0.0257025825192328,0.00673357219523329,0.0125047810165756,0.0389003840218901,0.000135761972594815
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PLXDC1,Plexin domain-containing protein 1,42345,-0.0117732068885836,0.00308771711091983,-0.0178251324259865,-0.00572128135118075,0.000137963685930897
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TGFB1,Transforming growth factor beta-1 proprotein,42745,0.0141583540869923,0.00371487000065264,0.00687720888571316,0.0214394992882715,0.000138869035902418
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SEPTIN8,Septin-8,40469,0.0120776351008842,0.0031713792029401,0.00586173186312157,0.0182935383386468,0.000140654578204616
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CRYGD,Gamma-crystallin D,40482,0.0362002629446433,0.00950750306265985,0.01756555694183,0.0548349689474566,0.000141094992219197
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ARAF,Serine/threonine-protein kinase A-Raf,40301,0.0254530607504917,0.00670489762363445,0.0123114614081682,0.0385946600928152,0.000147718805362396
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TRIM24,Transcription intermediary factor 1-alpha,40286,0.0240149503439758,0.00633510568112591,0.011598143208969,0.0364317574789825,0.000150974427474661
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CAMLG,Guided entry of tail-anchored proteins factor CAMLG,40181,0.0202538978334901,0.00534537351417731,0.00977696574570261,0.0307308299212777,0.000152030649518873
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LRPAP1,Alpha-2-macroglobulin receptor-associated protein,42710,0.021241695345689,0.00562142708813088,0.0102236982529524,0.0322596924384255,0.000158325135113033
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FOXJ3,Forkhead box protein J3,40198,0.0161210962643001,0.00426989130293123,0.00775210931055486,0.0244900832180453,0.0001605084901124
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,UNG,Uracil-DNA glycosylase,40450,0.0126282415094647,0.00334505117961075,0.00607194119742763,0.0191845418215018,0.000160700206371575
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MSLN,Mesothelin,42552,0.0220340341784892,0.00583812436776386,0.010591310417672,0.0334767579393063,0.000161240009421808
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,WAS,Wiskott-Aldrich syndrome protein,42369,0.0244826475977023,0.00648692558132815,0.0117682734582992,0.0371970217371055,0.000161256465612347
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CCL21,C-C motif chemokine 21,42675,0.0155840594177771,0.00413069909318251,0.00748788919513937,0.0236802296404148,0.000162154607863582
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CSF2RB,Cytokine receptor common subunit beta,40198,0.0160714585436154,0.00426459272864866,0.00771285679546406,0.0244300602917668,0.000165036379396401
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PRTN3,Myeloblastin,42275,0.0179543614252922,0.00476922822914872,0.00860667409616069,0.0273020487544237,0.000167528153817916
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,UBE2Z,Ubiquitin-conjugating enzyme E2 Z,40198,0.0215644988447605,0.00573078364265436,0.010332162905158,0.032796834784363,0.000168810919082269
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DPP4,Dipeptidyl peptidase 4,42440,0.0103913009885462,0.00276240786510408,0.00497698157294223,0.0158056204041502,0.000169501301029334
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD164,Sialomucin core protein 24,42610,0.0100521905952073,0.00267415509872211,0.00481084660171196,0.0152935345887027,0.000171306782603507
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NPPB,Natriuretic peptides B,42356,-0.0520779704390354,0.0138661653595685,-0.0792556545437896,-0.0249002863342811,0.000173561930142884
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,APOC1,Apolipoprotein C-I,40515,-0.0135614720323324,0.0036112668707636,-0.020639555099029,-0.0064833889656357,0.000173985555485093
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ARHGEF10,Rho guanine nucleotide exchange factor 10,40481,0.0340467124458936,0.00908277666205525,0.0162444701882653,0.0518489547035219,0.000178788996236138
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,WASF1,Wiskott-Aldrich syndrome protein family member 1,42356,0.0338454790760679,0.00903145203563611,0.0161438330862212,0.0515471250659147,0.000179360278713435
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,YES1,Tyrosine-protein kinase Yes,42586,0.0413959276298861,0.0110501015010823,0.0197377286877649,0.0630541265720073,0.000180284173449195
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PTP4A3,Protein tyrosine phosphatase type IVA 3,40198,0.0194769208142711,0.00520201865135766,0.00928096425761005,0.0296728773709321,0.000181958187246945
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MANSC1,MANSC domain-containing protein 1,42678,0.0102841825143333,0.00275266325394093,0.00488896253660906,0.0156794024920575,0.000187678701063453
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,40282,0.0138234813855707,0.00370237527902033,0.00656682583869089,0.0210801369324506,0.000189647234525495
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PLIN3,Perilipin-3,42635,0.0153489588502099,0.00411620436497916,0.00728119829485074,0.023416719405569,0.000193099116153915
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,40448,0.0110458054959401,0.00296312444767885,0.00523808157848958,0.0168535294133907,0.000194139020282923
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BGLAP,Osteocalcin,40526,0.0329356063945676,0.00884185231469411,0.0156055758577671,0.0502656369313681,0.000196289060698379
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MMUT,"Methylmalonyl-CoA mutase, mitochondrial",40115,0.0181093514467916,0.00486445296762951,0.00857502363023777,0.0276436792633454,0.000198021270663243
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GFER,FAD-linked sulfhydryl oxidase ALR,42345,0.0227759936033396,0.00612688082613423,0.0107673071841165,0.0347846800225627,0.000202128406974755
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PLIN1,Perilipin-1,42310,0.0126825844466914,0.00341232997036237,0.00599441770478114,0.0193707511886016,0.000202686325830569
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MOCS2,Molybdopterin synthase catalytic subunit,40282,0.024014696694483,0.00646692662674945,0.0113395205060541,0.0366898728829119,0.00020544432221739
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TXN,Thioredoxin,40383,0.0161984268384783,0.00436254751077685,0.00764783371735566,0.0247490199596009,0.000205758006586629
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ACHE,Acetylcholinesterase,40282,-0.0121166793691072,0.0032637648852898,-0.0185136585442752,-0.00571970019393915,0.000206239267277697
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CTRC,Chymotrypsin-C,42625,0.0239850468375982,0.00648040279895145,0.0112834573516534,0.0366866363235431,0.000215468693219974
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RNF5,E3 ubiquitin-protein ligase RNF5,40222,0.0264476893861044,0.00714663974029636,0.0124402754951235,0.0404551032770852,0.000216037651040905
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CHI3L1,Chitinase-3-like protein 1,42415,-0.029866213434857,0.0080752309510715,-0.0456936660989571,-0.0140387607707568,0.000217758531584132
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EFCAB2,Dynein regulatory complex protein 8,40301,0.0126177366628189,0.00341292067588027,0.0059284121380936,0.0193070611875442,0.000219169867142511
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DYNLT3,Dynein light chain Tctex-type 3,40450,0.0156998847162917,0.00424815460370181,0.0073735016930362,0.0240262677395473,0.000220326118826913
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MEPE,Matrix extracellular phosphoglycoprotein,42617,0.00930366199980816,0.00251813528377018,0.0043681168436186,0.0142392071559977,0.000221053056726069
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HEPACAM2,HEPACAM family member 2,40482,-0.0152132433786553,0.00412116523999318,-0.023290727249042,-0.00713575950826871,0.000223993568948761
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CHAD,Chondroadherin,40282,0.0188116930450106,0.00509693638026858,0.00882169773968416,0.028801688350337,0.000224634852646984
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EPO,Erythropoietin,42593,-0.0266489102366292,0.00722628521945396,-0.040812429266759,-0.0124853912064995,0.000227118041836117
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,40115,-0.0201753483881514,0.00547369248557375,-0.0309037856598759,-0.00944691111642684,0.000229021158612074
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ATXN10,Ataxin-10,42310,0.0259829361442324,0.00707332294189448,0.0121192231781192,0.0398466491103456,0.000240324299729246
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HMCN2,Hemicentin-2,40268,-0.0210694143561405,0.00573919339813303,-0.0323182334164813,-0.00982059529579981,0.00024260125236207
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ACP6,Lysophosphatidic acid phosphatase type 6,42688,0.0245650981913888,0.00670023640495227,0.0114326348376824,0.0376975615450953,0.000247026838372995
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,42475,0.0396432651407528,0.0108182901498723,0.018439416447003,0.0608471138345026,0.000248819351260875
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,42610,0.0217702842491669,0.00594310860553653,0.0101217913823153,0.0334187771160184,0.00025012657114063
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CES2,Cocaine esterase,42586,0.0196056758353221,0.00536105701013627,0.00909800409545497,0.0301133475751891,0.000256108082815771
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GOLGA3,Golgin subfamily A member 3,40481,0.0279302398508802,0.0076395060051764,0.0129568080807345,0.042903671621026,0.000257318050033439
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,VAT1,Synaptic vesicle membrane protein VAT-1 homolog,42586,0.00703144432222077,0.00192629825413274,0.0032558997441206,0.0108069889003209,0.000262995800496036
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LY75,Lymphocyte antigen 75,42593,0.0138926116960734,0.0038065231435026,0.00643182633480826,0.0213533970573384,0.000263559700627296
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TNIP1,TNFAIP3-interacting protein 1,40482,0.0314863240782269,0.0086378628702284,0.0145561128525793,0.0484165353038746,0.000268434026947745
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NAP1L4,Nucleosome assembly protein 1-like 4,40427,0.0147527374590609,0.00405096955043293,0.00681283714021239,0.0226926377779095,0.000271977947507807
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DOK1,Docking protein 1,40482,0.0480645792352438,0.0132262578549096,0.0221411138396211,0.0739880446308666,0.000280270585010345
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FUOM,Fucose mutarotase,40282,0.0224876327304389,0.00619303445382447,0.0103492852009429,0.0346259802599349,0.000283469094951487
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SLC27A4,Long-chain fatty acid transport protein 4,42310,0.0236480998884067,0.00651652844766198,0.0108757041309893,0.0364204956458242,0.000285667474746752
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",40301,0.0173989288719649,0.0047968623649849,0.00799707863659454,0.0268007791073354,0.00028785335754627
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CETN2,Centrin-2,42310,0.0237963563806524,0.00656598072525465,0.0109270341591533,0.0366656786021515,0.000290965700550222
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RABEP1,Rab GTPase-binding effector protein 1,40282,0.0276729474498073,0.00763546101000631,0.012707443870195,0.0426384510294197,0.000291079268640195
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NIT1,Deaminated glutathione amidase,40222,0.0167683305483699,0.00463213334636073,0.00768934918950287,0.0258473119072369,0.000295920857793219
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DKK3,Dickkopf-related protein 3,42793,0.0106803266097269,0.00295254934348915,0.00489332989648812,0.0164673233229656,0.000298743078996717
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BGN,Biglycan,42327,-0.0425124618112048,0.0117534130964773,-0.0655491514803002,-0.0194757721421094,0.000299118715633803
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NGRN,Neugrin,40482,0.00818341965102944,0.00226260487130836,0.00374871410326506,0.0126181251987938,0.000299553131100529
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CCT5,T-complex protein 1 subunit epsilon,42345,0.016188136354963,0.00448378099934728,0.00739992559624233,0.0249763471136837,0.00030689010476632
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NFKB1,Nuclear factor NF-kappa-B p105 subunit,40115,0.0259866918528132,0.007197985543917,0.0118786401867358,0.0400947435188905,0.000307244884260487
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DAPK2,Death-associated protein kinase 2,40198,0.0190963902769854,0.00529660940878271,0.00871503583577128,0.0294777447181995,0.000313051939610705
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AGER,Advanced glycosylation end product-specific receptor,42586,0.0147927163737336,0.0041103829204862,0.00673636584958068,0.0228490668978866,0.000320761252766722
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RRM2,Ribonucleoside-diphosphate reductase subunit M2,42345,0.0179338206959053,0.00498640927259629,0.0081604585216166,0.0277071828701941,0.00032365993171753
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ERMAP,Erythroid membrane-associated protein,40198,0.0157077183982701,0.00437593084856577,0.0071308939350812,0.024284542861459,0.000332662208605831
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SPINT2,Kunitz-type protease inhibitor 2,42675,0.0141564146368726,0.00394561571321291,0.00642300783897526,0.0218898214347699,0.000334552779964797
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GPKOW,G-patch domain and KOW motifs-containing protein,42310,0.0100542423483435,0.002814502983431,0.00453781650081876,0.0155706681958683,0.000355130870955296
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",40222,0.0117012143443075,0.00328059735518395,0.00527124352814698,0.0181311851604681,0.000362907117025982
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CALCA,Calcitonin,42475,0.0219993654621449,0.00617331158717239,0.00989967475128705,0.0340990561730028,0.0003670514546504
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MB,Myoglobin,42793,0.0185126824650248,0.00519495377725835,0.00833057306159844,0.0286947918684512,0.000367070655516397
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NFKBIE,NF-kappa-B inhibitor epsilon,42345,0.017224272880865,0.00483434882223001,0.00774894918929415,0.0266995965724358,0.000368086585332188
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,REEP4,Receptor expression-enhancing protein 4,40481,0.0215345116721936,0.00604426734971335,0.00968774766675541,0.0333812756776317,0.000368434090410961
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,JAM3,Junctional adhesion molecule C,40282,0.0176849755629248,0.00496471543965008,0.0079541333012106,0.0274158178246389,0.000369397217117521
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CHL1,Neural cell adhesion molecule L1-like protein,42667,0.0106303973379655,0.00298551635769101,0.00477878527689112,0.0164820093990399,0.000371203872675909
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,42593,0.0212512747294205,0.00597678597130627,0.00953677422566019,0.0329657752331808,0.000378365580355013
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,40282,0.00752746643726356,0.00211752487581368,0.00337711768066874,0.0116778151938584,0.000379780501677218
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,F3,Tissue factor,42635,-0.00948464872525499,0.00267175118965816,-0.014721281056985,-0.00424801639352499,0.000386584242824599
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NFE2,Transcription factor NF-E2 45 kDa subunit,40222,0.0257609426008304,0.00725847576835913,0.0115343300948465,0.0399875551068143,0.00038818133171517
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MTSS2,Protein MTSS 2,40450,0.0341247602994915,0.00962118616273944,0.0152672354205222,0.0529822851784608,0.00039147382693527
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NID2,Nidogen-2,42610,0.0256048530807601,0.00722663891390035,0.0114406408095154,0.0397690653520048,0.000396765153384288
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BIN2,Bridging integrator 2,42610,0.0311943137312851,0.00880878365535162,0.0139290977667959,0.0484595296957743,0.000399550409909174
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SCARA5,Scavenger receptor class A member 5,42710,0.010658720052023,0.00301745527643522,0.00474450771020994,0.016572932393836,0.000413250799668312
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,S100A16,Protein S100-A16,42291,-0.0210048378564037,0.00595269186685637,-0.0326721139154422,-0.00933756179736523,0.000419150715807609
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GRK5,G protein-coupled receptor kinase 5,42356,0.0175338637427536,0.00496939643560598,0.00779384672896592,0.0272738807565414,0.000419554506430386
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FCRL3,Fc receptor-like protein 3,42369,0.019493379393722,0.00552945864608826,0.008655640447389,0.030331118340055,0.00042432977881138
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SIGLEC5,Sialic acid-binding Ig-like lectin 5,42610,0.0408495957221292,0.011619534477699,0.0180753081458392,0.0636238832984193,0.0004402148608402
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IFNG,Interferon gamma,42369,0.0388839685878761,0.0110621140482557,0.0172022250532949,0.0605657121224573,0.000441134926037869
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MRI1,Methylthioribose-1-phosphate isomerase,40181,0.0236207662158237,0.00671976446123901,0.0104500278717952,0.0367915045598522,0.000441328825502264
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HSPB6,Heat shock protein beta-6,42720,0.0135496126193429,0.00386073950069267,0.00598256319798525,0.0211166620407005,0.000450257617023656
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,POSTN,Periostin,40526,0.0132205055216684,0.00376767663106764,0.00583585932477583,0.020605151718561,0.000451662350726884
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PSME2,Proteasome activator complex subunit 2,42440,0.0123849376166198,0.0035316065460059,0.0054629887864482,0.0193068864467913,0.000454886441517142
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EZR,Ezrin,42710,0.00813839673582364,0.00233006349411267,0.00357147228736281,0.0127053211842845,0.000479549985515408
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,OMD,Osteomodulin,42675,0.0144406834618167,0.00413465230576725,0.00633676494251292,0.0225446019811205,0.00047987649960952
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CWC15,Spliceosome-associated protein CWC15 homolog,40382,0.020291725944458,0.00581511756541182,0.00889409551625078,0.0316893563726651,0.000485827193179924
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RNF149,E3 ubiquitin-protein ligase RNF149,40222,0.0110654168226699,0.0031719340942442,0.00484842599795131,0.0172824076473886,0.000487561832015883
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",40481,0.0139483480801858,0.00400064713422117,0.00610707969711234,0.0217896164632593,0.000491204300840107
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BCAM,Basal cell adhesion molecule,42610,0.0084049071957038,0.00241297583484604,0.00367547455940557,0.013134339832002,0.000497014430081873
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BRSK2,Serine/threonine-protein kinase BRSK2,40481,0.0129491451383862,0.0037202890914547,0.00565737851913498,0.0202409117576374,0.000502028074446164
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IFT20,Intraflagellar transport protein 20 homolog,40181,0.0146117775898421,0.00419886405836025,0.00638200403545602,0.0228415511442282,0.000503479485088253
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FAS,Tumor necrosis factor receptor superfamily member 6,42759,0.0113489535046821,0.0032622603383987,0.00495492324142068,0.0177429837679436,0.000505127849102261
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FURIN,Furin,42678,0.011081746515967,0.00318713794724419,0.00483495613936841,0.0173285368925656,0.000508614855836036
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RNASET2,Ribonuclease T2,42748,0.00939057175363873,0.00270176499406594,0.00409511236526949,0.014686031142008,0.000511083316032315
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ADGRG1,Adhesion G-protein coupled receptor G1,42586,-0.0276192928012673,0.00794861624906936,-0.0431985806494432,-0.0120400049530914,0.000512986492973528
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AZI2,5-azacytidine-induced protein 2,40481,0.0186522050401495,0.00536937801015971,0.00812822414023645,0.0291761859400625,0.000515047030550531
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,40481,0.00908821895850731,0.00262308409299083,0.00394697413624528,0.0142294637807693,0.000532780478565079
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PLXNA4,Plexin-A4,42593,0.0276112970678608,0.00798185180227542,0.011966867535401,0.0432557266003206,0.000543347473427349
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ANXA1,Annexin A1,40234,0.0140632579746089,0.00407516613397694,0.00607593235201411,0.0220505835972037,0.000560675186819307
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SEL1L,Protein sel-1 homolog 1,40222,0.0110154292533252,0.003194076889775,0.0047550385493662,0.0172758199572842,0.000565386577626137
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RAB33A,Ras-related protein Rab-33A,40115,0.0221224423007134,0.00642042464425328,0.00953840999797698,0.0347064746034498,0.000571861396682746
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,VWC2L,von Willebrand factor C domain-containing protein 2-like,40481,0.0152554763089339,0.00443975954149372,0.00655354760760622,0.0239574050102616,0.000592269592203997
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ANXA10,Annexin A10,42310,0.0290412448075601,0.00845629514497753,0.0124669063234042,0.0456155832917161,0.000595978264187774
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CSF3R,Granulocyte colony-stimulating factor receptor,40198,0.0101325843102173,0.00295204460789784,0.00434657687873757,0.0159185917416971,0.000600476117956667
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,42710,0.00956514528579185,0.00278705273607102,0.00410252192309266,0.015027768648491,0.000600957005910561
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FUT8,"Alpha-(1,6)-fucosyltransferase",42494,0.0197276204722712,0.00575043528090359,0.00845676732170013,0.0309984736228422,0.000604009004165993
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,42291,0.0162272134682519,0.00473598982552364,0.00694467341022556,0.0255097535262782,0.000613604079045891
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CABP2,Calcium-binding protein 2,40181,0.0216690011381371,0.00632708931331086,0.00926790608404783,0.0340700961922264,0.000617506137772585
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD200R1,Cell surface glycoprotein CD200 receptor 1,42557,0.0117823715224296,0.00344056937693948,0.00503885554362818,0.018525887501231,0.000617688348478339
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,S100P,Protein S100-P,42356,0.0182408425175327,0.00533175376561918,0.00779060513691911,0.0286910798981463,0.000625415244563311
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CCL19,C-C motif chemokine 19,42710,0.0438349907952633,0.0128181531751766,0.0187114105719171,0.0689585710186095,0.000628618744993967
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RAPGEF2,Rap guanine nucleotide exchange factor 2,40301,0.0176017434177071,0.00515083094690655,0.00750611476177023,0.0276973720736439,0.000634810019326626
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KAZN,Kazrin,40448,0.0347100596690515,0.0101592996700349,0.0147978323157831,0.0546222870223198,0.000636373010179198
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PRSS27,Serine protease 27,42602,0.0134664759332726,0.00394571430394596,0.00573287589753852,0.0212000759690067,0.000644566816056281
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BOLA1,BolA-like protein 1,40135,0.0180605672662262,0.00529233999540301,0.0076875808752363,0.0284335536572161,0.000645826105838216
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",42637,0.0114130349171139,0.00334571584044859,0.0048554318698347,0.0179706379643932,0.000648587985908874
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,40198,0.0180659800608839,0.00530150971679009,0.00767502101597533,0.0284569391057925,0.000657463998464537
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SERPINE1,Plasminogen activator inhibitor 1,42793,0.0219358004481684,0.00643889326556283,0.00931556964766525,0.0345560312486715,0.000659278520130671
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DCTN1,Dynactin subunit 1,42720,0.0214542720703054,0.0063051010268411,0.00909627405769689,0.033812270082914,0.000669205415941235
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FOLR1,Folate receptor alpha,42599,0.0101124343575841,0.0029735261716426,0.00428432306116463,0.0159405456540036,0.000673795009061263
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EFHD1,EF-hand domain-containing protein D1,40481,0.0119818780115311,0.00353522031010988,0.00505284620371573,0.0189109098193465,0.000703143290670436
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TPP1,Tripeptidyl-peptidase 1,42544,0.014921335320028,0.00440818959851383,0.00628128370694091,0.0235613869331151,0.000714060008503749
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LGALS4,Galectin-4,42617,-0.0187210643301809,0.00553132696886702,-0.0295624651891602,-0.00787966347120151,0.000714985663092229
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ROBO2,Roundabout homolog 2,42710,0.00774518693411399,0.00229099446398194,0.00325483778470938,0.0122355360835186,0.000725035787912812
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CDH4,Cadherin-4,40135,0.0164445459929281,0.00487110953508126,0.00689717130416884,0.0259919206816874,0.000738214369734067
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SIGLEC9,Sialic acid-binding Ig-like lectin 9,42705,0.00974018930473314,0.00288803110061778,0.0040796483475223,0.015400730261944,0.000746695686064845
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,F11R,Junctional adhesion molecule A,42610,0.0182451862313624,0.00541521727638443,0.00763136036964895,0.0288590120930759,0.000755870438219437
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,F12,Coagulation factor XII,40538,0.0136751579417093,0.00405909349550249,0.00571933469052444,0.0216309811928942,0.000756877969729516
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TXLNA,Alpha-taxilin,42494,0.028729881448959,0.00854546918637742,0.0119807618436593,0.0454790010542588,0.000775977278608713
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,42618,0.0192306232899993,0.00572316456043759,0.00801322075154166,0.030448025828457,0.000781205848509077
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,40029,0.0109791002671605,0.00327048080317377,0.00456895789293994,0.0173892426413811,0.000790558242188859
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GC,Vitamin D-binding protein,40538,0.00850594549296375,0.00253417627396624,0.00353895999598992,0.0134729309899376,0.000791969223896623
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RABGAP1L,Rab GTPase-activating protein 1-like,42369,0.0196757469501951,0.00586377828792233,0.00818274150586728,0.0311687523945228,0.000794533024921113
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PLA2G1B,Phospholipase A2,42781,0.0149616588288781,0.00446336804935428,0.00621345745214373,0.0237098602056125,0.000804196903226738
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PSPN,Persephin,42593,0.0304223503814441,0.0090983694399897,0.0125895462790643,0.0482551544838239,0.000828913438072953
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MYO9B,Unconventional myosin-IXb,42369,0.0215512556106405,0.0064463526140519,0.00891640448709875,0.0341861067341822,0.000830577754786304
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CLEC1A,C-type lectin domain family 1 member A,42356,0.0114899315454165,0.00344055039807885,0.004746452765182,0.0182334103256511,0.000841436866260885
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PAEP,Glycodelin,42494,0.0294240312868589,0.00881660728410005,0.0121434810100228,0.046704581563695,0.000848158255567807
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,XRCC4,DNA repair protein XRCC4,42310,0.0120360477499757,0.00360689436926671,0.00496653478621293,0.0191055607137384,0.000849367846312236
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IGSF9,Protein turtle homolog A,40510,-0.0269547354745687,0.00809388157949023,-0.0428187433703695,-0.0110907275787679,0.000870421977674173
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LRP11,Low-density lipoprotein receptor-related protein 11,42635,0.0122007746930544,0.00366435597809692,0.00501863697598447,0.0193829124101244,0.000872103339601809
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SHBG,Sex hormone-binding globulin,40531,0.0164592505475574,0.00494359290009818,0.00676980846336501,0.0261486926317499,0.00087307552482918
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IMPACT,Protein IMPACT,40482,0.0181479006797094,0.00546097859684687,0.00744438262988956,0.0288514187295293,0.000892755259945351
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BRDT,Bromodomain testis-specific protein,40115,0.0121210897705984,0.00364762552637608,0.00497174373890129,0.0192704358022955,0.000893450068862496
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,40450,-0.0123816252319626,0.00372939525888795,-0.019691239939383,-0.00507201052454225,0.000903007169442809
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,42793,0.00893448048423968,0.00269401202938121,0.00365421690665252,0.0142147440618269,0.000914169547054959
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TCN1,Transcobalamin-1,40336,0.0111046806439359,0.00335064765475268,0.00453741124062062,0.0176719500472511,0.000922024773964989
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,VNN1,Pantetheinase,40531,0.023614352967792,0.00712647100950054,0.00964646978917097,0.0375822361464131,0.000923881132243002
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DMD,Dystrophin,40222,0.016623572748123,0.00503808694731679,0.00674892233138207,0.0264982231648639,0.00097136545344166
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BOLA2_BOLA2B,BolA-like protein 2,40222,0.0174528632019377,0.0052900115029784,0.00708444065610008,0.0278212857477754,0.000972643875417885
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SNX5,Sorting nexin-5,40222,0.00936756800440763,0.002842149974145,0.00379695405508344,0.0149381819537318,0.00098401240550545
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,VNN2,Vascular non-inflammatory molecule 2,42586,0.0146963811393758,0.00445930855923426,0.00595613636327665,0.0234366259154749,0.000984447227361824
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GH1,Somatotropin,42612,0.0552090401336605,0.0167715634221877,0.0223367758261726,0.0880813044411484,0.000997968991845065
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AP3S2,AP-3 complex subunit sigma-2,40482,0.0151903260405528,0.00463681428506272,0.00610217004182982,0.0242784820392757,0.00105596319531264
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,YJU2,Splicing factor YJU2,40450,0.0103696446848716,0.00317004660733036,0.00415635333450404,0.0165829360352391,0.00107439728442793
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,VMO1,Vitelline membrane outer layer protein 1 homolog,42586,0.0222151518948333,0.00680469747769543,0.00887794483855026,0.0355523589511164,0.0010986332464446
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FGF21,Fibroblast growth factor 21,42688,0.0372478773259079,0.0114369311473198,0.014831492277161,0.0596642623746548,0.00112951196758218
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ARHGAP1,Rho GTPase-activating protein 1,42345,0.0143787500488188,0.00441570980166161,0.00572395883756204,0.0230335412600756,0.00113171549992169
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SMS,Spermine synthase,40135,0.020241779801103,0.00623095713107085,0.00802910382420416,0.0324544557780019,0.00116331408929047
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,S100A13,Protein S100-A13,40198,0.011321001078452,0.00348647438687998,0.00448751128016721,0.0181544908767367,0.00116928325312596
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",40222,0.0217029218354532,0.00669029133241681,0.00858995082391621,0.0348158928469901,0.00118238471917526
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GBA,Lysosomal acid glucosylceramidase,40181,0.0176254263323558,0.0054343157308694,0.00697416749985177,0.0282766851648598,0.00118482885268055
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CDON,Cell adhesion molecule-related/down-regulated by oncogenes,42637,-0.0082135334771636,0.00253256927799782,-0.0131773692620393,-0.00324969769228789,0.00118499255406497
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SERPINE2,Glia-derived nexin,40510,0.0203104702285866,0.00626496330988036,0.00803114214122111,0.0325897983159521,0.00119073707986394
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NEDD9,Enhancer of filamentation 1,40198,0.0105742503445044,0.00326299356325449,0.00417878296052561,0.0169697177284832,0.00119608165071699
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TG,Thyroglobulin,40450,0.0365029144538682,0.0112934962329598,0.014367661837267,0.0586381670704694,0.00123191734613584
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CLEC4M,C-type lectin domain family 4 member M,40503,0.0156051012473462,0.00483549483911353,0.00612753136268372,0.0250826711320087,0.00125364839049877
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CPXM1,Probable carboxypeptidase X1,42678,0.0219290427008185,0.00680131029171742,0.00859847452905236,0.0352596108725846,0.00126609100707689
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CNTN3,Contactin-3,42610,0.00982470694877887,0.00304713868910342,0.00385231511813618,0.0157970987794216,0.0012660964406677
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MYL4,Myosin light chain 4,40222,-0.0164615412047057,0.00510964894812177,-0.0264764531430244,-0.00644662926638701,0.00127821140650345
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ERBB2,Receptor tyrosine-protein kinase erbB-2,42678,0.0074286295668242,0.00230615639516901,0.00290856303229294,0.0119486961013555,0.00127950414517746
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CPPED1,Serine/threonine-protein phosphatase CPPED1,42710,0.0204367848774802,0.00634986300852102,0.00799105338077902,0.0328825163741814,0.00129184682356923
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FMNL1,Formin-like protein 1,42310,0.0194588081560302,0.00604753579143166,0.00760563800482411,0.0313119783072362,0.00129562763207274
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KLK11,Kallikrein-11,42542,0.0103187791188877,0.00321068276777186,0.00402584089405483,0.0166117173437205,0.00131261343115967
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,WASF3,Wiskott-Aldrich syndrome protein family member 3,42310,0.0265242239923578,0.00825950742070449,0.010335589447777,0.0427128585369386,0.00132428466433027
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,42673,0.010962548567581,0.00341456976535296,0.00426999182748921,0.0176551053076728,0.00132805118245401
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD226,CD226 antigen,40198,0.0133016109626685,0.00414326747774982,0.00518080670627883,0.0214224152190581,0.00132923770080818
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AMOTL2,Angiomotin-like protein 2,40403,0.0151648350599613,0.00472415309763053,0.00590549498860545,0.0244241751313171,0.00133079267552207
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ATP6V1D,V-type proton ATPase subunit D,42586,0.00821525677249505,0.00256159303689858,0.00319453442017383,0.0132359791248163,0.00134400663882177
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,42294,0.0179976554871125,0.00561717411284694,0.00698799422593252,0.0290073167482925,0.00135837697021355
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GMPR,GMP reductase 1,42753,0.0154364596271356,0.00481869058849255,0.00599182607369022,0.024881093180581,0.00136103043674243
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FNDC1,Fibronectin type III domain-containing protein 1,40482,0.0147441723164723,0.00460510222974017,0.00571817194618158,0.023770172686763,0.00136996136309719
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IDS,Iduronate 2-sulfatase,42753,0.0027374917080803,0.00085515478018683,0.00106138833891412,0.00441359507724649,0.00137188613400907
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TGOLN2,Trans-Golgi network integral membrane protein 2,40531,0.00853626252261635,0.00267266366574505,0.00329784173775605,0.0137746833074767,0.00140740938193146
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PODXL,Podocalyxin,42586,0.00477159359171745,0.00149597818324039,0.00183947635256628,0.00770371083086862,0.00142790882407423
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CNPY2,Protein canopy homolog 2,42356,0.0192716771226578,0.00604591313070865,0.00742168738646889,0.0311216668588468,0.00143816934736525
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GHR,Growth hormone receptor,40282,0.00884492878758667,0.00277615040932979,0.00340367398530029,0.0142861835898731,0.00144633868255542
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,42345,0.0148767331060768,0.00466958344277079,0.00572434955824611,0.0240291166539076,0.00144651433988374
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EGFL7,Epidermal growth factor-like protein 7,42345,0.0123918168178826,0.00389208273659737,0.00476333465415171,0.0200202989816134,0.00145667745089925
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",42345,0.015467724060264,0.00486831753580647,0.00592582169008333,0.0250096264304447,0.00149037146183693
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ATP6V1F,V-type proton ATPase subunit F,42291,0.0206183364609262,0.00649018616206656,0.00789757158327574,0.0333391013385767,0.00149230456723421
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TRIM21,E3 ubiquitin-protein ligase TRIM21,42593,0.0243612504080216,0.00767426293310904,0.00931969505912792,0.0394028057569154,0.00150481516730578
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MME,Neprilysin,42586,-0.0251618289587168,0.00793395033194686,-0.0407123716093327,-0.00961128630810098,0.00152041719736101
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FES,Tyrosine-protein kinase Fes/Fps,42345,0.0147344099538947,0.00464910788219748,0.00562215850478766,0.0238466614030018,0.00153157545336098
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GABARAP,Gamma-aminobutyric acid receptor-associated protein,40450,0.0155071530974674,0.00490080138974575,0.00590158237356572,0.0251127238213691,0.00155919668265485
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD6,T-cell differentiation antigen CD6,42745,0.0163083174523939,0.00515422937609765,0.00620602787524246,0.0264106070295453,0.00155925799456041
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MTUS1,Microtubule-associated tumor suppressor 1,40301,0.0174805205248911,0.0055282805382413,0.00664509066993816,0.0283159503798441,0.0015710157342331
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CST6,Cystatin-M,42331,0.0156582557712105,0.0049591129540705,0.00593839438123233,0.0253781171611887,0.00159504030407577
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RBFOX3,RNA binding protein fox-1 homolog 3,40481,0.0123913019954651,0.00393411232518097,0.00468044183811041,0.0201021621528198,0.00163860638392744
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,C2orf69,UPF0565 protein C2orf69,40181,0.0187523370725175,0.00597041943971286,0.00705031497068031,0.0304543591743547,0.00168891225438809
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ITGB2,Integrin beta-2,42568,0.00875440697586059,0.00279811974978551,0.00327009226628098,0.0142387216854402,0.00175973740307056
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PRSS53,Serine protease 53,40482,0.0114163359258159,0.00365027900103974,0.00426178908377799,0.0185708827678538,0.00176733475212625
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,40481,0.0201009779018534,0.00642784326265189,0.00750240510705569,0.0326995506966511,0.00176944597975874
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RAB6A,Ras-related protein Rab-6A,42593,-0.0140096809926887,0.00448685898530793,-0.0228039246038922,-0.00521543738148512,0.00179776780463099
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LYPD8,Ly6/PLAUR domain-containing protein 8,42345,-0.0154744393962693,0.00496211737832758,-0.0252001894577913,-0.00574868933474722,0.0018215706762184
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EPHA2,Ephrin type-A receptor 2,42124,0.0102901722744042,0.00330048038725378,0.00382123071538678,0.0167591138334216,0.00182618445970874
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SMTN,Smoothelin,40459,0.0280215166720094,0.00899299350641502,0.010395249399436,0.0456477839445828,0.00183828080335232
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LPP,Lipoma-preferred partner,40115,0.0200323002566886,0.00643598545599784,0.00741776876293279,0.0326468317504443,0.00185960041916725
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CLEC3B,Tetranectin,40268,0.00640296883509661,0.00205788100102421,0.00236952207308916,0.010436415597104,0.00186652079929597
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AMBP,Protein AMBP,42705,0.00636853124276041,0.00204700528293406,0.00235640088820966,0.0103806615973112,0.00186751326939822
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD69,Early activation antigen CD69,42584,0.0265334032779438,0.00853729951290616,0.00980029623264772,0.0432665103232399,0.00188791678895698
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PAGR1,PAXIP1-associated glutamate-rich protein 1,40222,0.0132323303747627,0.00426286078480943,0.00487712323653627,0.0215875375129892,0.00191344341819272
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FOXO1,Forkhead box protein O1,42593,0.0256216288163588,0.00826132779644976,0.00942942633531723,0.0418138312974003,0.0019301207135385
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MANSC4,MANSC domain-containing protein 4,40115,0.0217331211378823,0.00702980252735838,0.00795470818425993,0.0355115340915048,0.00199602997919
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ITGB1BP1,Integrin beta-1-binding protein 1,42345,0.0124506937055319,0.00402778419903007,0.00455623667543296,0.0203451507356308,0.00199764812292889
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CDH3,Cadherin-3,42710,0.0113435024130737,0.00367047075981486,0.00414937972383654,0.0185376251023108,0.00200241922499825
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SNAP23,Synaptosomal-associated protein 23,42635,0.026096131252343,0.00844878795381362,0.00953650686286835,0.0426557556418177,0.0020141540390373
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ADGRE5,Adhesion G protein-coupled receptor E5,42736,0.00940628807656747,0.00305111114098133,0.00342611024024406,0.0153864659128909,0.00205402100155289
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PREB,Prolactin regulatory element-binding protein,42369,0.00889296009887258,0.0028879190325249,0.00323263879512377,0.0145532814026214,0.00207868343745371
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HRG,Histidine-rich glycoprotein,40478,0.00926394456039389,0.00302380449125519,0.00333728775753371,0.0151906013632541,0.00219154123703224
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,40301,0.0219074780797017,0.00715989533772147,0.00787408321776761,0.0359408729416358,0.0022205116923678
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,42345,0.0192402407500607,0.00629027408121024,0.00691130355088862,0.0315691779492328,0.00222725463660038
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,40135,0.0185136531660064,0.00605399041792944,0.00664783194686473,0.0303794743851482,0.0022329004364654
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KLF4,Krueppel-like factor 4,40135,0.0119557267924764,0.00391884009874927,0.00427480019892784,0.019636653386025,0.00228753915324964
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LIF,Leukemia inhibitory factor,42310,0.0153660392272071,0.00503979031273496,0.00548805021424655,0.0252440282401676,0.00230104801201624
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LEP,Leptin,42635,0.0197658047930237,0.00648295136896531,0.0070592201098517,0.0324723894761957,0.00230135278150187
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SLC4A1,Band 3 anion transport protein,40526,-0.0139779687731316,0.00458847363035162,-0.0229713770886207,-0.00498456045764239,0.0023219218530065
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CES3,Carboxylesterase 3,42586,0.0208953041420705,0.00688249313763098,0.00740561759231375,0.0343849906918272,0.00240193672802009
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,40448,0.0321801845751671,0.0106038503005375,0.0113966379861136,0.0529637311642207,0.00241273534267945
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NTF4,Neurotrophin-4,42345,0.0115946755806744,0.00382265632391484,0.00410226918580133,0.0190870819755475,0.00242490247639336
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,OPLAH,5-oxoprolinase,40222,0.0200225282363741,0.00660516362841514,0.00707640752468044,0.0329686489480678,0.00244032068175006
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RPA2,Replication protein A 32 kDa subunit,40198,0.00939620914279022,0.00310539437111309,0.00330963617540857,0.0154827821101719,0.00248573773213814
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CX3CL1,Fractalkine,42494,0.0101916393600046,0.00336887429609821,0.00358864573965211,0.0167946329803571,0.00248913780229968
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BTC,Probetacellulin,42345,0.0220030069715511,0.00730705138493555,0.00768118625707739,0.0363248276860247,0.00260709910614255
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,C2CD2L,Phospholipid transfer protein C2CD2L,42291,0.012676405021754,0.00421062242157251,0.00442358507547188,0.0209292249680361,0.00261248238546387
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PDCD1LG2,Programmed cell death 1 ligand 2,42586,0.00939962410005741,0.00312228754287502,0.00327994051602236,0.0155193076840925,0.00261310108213974
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RALB,Ras-related protein Ral-B,40198,0.00884428646803278,0.00293860897739405,0.00308461287234045,0.0146039600637251,0.00262111495570663
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LTB,Lymphotoxin-beta,40450,0.0105619859613454,0.00351015365458194,0.00368208479836479,0.017441887124326,0.00262705482433699
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CPE,Carboxypeptidase E,42587,0.0113605614088566,0.003777464796186,0.00395673040833206,0.0187643924093812,0.00263932740121677
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BMP6,Bone morphogenetic protein 6,42341,0.0119306856754854,0.00396987902066771,0.00414972279497664,0.0197116485559941,0.00265817586208067
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SERPINA4,Kallistatin,40341,0.0070729491310885,0.00235585676987298,0.00245546986213747,0.0116904284000395,0.00268556704414193
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MAVS,Mitochondrial antiviral-signaling protein,42345,0.0265186543803755,0.00884492038944221,0.00918261041706879,0.0438546983436822,0.00272105772907008
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ATRAID,All-trans retinoic acid-induced differentiation factor,40448,0.00871438698672904,0.00290942405168168,0.00301191584543294,0.0144168581280251,0.00274837093341603
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DDHD2,Phospholipase DDHD2,40481,0.0191353773777048,0.00639361481052896,0.00660389234906808,0.0316668624063416,0.00276948549536211
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,USP28,Ubiquitin carboxyl-terminal hydrolase 28,40482,0.0111120651674154,0.00371736861133288,0.00382602268920291,0.0183981076456278,0.00280285125786731
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SERPINB9,Serpin B9,42494,0.00958310264680553,0.00320681212079025,0.00329775089005664,0.0158684544035544,0.00280993012003717
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,40526,0.0414472745057617,0.0138952902654573,0.0142125055854654,0.068682043426058,0.00286205585354684
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CLSPN,Claspin,42291,0.010243624294108,0.00343474802541306,0.00351151816429836,0.0169757304239176,0.00286570409157166
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PFDN2,Prefoldin subunit 2,42310,0.0161690089693461,0.00542511592409958,0.00553578175811098,0.0268022361805813,0.00288401266391783
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TGFBR2,TGF-beta receptor type-2,42678,0.0104434230684722,0.00351643810152323,0.00355120438948671,0.0173356417474578,0.00298434121447182
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CLSTN1,Calsyntenin-1,42310,0.0154420455492741,0.00521001014138021,0.00523042567216886,0.0256536654263793,0.00304294590098642
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CSNK2A1,Casein kinase II subunit alpha,40481,-0.0129698669900137,0.004381552788159,-0.0215577104548053,-0.00438202352522203,0.00308171066518865
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ART3,Ecto-ADP-ribosyltransferase 3,42688,0.0104250614686479,0.0035258511161564,0.00351439328098131,0.0173357296563144,0.0031143805388535
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,C1GALT1C1,C1GALT1-specific chaperone 1,40115,0.00944842675581679,0.00319872068489447,0.00317893421342363,0.01571791929821,0.00314542001115526
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BCR,Breakpoint cluster region protein,42593,0.0261481275460704,0.00887141720086672,0.00876014983237162,0.0435361052597692,0.00320950835751358
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DUSP3,Dual specificity protein phosphatase 3,42310,0.0247068921427984,0.00838498474442439,0.00827232204372664,0.0411414622418702,0.00321891424908997
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,COMT,Catechol O-methyltransferase,42213,0.0238616831506624,0.0081090646384652,0.00796791645927064,0.0397554498420542,0.00326049187831861
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PER3,Period circadian protein homolog 3,40198,0.035427040006759,0.0120513750829752,0.0118063448441277,0.0590477351693904,0.0032924737185719
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BRAP,BRCA1-associated protein,40341,0.0311913459704622,0.010629847231684,0.0103568453963616,0.0520258465445628,0.00334963711916245
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TARS1,"Threonine--tRNA ligase 1, cytoplasmic",40450,0.0108251355536242,0.00369051925333936,0.00359171781707908,0.0180585532901694,0.00336133526207469
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EBI3_IL27,Interleukin-27,42688,0.00885451880592935,0.00302030108205654,0.00293472868509853,0.0147743089267602,0.00337713327202656
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TNFSF13,Tumor necrosis factor ligand superfamily member 13,42675,0.00792808815746711,0.00270675227399887,0.00262285370042933,0.0132333226145049,0.0034061954443966
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SCT,Secretin,40181,-0.0143312037836915,0.00489624130637803,-0.0239278367441924,-0.00473457082319055,0.00342971721487122
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SDCCAG8,Serologically defined colon cancer antigen 8,40450,0.0324153025160949,0.0110856543234264,0.0106874200421791,0.0541431849900107,0.00346168459197573
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,QSOX1,Sulfhydryl oxidase 1,40341,0.0123924859877223,0.00424409112966134,0.00407406737358609,0.0207109046018585,0.00350801401339363
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SSNA1,Sjoegren syndrome nuclear autoantigen 1,40448,0.01473675496237,0.00505812995276462,0.00482282025495133,0.0246506896697886,0.00358129322326857
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GPR158,Probable G-protein coupled receptor 158,40481,0.0102782493038682,0.0035279130404424,0.00336353974460107,0.0171929588631353,0.00358208801228146
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BTD,Biotinidase,40538,0.00586365108523566,0.00201362604300597,0.00191694404094396,0.00981035812952737,0.0035983839867291
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,40301,0.019935593070175,0.00684818971542005,0.00651314122795174,0.0333580449123983,0.00360903699332895
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ACY1,Aminoacylase-1,42635,-0.0171869381300695,0.005904415159459,-0.0287595918426092,-0.00561428441752989,0.00361024966922428
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ITM2A,Integral membrane protein 2A,42593,0.0175717047384593,0.00603778851623543,0.00573763924663783,0.0294057702302807,0.00361689999966712
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EPHB4,Ephrin type-B receptor 4,42793,0.00751285494145162,0.00258318506769062,0.00244981220877801,0.0125758976741252,0.00363907400341595
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CNTN5,Contactin-5,42639,0.0108315972116319,0.00372861245597616,0.00352351679791858,0.0181396776253451,0.00367858517522307
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NAA10,N-alpha-acetyltransferase 10,40115,0.0146328572424222,0.0050379591636262,0.00475845728171485,0.0245072572031295,0.00368553322326386
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SERPINA1,Alpha-1-antitrypsin,40326,0.00232660999686849,0.000801706325792948,0.00075526559831431,0.00389795439542267,0.00371429601411282
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL22RA1,Interleukin-22 receptor subunit alpha-1,42369,-0.0122558008415322,0.00422775318046098,-0.0205421970752357,-0.00396940460782868,0.0037510163711221
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CCER2,Coiled-coil domain-containing glutamate-rich protein 2,40222,0.0183773954123253,0.00633974874345929,0.00595148787514511,0.0308033029495055,0.00375382933283244
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TNFSF11,Tumor necrosis factor ligand superfamily member 11,42593,0.0169928711952235,0.00588495364639028,0.00545836204829858,0.0285273803421485,0.00388923642509042
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD33,Myeloid cell surface antigen CD33,42678,0.0226703765004895,0.0078596024767109,0.00726555564613612,0.0380751973548429,0.00392759204687832
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PBLD,Phenazine biosynthesis-like domain-containing protein,42310,0.0143322001083259,0.00500062404232221,0.00453097698537438,0.0241334232312774,0.00416247275370566
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MELTF,Melanotransferrin,40510,0.00846686178142012,0.00295466581911625,0.00267571677595226,0.014258006786888,0.00416999534069941
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BRD2,Bromodomain-containing protein 2,40135,0.00999526896337589,0.00350213436183796,0.0031310856141735,0.0168594523125783,0.00432467222946176
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SLIT2,Slit homolog 2 protein,42310,0.0146805027159138,0.00514526882555933,0.00459577581781753,0.0247652296140101,0.00433485332831844
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BDNF,Brain-derived neurotrophic factor,40526,0.0233103511801445,0.0081825192204218,0.00727261350811778,0.0393480888521712,0.00439636731859178
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ARHGEF5,Rho guanine nucleotide exchange factor 5,40135,0.0207474589267036,0.0072835367443927,0.00647172690769388,0.0350231909457133,0.00440020021666936
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BCL2,Apoptosis regulator Bcl-2,40448,0.0159507117677135,0.00560107545893802,0.00497260386819495,0.026928819667232,0.0044103096138641
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TNN,Tenascin-N,40526,0.0121965186178333,0.0043116632156087,0.00374565871524027,0.0206473785204264,0.00468155889100472
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,VGF,Neurosecretory protein VGF,40481,0.00872090832053611,0.00308780515201245,0.00266881022259171,0.0147730064184805,0.00474661023573523
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SEPTIN7,Septin-7,40301,0.0150441922886843,0.00533510252734645,0.00458739133508528,0.0255009932422833,0.00481311078084099
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,40222,0.011479836019949,0.00407258059791526,0.0034975780480351,0.0194620939918629,0.00482877272850423
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,INSL3,Insulin-like 3,40482,0.02149327585349,0.00764892617050109,0.00650138055930789,0.0364851711476722,0.00496309212393186
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TJAP1,Tight junction-associated protein 1,42678,0.022570881778182,0.00803643468981548,0.00681946978614361,0.0383222937702203,0.00498337628663581
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,F7,Coagulation factor VII,42670,0.00848762344670366,0.00302918902499935,0.00255041295770494,0.0144248339357024,0.00508678701915608
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EDAR,Tumor necrosis factor receptor superfamily member EDAR,42593,0.0246699656986887,0.00882569350581549,0.00737160642729029,0.041968324970087,0.00519343443576283
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ARSA,Arylsulfatase A,42610,0.0121562138752625,0.00435123054593291,0.00362780200523401,0.020684625745291,0.00521759629006205
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",40481,0.0130715569642553,0.00469101721117097,0.00387716323036019,0.0222659506981504,0.00533682648305635
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ITGAV,Integrin alpha-V,42720,-0.00447059382552495,0.00160454419519308,-0.00761550044810339,-0.00132568720294652,0.00534029152550878
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EDN1,Endothelin-1,40222,0.00829816736785123,0.002979463479046,0.00245841894892107,0.0141379157867814,0.00535989702240302
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HEXIM1,Protein HEXIM1,42593,0.0218005797169938,0.00785355556428975,0.00640761081098586,0.0371935486230017,0.00551277722941523
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CCN4,CCN family member 4,42720,0.0108687151140238,0.00391748628640944,0.00319044199266126,0.0185469882353863,0.00553776960772756
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD8A,T-cell surface glycoprotein CD8 alpha chain,42710,0.0141171064856805,0.0050894898307447,0.00414170641742085,0.0240925065539401,0.00554857485870609
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MUC13,Mucin-13,42310,-0.0141653008920041,0.00510729138783813,-0.0241755920121668,-0.00415500977184135,0.00555275653918866
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CPA4,Carboxypeptidase A4,40059,0.0120290079447445,0.00433928033053864,0.00352401849688873,0.0205339973926002,0.00557872339876526
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MST1,Hepatocyte growth factor-like protein,40369,0.0177793948356887,0.0064195921371229,0.00519699424692784,0.0303617954244496,0.0056226033382752
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TAX1BP1,Tax1-binding protein 1,40482,0.017009694762351,0.00615893613471547,0.00493817993830869,0.0290812095863933,0.0057578195273984
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,42494,0.0289433431292054,0.0104947378765369,0.00837365689119312,0.0495130293672176,0.00582550128355551
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IQGAP2,Ras GTPase-activating-like protein IQGAP2,42586,0.0143219807197194,0.00520608852084496,0.00411804721886324,0.0245259142205755,0.0059492386212286
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CTSH,Pro-cathepsin H,42331,0.0200150880782168,0.00729379817975598,0.00571924364589506,0.0343109325105385,0.00607549387601252
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PSMD1,26S proteasome non-ATPase regulatory subunit 1,40481,0.0132839973688383,0.0048427473930991,0.00379221247836403,0.0227757822593125,0.00609636613838528
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ATP6V1G2,V-type proton ATPase subunit G 2,40115,0.0270376965960319,0.00985881593125991,0.00771441737076244,0.0463609758213013,0.00610748077160988
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KLRK1,NKG2-D type II integral membrane protein,40482,0.0130834402099179,0.00477590695451215,0.0037226625790741,0.0224442178407617,0.00616354969520953
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BAMBI,BMP and activin membrane-bound inhibitor homolog,42345,0.00801913956833069,0.00293276712787858,0.00227091599768867,0.0137673631389727,0.00625919206966901
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SFRP4,Secreted frizzled-related protein 4,40282,0.0107693110653443,0.00394702589646024,0.00303314030828227,0.0185054818224064,0.00637306357968315
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DCXR,L-xylulose reductase,42678,0.0140127081719716,0.00513610690184055,0.00394593864436414,0.0240794776995791,0.00637491176706745
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,COL3A1,Collagen alpha-1(III) chain,40526,-0.00620354646928589,0.00228451332361198,-0.0106811925835654,-0.00172590035500641,0.0066280400356334
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,APOB,Apolipoprotein B-100,40531,0.00594306038509339,0.00218949151025705,0.00165165702498957,0.0102344637451972,0.00665051181187538
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HPGDS,Hematopoietic prostaglandin D synthase,42345,0.0101694368613736,0.00375234249200373,0.0028148455770463,0.0175240281457009,0.00673385914734411
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CHCHD6,MICOS complex subunit MIC25,40450,0.00766174812655962,0.00282869342754685,0.00211750900856778,0.0132059872445514,0.0067673570658608
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SUOX,"Sulfite oxidase, mitochondrial",40481,0.0164462450634908,0.00607471358989779,0.00453980642729109,0.0283526836996904,0.00679292064353453
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,42635,0.0166930530226615,0.00616678360020731,0.00460615716625513,0.0287799488790678,0.00679943121947137
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SPARC,SPARC,42678,0.0184942068138709,0.00684016227455992,0.00508748875573346,0.0319009248720084,0.00686442604781195
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CREBZF,CREB/ATF bZIP transcription factor,40079,-0.00694294639312632,0.00256793925850159,-0.0119761073397894,-0.0019097854464632,0.00686779589622227
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,C7orf50,Uncharacterized protein C7orf50,40482,0.00600329488084858,0.00222306052709251,0.00164609624774726,0.0103604935139499,0.00693461068881148
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ADGRE2,Adhesion G protein-coupled receptor E2,42675,0.00749098717930092,0.00277511229038071,0.00205176709015474,0.0129302072684471,0.0069562614196129
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AXIN1,Axin-1,42593,0.0248527944419611,0.00921747661741856,0.00678654027182073,0.0429190486121015,0.00702086715893573
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NXPH3,Neurexophilin-3,40198,0.0081140412702822,0.00301282064023789,0.00220891281541594,0.0140191697251485,0.0070883191663744
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",42310,0.0133704353041762,0.00497910196173871,0.00361139545916828,0.023129475149184,0.00725535808033011
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CXCL8,Interleukin-8,42493,0.0183014484860374,0.00682017210486096,0.00493391116050997,0.0316689858115649,0.00729615951347867
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GPNMB,Transmembrane glycoprotein NMB,42314,0.00764508080863114,0.00285228570418202,0.00205460082843438,0.0132355607888279,0.00736404203723363
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,40276,0.0121906033338427,0.00454827932275666,0.00327597586123965,0.0211052308064458,0.00736722303647287
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DKK4,Dickkopf-related protein 4,42476,0.0121502159266759,0.00453587773356634,0.00325989556888592,0.021040536284466,0.00740015155370386
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,STC2,Stanniocalcin-2,42590,0.00651816756485523,0.00243511053939147,0.00174535090764795,0.0112909842220625,0.00744319266889895
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LHB,Lutropin subunit beta,42345,0.0220832854086988,0.00825142690722279,0.00591048867054216,0.0382560821468555,0.00745324780680696
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CLEC12A,C-type lectin domain family 12 member A,40198,0.0054298572170192,0.00203007386791166,0.00145091243591234,0.00940880199812606,0.00749046688703477
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FCRL6,Fc receptor-like protein 6,42593,0.0182774440760523,0.00685423695951041,0.00484313963541185,0.0317117485166927,0.00767169592927914
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LGALS3BP,Galectin-3-binding protein,40538,0.00799313631406356,0.00299787808841692,0.00211729526076639,0.0138689773673607,0.00768080413261525
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CSDE1,Cold shock domain-containing protein E1,40115,0.0304413843189564,0.0114256437788058,0.00804712251249699,0.0528356461254159,0.0077261215916562
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CTHRC1,Collagen triple helix repeat-containing protein 1,40526,-0.00766260718108772,0.00287652041332529,-0.0133005871912053,-0.00202462717097016,0.00773622316736476
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ADIPOQ,Adiponectin,40538,-0.0180058157547468,0.00676091892467658,-0.0312572168471129,-0.00475441466238071,0.00775060417479987
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MICALL2,MICAL-like protein 2,40181,0.0179013989110398,0.00672428129654379,0.00472180756981398,0.0310809902522656,0.00777441746692337
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ATXN3,Ataxin-3,40482,0.0161423484293917,0.0060676339455242,0.00424978589616425,0.0280349109626191,0.0078157661016335
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,42356,0.0127670449237486,0.00479991812846952,0.00335920539194838,0.0221748844555489,0.00782710047449693
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NCAM2,Neural cell adhesion molecule 2,42610,0.00706403418857741,0.00265941557802744,0.00185157965564363,0.0122764887215112,0.00791118615172058
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RHOC,Rho-related GTP-binding protein RhoC,42442,0.0298187841235655,0.0112283080468103,0.00781130035181741,0.0518262678953136,0.00792436005569355
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NBN,Nibrin,42369,0.0138912404594936,0.00523432992379144,0.00363195380886236,0.0241505271101248,0.00796695939452543
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PON1,Serum paraoxonase/arylesterase 1,40531,-0.00710734132324424,0.00268154538900619,-0.0123631702856964,-0.0018515123607921,0.00804927746097114
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FGFR4,Fibroblast growth factor receptor 4,40282,0.0138083284939736,0.00521491014046,0.00358710461867201,0.0240295523692752,0.00811187713560567
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TPMT,Thiopurine S-methyltransferase,42345,0.0188135185907126,0.00711393722811047,0.00487020162361603,0.0327568355578091,0.00818846794443223
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CHP1,Calcineurin B homologous protein 1,40135,0.0191920052894694,0.00725924083755501,0.00496389324786162,0.0334201173310773,0.00820971970243842
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CLEC7A,C-type lectin domain family 7 member A,42753,0.0157374459028818,0.00595460499384421,0.0040664201149471,0.0274084716908164,0.00822929609750276
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,42345,0.0149832956064666,0.00567152075000605,0.0038671149364548,0.0260994762764785,0.00825526369760617
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FIS1,Mitochondrial fission 1 protein,42623,0.0193673090629945,0.00735109329849975,0.00495916619793501,0.033775451928054,0.0084329149523015
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,40510,0.00827755951653539,0.00314715202306921,0.00210914155131975,0.014445977481751,0.00854565451210473
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",40482,0.0139869721880899,0.00532007626569335,0.00355962270733097,0.0244143216688489,0.008572911145343
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ARTN,Artemin,42369,0.0114962571000913,0.00438251318098142,0.00290653126536773,0.0200859829348149,0.00872056183433577
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,40450,0.0169549770614776,0.00646351731091389,0.00428648313208642,0.0296234709908689,0.00872303727388424
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TBC1D5,TBC1 domain family member 5,42593,0.0200440278826712,0.00764252472240093,0.00506467942676536,0.035023376338577,0.00873355068702144
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TFF1,Trefoil factor 1,42555,0.0212716320734102,0.00812218695651938,0.00535214563863217,0.0371911185081882,0.00882994975904742
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GP2,Pancreatic secretory granule membrane major glycoprotein GP2,42172,-0.0220378578546562,0.00841904578846864,-0.0385391876000547,-0.00553652810925767,0.00886482466591367
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NMRK2,Nicotinamide riboside kinase 2,40079,-0.0108475254288811,0.00416950150318414,-0.019019748375122,-0.00267530248264022,0.00929058573701215
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PACS2,Phosphofurin acidic cluster sorting protein 2,40115,0.015696298279373,0.00605576404460796,0.00382700075194137,0.0275655958068046,0.0095557929016875
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CASP4,Caspase-4,40301,0.0439047952161926,0.0169391319245769,0.0107040966440218,0.0771054937883633,0.00955682137919648
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,VSTM1,V-set and transmembrane domain-containing protein 1,42310,0.0127741776554416,0.00494931425655913,0.00307352171258567,0.0224748335982975,0.00986223050616438
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FGF2,Fibroblast growth factor 2,42593,0.0172315420577114,0.00667856660446851,0.00414155151295314,0.0303215326024697,0.00988697766474527
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TMPRSS5,Transmembrane protease serine 5,42437,0.00960309715479037,0.00372746970274377,0.00229725653741258,0.0169089377721682,0.00999699570719284
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",40079,0.0130121453077694,0.00505888500755621,0.00309673069295927,0.0229275599225796,0.0101204275653984
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SUSD5,Sushi domain-containing protein 5,40234,0.00877857317179208,0.00341441676448147,0.0020863163134084,0.0154708300301758,0.0101525853624924
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SART1,U4/U6.U5 tri-snRNP-associated protein 1,40115,0.00942727695631503,0.00366834801352624,0.00223731484980361,0.0166172390628265,0.0101860122307036
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NCAM1,Neural cell adhesion molecule 1,42688,0.00760543912428367,0.00296144865159721,0.00180099976715313,0.0134098784814142,0.0102350042156468
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL31,Interleukin-31,40198,0.0141482122065958,0.00552613215767506,0.00331699317755263,0.0249794312356389,0.0104732881450159
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,42356,-0.00840324002003841,0.00328367778727562,-0.0148392484830986,-0.0019672315569782,0.0105056168435259
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HJV,Hemojuvelin,40481,0.0110111977569856,0.00430709484675587,0.00256929185734413,0.0194531036566271,0.0105853029377944
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NXPH1,Neurexophilin-1,42310,0.00973306356516923,0.00381315132722204,0.00225928696381403,0.0172068401665244,0.0107065610093821
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,40198,0.00776867234827417,0.00304484705239587,0.00180077212557827,0.0137365725709701,0.0107420147951756
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,42356,0.00533866405115701,0.00209641909625409,0.001229682622499,0.00944764547981502,0.0108902336027219
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,42675,0.0143275134097565,0.00562772790195412,0.00329716672192641,0.0253578600975865,0.0109113327430226
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PDIA5,Protein disulfide-isomerase A5,40079,0.0153156486277293,0.00601739100237944,0.00352156226306559,0.027109734992393,0.0109342306556469
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PCDH17,Protocadherin-17,42635,0.00927062620239743,0.003647834249123,0.00212087107411635,0.0164203813306785,0.0110519144524845
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PARD3,Partitioning defective 3 homolog,40301,0.0184538981273249,0.00726794326261751,0.00420872933259461,0.0326990669220552,0.0111279263744676
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TADA3,Transcriptional adapter 3,40450,0.00979484952474092,0.00386384227981757,0.00222171865629848,0.0173679803931834,0.011258079697729
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CRISP2,Cysteine-rich secretory protein 2,42720,0.0147302647365867,0.00581740558636738,0.00332814978730666,0.0261323796858668,0.0113493166127985
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MSTN,Growth/differentiation factor 8,42356,-0.013187030849104,0.00521917785121212,-0.0234166194374797,-0.00295744226072821,0.0115272710395498
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,42191,0.0210914236471414,0.008358564369689,0.00470863748255092,0.0374742098117318,0.0116367203830463
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CCL16,C-C motif chemokine 16,42793,0.0128608474625036,0.00509814253654511,0.00286848809087518,0.022853206834132,0.0116586200860423
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SH2B3,SH2B adapter protein 3,42345,0.0239225395208502,0.00949120520866695,0.00531977731186294,0.0425253017298374,0.0117307091465967
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",40079,0.0143642538102881,0.00570262355299386,0.00318711164642014,0.0255413959741561,0.0117869146760049
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SERPINF1,Pigment epithelium-derived factor,40350,0.00655491185634737,0.00260863344553766,0.00144199030309355,0.0116678334096012,0.0119925184373943
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CDC27,Cell division cycle protein 27 homolog,42345,0.0147536406325552,0.00587401001168143,0.00324058100965962,0.0262667002554508,0.0120276402373425
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD36,Platelet glycoprotein 4,40198,0.01099360022947,0.0043772186726909,0.00241425163099583,0.0195729488279441,0.0120344559476918
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MUC16,Mucin-16,42586,0.0472359137079265,0.0188082160221183,0.0103718103045746,0.0841000171112783,0.0120352689722731
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,42678,-0.0110359921419822,0.00439603744646912,-0.0196522255370617,-0.00241975874690276,0.0120696606338137
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL17A,Interleukin-17A,42346,0.0106171288126763,0.00423129735832863,0.00232378599035217,0.0189104716350004,0.0121127634326416
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HSPA2,Heat shock-related 70 kDa protein 2,40450,0.00843035151960324,0.00336471221617157,0.00183551557590696,0.0150251874632995,0.0122411770916784
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CST7,Cystatin-F,42641,0.0229590899280167,0.00917575100463017,0.00497461795894151,0.0409435618970918,0.012355999354893
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GIMAP8,GTPase IMAP family member 8,40079,0.0129189067188766,0.00516658698972849,0.00279239621900876,0.0230454172187444,0.0124173765790253
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NFIC,Nuclear factor 1 C-type,40481,0.0116282262492349,0.00465044673462771,0.00251335064936459,0.0207431018491052,0.0124175059913522
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FOSB,Protein fosB,42310,0.00937963475300542,0.00375894114813557,0.0020121101026597,0.0167471594033511,0.0125977440327992
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LAMTOR5,Ragulator complex protein LAMTOR5,40450,0.00981865844347397,0.00393619143075309,0.0021037232391979,0.01753359364775,0.0126292434925294
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PKN3,Serine/threonine-protein kinase N3,40301,0.0182189218572965,0.00731368809469451,0.00388409319169526,0.0325537505228977,0.012750324859643
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,40198,0.0121780917927823,0.00488924069634083,0.00259518002795426,0.0217610035576103,0.0127604232764521
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TPSAB1,Tryptase alpha/beta-1,42740,0.0127562954127735,0.00512865837943175,0.00270412498908725,0.0228084658364597,0.0128851487070728
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KLRC1,NKG2-A/NKG2-B type II integral membrane protein,40135,0.0150079064596602,0.00603448710961303,0.0031803117248187,0.0268355011945018,0.0128965061947647
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PDIA2,Protein disulfide-isomerase A2,40079,0.0102747456446932,0.00413948121556742,0.00216136246218106,0.0183881288272054,0.0130747937986144
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,APLP1,Amyloid-like protein 1,42635,0.0125235851244245,0.005048362059096,0.00262879548859638,0.0224183747602527,0.0131237851484545
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CXADR,Coxsackievirus and adenovirus receptor,42593,-0.0125504003582264,0.00506908530925829,-0.0224858075643726,-0.00261499315208012,0.0133034291807148
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DARS1,"Aspartate--tRNA ligase, cytoplasmic",42475,0.0175873445762229,0.00710548404398669,0.00366059585000894,0.0315140933024368,0.0133293267339115
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HYAL1,Hyaluronidase-1,42543,0.00561498199306257,0.00226896552749792,0.00116780955916665,0.0100621544269585,0.013347586744803
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,42593,0.00925327046580188,0.00374177432604623,0.00191939278675127,0.0165871481448525,0.0134121036160405
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ODAM,Odontogenic ameloblast-associated protein,42291,0.0135635168036917,0.00551572676476981,0.00275269234474284,0.0243743412626405,0.0139428739093014
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,40448,-0.00744368051739918,0.00302761943651879,-0.013377814612976,-0.00150954642182235,0.0139632579009987
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,40198,0.0105349567698111,0.0042867555180137,0.00213291595450428,0.018936997585118,0.0140037738286794
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PTH,Parathyroid hormone,40181,0.0196897325429812,0.00801290540162315,0.00398443795579981,0.0353950271301625,0.0140157614187385
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,40301,0.0126443023996206,0.0051549024614191,0.00254069357523916,0.022747911224002,0.0141874437003148
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NUDT15,Nucleotide triphosphate diphosphatase NUDT15,40115,0.0126043624684811,0.00514814736110104,0.00251399364072311,0.0226947312962392,0.0143676424735095
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AMN,Protein amnionless,42369,0.011263909993161,0.00460268149397095,0.00224265426497799,0.0202851657213441,0.0144080806987837
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MYOM3,Myomesin-3,40282,-0.0221809721106075,0.0090869277450626,-0.0399913504909302,-0.00437059373028484,0.0146631660520041
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PRSS2,Trypsin-2,42688,0.0133106704368348,0.00546284508235838,0.00260349407541237,0.0240178467982572,0.0148396441152744
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL19,Interleukin-19,42260,0.0172983078713716,0.00710406396856612,0.003374342492982,0.0312222732497612,0.0149055875867564
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,OMG,Oligodendrocyte-myelin glycoprotein,42586,0.0157023493096491,0.0064846569851464,0.00299242161876213,0.028412277000536,0.0154714220191822
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GPRC5C,G-protein coupled receptor family C group 5 member C,40450,0.0134464901123518,0.00555786231591046,0.00255307997316727,0.0243399002515363,0.0155634329534379
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KLRB1,Killer cell lectin-like receptor subfamily B member 1,42753,0.00947491806649828,0.00391776769979417,0.00179609337490171,0.0171537427580948,0.0155999524290282
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD200,OX-2 membrane glycoprotein,42593,0.00648429321642088,0.00268476141509036,0.00122216084284377,0.011746425589998,0.0157389454369872
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,40301,-0.0107607895315178,0.00445864553776695,-0.019499734785541,-0.00202184427749456,0.0158176795704241
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CNDP1,Beta-Ala-His dipeptidase,42688,-0.010891878780369,0.0045144593690155,-0.0197402191436393,-0.0020435384170986,0.0158496089450802
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NUP50,Nuclear pore complex protein Nup50,40115,-0.00819541519351167,0.0034096766503802,-0.0148783814282569,-0.00151244895876648,0.0162521765412793
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SCRIB,Protein scribble homolog,40222,0.021286589519855,0.00887403238581452,0.00389348604365859,0.0386796929960515,0.0164676223517169
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GGT5,Glutathione hydrolase 5 proenzyme,42494,-0.00552973275293636,0.00230874273935722,-0.0100548685220765,-0.00100459698379621,0.016628341663609
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SPTLC1,Serine palmitoyltransferase 1,40482,0.00906739488790609,0.00378648849983172,0.00164587742823593,0.0164889123475763,0.016651481779632
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FUCA1,Tissue alpha-L-fucosidase,42720,-0.019661057015956,0.00822108067043798,-0.0357743751300144,-0.00354773890189753,0.01679135657385
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PDZD2,PDZ domain-containing protein 2,40115,0.0141482685838821,0.0059195422690075,0.0025459657366274,0.0257505714311368,0.0168608608650211
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LECT2,Leukocyte cell-derived chemotaxin-2,40510,0.0156248363271861,0.00653859175877955,0.0028091964799782,0.028440476174394,0.016881472890906
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AMPD3,AMP deaminase 3,40482,-0.0165335420508911,0.00692109766218005,-0.030098893468764,-0.00296819063301814,0.0169170082507128
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IGDCC3,Immunoglobulin superfamily DCC subclass member 3,40135,0.011767432340329,0.00492656077116033,0.00211137322885473,0.0214234914518032,0.0169309618873756
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CA5A,"Carbonic anhydrase 5A, mitochondrial",42356,0.0215145233828451,0.00902302570520383,0.00382939300064558,0.0391996537650446,0.0171209676500422
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FAM3D,Protein FAM3D,40448,-0.0200008078087366,0.00839714153294558,-0.0364592052133099,-0.00354241040416324,0.0172420061060147
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,VSNL1,Visinin-like protein 1,40482,0.00890678611681639,0.00374856418738217,0.00155960030954733,0.0162539719240854,0.0175155505283013
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,42593,0.00914587162882513,0.00385203249606653,0.00159588793653473,0.0166958553211155,0.0175963759240703
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AOC3,Membrane primary amine oxidase,42688,0.0070158712452778,0.00296005739257117,0.00121415875583831,0.0128175837347173,0.0177933646779995
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PSAPL1,Proactivator polypeptide-like 1,40448,0.0118546340442126,0.00500324912146726,0.00204826576613679,0.0216610023222885,0.0178343684454335
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,JUN,Transcription factor AP-1,42369,0.0111050536920221,0.0046939318884576,0.00190494719064525,0.020305160193399,0.0180040035449957
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SRPX,Sushi repeat-containing protein SRPX,40510,0.00855870717102948,0.00362093630627309,0.00146167201073424,0.0156557423313247,0.0181116069330542
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ING1,Inhibitor of growth protein 1,42291,0.0108513502576939,0.00460595203928684,0.00182368426069172,0.0198790162546961,0.018490515937532
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HGFAC,Hepatocyte growth factor activator,40427,0.00641109008885842,0.00272332119744297,0.00107338054187021,0.0117487996358466,0.0185825429263607
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DKKL1,Dickkopf-like protein 1,42586,-0.0202367436532713,0.00861477438737904,-0.0371217014525342,-0.00335178585400836,0.0188346091609047
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TYRO3,Tyrosine-protein kinase receptor TYRO3,42635,0.00652833125525227,0.00278085473887923,0.00107785596704899,0.0119788065434556,0.0189092836877579
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TPR,Nucleoprotein TPR,40115,0.0111700108668247,0.00475801540266725,0.00184430067759686,0.0204957210560525,0.0189115499364502
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NFX1,Transcriptional repressor NF-X1,40115,0.0156019890802658,0.00665122498702573,0.00256558810569537,0.0286383900548362,0.0190075640186565
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CKB,Creatine kinase B-type,40526,0.0138152828748039,0.00588986559983282,0.00227114629913154,0.0253594194504762,0.0190135078886355
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PRKCQ,Protein kinase C theta type,42369,0.0100602144206961,0.00429422000117175,0.00164354321839948,0.0184768856229927,0.0191578346323454
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ITPA,Inosine triphosphate pyrophosphatase,40115,0.0153969064008482,0.00657528168028986,0.00250935430748008,0.0282844584942164,0.0192173850595455
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CDH1,Cadherin-1,42187,-0.00914308581526368,0.00390671603167047,-0.0168002492373378,-0.00148592239318956,0.0192806864302188
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ANGPTL3,Angiopoietin-related protein 3,42651,0.00815363578837454,0.00349654654978169,0.00130040455080243,0.0150068670259467,0.0197200439358662
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,COL4A1,Collagen alpha-1(IV) chain,42635,-0.00909845293752742,0.00390502393540158,-0.0167522998509145,-0.00144460602414032,0.0198243017208505
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HEBP1,Heme-binding protein 1,42356,0.011989245496831,0.00516973408014071,0.00185656669975526,0.0221219242939068,0.02040363867901
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CHIT1,Chitotriosidase-1,42698,0.0350201313091413,0.0151131303456466,0.00539839583167396,0.0646418667866086,0.0205077702443787
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PCARE,Photoreceptor cilium actin regulator,40135,0.0190448234884122,0.00823320915996693,0.002907733534877,0.0351819134419474,0.0207316712031165
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PRL,Prolactin,42710,-0.0169207592781328,0.00732786115892584,-0.0312833671496274,-0.00255815140663814,0.0209530752917601
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MCTS1,Malignant T-cell-amplified sequence 1,40448,0.00617440043041686,0.00267669911405123,0.000928070166876445,0.0114207306939573,0.0210884000454832
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TNFAIP8,Tumor necrosis factor alpha-induced protein 8,42369,0.00837900358397367,0.00363426076150813,0.00125585249141773,0.0155021546765296,0.0211507275397697
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NRCAM,Neuronal cell adhesion molecule,42635,0.00656032306421182,0.00284638799279893,0.000981402598325931,0.0121392435300977,0.0211935702133544
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CA9,Carbonic anhydrase 9,42720,-0.0109338282159255,0.00474764131764946,-0.0202392051985184,-0.00162845123333256,0.021293820412006
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TFF3,Trefoil factor 3,42612,0.00969952843641115,0.0042194674262904,0.00142937228088197,0.0179696845919403,0.0215340606349835
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",40135,-0.0123446166548273,0.00537644316979748,-0.0228824452676303,-0.00180678804202421,0.0216914720353559
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PIGR,Polymeric immunoglobulin receptor,42463,0.00804768225773101,0.00350580126558772,0.00117631177717907,0.0149190527382829,0.0217181235194305
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,42494,0.00682125854547965,0.00297241896624693,0.000995317371635663,0.0126471997193236,0.0217571643858933
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CA7,Carbonic anhydrase 7,40301,-0.00789386288660635,0.00345330068606192,-0.0146623322312877,-0.00112539354192499,0.0222794844141173
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GLO1,Lactoylglutathione lyase,42356,0.0129158155231755,0.00566822497632776,0.00180609456957315,0.024025536476778,0.0227047207722991
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,42653,0.016826947149169,0.00739194835057892,0.00233872838203433,0.0313151659163037,0.0228383926516046
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HMOX1,Heme oxygenase 1,42499,-0.0107671711731356,0.00473161443937902,-0.0200411354743185,-0.00149320687195276,0.0228869368532217
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ITGB1,Integrin beta-1,42637,0.00476246880552463,0.00209430628557883,0.000657628485790126,0.00886730912525913,0.0229812106487383
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DNER,Delta and Notch-like epidermal growth factor-related receptor,42586,0.00554200835148953,0.00244409193763465,0.000751588153725624,0.0103324285492534,0.0233748172160801
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CLGN,Calmegin,40181,0.0103128190821087,0.0045541355368296,0.00138671342992266,0.0192389247342947,0.0235630617414856
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CCL28,C-C motif chemokine 28,42537,0.0129954336394687,0.00574325796043888,0.00173864803700854,0.0242522192419289,0.0236684344497609
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CRISP3,Cysteine-rich secretory protein 3,40438,0.00606511955041619,0.00268202276427561,0.000808354932435987,0.0113218841683964,0.0237536749420101
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CNST,Consortin,42635,0.0238193620927376,0.0105822296261868,0.00307819202541142,0.0445605321600638,0.0244090326992931
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CENPJ,Centromere protein J,40301,0.0156096092962995,0.00694737286215107,0.00199275848648342,0.0292264601061156,0.0246700507504
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SORCS2,VPS10 domain-containing receptor SorCS2,42345,0.00824017823240375,0.00367277777364441,0.00104153379606071,0.0154388226687468,0.0248758806438095
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PBK,Lymphokine-activated killer T-cell-originated protein kinase,40079,-0.00677018409887627,0.00302034458535233,-0.0126900594861668,-0.000850308711585708,0.0250120237439667
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CSNK1D,Casein kinase I isoform delta,40198,0.0137912645359432,0.00615423055116815,0.00172897265565363,0.0258535564162328,0.0250497926720814
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,STX1B,Syntaxin-1B,40181,0.008906069717425,0.00398025333990689,0.0011047731712075,0.0167073662636425,0.0252694970344806
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RAB39B,Ras-related protein Rab-39B,40115,0.0202809972828235,0.00906667085824628,0.00251032240066076,0.0380516721649862,0.0253146983098791
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KRT6C,"Keratin, type II cytoskeletal 6C",40115,-0.00860095306995847,0.00384798568778202,-0.0161430050180112,-0.0010589011219057,0.0254254577949972
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HNF1A,Hepatocyte nuclear factor 1-alpha,40181,0.0156931985418415,0.00703498750921917,0.00190462302377188,0.029481774059911,0.0257187416289048
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PGLYRP2,N-acetylmuramoyl-L-alanine amidase,40420,0.00659651883307306,0.00295856816067798,0.000797725238144227,0.0123953124280019,0.0257915721480824
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PTPRB,Receptor-type tyrosine-protein phosphatase beta,40510,0.00642013657466106,0.00288243834705179,0.00077055741443955,0.0120697157348826,0.0259449303830002
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL1R2,Interleukin-1 receptor type 2,42599,-0.00433067172059488,0.00194531397247569,-0.00814348710664724,-0.000517856334542529,0.026016871866962
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PCDH7,Protocadherin-7,40448,0.00789362442960193,0.00354978860393942,0.000936038765880672,0.0148512100933232,0.0261891765202189
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,JCHAIN,Immunoglobulin J chain,42369,0.0136393745372514,0.00613816622067005,0.00160856874473811,0.0256701803297647,0.0262961592873872
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CLSTN2,Calsyntenin-2,42753,-0.00862789828391397,0.00388320684654947,-0.0162389837031509,-0.001016812864677,0.0263099713897336
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CEND1,Cell cycle exit and neuronal differentiation protein 1,40135,0.0128752557049488,0.00579990157913675,0.00150744860984077,0.0242430628000568,0.0264453400200982
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,REG3G,Regenerating islet-derived protein 3-gamma,40450,0.00892123405790356,0.00401960680949712,0.00104280471128921,0.0167996634045179,0.026477372540639
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CPQ,Carboxypeptidase Q,40515,-0.00774831795974262,0.00349175790522702,-0.0145921634539876,-0.000904472465497659,0.0265043867080893
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GSTP1,Glutathione S-transferase P,42236,0.0152640812907079,0.00688275113208348,0.00177388907182428,0.0287542735095915,0.0265904374638378
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SCARB1,Scavenger receptor class B member 1,42310,0.0126439413670976,0.00570156615751015,0.00146887169837774,0.0238190110358175,0.026597414796283
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DDR1,Epithelial discoidin domain-containing receptor 1,42710,0.00504781702837115,0.00228048171367901,0.000578072869560282,0.00951756118718201,0.0268807121771455
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,STAM,Signal transducing adapter molecule 1,40450,0.00807467518618459,0.00366346440033959,0.000894284961518993,0.0152550654108502,0.0275368383332178
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",40115,0.0190172102807052,0.00864209855105311,0.00207869712064111,0.0359557234407693,0.0277900640460321
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CDH5,Cadherin-5,42793,0.00648523652268581,0.00294808853665483,0.000706982990842348,0.0122634900545293,0.0278370951711097
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ZPR1,Zinc finger protein ZPR1,40135,0.0209817918531791,0.00954989147731781,0.00226400455763623,0.039699579148722,0.0280362505300325
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LARP1,La-related protein 1,40450,0.013113335157959,0.00598517224884579,0.00138239755022124,0.0248442727656967,0.0284743643029527
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,40222,-0.00548578573627905,0.00251130783581177,-0.0104079490944701,-0.00056362237808798,0.0289513707155934
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",40481,0.0154312337181428,0.0070657917470818,0.00158228189386251,0.0292801855424231,0.0289874977385879
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,42345,0.0262117237368545,0.0120281658658876,0.00263651863971483,0.0497869288339941,0.0293348412768644
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ZHX2,Zinc fingers and homeoboxes protein 2,40482,0.00692645501841766,0.00318090544673722,0.000691880342812717,0.0131610296940226,0.0294631374234009
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HDGF,Hepatoma-derived growth factor,42699,0.0197376714804175,0.00909288598694526,0.00191561494600477,0.0375597280148302,0.0299733510281839
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CNTN1,Contactin-1,42793,0.00590168492203063,0.00272325400194868,0.000564107078211211,0.01123926276585,0.0302411387520919
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",42586,0.0204957628824385,0.00945811308587763,0.00195786123411831,0.0390336645307586,0.0302521680908669
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,THBS2,Thrombospondin-2,42610,-0.00823556231054596,0.00380141711077778,-0.0156863398476704,-0.000784784773421521,0.0302947223004892
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CALB1,Calbindin,42586,0.00968038586168239,0.00446953398762573,0.00092009924593596,0.0184406724774288,0.0303394594906809
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD209,CD209 antigen,42667,0.00823410017723658,0.00380391083374837,0.000778434943089786,0.0156897654113834,0.0304327160953563
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FBP1,"Fructose-1,6-bisphosphatase 1",42635,0.015463234446604,0.00715038724947214,0.00144847543763864,0.0294779934555694,0.0305916159738134
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RANBP1,Ran-specific GTPase-activating protein,40222,0.0110566961459367,0.00512475114440965,0.00101218390289378,0.0211012083889796,0.0309875634322248
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TSPAN1,Tetraspanin-1,42356,0.0143384045389728,0.00665184469828673,0.00130078893033083,0.0273760201476148,0.0311366474198703
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FOLR3,Folate receptor gamma,42628,0.0391958653378925,0.0181874824934253,0.00354839965077881,0.0748433310250061,0.0311716276690593
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TPBGL,Trophoblast glycoprotein-like,40181,-0.00888123377658995,0.00412124654739766,-0.0169588770094894,-0.000803590543690549,0.0311844908495885
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ADA,Adenosine deaminase,42753,0.00728511392996238,0.00338913501564634,0.000642409299295549,0.0139278185606292,0.0316084947442305
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PLXDC2,Plexin domain-containing protein 2,40482,-0.00574116251769794,0.0026713384826553,-0.0109769859437023,-0.000505339091693558,0.0316420623937227
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",42581,-0.0142429481077364,0.00665632438934324,-0.0272893439108491,-0.00119655230462362,0.0323920539976665
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DNAJB8,DnaJ homolog subfamily B member 8,42356,0.0121614674490305,0.00569891869394642,0.000991586808895488,0.0233313480891654,0.0328615697059007
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GSAP,Gamma-secretase-activating protein,42345,0.0178566140677279,0.0083857060992594,0.00142063011317944,0.0342925980222763,0.0332387987673068
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CCN3,CCN family member 3,42778,0.00739301716548035,0.00347331567680886,0.00058531843893499,0.0142007158920257,0.0333120501765866
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LMOD2,Leiomodin-2,40135,0.0130023866759343,0.00610992389547631,0.00102693584080071,0.0249778375110678,0.0333530128035072
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,42112,-0.00782820256239574,0.00368886943481115,-0.0150583866546256,-0.000598018470165883,0.0338471176602837
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NAPRT,Nicotinate phosphoribosyltransferase,40482,0.00702022366765512,0.00331430106652106,0.000524193577273844,0.0135162537580364,0.0341832167374159
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GHRHR,Growth hormone-releasing hormone receptor,42310,0.011676420027334,0.00551381034899831,0.000869351743297336,0.0224834883113707,0.0342219531947377
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL17RA,Interleukin-17 receptor A,42610,0.00911636045853863,0.00430832548054581,0.000672042516668837,0.0175606784004084,0.0343642884082247
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CRACR2A,EF-hand calcium-binding domain-containing protein 4B,42345,0.0174128966068866,0.00824187013427321,0.00125883114371116,0.0335669620700621,0.0346421545819138
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GBP6,Guanylate-binding protein 6,40115,-0.00956323166269687,0.00452989194162033,-0.0184418198682727,-0.000684643457121025,0.0347830262942909
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ARHGAP30,Rho GTPase-activating protein 30,40301,0.00789303196452994,0.0037387685097256,0.000565045685467758,0.0152210182435921,0.0347832937986449
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NEK7,Serine/threonine-protein kinase Nek7,40301,0.0157040025771575,0.00745317089059422,0.0010957876315928,0.0303122175227222,0.0351379468846329
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SIL1,Nucleotide exchange factor SIL1,40222,0.00638436271497141,0.00303227730586427,0.000441099195477449,0.0123276262344654,0.0352731455982635
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,42688,0.00880010808235214,0.00418118340786055,0.000604988602945472,0.0169952275617588,0.0353364698322976
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SSH3,Protein phosphatase Slingshot homolog 3,40079,-0.00593620790033159,0.00284133256657776,-0.011505219730824,-0.000367196069839171,0.0367098499324411
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GGA1,ADP-ribosylation factor-binding protein GGA1,42310,-0.013391490734705,0.00643589697109504,-0.0260058487980513,-0.000777132671358712,0.0374761800028204
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,POMC,Pro-opiomelanocortin,40222,0.0142127650842506,0.00684179230736681,0.000802852161811626,0.0276226780066895,0.0377927887895848
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NFYA,Nuclear transcription factor Y subunit alpha,40115,0.00796573110401395,0.0038362811439888,0.000446620061795905,0.015484842146232,0.0378784495556718
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RIPK4,Receptor-interacting serine/threonine-protein kinase 4,40115,0.0145984769367648,0.00703991232188472,0.000800248785870695,0.0283967050876588,0.0381330630005516
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ARHGEF12,Rho guanine nucleotide exchange factor 12,42593,0.0209014185159335,0.0100894166454501,0.0011261618908513,0.0406766751410156,0.0383201575885169
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ART5,Ecto-ADP-ribosyltransferase 5,40135,0.0130477376717593,0.00630366003225712,0.000692564008535396,0.0254029113349833,0.038488216615137
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KLK7,Kallikrein-7,40008,0.00792600125094568,0.00383713081782726,0.000405224848004264,0.0154467776538871,0.0388894458501363
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ERC2,ERC protein 2,40181,0.0153696917747515,0.00744217405052525,0.000783030635722028,0.029956352913781,0.0389260341143882
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CCS,Copper chaperone for superoxide dismutase,42494,0.00958609293380547,0.00464283368394563,0.000486138913272042,0.0186860469543389,0.0389700359278086
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PPM1A,Protein phosphatase 1A,42345,0.00643472316295205,0.00311659303978055,0.000326200804982173,0.0125432455209219,0.0389741886352497
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GLRX,Glutaredoxin-1,42545,0.0112934290620763,0.00547756841723592,0.000557394964293953,0.0220294631598587,0.0392499432547908
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RLN1,Prorelaxin H1,40481,-0.00976133816889098,0.00474491322680046,-0.0190613680934199,-0.000461308244362078,0.0396878346437408
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,UNC79,Protein unc-79 homolog,40079,0.0111979038981808,0.00544858799244626,0.000518671432986161,0.0218771363633755,0.0398841043429998
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LIFR,Leukemia inhibitory factor receptor,42593,-0.00485363171365656,0.00236188962620193,-0.00948293538101234,-0.000224328046300778,0.0399004537080825
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FDX1,"Adrenodoxin, mitochondrial",40115,0.0124700462168579,0.00608370729846119,0.000545979911873934,0.0243941125218418,0.040413190194914
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CES1,Liver carboxylesterase 1,42660,0.0161936387723422,0.00790870670604262,0.000692573628498684,0.0316947039161858,0.0406214088061315
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ADD1,Alpha-adducin,40282,0.0142272232668249,0.006958805780499,0.000587963937046854,0.0278664825966029,0.0409285261392694
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,42356,0.0055358237585764,0.00271741948891925,0.000209681560294679,0.0108619659568581,0.0416537729614521
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NOP56,Nucleolar protein 56,40115,0.0223772480702387,0.0109915157258031,0.00083387724766467,0.0439206188928128,0.0417879434584341
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,40448,0.0140032145593388,0.00690502389347543,0.000469367728126993,0.0275370613905507,0.0425863281316031
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MILR1,Allergin-1,42369,0.0102175477200788,0.00504716843573694,0.000325097586034379,0.0201099978541232,0.0429479255166686
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,F13B,Coagulation factor XIII B chain,40478,0.00512364323425842,0.00253412418287875,0.000156759835816077,0.0100905266327008,0.0432144145471238
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MPRIP,Myosin phosphatase Rho-interacting protein,40416,0.00857966440051682,0.00425043097121223,0.000248819696940844,0.0169105091040928,0.0435588063925084
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TXK,Tyrosine-protein kinase TXK,40301,0.0148509907152762,0.00735889083457159,0.00042756467951586,0.0292744167510365,0.0436046561871365
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,APOD,Apolipoprotein D,40032,-0.00860916948231052,0.00427144384129174,-0.0169811994112423,-0.000237139553378708,0.0438750982347829
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD58,Lymphocyte function-associated antigen 3,42599,-0.00349556621013319,0.00173808174295803,-0.00690220642633093,-8.89259939354514e-05,0.0443281915770137
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PXN,Paxillin,42310,0.0100445434895705,0.00499859242215951,0.000247302342137866,0.0198417846370032,0.0445072928014893
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RGL2,Ral guanine nucleotide dissociation stimulator-like 2,40301,0.0128253061897392,0.0063848387350058,0.000311022269127863,0.0253395901103506,0.0445917756666455
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CLIC5,Chloride intracellular channel protein 5,40181,0.00622972519252123,0.00310280377247739,0.000148229798465552,0.0123112205865769,0.0446918715721021
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL10,Interleukin-10,42369,0.0166643997334069,0.00832649865647567,0.000344462366714614,0.0329843371000993,0.045373065341155
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ZBTB16,Zinc finger and BTB domain-containing protein 16,42345,0.0140406923911794,0.0070247030597387,0.000272274394091556,0.0278091103882672,0.0456549212152081
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BMP10,Bone morphogenetic protein 10,40282,0.00563479966457211,0.00282228891132342,0.000103113398378213,0.011166485930766,0.0459000851606615
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TLR2,Toll-like receptor 2,40301,0.004584830165469,0.0022965906432973,8.35125046062986e-05,0.00908614782633171,0.0459187180157803
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EPGN,Epigen,40450,-0.00888776379782236,0.00446385690309187,-0.0176369233278824,-0.000138604267762292,0.0464994868225034
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,40198,0.00685169872152167,0.00344255448090719,0.000104291938943572,0.0135991055040998,0.0465831553872294
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,STAU1,Double-stranded RNA-binding protein Staufen homolog 1,40079,0.0127296994477842,0.00640763382772212,0.000170737145448891,0.0252886617501196,0.0469866825897695
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MSMB,Beta-microseminoprotein,42558,0.0140696295773196,0.00709505038547825,0.000163330821782201,0.027975928332857,0.0473855900453282
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,UROS,Uroporphyrinogen-III synthase,40181,-0.0131680301918057,0.00665361013088141,-0.0262091060483333,-0.000126954335278153,0.0478318670854855
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AGBL2,Cytosolic carboxypeptidase 2,40135,0.0175811464787117,0.00889846553425828,0.000140154031565465,0.0350221389258579,0.0482081442108717
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DLL4,Delta-like protein 4,40222,0.0165736723843305,0.00839970033936691,0.000110259719171363,0.0330370850494896,0.0485060688688145
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TLR1,Toll-like receptor 1,40198,0.00517842436004394,0.00262529071890887,3.28545509825631e-05,0.0103239941691053,0.0485758833071668
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NOS1,"Nitric oxide synthase, brain",42310,0.0104897880227807,0.00531891033631345,6.4723763606344e-05,0.0209148522819551,0.0486113369085285
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PCDHB15,Protocadherin beta-15,40450,-0.00777155851655499,0.00395144918914345,-0.0155163989272762,-2.67181058338298e-05,0.0492352302525005
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AMBN,Ameloblastin,42369,-0.00551366450487185,0.00280869646019077,-0.0110187095668458,-8.61944289795059e-06,0.0496591812667394
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AIDA,"Axin interactor, dorsalization-associated protein",40181,0.0161878001497638,0.00824727833797278,2.31346073371642e-05,0.0323524656921904,0.0496940159965028
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CASP9,Caspase-9,40198,0.0119974248768861,0.00612169667514247,-1.10060639314617e-06,0.0239959503601653,0.0500420106165508
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SERPINA11,Serpin A11,42793,0.00784014967241856,0.00400152681761078,-2.84289009857067e-06,0.0156831422349357,0.0500992872427597
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,JAM2,Junctional adhesion molecule B,42710,0.00545014513000933,0.00278340684729966,-5.33229069801192e-06,0.0109056225507167,0.0502406679538841
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NCF2,Neutrophil cytosol factor 2,42577,0.0158421146032894,0.00809737113819204,-2.87328275670323e-05,0.0317129620341458,0.0504327473695949
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GKN1,Gastrokine-1,42016,-0.00539109071454831,0.00275566766472779,-0.0107921993374148,1.00179083181466e-05,0.0504438940638009
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL18RAP,Interleukin-18 receptor accessory protein,42424,0.0329554089224433,0.0168503919925796,-7.13593830126424e-05,0.0659821772278993,0.0505138457954476
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RNASE10,Inactive ribonuclease-like protein 10,40222,0.00947024079337721,0.0048459679806777,-2.78564487510811e-05,0.0189683380355055,0.0506967038902477
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",40222,-0.00706741595550769,0.00362236835924372,-0.0141672579396254,3.2426028610001e-05,0.0510765775841878
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PCDH12,Protocadherin-12,40481,-0.00492294684497092,0.0025273729280488,-0.00987659778394656,3.07040940047271e-05,0.0514575057976418
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PTS,6-pyruvoyl tetrahydrobiopterin synthase,42249,0.0105090627202991,0.00539679963518247,-6.86645646585382e-05,0.0210867900052568,0.0515229703609655
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PTPRM,Receptor-type tyrosine-protein phosphatase mu,42578,0.00466461891531862,0.00239575175429025,-3.10545230902811e-05,0.00936029235372752,0.0515511070305714
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ECE1,Endothelin-converting enzyme 1,42310,0.00677205682004879,0.0034855429525301,-5.96073669102129e-05,0.0136037210070078,0.0520497706542491
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DEFB4A_DEFB4B,Beta-defensin 4A,42476,0.0284453775768825,0.0146610286336427,-0.000290238545057154,0.0571809936988222,0.0523761132908052
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GGT1,Glutathione hydrolase 1 proenzyme,42589,0.00951894084219439,0.00491471158204301,-0.000113893858609902,0.0191517755429987,0.0527876271634373
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CIT,Citron Rho-interacting kinase,40181,0.00859587440112039,0.00444023775659099,-0.000106991601797952,0.0172987404040387,0.0529050694147016
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,42635,0.00627101726179588,0.00323968023218467,-7.87559932860738e-05,0.0126207905168778,0.0529266008209517
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ANGPT2,Angiopoietin-2,42720,0.00715902317714733,0.00370047542403877,-9.39086539686537e-05,0.0144119550082633,0.0530574581479756
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DHPS,Deoxyhypusine synthase,40450,0.00765858399473251,0.00395915819201146,-0.000101366061609964,0.015418534051075,0.0530893570010456
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RABEPK,Rab9 effector protein with kelch motifs,42345,0.0108646506425185,0.00562417043635613,-0.000158723412739486,0.0218880246977766,0.0534083273659032
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KRT14,"Keratin, type I cytoskeletal 14",41947,0.00555609234956931,0.00287639639568043,-8.16445859643331e-05,0.0111938292851029,0.0534290891885309
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,40115,0.0126708812760223,0.00656758241816487,-0.000201580263580848,0.0255433428156254,0.0537186653839729
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FSHB,Follitropin subunit beta,40222,0.0102326350340423,0.00530428174210792,-0.000163757180489185,0.0206290272485738,0.0537406814322338
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SAT2,Thialysine N-epsilon-acetyltransferase,40301,0.012752990191867,0.00661929582342676,-0.000220829622049485,0.0257268100057834,0.054050180299203
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,COL9A1,Collagen alpha-1(IX) chain,42593,0.00914523039721473,0.00475483738917382,-0.000174250885565944,0.0184647116799954,0.0544569071763482
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,40181,0.0202634334406992,0.0105384675678979,-0.000391962992380639,0.0409188298737789,0.0545301812223533
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,42586,0.00521508895649625,0.00271448370339396,-0.000105299102155917,0.0105354770151484,0.0547266392114262
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GET3,ATPase GET3,40510,0.0101378306579871,0.00527786512326618,-0.000206784983614655,0.0204824462995888,0.0547794599157024
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NOS2,"Nitric oxide synthase, inducible",40115,0.00751460687183476,0.00391297537815783,-0.000154824869354591,0.0151840386130241,0.0548292458697041
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CENPF,Centromere protein F,40301,-0.0102176172435498,0.00534029800600475,-0.0206846013353191,0.000249366848219546,0.0557347382928226
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IMPG1,Interphotoreceptor matrix proteoglycan 1,40135,0.00564831162560595,0.00295627420214174,-0.000145985810591868,0.0114426090618038,0.05607975994006
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,VWF,von Willebrand factor,42793,0.0134319474497123,0.0070329156258668,-0.000352567176986594,0.0272164620764113,0.056171099818121
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,COL24A1,Collagen alpha-1(XXIV) chain,40448,0.0104155569399296,0.00545473190817338,-0.000275717600090175,0.0211068314799495,0.0562290157490369
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TNPO1,Transportin-1,40301,0.00663495859829686,0.00347541570998064,-0.000176856193265194,0.0134467733898589,0.0562733589920354
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PRDX6,Peroxiredoxin-6,42720,-0.0113051445608168,0.00593625745755179,-0.0229402091776183,0.000329920055984661,0.0568763247963775
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL36A,Interleukin-36 alpha,40198,0.0107153013193026,0.0056457177953993,-0.000350305559680063,0.0217809081982852,0.0577285513205023
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TGFB2,Transforming growth factor beta-2 proprotein,40450,0.00969940784224632,0.00511304586809099,-0.00032216205921202,0.0197209777437047,0.0578545474994556
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",40198,0.00803751428411939,0.00424700826679104,-0.000286621918791048,0.0163616504870298,0.0584490125053529
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL5,Interleukin-5,42369,0.0258110776717625,0.0136672123783874,-0.000976658589876715,0.0525988139334018,0.0589754365620183
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SCN2B,Sodium channel subunit beta-2,40181,-0.00539478134546178,0.00285793153615873,-0.0109963271563329,0.000206764465409332,0.0590989599592488
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PDCL2,Phosducin-like protein 2,40079,0.00981230220481285,0.00521172638100017,-0.000402681501947489,0.0200272859115732,0.059762869871069
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DPP10,Inactive dipeptidyl peptidase 10,42593,0.00661528026221131,0.00351455946712752,-0.000273256293358625,0.0135038168177813,0.059823704582969
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,INSL5,Insulin-like peptide INSL5,40448,-0.0181577772452254,0.00964790173514671,-0.037067664646113,0.000752110155662112,0.0598557999883099
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DTX2,Probable E3 ubiquitin-protein ligase DTX2,40181,0.011681926614125,0.00622070112879503,-0.000510647598313218,0.0238745008265633,0.0604197285014486
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IGFBPL1,Insulin-like growth factor-binding protein-like 1,42635,-0.0064185246396038,0.00341837724930377,-0.0131185440482392,0.000281494769031578,0.060450352541759
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",42356,0.0160879200383017,0.00857582846204943,-0.000720703747315178,0.0328965438239186,0.0606827443069842
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TEF,Thyrotroph embryonic factor,40115,0.00798668583797951,0.00426702178628456,-0.000376676863138217,0.0163500485390972,0.0612715470815172
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CAT,Catalase,40360,0.00992320998765446,0.00531930733445714,-0.000502632387881539,0.0203490523631905,0.0621364470610402
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PSMG4,Proteasome assembly chaperone 4,40198,0.0104054900922825,0.00558229672116604,-0.000535811481202974,0.0213467916657679,0.0623460754466071
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LAMB1,Laminin subunit beta-1,40222,0.00554170643151747,0.00297320331371461,-0.000285772063363157,0.0113691849263981,0.0623645336491559
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TMPRSS11B,Transmembrane protease serine 11B,40135,0.0142204786028067,0.00763252094920557,-0.000739262457636248,0.0291802196632496,0.0624689131920308
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,USP47,Ubiquitin carboxyl-terminal hydrolase 47,40115,0.0152929185438605,0.00820910972291938,-0.000796936513061513,0.0313827736007825,0.0625002831954591
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TRIM40,E3 ubiquitin ligase TRIM40,40181,0.0130646339657974,0.00701335625945031,-0.00068154430272523,0.02681081223432,0.0625139880847505
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SGSH,N-sulphoglucosamine sulphohydrolase,40331,0.0103799667601859,0.00557303852908429,-0.000543188756819316,0.0213031222771911,0.0625543455878617
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NFAT5,Nuclear factor of activated T-cells 5,40198,0.0157164109281523,0.00845826621929219,-0.00086179086166039,0.032294612717965,0.0631797148571343
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BCL2L15,Bcl-2-like protein 15,40198,0.0102387054427816,0.00551350478210659,-0.000567763930147302,0.0210451748157105,0.0633345766296769
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IGHMBP2,DNA-binding protein SMUBP-2,40115,0.0099942589894235,0.0053842956474402,-0.000558960479559296,0.0205474784584063,0.0634538391971839
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ERVV_1,,40115,0.00795532010050626,0.00428646026198954,-0.000446142012993247,0.0163567822140058,0.0634921207233195
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EPHA4,Ephrin type-A receptor 4,40282,0.00530465716295918,0.00286278484789972,-0.000306401138924267,0.0109157154648426,0.0639130729291192
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ATP5F1D,"ATP synthase subunit delta, mitochondrial",40115,0.00945835902779574,0.00510540871260303,-0.000548242048906192,0.0194649601044977,0.0639644584271648
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CRNN,Cornulin,42208,0.0125170624570697,0.00677320606488951,-0.000758421430113721,0.0257925463442531,0.0646212228556013
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IDI2,Isopentenyl-diphosphate delta-isomerase 2,42310,0.00876147381321285,0.00474340426664538,-0.000535598549412087,0.0180585461758378,0.0647572399759314
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,STX3,Syntaxin-3,40482,0.00700948312452003,0.00379725762070264,-0.000433141812057139,0.0144521080610972,0.0649281022990045
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SPINK8,Serine protease inhibitor Kazal-type 8,40115,0.00685323643208264,0.00371353823858527,-0.000425298515544484,0.0141317713797098,0.0649957411108766
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TUBB3,Tubulin beta-3 chain,40135,0.00507920175910269,0.00275539379900187,-0.000321370086940973,0.0104797736051463,0.0653024866536848
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ACSL1,Long-chain-fatty-acid--CoA ligase 1,40115,0.00700761172335177,0.00383188388275658,-0.000502880686851132,0.0145181041335547,0.0674622109888607
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NTproBNP,N-terminal prohormone of brain natriuretic peptide,42635,-0.0206519154232202,0.0112933912914151,-0.0427869623543938,0.00148313150795331,0.0674708147068631
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SELPLG,P-selectin glycoprotein ligand 1,42593,-0.00489874141807664,0.00268442368976924,-0.0101602118500244,0.000362729013871076,0.0680419387309547
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GBP4,Guanylate-binding protein 4,42310,0.00881579922730871,0.00483930794587199,-0.000669244346600387,0.0183008428012178,0.0685222814253719
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MTPN,Myotrophin,42356,0.00592097573531576,0.00325359072539357,-0.000456062086455647,0.0122980135570872,0.0688078955693583
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FOXO3,Forkhead box protein O3,42345,0.0168156177877016,0.00926706979244901,-0.00134783900549849,0.0349790745809016,0.0696149317449688
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PSRC1,Proline/serine-rich coiled-coil protein 1,42345,0.0104463287072667,0.00576727320288498,-0.000857526770387839,0.0217501841849213,0.0701154394734171
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RBP1,Retinol-binding protein 1,40181,0.0121401564306873,0.00670498408426049,-0.00100161237446322,0.0252819252358379,0.070227502894545
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ANGPT1,Angiopoietin-1,42553,0.0148167058022222,0.00818483849358447,-0.00122557764520339,0.0308589892496477,0.0702775559926635
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LIPF,Gastric triacylglycerol lipase,40222,-0.0110343859227408,0.00609745587749323,-0.0229853994426275,0.000916627597145952,0.0703741155327277
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KRT18,"Keratin, type I cytoskeletal 18",42586,0.0142621243596111,0.00788132823324214,-0.00118527897754346,0.0297095276967657,0.0703788165054901
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CADPS,Calcium-dependent secretion activator 1,40181,0.00760195921217588,0.00420235276462994,-0.000634652206498806,0.0158385706308506,0.0704819094932857
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RPL14,60S ribosomal protein L14,40222,0.00706245920946628,0.00391681667895893,-0.000614501481293225,0.0147394199002258,0.0713979102066473
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DLGAP5,Disks large-associated protein 5,40481,0.00897224367965513,0.00497956251070918,-0.000787698841334866,0.0187321862006451,0.0716014032719209
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TCTN3,Tectonic-3,40510,0.0052576340341974,0.00292871781679682,-0.000482652886724375,0.0109979209551192,0.0726485248469402
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LPCAT2,Lysophosphatidylcholine acyltransferase 2,42586,0.00694734945933188,0.00387781387151596,-0.000653165728839398,0.0145478646475032,0.0732254986435797
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,APOH,Beta-2-glycoprotein 1,42610,0.00638583731299216,0.00356727259493015,-0.000606016973070927,0.0133776915990552,0.0734575570744464
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ASS1,Argininosuccinate synthase,40115,-0.0136368305555444,0.00761823910208812,-0.0285685791956371,0.00129491808454831,0.0734777527615065
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ALPP,"Alkaline phosphatase, placental type",42586,-0.017670953579219,0.00987354478090507,-0.0370231013497929,0.00168119419135498,0.0735203325264527
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SSBP1,"Single-stranded DNA-binding protein, mitochondrial",40198,0.00618830970947898,0.00346111752357564,-0.000595480636729276,0.0129721000556872,0.0738113654035581
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DCTN2,Dynactin subunit 2,42586,-0.0163556145722131,0.00915552379193836,-0.0343004412044123,0.0015892120599861,0.074053827808733
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NLGN1,Neuroligin-1,40181,0.0122351459130996,0.00684916893412226,-0.00118922519778,0.0256595170239792,0.0740670294104612
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,VEGFD,Vascular endothelial growth factor D,42733,0.00629774711067841,0.00353213814202425,-0.000625243647689119,0.0132207378690459,0.074611244725817
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MZT1,Mitotic-spindle organizing protein 1,42345,0.00898537350328972,0.00504314006868614,-0.000899181031335104,0.0188699280379146,0.0748208853490392
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL5RA,Interleukin-5 receptor subunit alpha,42593,0.0100619730829002,0.00564763309389741,-0.00100738778113867,0.0211313339469392,0.0748327942134472
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MN1,Transcriptional activator MN1,40181,0.0103588618915678,0.00581730331293206,-0.00104305260177906,0.0217607763849146,0.07498938057899
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ABO,Histo-blood group ABO system transferase,40531,0.0253873992425569,0.0142602105213751,-0.00256261337933829,0.0533374118644521,0.0750542656210921
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GUK1,Guanylate kinase,40115,-0.00670845266321492,0.00377417092594698,-0.014105827678071,0.000688922351641156,0.0755197640872576
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ITGAM,Integrin alpha-M,42610,-0.00550235808703735,0.00309751030048868,-0.0115734782759952,0.000568762101920476,0.0756928168634242
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD3D,T-cell surface glycoprotein CD3 delta chain,40135,0.00591278710209696,0.00333255147527555,-0.00061901378944312,0.012444587993637,0.0760492313742686
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,M6PR,Cation-dependent mannose-6-phosphate receptor,40222,0.00694853390134691,0.00391802514067405,-0.000730795374374216,0.014627863177068,0.0761770200520027
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CELA3A,Chymotrypsin-like elastase family member 3A,42780,0.0102854448797462,0.00581376778408578,-0.00110953997706193,0.0216804297365543,0.0768907713400908
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ERI1,3'-5' exoribonuclease 1,40301,0.00595163805939399,0.00336834254420709,-0.000650313327251911,0.0125535894460399,0.0772667854562204
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DCUN1D2,DCN1-like protein 2,40079,0.0138823464606504,0.00787293850439773,-0.00154861300796914,0.02931330592927,0.0778780868956824
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PXDNL,Peroxidasin-like protein,40450,0.00963610325334549,0.00546764607025729,-0.00108048304435879,0.0203526895510498,0.0780312278350946
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LAYN,Layilin,42475,0.00652464412421539,0.0037022183411048,-0.000731703824350012,0.0137809920727808,0.0780313727083706
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL32,Interleukin-32,42593,-0.00762159791520039,0.00432551250260495,-0.0160996024203061,0.000856406589905314,0.0780903436705757
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PNLIP,Pancreatic triacylglycerol lipase,40531,-0.0112709212583123,0.00639886222156537,-0.0238126912125804,0.00127084869595583,0.0781985929717461
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TMOD4,Tropomodulin-4,40079,-0.00713358472396223,0.00405286567706608,-0.0150772014510117,0.000810032003087283,0.0784132536376194
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",40510,0.0126889551838525,0.00720911300202574,-0.00144090630011797,0.0268188166678229,0.0784132715804644
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DEFB118,Beta-defensin 118,40135,0.00981391458022462,0.00558520887919991,-0.00113309482300719,0.0207609239834564,0.0789243370975095
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PSCA,Prostate stem cell antigen,40448,-0.0458022452787629,0.0260793677540896,-0.0969178060767784,0.00531331551925267,0.07907059978035
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ELAVL4,ELAV-like protein 4,40135,0.0145790995910497,0.00831956376392292,-0.00172724538623923,0.0308854445683386,0.0797352083082051
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CLNS1A,Methylosome subunit pICln,40181,-0.00573024386497522,0.00327213584113541,-0.0121436301136006,0.000683142383650179,0.0799351807540258
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PPME1,Protein phosphatase methylesterase 1,42586,0.0102074773878814,0.00583345531562737,-0.00122609503074827,0.021641049806511,0.080172854543547
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RARRES1,Retinoic acid receptor responder protein 1,42345,0.00563658118935648,0.00322689766418506,-0.000688138232446247,0.0119613006111592,0.0807041815695256
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DENR,Density-regulated protein,40198,0.00973884814661479,0.00557614185170952,-0.00119038988273587,0.0206680861759654,0.0807483841451549
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TPPP3,Tubulin polymerization-promoting protein family member 3,42310,0.00677386734710826,0.00387917048123755,-0.000829306796117341,0.0143770414903339,0.080796935380111
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,40481,0.00668282216723458,0.00382720718462225,-0.000818503914625037,0.0141841482490942,0.0808146217514446
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,UGDH,UDP-glucose 6-dehydrogenase,40115,0.0164013623237245,0.00939609661238618,-0.0020149870365524,0.0348177116840014,0.0809171898546183
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ZNF830,Zinc finger protein 830,40450,-0.0132772857011376,0.00760645080021372,-0.0281859292695565,0.00163135786728128,0.0809199940884196
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,APOA2,Apolipoprotein A-II,40531,-0.00841225929613234,0.00482132227544942,-0.0178620509560132,0.00103753236374851,0.0810462002035839
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SELENOP,Selenoprotein P,40538,0.00393083659266849,0.0022562922671552,-0.00049149625095569,0.00835316943629268,0.0815064315356409
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD276,CD276 antigen,42617,-0.0062606039862392,0.00359384590810532,-0.0133045419661256,0.000783333993647234,0.0815252914600475
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HDDC2,5'-deoxynucleotidase HDDC2,40448,0.00749166410430937,0.00430410940464484,-0.000944390328794517,0.0159277185374133,0.0817838496503149
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,40481,0.00404665834024558,0.00232615855447462,-0.000512612426524665,0.00860592910701583,0.0819510302800724
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CEBPB,CCAAT/enhancer-binding protein beta,42356,0.00647147127545859,0.00372341575980157,-0.000826423613752481,0.0137693661646697,0.0822259343955551
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PRCP,Lysosomal Pro-X carboxypeptidase,42732,0.00531544108797891,0.00307003596220868,-0.000701829397950112,0.0113327115739079,0.0834043416934689
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SHD,SH2 domain-containing adapter protein D,40082,0.0149060673795984,0.00862825778389348,-0.00200531787683287,0.0318174526360296,0.084090623255717
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DSG4,Desmoglein-4,42542,0.00846542904590208,0.00490805434499966,-0.00115435747029726,0.0180852155621014,0.0845860496272478
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DGCR6,Protein DGCR6,40135,0.00747991564936712,0.004338520779303,-0.00102358507806677,0.015983416376801,0.084723366005969
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PDGFRA,Platelet-derived growth factor receptor alpha,42635,0.00487043467646252,0.00283295872206803,-0.000682164418790823,0.0104230337717159,0.0856002111309658
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CA2,Carbonic anhydrase 2,42572,0.0116653961389595,0.00679063053248129,-0.00164423970470387,0.0249750319826228,0.0858441243768954
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MYL6B,Myosin light chain 6B,40181,0.0153020739333562,0.00892450962256656,-0.00218996492687424,0.0327941127935867,0.0864445336313
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DDA1,DET1- and DDB1-associated protein 1,40115,0.00675227155463313,0.00395503865086135,-0.000999604201055104,0.0145041473103214,0.0878025249754859
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KRT5,"Keratin, type II cytoskeletal 5",42310,0.00858314188253149,0.00502827138171298,-0.00127227002562594,0.0184385537906889,0.0878500600785023
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DCC,Netrin receptor DCC,40181,0.00387904622541746,0.00227327906978977,-0.000576580751370485,0.0083346732022054,0.0879682075731816
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CA3,Carbonic anhydrase 3,42769,0.00993501695969638,0.00583033207960477,-0.00149243391632898,0.0213624678357217,0.0883997721422296
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BTLA,B- and T-lymphocyte attenuator,40079,0.0147101215779156,0.00865174106124416,-0.00224729090212294,0.0316675340579542,0.0891125033880285
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BAG3,BAG family molecular chaperone regulator 3,42474,0.00673866219665181,0.00396743938852547,-0.0010375190048581,0.0145148433981617,0.0894384549311598
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BAG6,Large proline-rich protein BAG6,42356,0.00590707707668446,0.00347875083768544,-0.00091127456517901,0.0127254287185479,0.089522818994624
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CAPS,Calcyphosin,40482,0.0172046704611235,0.0101333478313539,-0.00265669128833015,0.0370660322105771,0.0895680016803618
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CCDC50,Coiled-coil domain-containing protein 50,40481,0.0125454983101547,0.00739567563354573,-0.00195002593159492,0.0270410225519043,0.0898511854940213
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NRTN,Neurturin,42369,0.00814786923344449,0.00482354612415159,-0.00130628116989263,0.0176020196367816,0.0912073475378665
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GASK1A,Golgi-associated kinase 1A,40115,0.00716144964624705,0.00423995540674649,-0.00114886295097607,0.0154717622434702,0.0912405203865683
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MYO6,Unconventional myosin-VI,40481,0.00601413139431049,0.00356230362746216,-0.000967983715515351,0.0129962465041363,0.091386980015634
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",42310,0.00496489617082985,0.00294913536109626,-0.000815409136918818,0.0107452014785785,0.092300379627461
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FGL1,Fibrinogen-like protein 1,40531,0.0108328068047728,0.00644247779414317,-0.00179444967174777,0.0234600632812935,0.0926999954661065
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MYOM1,Myomesin-1,40135,0.00791942994710974,0.00471477803256065,-0.00132153499670914,0.0171603948909286,0.0930435367709939
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ATF2,Cyclic AMP-dependent transcription factor ATF-2,42310,0.0109683255325602,0.00654093079022324,-0.00185189881627738,0.0237885498813977,0.0935906914128717
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EP300,Histone acetyltransferase p300,40198,0.0050869643006741,0.00303591855941985,-0.000863436075788808,0.011037364677137,0.0938463249125165
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GIMAP7,GTPase IMAP family member 7,40282,-0.00522815343268363,0.00312414673736813,-0.0113514810379252,0.000895174172557914,0.0942637961887116
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,42345,0.0131840875557476,0.00788554815583837,-0.00227158682969559,0.0286397619411908,0.0945618400816895
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CSRP3,Cysteine and glycine-rich protein 3,40115,0.0163639964055606,0.00981807806836349,-0.00287943660843179,0.0356074294195531,0.0955985804817718
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,YY1,Transcriptional repressor protein YY1,40198,0.00460495664217081,0.00276475830012502,-0.00081396962607423,0.0100238829104159,0.0958233626715912
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FCN1,Ficolin-1,40514,0.00907931165478975,0.00545774065133189,-0.00161786002182074,0.0197764833314002,0.096226876426072
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BCL7B,B-cell CLL/lymphoma 7 protein family member B,40450,0.00723595216737661,0.00435148554470344,-0.00129295950024214,0.0157648638349954,0.0963664217262708
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CGA,Glycoprotein hormones alpha chain,42610,0.0102248348778727,0.00617158298546311,-0.00187146777363502,0.0223211375293804,0.0975912906374076
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CLEC14A,C-type lectin domain family 14 member A,42610,0.00541114824297408,0.00326754657846025,-0.000993243050808005,0.0118155395367562,0.0977395587970697
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PRR4,Proline-rich protein 4,40197,0.0112927797996576,0.00682562924628719,-0.00208545352306535,0.0246710131223805,0.0980611421972084
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SULT1A1,Sulfotransferase 1A1,42710,0.0206317804461499,0.012476986326267,-0.00382311275333346,0.0450866736456332,0.0982347103085136
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SPON2,Spondin-2,42561,0.00580775249463879,0.0035129184743617,-0.00107756771511015,0.0126930727043877,0.0983023174950978
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CSF2,Granulocyte-macrophage colony-stimulating factor,40115,-0.00595058784877232,0.00360396172615757,-0.0130143528320412,0.00111317713449652,0.0987420015198723
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,42753,0.00576608567922248,0.00349519847258709,-0.00108450332704822,0.0126166746854932,0.099024150723906
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MYH7B,Myosin-7B,40079,-0.00726753799098129,0.00440655469858924,-0.0159043852002162,0.00136930921825362,0.0991239990960762
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CHGB,Secretogranin-1,42663,0.00692634350875592,0.00420741198295081,-0.00132018397782766,0.0151728709953395,0.0997409354273191
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,UXS1,UDP-glucuronic acid decarboxylase 1,42345,0.00851671698676735,0.00518230588033674,-0.00164060253869267,0.0186740365122274,0.100319496810352
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TNR,Tenascin-R,42494,0.00680342195291023,0.00414900824045995,-0.00132863419839127,0.0149354781042117,0.101076511755958
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CRTAP,Cartilage-associated protein,40181,0.00769372151697418,0.00469835076607655,-0.00151504598453586,0.0169024890184842,0.101547027227219
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RCOR1,REST corepressor 1,42356,0.00710562904018848,0.00433988332622214,-0.00140054227920691,0.0156118003595839,0.101594686926276
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ELN,Elastin,40510,0.00585955549948878,0.00358307939564386,-0.00116328011597319,0.0128823911149507,0.10200546283339
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD99,CD99 antigen,42610,-0.00323362610701699,0.00197897543875852,-0.00711241796698368,0.000645165752949702,0.10228441073323
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DLK1,Protein delta homolog 1,42793,0.00878185581110262,0.00537681404397688,-0.00175669971509206,0.0193204113372973,0.102432764033043
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IGSF3,Immunoglobulin superfamily member 3,42586,0.00577886522984006,0.00353905682021369,-0.00115768613777878,0.0127154165974589,0.102517144184243
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",40301,0.0113193288995064,0.00693414977489016,-0.00227160465927836,0.0249102624582911,0.102622903828937
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,40135,0.00530918492493,0.00325841867236371,-0.00107731567290287,0.0116956855227629,0.103262510921711
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,42593,0.0138283531909847,0.00848827553957602,-0.00280866686658426,0.0304653732485537,0.10331277812526
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,42586,0.00691427941070291,0.00425859611619436,-0.00143256897703803,0.0152611277984438,0.104483599909138
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LUZP2,Leucine zipper protein 2,40450,0.00731192699444041,0.0045062783569049,-0.0015203785850932,0.016144232573974,0.10470105948906
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,42494,0.00977761203586351,0.00604597361225423,-0.00207249624415479,0.0216277203158818,0.105856564636889
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ATP5PO,"ATP synthase subunit O, mitochondrial",42310,0.00648256987546194,0.00401201374729976,-0.0013809770692456,0.0143461168201695,0.106163873548034
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL22,Interleukin-22,40450,0.0110885866509606,0.00686679997330146,-0.00237034129671022,0.0245475145986315,0.106379579126164
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PECAM1,Platelet endothelial cell adhesion molecule,42610,0.00474303397175443,0.00293868898410309,-0.00101679643708762,0.0105028643805965,0.106551685628059
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,40172,0.00433358082219381,0.00268542566232695,-0.000929853475967007,0.00959701512035463,0.106612412179248
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CTSD,Cathepsin D,41746,0.00664325883259479,0.00412744389853315,-0.00144653120853019,0.0147330488737198,0.107524903793192
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ICAM2,Intercellular adhesion molecule 2,42793,0.00510755471177746,0.00317467271191507,-0.00111480380357607,0.011329913227131,0.107673561578569
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MYL3,Myosin light chain 3,40222,-0.0115454726328983,0.00718736025302641,-0.0256326987288301,0.00254175346303343,0.108223934609756
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LEO1,RNA polymerase-associated protein LEO1,40481,0.00511256157853036,0.00318650550614912,-0.00113298921352191,0.0113581123705826,0.10864475411609
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,40079,0.00925254383778139,0.00576777821358476,-0.00205230146084473,0.0205573891364075,0.108703799350149
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ADH1B,All-trans-retinol dehydrogenase,40282,0.0116758463081391,0.00728208810148134,-0.00259704637076433,0.0259487389870425,0.10888254223145
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",40198,-0.00445039357210156,0.00278617516182336,-0.00991129688927534,0.00101050974507222,0.110224686483829
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,UPB1,Beta-ureidopropionase,40510,-0.0140025808605594,0.00877371733126846,-0.0311990668298456,0.00319390510872679,0.11052363939075
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FRMD4B,FERM domain-containing protein 4B,40115,0.0109612940693068,0.00687007786747734,-0.00250405855094876,0.0244266466895624,0.110626646158609
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PDCD6,Programmed cell death protein 6,42635,0.0110048330906992,0.00690052444301646,-0.00252019481761304,0.0245298609990115,0.110784475284194
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LRRN1,Leucine-rich repeat neuronal protein 1,42369,0.0061957192337728,0.00388504660830983,-0.00141897211851447,0.0138104105860601,0.110789768523019
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,42793,0.00367716476035501,0.0023076223269022,-0.000845775000373294,0.00820010452108332,0.111074360489834
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MATN3,Matrilin-3,42474,0.00510377866359451,0.00320502839073434,-0.00117807698224481,0.0113856343094338,0.111312249157411
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,YOD1,Ubiquitin thioesterase OTU1,40115,0.00987175450650103,0.00620851895434068,-0.0022969426440067,0.0220404516570088,0.111856149204078
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NOTCH3,Neurogenic locus notch homolog protein 3,42793,-0.00529527680031615,0.00333322150297992,-0.0118283909461568,0.00123783734552449,0.112165766674938
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NDRG1,Protein NDRG1,42310,0.0101303749964145,0.00638475452096823,-0.00238374386468319,0.0226444938575123,0.112615892097586
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KDM3A,Lysine-specific demethylase 3A,40198,-0.0136172335804176,0.00859459153943837,-0.0304626329977168,0.00322816583688156,0.113132443707137
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,40115,0.00749714666120184,0.00475455567727085,-0.00182178246624903,0.0168160757886527,0.114862612032376
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PSG1,Pregnancy-specific beta-1-glycoprotein 1,42494,-0.0183824751800355,0.0117084577177305,-0.0413310523067873,0.00456610194671627,0.116434994163562
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,REXO2,"Oligoribonuclease, mitochondrial",40115,0.00739018409976868,0.00470789045289711,-0.00183728118790965,0.016617649387447,0.116503586356309
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL9,Interleukin-9,40301,0.00865258242288289,0.0055168350505348,-0.00216041427616532,0.0194655791219311,0.11681721376082
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MAP3K5,Mitogen-activated protein kinase kinase kinase 5,42345,0.0150085278370051,0.00957470339954984,-0.00375789082611262,0.0337749465001228,0.117017528696885
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MAEA,E3 ubiquitin-protein transferase MAEA,42345,0.0060732210623219,0.00387445234400426,-0.00152070553192644,0.0136671476565703,0.11702090016678
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TPSD1,Tryptase delta,40481,0.00589226799054471,0.0037638268190833,-0.00148483257485856,0.013269368555948,0.117493931555846
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AGXT,Serine--pyruvate aminotransferase,42635,0.0114822806826175,0.00736860954865006,-0.00296019403273659,0.0259247553979716,0.119192882082224
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD2,T-cell surface antigen CD2,40115,0.00589445399117801,0.00378431069049302,-0.00152279496218831,0.0133117029445443,0.119356344284851
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,VWA1,von Willebrand factor A domain-containing protein 1,42688,0.00626244133874657,0.00402668426782194,-0.00162985982618442,0.0141547425036776,0.119913502052254
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CSPG5,Chondroitin sulfate proteoglycan 5,40135,0.00779573208776376,0.00503182944497378,-0.00206665362438485,0.0176581177999124,0.121342423960948
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MRPL52,"39S ribosomal protein L52, mitochondrial",40058,0.00402935974129519,0.00260158013310434,-0.00106973731958931,0.00912845680217969,0.121455936154706
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SORBS1,Sorbin and SH3 domain-containing protein 1,40481,0.00623360418027869,0.00402667107693191,-0.00165867113050786,0.0141258794910652,0.1216313588715
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,UPK3A,Uroplakin-3a,40135,0.00773470778484762,0.00500715900393262,-0.00207932386286033,0.0175487394325556,0.122440552619206
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PDRG1,p53 and DNA damage-regulated protein 1,40181,0.00775481355190205,0.00502547925733243,-0.00209512579246952,0.0176047528962736,0.122835483174737
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SCN2A,Sodium channel protein type 2 subunit alpha,40135,0.00754344426267327,0.00489203260025232,-0.00204493963382128,0.0171318281591678,0.123105991563699
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NHLRC3,NHL repeat-containing protein 3,40012,0.00486518559056014,0.00315777023681087,-0.00132404407358916,0.0110544152547095,0.123418372342537
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",40181,0.00752755030302762,0.00489524064202761,-0.0020671213553465,0.0171222219614017,0.1241438459788
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DOC2B,Double C2-like domain-containing protein beta,40181,0.00546054626802032,0.00355211107128175,-0.00150159143169191,0.0124226839677325,0.124256519021293
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IGFL4,Insulin growth factor-like family member 4,40198,0.0110919282466393,0.00721955939341362,-0.00305840816445136,0.02524226465773,0.124475943229956
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MTR,Methionine synthase,40115,0.0100064714303171,0.00651902577216045,-0.00277081908311732,0.0227837619437516,0.124821580806262
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",40267,-0.00955167331746458,0.00623256925417771,-0.0217675090556529,0.00266416242072374,0.125417342778759
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ITGBL1,Integrin beta-like protein 1,40526,0.00581505676859374,0.00380548227901373,-0.00164368849827318,0.0132738020354607,0.126522191243782
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SPINK5,Serine protease inhibitor Kazal-type 5,42610,0.0051542966255144,0.0033744565842137,-0.00145963827954446,0.0117682315305733,0.126673983780306
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TJP3,Tight junction protein ZO-3,40135,0.00629442730716486,0.00412163122775318,-0.00178396989923138,0.0143728245135611,0.126747907496222
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SMPD1,Sphingomyelin phosphodiesterase,42643,-0.00737099810735365,0.00482923753013437,-0.016836303666417,0.00209430745170971,0.126951835448306
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CLASP1,CLIP-associating protein 1,40079,0.0108432302565691,0.00713440925943744,-0.00314021189192827,0.0248266724050665,0.128577782434091
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL24,Interleukin-24,42369,0.00753004502066227,0.00495537666471788,-0.00218249324218477,0.0172425832835093,0.128642911003679
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,40450,0.0143945398642103,0.0094786687656922,-0.00418365091654637,0.0329727306449671,0.128885092853265
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LYPLA2,Acyl-protein thioesterase 2,40135,0.016646359981112,0.0109720340803929,-0.00485882681645818,0.0381515467786822,0.129254522631519
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,40079,-0.00672841037003948,0.00444250758634528,-0.0154357252392762,0.00197890449919727,0.129914838654883
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ATP1B4,Protein ATP1B4,40079,-0.00628186232153539,0.00415331520617548,-0.0144223601256393,0.00185863548256855,0.130437392118486
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PRUNE2,Protein prune homolog 2,40301,0.00444284014438753,0.00294781572662261,-0.00133487867979278,0.0102205589685678,0.131797204239297
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,VSIG10,V-set and immunoglobulin domain-containing protein 10,40450,0.00494154256879716,0.00328274137680955,-0.00149263052974956,0.0113757156673439,0.132272521604621
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,VPS37A,Vacuolar protein sorting-associated protein 37A,42586,0.0116520421564697,0.00775212186939675,-0.00354211670754791,0.0268462010204873,0.132842566759166
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,42494,0.00496825666607936,0.0033323511453561,-0.0015631515788186,0.0114996649109773,0.136007184681809
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FAP,Prolyl endopeptidase FAP,42793,-0.00397675251662424,0.00267219477687124,-0.00921425427929187,0.00126074924604339,0.136722109162666
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PFDN4,Prefoldin subunit 4,40079,0.00766381037531634,0.00515891757471699,-0.00244766807112896,0.0177752888217616,0.137428155662222
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,THRAP3,Thyroid hormone receptor-associated protein 3,40115,0.0160619008690446,0.0108286509487422,-0.00516225499049022,0.0372860567285794,0.138029393678512
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ENPEP,Glutamyl aminopeptidase,40115,0.00694030667237468,0.00468602548201036,-0.00224430327236562,0.016124916617115,0.138618196866144
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TRAF2,TNF receptor-associated factor 2,42593,0.0100122650575465,0.00676758528513194,-0.00325220210131211,0.0232767322164051,0.139045133361877
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FASLG,Tumor necrosis factor ligand superfamily member 6,42753,0.00528942009211504,0.00357932300111357,-0.00172605299006755,0.0123048931742976,0.139492282922998
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DDX1,ATP-dependent RNA helicase DDX1,40448,-0.00723876496183194,0.00490098645706499,-0.0168446984176793,0.00236716849401545,0.139703182989546
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GH2,Growth hormone variant,42345,0.0241357677568821,0.0163451232309417,-0.0079006737757636,0.0561722092895278,0.139797666459308
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DDX39A,ATP-dependent RNA helicase DDX39A,40198,-0.00351643978199782,0.00238598896032078,-0.00819297814422654,0.0011600985802309,0.140567524062446
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,40222,-0.00509237116975174,0.00345827716110322,-0.011870594405514,0.00168585206601057,0.140909915361201
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SLC16A1,Monocarboxylate transporter 1,42310,0.00828215844232694,0.00563103975838385,-0.00275467948410541,0.0193189963687593,0.141367992650745
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MAG,Myelin-associated glycoprotein,40181,0.00707318623782351,0.00481366219325462,-0.00236159166095556,0.0165079641366026,0.141753465439941
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SPRING1,SREBP regulating gene protein,40079,0.00853413536351936,0.00581271748733168,-0.00285879091165073,0.0199270616386895,0.142083305463639
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PVR,Poliovirus receptor,42710,-0.00526774493874211,0.00359338641232513,-0.0123107823068994,0.00177529242941514,0.142683645911485
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HAVCR1,Hepatitis A virus cellular receptor 1,42705,0.00950718752356069,0.00648593398605537,-0.00320524308910784,0.0222196181362292,0.142721620226377
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,40222,0.00568935383470666,0.00388133431864827,-0.00191806142984395,0.0132967690992573,0.142724692799791
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL2RB,Interleukin-2 receptor subunit beta,42369,0.00563329736985278,0.0038490971289222,-0.00191093300283472,0.0131775277425403,0.143344260807477
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SMARCA2,Probable global transcription activator SNF2L2,42310,0.0104047332328205,0.00711571204996942,-0.00354206238511957,0.0243515288507605,0.143705016514596
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",40481,-0.00614094089855658,0.00420177630155832,-0.0143764224496109,0.00209454065249773,0.143903187827587
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PYDC1,Pyrin domain-containing protein 1,40222,0.00612497454225206,0.00419342269745621,-0.0020941339447621,0.0143440830292662,0.144149717196289
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,42494,0.00983280992267853,0.00674957003070554,-0.00339634733750432,0.0230619671828614,0.145193718189207
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TSLP,Thymic stromal lymphopoietin,42356,0.00871034999754612,0.00598484116906502,-0.00301993869382131,0.0204406386889136,0.145581843629938
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PEPD,Xaa-Pro dipeptidase,40531,0.00377575262554105,0.00259432787385839,-0.0013091300072214,0.0088606352583035,0.145589674943378
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CYTH3,Cytohesin-3,40079,-0.010639376547876,0.00733814190094859,-0.0250221346737353,0.0037433815779832,0.147122645039534
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EVI2B,Protein EVI2B,40079,0.00582671821136863,0.0040224227952963,-0.00205723046741212,0.0137106668901494,0.147489480507652
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MEGF11,Multiple epidermal growth factor-like domains protein 11,40115,0.0047888965222507,0.00330621594656755,-0.0016912867330217,0.0112690797775231,0.147519269728777
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,40450,0.00675926708061962,0.00468515874413668,-0.00242364405788827,0.0159421782191275,0.149133512810815
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TMEM25,Transmembrane protein 25,40481,-0.00643591915016174,0.00446977022127554,-0.0151966687838618,0.00232483048353831,0.149929947340746
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CDHR1,Cadherin-related family member 1,42310,-0.0060408927405749,0.00419614060295363,-0.014265328322364,0.00218354284121422,0.149995781128135
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GIPC2,PDZ domain-containing protein GIPC2,40482,0.00435973555785316,0.00302934282853279,-0.00157777638607111,0.0102972475017774,0.1501304425964
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IFNAR1,Interferon alpha/beta receptor 1,40448,0.0036167466083548,0.00251395124325419,-0.00131059782842341,0.008544091045133,0.150271810012442
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DDX25,ATP-dependent RNA helicase DDX25,40181,-0.00534393609474394,0.00371741202791966,-0.0126300636694665,0.00194219147997859,0.150592513095099
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EFNB2,Ephrin-B2,40181,0.00769551510904991,0.00535360869430942,-0.00279755793179655,0.0181885881498964,0.150620224135454
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RPS10,40S ribosomal protein S10,40115,-0.00572842612346078,0.00399966074372676,-0.0135677611811652,0.00211090893424367,0.152107200014036
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CEP350,Centrosome-associated protein 350,40079,0.00534204710340867,0.00373483832589384,-0.00197823601534326,0.0126623302221606,0.152651354596051
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FAM171B,Protein FAM171B,40450,0.00370580312927929,0.00259111007674918,-0.0013727726211491,0.00878437887970769,0.152687659399969
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,40135,0.00892477736205646,0.00624823474069348,-0.00332176272970277,0.0211713174538157,0.153214564846781
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DPP7,Dipeptidyl peptidase 2,42550,0.00839998327767046,0.00589482215102158,-0.00315386813833183,0.0199538346936728,0.154187349080559
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KHK,Ketohexokinase,40222,0.00868874100909542,0.00612342467838409,-0.0033131713605374,0.0206906533787282,0.155946256315801
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL20,Interleukin-20,42369,0.00681509507315183,0.00482095681154316,-0.00263398027747276,0.0162641704237764,0.157491398200185
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DEFB103A_DEFB103B,Beta-defensin 103,40134,0.00588781983997691,0.00417525454800181,-0.00229567907410664,0.0140713187540604,0.158517841535675
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FGR,Tyrosine-protein kinase Fgr,42310,0.00787122816849243,0.00560041725854332,-0.00310558965825248,0.0188480459952373,0.159904733987953
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RASA1,Ras GTPase-activating protein 1,42310,0.00444282958436677,0.00317638315209515,-0.00178288139373973,0.0106685405624733,0.161924486836279
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NLGN2,Neuroligin-2,40135,0.00658470983783175,0.00470835910138655,-0.00264367400088588,0.0158130936765494,0.161986878263849
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GFRAL,GDNF family receptor alpha-like,40108,-0.00860656431393123,0.00615568293592318,-0.0206717028683407,0.0034585742404782,0.162096623364276
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ID4,DNA-binding protein inhibitor ID-4,40301,-0.00595005510169796,0.00425935502394703,-0.0142983909486341,0.00239828074523821,0.16246010956499
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MRPL24,"39S ribosomal protein L24, mitochondrial",40115,0.00534982480564682,0.00383493538788554,-0.00216664855460883,0.0128662981659025,0.163037136633129
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NCS1,Neuronal calcium sensor 1,42720,0.00393857908599911,0.00282667143860404,-0.00160169693366481,0.00947885510566303,0.163532976934085
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RBPMS,RNA-binding protein with multiple splicing,40198,0.00871658937744057,0.00625948311560515,-0.00355199752914552,0.0209851762840267,0.163786650555453
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SPAG1,Sperm-associated antigen 1,40481,0.0077961710873646,0.0056062385094499,-0.00319205639115721,0.0187843985658864,0.164366822560601
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SIGLEC15,Sialic acid-binding Ig-like lectin 15,42310,0.0104905877873563,0.00757595642460918,-0.00435828680487765,0.0253394623795903,0.166161275434042
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ARHGAP5,Rho GTPase-activating protein 5,40079,0.0108271170740089,0.00783557426091324,-0.00453060847738109,0.0261848426253988,0.167064590538446
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RAB6B,Ras-related protein Rab-6B,42310,0.0066742728955577,0.0048323010838608,-0.00279703722880947,0.0161455830199249,0.167247452538983
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TLR4,Toll-like receptor 4,40198,0.00396791689408362,0.00287393082761534,-0.00166498752804245,0.00960082131620968,0.167412042812198
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TBR1,T-box brain protein 1,40181,0.00656054919878183,0.004760760397644,-0.00277054118060041,0.0158916395781641,0.168216995535197
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GNAS,Neuroendocrine secretory protein 55,40481,0.0115765390496149,0.00840176186870272,-0.00489091421304238,0.0280439923122723,0.168270619053917
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CPVL,Probable serine carboxypeptidase CPVL,42697,0.00556909115377666,0.00404678601549687,-0.0023626094365972,0.0135007917441505,0.168789868008069
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ATG4A,Cysteine protease ATG4A,42345,0.00789643039723457,0.00574658871184039,-0.0033668834779726,0.0191597442724417,0.169431742744005
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MORF4L1,Mortality factor 4-like protein 1,40301,0.00536386498233249,0.00391687627983561,-0.0023132125261453,0.0130409424908103,0.170894415643501
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RGS8,Regulator of G-protein signaling 8,42369,0.00865098029534118,0.00632204101180011,-0.00374022008778703,0.0210421806784694,0.171215217368206
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BTN1A1,Butyrophilin subfamily 1 member A1,40428,0.00527648664211239,0.00387136953045022,-0.00231139763757004,0.0128643709217948,0.172925298485195
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GPR101,Probable G-protein coupled receptor 101,40135,-0.00805582051898371,0.00591624483869317,-0.0196516604028223,0.00354001936485491,0.173338233644862
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GPHA2,Glycoprotein hormone alpha-2,40448,0.00620777049636848,0.00456329225135553,-0.00273628231628836,0.0151518233090253,0.173739793101954
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,40198,0.00445936338742556,0.0032816630504584,-0.0019726961914729,0.010891422966324,0.17421468015752
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CCL15,C-C motif chemokine 15,42793,0.00594550070538393,0.00437593964744094,-0.00263134100360031,0.0145223424143682,0.174270618262576
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PON3,Serum paraoxonase/lactonase 3,42675,-0.00376808243642278,0.00278136798351652,-0.00921956368411515,0.0016833988112696,0.175517155805576
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PMS1,PMS1 protein homolog 1,40181,0.0069048573049575,0.00509939105517264,-0.00308994916318088,0.0168996637730959,0.175746596151685
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RFC4,Replication factor C subunit 4,40450,0.0027923162815567,0.00206659507964501,-0.00125821007454753,0.00684284263766092,0.176668912657853
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PQBP1,Polyglutamine-binding protein 1,42345,0.00751574447873871,0.00556476767019967,-0.00339120015485265,0.0184226891123301,0.17684861022533
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,40448,0.00540279054196651,0.00400209284869101,-0.00244131144146787,0.0132468925254009,0.177045922971589
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KIRREL1,Kin of IRRE-like protein 1,40135,0.00759767808236786,0.00563712017936433,-0.00345107746918622,0.018646433633922,0.177752478349603
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GLP1R,Glucagon-like peptide 1 receptor,40135,-0.00499952908521349,0.00371637421585737,-0.0122836225482939,0.00228456437786696,0.178565735292026
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CEP85,Centrosomal protein of 85 kDa,42345,0.0083796454413389,0.00624024147224343,-0.00385122784425823,0.020610518726936,0.179346985313759
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CTSZ,Cathepsin Z,42647,0.0042255097320834,0.00315118697163805,-0.00195081673232718,0.010401836196494,0.179966996625923
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SERPINI2,Serpin I2,40448,-0.00733654338947691,0.00548140693404986,-0.0180801009802146,0.00340701420126082,0.180779545222184
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RET,Proto-oncogene tyrosine-protein kinase receptor Ret,42586,-0.00520488080374408,0.00389036898594556,-0.0128300040161974,0.00242024240870922,0.180955430499584
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FGF7,Fibroblast growth factor 7,40079,0.0104075219913175,0.00778944064141255,-0.00485978166585115,0.0256748256484861,0.181542408687263
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DNAJA1,DnaJ homolog subfamily A member 1,40079,0.00625084911363281,0.00468322466314745,-0.0029282712261362,0.0154299694534018,0.181992042572537
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CTBS,Di-N-acetylchitobiase,40382,0.00350727475744704,0.00262815490654213,-0.00164390885937554,0.00865845837426962,0.182066951743545
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,40135,0.00756758165231979,0.00568527657125554,-0.00357556042734107,0.0187107237319806,0.183189052443811
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MED21,Mediator of RNA polymerase II transcription subunit 21,40115,0.00627107621194566,0.00471826050550779,-0.00297671437884961,0.0155188668027409,0.183840216752478
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TK1,"Thymidine kinase, cytosolic",40301,0.00590951619680888,0.00445064106540178,-0.00281374029137862,0.0146327726849964,0.184274815517787
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MVK,Mevalonate kinase,42369,-0.0103596763783577,0.00780655429735684,-0.0256605228011771,0.00494117004446174,0.18451562797612
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",42586,0.00538818965066631,0.00406115682606347,-0.00257167772841809,0.0133480570297507,0.18460995693007
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PGM2,Phosphoglucomutase-2,40181,0.00778315188841775,0.00586680891991993,-0.0037157935946253,0.0192820973714608,0.184654890187132
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MFAP3,Microfibril-associated glycoprotein 3,42356,0.00630528504199822,0.00476083910261159,-0.0030259595991205,0.0156365296831169,0.185391157614628
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NPTX2,Neuronal pentraxin-2,40526,0.00425610643448806,0.00321466715482474,-0.00204464118896843,0.0105568540579446,0.185541411764092
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,POF1B,Protein POF1B,40198,-0.00605643095514213,0.00457472651437849,-0.015022894923324,0.00291003301303972,0.185567350916991
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CBLIF,Cobalamin binding intrinsic factor,42612,-0.0104808558485571,0.00792902723493638,-0.0260217492290324,0.00506003753191818,0.186246049773307
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CCL25,C-C motif chemokine 25,42753,-0.0061872800501829,0.00468939721086995,-0.015378498583488,0.00300393848312221,0.187051332594552
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DSG2,Desmoglein-2,42610,-0.00350549747545873,0.00266029934938583,-0.00871968420025496,0.00170868924933749,0.187623948832717
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,40538,0.0024182744575651,0.00183642157797481,-0.00118111183526553,0.00601766075039574,0.187918668039976
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,F10,Coagulation factor X,40531,0.00365275307305277,0.00277867416231538,-0.00179344828508538,0.00909895443119091,0.188682094066848
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PCSK7,Proprotein convertase subtilisin/kexin type 7,40450,0.0058857718727904,0.00448022181978494,-0.00289546289398809,0.0146670066395689,0.18896610593979
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CPLX2,Complexin-2,40079,-0.00409346281079455,0.00311963933541523,-0.0102079559082084,0.0020210302866193,0.189494164026153
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DCN,Decorin,42356,0.00309032586451753,0.00235693243869283,-0.00152926171532041,0.00770991344435548,0.189825106458244
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TET2,Methylcytosine dioxygenase TET2,40285,0.0131556726335436,0.0100409172798371,-0.00652452523493723,0.0328358705020244,0.190153203619548
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GLA,Alpha-galactosidase A,40266,0.00477855109782258,0.0036490021466088,-0.00237349310953067,0.0119305953051758,0.190375254004991
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,VTCN1,V-set domain-containing T-cell activation inhibitor 1,42345,0.00407750225520667,0.00312116673973038,-0.00203998455466488,0.0101949890650782,0.191438320796189
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PCSK9,Proprotein convertase subtilisin/kexin type 9,42793,0.00503830793729484,0.00385943031490639,-0.00252617547992168,0.0126027913545114,0.191760457194554
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CPM,Carboxypeptidase M,42654,0.00429388094036853,0.00329422884376006,-0.00216280759340119,0.0107505694741383,0.192441569120072
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KIRREL2,Kin of IRRE-like protein 2,42310,0.00516247459606048,0.00396207591037672,-0.0026031941882779,0.0129281433803989,0.192607141498994
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HIP1,Huntingtin-interacting protein 1,40115,0.00427008436643142,0.00328242582742589,-0.00216347025532333,0.0107036389881862,0.193322572686927
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD207,C-type lectin domain family 4 member K,42364,0.00503842498871398,0.00388811373548804,-0.00258227793284258,0.0126591279102705,0.195048742969473
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GSTA1,Glutathione S-transferase A1,42610,0.0103959677391584,0.00804373786111725,-0.0053697584686314,0.0261616939469482,0.196230548807961
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MFAP4,Microfibril-associated glycoprotein 4,40282,0.00412290167957523,0.00319518550503296,-0.00213966191028937,0.0103854652694398,0.196956716121827
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TIMP4,Metalloproteinase inhibitor 4,42610,-0.00519368156015828,0.00403753067975035,-0.013107241692469,0.00271987857215241,0.198342794669983
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CEP290,Centrosomal protein of 290 kDa,40301,0.00686288049901153,0.00534828561030232,-0.00361975929718101,0.0173455202952041,0.199451382270458
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CA1,Carbonic anhydrase 1,42361,0.0075522497537004,0.00589068465402985,-0.0039934921681981,0.0190979916755989,0.199841874340791
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DDX4,Probable ATP-dependent RNA helicase DDX4,40198,-0.00670621877536,0.00526202640030872,-0.0170197905199651,0.00360735296924508,0.202528926582029
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FGF19,Fibroblast growth factor 19,42675,0.00963678614696008,0.00758082274799826,-0.00522162643911651,0.0244951987330367,0.203677362462692
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EGFLAM,Pikachurin,40448,0.0038514053502291,0.00303506368030437,-0.00209731946316747,0.00980013016362567,0.204477938709973
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RRP15,RRP15-like protein,40135,0.0114096791831047,0.00899682063463228,-0.00622408926077458,0.0290434476269839,0.204757043389325
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GCLM,Glutamate--cysteine ligase regulatory subunit,40115,0.00567818909947578,0.00448703247261432,-0.00311639454684829,0.0144727727457999,0.205731161757205
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ARG2,"Arginase-2, mitochondrial",40450,0.00530350004512669,0.00419129178863317,-0.00291143186059431,0.0135184319508477,0.205767895772624
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ADGRB3,Adhesion G protein-coupled receptor B3,42474,0.00424305274894213,0.00335733978469043,-0.00233733322905111,0.0108234387269354,0.206319007930236
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LMOD1,Leiomodin-1,40481,0.00442113857121123,0.00350232102408057,-0.00244341063598669,0.0112856877784092,0.206850635299366
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RBM19,Probable RNA-binding protein 19,40115,-0.00598581867195304,0.00474328284740614,-0.0152826530528691,0.00331101570896299,0.206991234122929
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,40222,0.00259097219340775,0.00205704200693026,-0.00144083014017555,0.00662277452699105,0.20785402364592
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EPHA10,Ephrin type-A receptor 10,42310,0.00826539253054786,0.00656808929380132,-0.00460806248530273,0.0211388475463984,0.208263535089378
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ISM1,Isthmin-1,42593,-0.0047218678523274,0.00375572974460883,-0.0120830981517607,0.00263936244710591,0.208687289081119
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD248,Endosialin,40526,0.0050119353940827,0.00398817837191426,-0.00280489421486925,0.0128287650030346,0.208888951348129
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ADGRD1,Adhesion G-protein coupled receptor D1,40282,-0.0047146268360182,0.00375390772702613,-0.0120722859809894,0.00264303230895302,0.209169599904472
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,40135,0.00927544357416052,0.0074071301197988,-0.00524253146064514,0.0237934186089662,0.210512193969326
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SLC13A1,Solute carrier family 13 member 1,40450,0.00767949509266115,0.00613815190830776,-0.00435128264762205,0.0197102728329444,0.210920834229316
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CDH23,Cadherin-23,40482,-0.00319661275221932,0.00255627498017438,-0.0082069117133611,0.00181368620892247,0.211144177158659
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CILP,Cartilage intermediate layer protein 1,40526,-0.00674217310999956,0.00539737796118813,-0.0173210339139283,0.00383668769392918,0.211633413960698
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AHNAK2,Protein AHNAK2,40222,-0.00368765595498917,0.00296048910902227,-0.00949021460867281,0.00211490269869448,0.21292897158885
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IGDCC4,Immunoglobulin superfamily DCC subclass member 4,40526,-0.0033059320621437,0.00265648674994203,-0.00851264609203008,0.00190078196774267,0.21335043376062
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HDAC9,Histone deacetylase 9,40135,0.00799571222882782,0.00642897034766718,-0.00460506965259985,0.0205964941102555,0.213636538992574
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MNAT1,CDK-activating kinase assembly factor MAT1,40301,0.00535848668659941,0.00431654165253818,-0.00310193495237541,0.0138189083255742,0.214490061693368
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NRP1,Neuropilin-1,42704,0.00335733807076823,0.00271397846628858,-0.00196205972315739,0.00867673586469385,0.216088516646815
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SCIN,Adseverin,40135,0.00881654733659199,0.00714362564883798,-0.00518495893513045,0.0228180536083144,0.217160916103034
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CA12,Carbonic anhydrase 12,42586,-0.00400181238196863,0.00324382993118738,-0.0103597190470959,0.00235609428315862,0.217347925993591
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ATF4,Cyclic AMP-dependent transcription factor ATF-4,40079,-0.00416938947390532,0.003398203266603,-0.0108298678764472,0.00249108892863657,0.219871905627226
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD101,Immunoglobulin superfamily member 2,40448,0.00523422535518234,0.00426627989447145,-0.00312768323798171,0.0135961339483464,0.219892315943836
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CEMIP2,Cell surface hyaluronidase,40198,0.00413455129774367,0.00336996843628193,-0.00247058683736891,0.0107396894328562,0.21989345229154
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL6ST,Interleukin-6 receptor subunit beta,42635,0.00210089164376529,0.00171415816594473,-0.00125885836148638,0.00546064164901697,0.220366452128897
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CHRDL2,Chordin-like protein 2,42635,0.00566467031595474,0.00462282352747712,-0.00339606379790041,0.0147254044298099,0.22045723071415
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,OLFM4,Olfactomedin-4,39869,-0.0148094664686292,0.0121119405409986,-0.0385488699289864,0.00892993699172794,0.221463882339547
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,40079,0.00694974927082096,0.00568909749854099,-0.00420088182631939,0.0181003803679613,0.221888858057654
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,42593,-0.0180125174407472,0.0147587877696546,-0.0469397414692703,0.0109147065877758,0.22231183417989
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,40510,0.00888680262958109,0.00729415367886041,-0.00540973858098531,0.0231833438401475,0.223117933712129
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ACRV1,Acrosomal protein SP-10,40198,-0.0095608947311148,0.00786190410405024,-0.0249702267750533,0.00584843731282368,0.223971310610532
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",40198,0.00764727245548497,0.00631543801377469,-0.00473098605151341,0.0200255309624834,0.225965287779139
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL11,Interleukin-11,42369,0.00743802718294144,0.00614427235514173,-0.00460474663313634,0.0194808009990192,0.226084747561965
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TDO2,"Tryptophan 2,3-dioxygenase",40181,0.00458443796257069,0.00379365893794314,-0.00285113355579786,0.0120200094809392,0.226901155436981
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CTRL,Chymotrypsin-like protease CTRL-1,40482,0.00831861568526199,0.00691887971826966,-0.00524238856254655,0.0218796199330705,0.229269928553504
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PI16,Peptidase inhibitor 16,40531,-0.00295933055907702,0.00246436982579225,-0.00778949541762983,0.00187083429947578,0.229835732149382
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL31RA,Interleukin-31 receptor subunit alpha,40144,-0.00450126905400059,0.00375607032092265,-0.011863166883009,0.00286062877500781,0.230787850617893
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TRIM26,Tripartite motif-containing protein 26,40079,-0.00660443452180885,0.0055219948605525,-0.0174275444484917,0.00421867540487405,0.231713518651547
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GPR15L,Protein GPR15L,40448,0.00709936668633065,0.00595451307520174,-0.00457147894106476,0.0187702123137261,0.233181889844624
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,WASL,Neural Wiskott-Aldrich syndrome protein,40198,-0.00714700609478037,0.00603145554440196,-0.0189686589618082,0.00467464677224746,0.236060653549361
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FBN2,Fibrillin-2,40181,0.00707813490219935,0.00597430734924398,-0.00463150750231884,0.0187877773067175,0.236137017066832
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,40481,0.0133732865462759,0.0112962502781165,-0.00876736399883248,0.0355139370913844,0.236489643278842
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CINP,Cyclin-dependent kinase 2-interacting protein,40301,-0.00508655781087793,0.00430527149005138,-0.0135248899313786,0.00335177430962277,0.23744055757145
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CNGB3,Cyclic nucleotide-gated cation channel beta-3,40135,0.00622554361035951,0.00527532432306581,-0.00411409206284947,0.0165651792835685,0.237976047327396
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,42661,0.00569438755360729,0.00482559395209242,-0.00376377659249385,0.0151525516997084,0.238005671771479
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AGT,Angiotensinogen,40531,0.00276563613925547,0.00234441063241632,-0.00182940870028052,0.00736068097879145,0.238155352981994
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MORC3,MORC family CW-type zinc finger protein 3,40482,-0.00325172085305382,0.00276898134709573,-0.00867892429336146,0.00217548258725382,0.240284321197894
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AKR7L,Aflatoxin B1 aldehyde reductase member 4,40198,-0.00786353917701364,0.0066999033680519,-0.0209953497783954,0.00526827142436809,0.24054882989072
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SPARCL1,SPARC-like protein 1,42643,0.00317796894206583,0.00271232164426862,-0.00213818148070067,0.00849411936483233,0.241346916453494
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,COL1A1,Collagen alpha-1(I) chain,42793,-0.00287595689795995,0.00245487602467082,-0.00768751390631476,0.00193560011039485,0.241406988097296
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SLAMF1,Signaling lymphocytic activation molecule,42369,0.00695044363809265,0.00593854286172851,-0.00468910037089523,0.0185899876470805,0.241863029310623
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CPTP,Ceramide-1-phosphate transfer protein,40115,0.00459558462221678,0.00392737828140709,-0.00310207680934111,0.0122932460537747,0.241969942796117
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HCG22,Protein PBMUCL2,40115,0.00652853641531882,0.00559997735588848,-0.0044474192022226,0.0175044920328602,0.243714796763936
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EXOSC10,Exosome component 10,40115,0.00688921429906753,0.00593350968713523,-0.00474046468771752,0.0185188932858526,0.245639208033015
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TOP1,DNA topoisomerase 1,40448,-0.0127342513004795,0.0109944665787931,-0.034283405794914,0.00881490319395494,0.246789932928147
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SOD3,Extracellular superoxide dismutase,40531,-0.00663205277709275,0.00573457166070496,-0.0178718132320745,0.00460770767788897,0.247499596298599
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NME1,Nucleoside diphosphate kinase A,40198,-0.00248855498330027,0.00215884655945663,-0.00671989423983526,0.00174278427323472,0.249048586104327
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BSND,Barttin,40079,-0.00386357324965913,0.00335418685715521,-0.0104377794896834,0.00271063299036509,0.249401507119516
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SLURP1,Secreted Ly-6/uPAR-related protein 1,40456,0.00424714033671036,0.003711777881384,-0.00302794431080228,0.011522224984223,0.252551161202942
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LSM1,U6 snRNA-associated Sm-like protein LSm1,42345,0.00633760383925872,0.0055434974904842,-0.00452765124209032,0.0172028589206078,0.252955593928249
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,42586,0.00509929158210418,0.00446481218822929,-0.00365174030682523,0.0138503234710336,0.253430121181797
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GALNT7,N-acetylgalactosaminyltransferase 7,42586,-0.00236097033876047,0.00207958028388284,-0.00643694769517083,0.00171500701764989,0.256265359766811
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HMBS,Porphobilinogen deaminase,42720,-0.00479297790528036,0.00422731893237849,-0.0130785230127422,0.00349256720218147,0.256894208466554
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HBQ1,Hemoglobin subunit theta-1,42720,0.00668980902407415,0.0059039766566906,-0.00488198522303943,0.0182616032711877,0.257191415616485
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TPRKB,EKC/KEOPS complex subunit TPRKB,40079,0.00734604842526682,0.00648396114197481,-0.0053625154130038,0.0200546122635374,0.257257313373845
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KLK3,Prostate-specific antigen,40526,0.0108491887165513,0.00961139585100059,-0.0079891471514099,0.0296875245845124,0.259012909191235
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DAND5,DAN domain family member 5,40198,0.0061287876660096,0.00543643639995318,-0.00452662767789864,0.0167842030099178,0.259617471811691
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DUSP29,Dual specificity phosphatase 29,40181,0.00743971700827736,0.00660806198758099,-0.00551208448738139,0.0203915185039361,0.260251658823905
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ALDH1A1,Retinal dehydrogenase 1,42610,0.00588287271803312,0.0052352378538728,-0.00437819347555757,0.0161439389116238,0.261157509459775
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ITGB5,Integrin beta-5,42678,-0.00409439197960764,0.00364722898585683,-0.011242960791887,0.00305417683267174,0.261625921832119
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AMIGO1,Amphoterin-induced protein 1,40181,0.00556701062351736,0.00496154771678279,-0.00415762290137692,0.0152916441484116,0.26187375588426
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DNLZ,DNL-type zinc finger protein,40135,0.0100010822545454,0.00891839471987072,-0.00747897139640122,0.027481135905492,0.26214251400501
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TPM3,Tropomyosin alpha-3 chain,40115,-0.00482077033542474,0.00430521998299806,-0.0132590015021009,0.00361746083125146,0.262844911289649
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SAP18,Histone deacetylase complex subunit SAP18,40301,0.0081084751368072,0.00726382986992503,-0.00612863140824586,0.0223455816818603,0.264326028236627
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LYAR,Cell growth-regulating nucleolar protein,42345,0.00592423067594425,0.00531966361376794,-0.00450231000704092,0.0163507713589294,0.265450746058713
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,VIPR1,Vasoactive intestinal polypeptide receptor 1,40222,-0.00257198132713962,0.00231142440655044,-0.00710237316397847,0.00195841050969923,0.265850511193523
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,40450,0.00988867018816918,0.00888701781984431,-0.00752988473872567,0.027307225115064,0.265856926917561
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,40115,-0.00354896262974389,0.00319043568393642,-0.00980221657025927,0.00270429131077148,0.266001200422665
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BRD1,Bromodomain-containing protein 1,40301,-0.00333608623762421,0.00300001531656365,-0.00921611625808898,0.00254394378284055,0.266152300575148
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,VSTM2B,V-set and transmembrane domain-containing protein 2B,40301,0.00441809478593137,0.00397464932129924,-0.00337221788381515,0.0122084074556779,0.266347804038777
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,APOM,Apolipoprotein M,42662,0.00305562539176192,0.00276273447176695,-0.00235933417290131,0.00847058495642515,0.268739841404107
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TDP1,Tyrosyl-DNA phosphodiesterase 1,40450,0.00728354780823832,0.00660249320914597,-0.00565733888168777,0.0202244344981644,0.26998512635547
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TMED10,Transmembrane emp24 domain-containing protein 10,40115,-0.00522317365222064,0.00473735616999474,-0.0145083917454103,0.00406204444096904,0.270246782260736
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KLK8,Kallikrein-8,42153,0.0040389381693579,0.00366850523277683,-0.00315133208688469,0.0112292084256005,0.270927320339478
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CLMP,CXADR-like membrane protein,42720,0.00236860554976715,0.00215150598701039,-0.00184834618477321,0.0065855572843075,0.270957222143658
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PLXNB2,Plexin-B2,42742,0.00259993526551768,0.00236198952048334,-0.00202956419462968,0.00722943472566503,0.271029587325962
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ARID4B,AT-rich interactive domain-containing protein 4B,42310,0.00451362887694389,0.00410533704816071,-0.0035328317374511,0.0125600894913389,0.271590306105941
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SNU13,NHP2-like protein 1,40115,0.00683865945861112,0.00622140139148394,-0.0053552872686974,0.0190326061859196,0.271698407260812
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ZP4,Zona pellucida sperm-binding protein 4,40079,-0.00340076261588584,0.00309900362494461,-0.00947480972077728,0.0026732844890056,0.272502686908556
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SCP2,Non-specific lipid-transfer protein,42345,-0.0079325968410216,0.00724473193147236,-0.0221322714267074,0.00626707774466421,0.273559948766492
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TSNAX,Translin-associated protein X,40115,0.00423545088245779,0.00386843823834521,-0.00334668806469882,0.0118175898296144,0.273596164232004
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,OFD1,Oral-facial-digital syndrome 1 protein,40301,0.00703335635860186,0.00645456629319628,-0.00561759357606285,0.0196843062932666,0.27588155453554
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PRKD2,Serine/threonine-protein kinase D2,40115,0.00487607851209483,0.0044831611409525,-0.00391091732417206,0.0136630743483617,0.276776774513313
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,42345,-0.00465263310134378,0.00428159568541558,-0.0130445606447583,0.00373929444207075,0.27720759946097
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ANK2,Ankyrin-2,40115,0.00784899489071268,0.00723331532126089,-0.00632830313895867,0.022026292920384,0.277893701458596
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GART,Trifunctional purine biosynthetic protein adenosine-3,40481,0.0028864136263544,0.00266368801563168,-0.00233441488428369,0.0081072421369925,0.278558461388618
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HLA_DRA,,42548,0.00390958571240694,0.00361326429731469,-0.00317241231032986,0.0109915837351437,0.279267916232882
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LRRC37A2,Leucine-rich repeat-containing protein 37A2,40448,0.00457856822226815,0.00424873886604765,-0.00374895995518525,0.0129060963997216,0.281222032049275
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BHLHE40,Class E basic helix-loop-helix protein 40,40135,0.0073972264272556,0.00687416343806933,-0.00607613391136029,0.0208705867658715,0.281910221834994
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL2RG,Cytokine receptor common subunit gamma,40450,0.00386393137212032,0.00359177473926361,-0.00317594711683636,0.010903809861077,0.282052210805175
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SPACA5_SPACA5B,Sperm acrosome-associated protein 5,40481,-0.00310355236261027,0.00288756319377323,-0.0087631762224058,0.00255607149718527,0.282487342158189
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,40448,0.00832103257001058,0.00774827689397437,-0.00686559014217919,0.0235076552822004,0.282881387492587
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,OMP,Olfactory marker protein,40135,0.00529412578311488,0.00493006553421482,-0.00436880266394616,0.0149570542301759,0.282915879814554
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CDC25A,M-phase inducer phosphatase 1,40079,-0.0041117235090695,0.00383010551927848,-0.0116187303268553,0.00339528330871632,0.283058315630215
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL13RA2,Interleukin-13 receptor subunit alpha-2,40135,0.00304870120422725,0.00284281764810632,-0.00252322138606113,0.00862062379451564,0.283554023899128
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DEFB116,Beta-defensin 116,40135,0.00808065336563841,0.00754365668387288,-0.00670491373475244,0.0228662204660292,0.284109794996438
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ANXA5,Annexin A5,42260,0.00322094660515229,0.00301030661409871,-0.00267925435848119,0.00912114756878578,0.284651256115915
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PSMA1,Proteasome subunit alpha type-1,42345,-0.00484473976636261,0.00452965662829487,-0.0137228667578205,0.00403338722509533,0.284837016201115
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NTRK2,BDNF/NT-3 growth factors receptor,42635,0.00267705098429232,0.00250584210966825,-0.00223439955065745,0.00758850151924209,0.285393623047858
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TEX33,Testis-expressed protein 33,40301,0.00399785529646528,0.00374233472709313,-0.00333712076863725,0.0113328313615678,0.285418172883014
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ABCA2,ATP-binding cassette sub-family A member 2,40115,-0.00378011046137964,0.00354194094674022,-0.0107223147169905,0.0031620937942312,0.285885866639976
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TFAP2A,Transcription factor AP-2-alpha,40135,0.00636640091537276,0.00597594406438126,-0.0053464494508145,0.01807925128156,0.286746464924489
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL17F,Interleukin-17F,42369,0.00788805260644046,0.0074102667217452,-0.00663607016818013,0.0224121753810611,0.287132535933513
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FZD8,Frizzled-8,40135,0.00476707998840137,0.00448211579840183,-0.00401786697646622,0.013552026953269,0.287543362620235
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GDF2,Growth/differentiation factor 2,42635,0.00373105013289757,0.00350962844889715,-0.00314782162694084,0.010609921892736,0.287760338069856
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GPC1,Glypican-1,42720,0.00310769244734904,0.00292814615957293,-0.0026314740254139,0.00884685892011198,0.288564633644183
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SEPTIN3,Neuronal-specific septin-3,40481,0.00777676615515818,0.00734106392042496,-0.00661171912887474,0.0221652514391911,0.289462455069547
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LSM8,U6 snRNA-associated Sm-like protein LSm8,40301,0.00895885335437205,0.00846859883966446,-0.00763960037137028,0.0255573070801144,0.290128206973652
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GIPR,Gastric inhibitory polypeptide receptor,40198,0.00506378532406294,0.00480251033550453,-0.00434913493352594,0.0144767055816518,0.291721216619596
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GLI2,Zinc finger protein GLI2,40198,-0.00330784605866903,0.00314774658676876,-0.0094774293687358,0.00286173725139774,0.293345229451535
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RBKS,Ribokinase,42316,0.0050919167268682,0.00484777003165078,-0.00440971253516733,0.0145935459889037,0.293570740221651
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TLR3,Toll-like receptor 3,42753,0.0062485433720583,0.00597073837157947,-0.00545410383623746,0.0179511905803541,0.295336096669919
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KLHL41,Kelch-like protein 41,40481,0.00491521172700215,0.0046966626934376,-0.00429024715213554,0.0141206706061398,0.295337503426126
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TCL1B,T-cell leukemia/lymphoma protein 1B,42356,0.00796806917500547,0.00762374788094428,-0.00697447667164533,0.0229106150216563,0.29596623069657
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FAM3C,Protein FAM3C,42612,0.00317486439985327,0.00304640143713285,-0.00279608241692712,0.00914581121663365,0.297352221726659
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MDM1,Nuclear protein MDM1,40181,0.00319539614494301,0.00306882987948549,-0.00281951041884855,0.00921030270873458,0.297785919504023
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SPTBN2,"Spectrin beta chain, non-erythrocytic 2",40135,0.00330219939852602,0.00317619627560474,-0.00292314530165926,0.00952754409871131,0.298515717522599
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,COL9A2,Collagen alpha-2(IX) chain,40301,0.00454575823697555,0.00438624414269055,-0.00405128028269793,0.013142796756649,0.30005356919204
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MFAP3L,Microfibrillar-associated protein 3-like,40181,0.00683205835789357,0.0066224208365718,-0.00614788648178716,0.0198120031975743,0.302256134736269
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BRME1,Break repair meiotic recombinase recruitment factor 1,40135,0.00423111531263015,0.00410674461480362,-0.00381810413238495,0.0122803347576452,0.30289924874498
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TIMP2,Metalloproteinase inhibitor 2,40510,0.00280825852169229,0.002727242672898,-0.0025371371171878,0.00815365416057238,0.303169981058699
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",42568,0.00768886906060566,0.00747098135208651,-0.00695425438948389,0.0223319925106952,0.303420975815954
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CRX,Cone-rod homeobox protein,42356,0.010725601408365,0.01042325709923,-0.00970398250612578,0.0311551853228557,0.303495434586982
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SLC44A4,Choline transporter-like protein 4,40181,-0.00719524460212645,0.00699756763480891,-0.0209104771663519,0.00651998796209901,0.303855170238964
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AHSP,Alpha-hemoglobin-stabilizing protein,42589,-0.00836552236772224,0.00814173810322075,-0.0243233290500349,0.00759228431459042,0.304210201672624
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CNTNAP4,Contactin-associated protein-like 4,40181,0.0103659936322944,0.0100951114867156,-0.00942042488166825,0.030152412146257,0.304521712178114
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BACH1,Transcription regulator protein BACH1,42593,0.00729946676929206,0.0071149113942327,-0.00664575956340403,0.0212446931019881,0.304938746832458
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NCLN,Nicalin,42369,-0.0052118381016022,0.00508343698545932,-0.0151753745931025,0.00475169838989807,0.305259950951303
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ADAMTSL4,ADAMTS-like protein 4,40222,-0.00237660221704593,0.00232543677055616,-0.006934458287336,0.00218125385324415,0.306802130569848
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LACRT,Extracellular glycoprotein lacritin,40418,-0.00516591225275667,0.00505651956725115,-0.0150766906045689,0.00474486609905558,0.306976183851442
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GLB1,Beta-galactosidase,42494,0.00411576507651273,0.00403977720626321,-0.00380219824776316,0.0120337284007886,0.30831174901178
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TPSG1,Tryptase gamma,40198,0.00265385839369346,0.00260776555677134,-0.00245736209757837,0.00776507888496528,0.308854699962698
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FABP9,Fatty acid-binding protein 9,42593,0.00563928477847609,0.00555539181942152,-0.00524928318759008,0.0165278527445423,0.310075929434
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HSP90B1,Endoplasmin,42246,0.00663906691219085,0.00654336784307428,-0.00618593406023473,0.0194640678846164,0.310303256662968
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EPPK1,Epiplakin,40222,0.00717576522507701,0.00709534532365865,-0.00673111160929395,0.021082642059448,0.311878701708579
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CBLN4,Cerebellin-4,42720,0.00321845368476696,0.00318519497634953,-0.00302452846887812,0.00946143583841204,0.312301813923353
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,VSIG2,V-set and immunoglobulin domain-containing protein 2,40450,0.00652706240797432,0.00648446799567771,-0.006182494863554,0.0192366196795026,0.314163727751545
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CREB3,Cyclic AMP-responsive element-binding protein 3,40079,-0.00569555345763501,0.00566568710535053,-0.016800300184122,0.00540919326885203,0.314788507594179
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ENOPH1,Enolase-phosphatase E1,40450,0.00541904958022001,0.00539424673474842,-0.00515367401988689,0.0159917731803269,0.315112047049708
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CST1,Cystatin-SN,39041,-0.0108520517495727,0.0108284207546158,-0.0320757564286196,0.0103716529294742,0.316280174886584
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,INHBC,Inhibin beta C chain,42610,0.0040125647905023,0.00400531487819188,-0.00383785237075378,0.0118629819517584,0.316453399558059
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CAPN3,Calpain-3,40450,-0.00375433253502422,0.00375077339095716,-0.0111058483813002,0.00359718331125181,0.31687302611275
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FTCD,Formimidoyltransferase-cyclodeaminase,40461,-0.00834766412943755,0.00834291030324613,-0.0246997683238,0.00800444006492486,0.317056322317914
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DDI2,Protein DDI1 homolog 2,40282,0.00768244221855669,0.0076899727369604,-0.00738990434588568,0.0227547887829991,0.317806447537658
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MMP15,Matrix metalloproteinase-15,40510,0.00475285961481086,0.00478391941412468,-0.00462362243687352,0.0141293416664952,0.320483961270375
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,REG1A,Lithostathine-1-alpha,42574,0.00506806694794974,0.00511736595654609,-0.00496197032688059,0.0150981042227801,0.322013004982081
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SSB,Lupus La protein,42310,0.00565457909943034,0.00571152086444302,-0.00554000179487797,0.0168491599937387,0.322177539620331
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PKLR,Pyruvate kinase PKLR,42635,-0.00631925544663107,0.00638683470871414,-0.0188374514757108,0.00619894058244864,0.322476005469151
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GSTM4,Glutathione S-transferase Mu 4,40115,0.00721926776328891,0.00731800256543887,-0.00712401726497127,0.0215625527915491,0.323905767398068
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ADGRG2,Adhesion G-protein coupled receptor G2,42635,0.00261115647120432,0.00265034617419984,-0.00258352203022736,0.007805834972636,0.3245370113441
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NXPE4,NXPE family member 4,40115,0.00323120939377623,0.00331181746627554,-0.00325995284012383,0.00972237162767629,0.329254356733775
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CASQ2,Calsequestrin-2,40115,0.00470589101665866,0.0048244337061544,-0.00474999904740397,0.0141617810807213,0.329369266626102
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL3RA,Interleukin-3 receptor subunit alpha,42369,-0.00312679487270413,0.00320943039997484,-0.00941727845665482,0.00316368871124656,0.329949180936969
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD177,CD177 antigen,42594,0.0125730433397423,0.0129113871755108,-0.0127332755242588,0.0378793622037434,0.330175950176461
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,39844,-0.00492385496727328,0.00506499846796397,-0.0148512519644827,0.00500354202993609,0.331006188897997
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PNMA2,Paraneoplastic antigen Ma2,40135,0.00422195110908697,0.00435067545659815,-0.0043053727858454,0.0127492750040193,0.331862227690112
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,REPS1,RalBP1-associated Eps domain-containing protein 1,40198,0.00367163512377032,0.00380337463464302,-0.00378297916013,0.0111262494076706,0.334384507978707
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EIF5,Eukaryotic translation initiation factor 5,40115,0.0041637585614225,0.004327016790575,-0.0043171943481045,0.0126447114709495,0.335935286309918
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DBH,Dopamine beta-hydroxylase,40514,-0.0103485656637168,0.0107587550010886,-0.0314357254658505,0.0107385941384169,0.336133494496015
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,UBE2B,Ubiquitin-conjugating enzyme E2 B,40450,0.00271709399097092,0.00282764388219482,-0.00282508801813093,0.00825927600007277,0.336621137944499
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EVPL,Envoplakin,40301,-0.00331508617194293,0.00345248743155801,-0.0100819615377966,0.00345178919391077,0.336974340375378
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",42369,-0.00555918881230168,0.00582889884639858,-0.0169838305512429,0.00586545292663954,0.340238425772071
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TP53INP1,Tumor protein p53-inducible nuclear protein 1,42356,0.00286781482322934,0.00301121861284463,-0.00303417365794614,0.00876980330440483,0.340923396853293
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PCNA,Proliferating cell nuclear antigen,40079,0.00583777231165334,0.00614488252191264,-0.00620619743129543,0.0178817420546021,0.342122271646843
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SORD,Sorbitol dehydrogenase,42657,0.00617268967539998,0.00652463570776118,-0.00661559631181194,0.0189609756626119,0.344135524582228
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EPN1,Epsin-1,40301,0.00411559229458136,0.00436611355864842,-0.00444199028036954,0.0126731748695323,0.34589506596741
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FGF12,Fibroblast growth factor 12,40198,0.00432266717575975,0.00459269117420704,-0.00467900752568605,0.0133243418772056,0.346620110148205
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GAST,Gastrin,40482,-0.0133820603004056,0.014225790740257,-0.0412646101513094,0.0145004895504982,0.346883831109423
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SLC28A1,Sodium/nucleoside cotransporter 1,40079,0.00544256092803937,0.00580374394155738,-0.0059327771974131,0.0168178990534918,0.348384847383218
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD3E,T-cell surface glycoprotein CD3 epsilon chain,40301,0.00338116458699508,0.00361376315529145,-0.00370181119737616,0.0104641403713663,0.349481304311471
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CEBPA,CCAAT/enhancer-binding protein alpha,40198,0.00339114460617433,0.00362762817064651,-0.00371900660829283,0.0105012958206415,0.349906522510869
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,40115,0.00237363525644218,0.0025411167094919,-0.00260695349416194,0.0073542240070463,0.35027740126203
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DNAJA4,DnaJ homolog subfamily A member 4,40482,-0.00646110454927011,0.00691811469106364,-0.0200206093437548,0.00709840024521462,0.350354782537718
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ENTR1,Endosome-associated-trafficking regulator 1,40222,0.00532778414836747,0.00571279489648417,-0.0058692938487415,0.0165248621454764,0.351044090815179
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TFF2,Trefoil factor 2,42653,0.00531455798831623,0.00570194620673244,-0.00586125657687936,0.0164903725535118,0.35132205545115
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MLLT1,Protein ENL,40079,0.00606970773209044,0.00652236918129579,-0.00671413586324931,0.0188535513274302,0.35208186874342
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SPRR1B,Cornifin-B,40301,-0.00758125082686477,0.00814727515052172,-0.0235499101218873,0.00838740846815779,0.352119066223447
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PADI2,Protein-arginine deiminase type-2,42369,0.00507011693722678,0.00546059972860991,-0.00563265853084865,0.0157728924053022,0.353170016655719
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",40079,-0.0050648523247501,0.00545537566723944,-0.0157573886325394,0.00562768398303921,0.353212953280048
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NAGA,Alpha-N-acetylgalactosaminidase,40165,0.00509705487263936,0.00549270334854199,-0.00566864369050293,0.0158627534357817,0.353444401266209
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ECM1,Extracellular matrix protein 1,40268,0.00339349273152143,0.00366135910306467,-0.00378277111048532,0.0105697565735282,0.354030001884501
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CDSN,Corneodesmosin,42709,0.00404117188090493,0.00436309112237728,-0.00451048671895454,0.0125928304807644,0.354349435449799
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PALM3,Paralemmin-3,40115,0.00650319092838063,0.00702887329498074,-0.00727340072978161,0.0202797825865429,0.354876603141028
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CST5,Cystatin-D,42356,-0.00516279468029524,0.00558376130552773,-0.0161069668391296,0.0057813774785391,0.355186399584362
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GID8,Glucose-induced degradation protein 8 homolog,40481,0.00309447494849276,0.00335732000724139,-0.00348587226570036,0.00967482216268588,0.356699637340668
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,40450,0.00404645453261494,0.00440462991373236,-0.00458662009830049,0.0126795291635304,0.358281575365203
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL2,Interleukin-2,42369,-0.00288372570648788,0.00314557079272893,-0.00904904446023658,0.00328159304726081,0.359286492962057
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PTPRH,Receptor-type tyrosine-protein phosphatase H,40448,0.00438895118891007,0.00481017364854127,-0.00503898916223081,0.013816891540051,0.361561461484367
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GPD1,Glycerol-3-phosphate dehydrogenase,40450,0.00462849617726354,0.00507387801476618,-0.00531630473167818,0.0145732970862053,0.361672124926477
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NPHS1,Nephrin,40198,0.00300187721878978,0.00329500114167873,-0.00345632501890054,0.00946007945648009,0.362294353692946
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,INSL4,Early placenta insulin-like peptide,40450,-0.00434781639976373,0.00477640715929764,-0.0137095744319871,0.00501394163245965,0.362700040727004
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HDAC8,Histone deacetylase 8,40198,-0.00527446195708281,0.00579725709867059,-0.0166370858704772,0.00608816195631154,0.362937235799691
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MYOM2,Myomesin-2,40115,-0.00449978776511815,0.0049511812618993,-0.0142041030384408,0.00520452750820448,0.363459315848137
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,40526,0.00352135628608434,0.0038753584302188,-0.00407434623714451,0.0111170588093132,0.363552614211296
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KLRF1,Killer cell lectin-like receptor subfamily F member 1,40198,0.00400049032238037,0.0044074282344931,-0.0046380690172261,0.0126390496619868,0.364072482693425
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FGF5,Fibroblast growth factor 5,42369,-0.00293344963980778,0.00323904632334728,-0.00928198043356844,0.00341508115395289,0.365136497174654
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DGKZ,Diacylglycerol kinase zeta,42369,0.00309114971078953,0.00341419515048453,-0.00360067278416014,0.0097829722057392,0.365279778603617
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KEL,Kell blood group glycoprotein,42310,-0.00320808529828758,0.00355456470952687,-0.0101750321289602,0.00375886153238508,0.366794354610687
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CUZD1,CUB and zona pellucida-like domain-containing protein 1,40181,-0.0035277777392336,0.00391835814678867,-0.0112077597069394,0.0041522042284722,0.367969505496741
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GAS2,Growth arrest-specific protein 2,40301,0.00464132941348075,0.00515946351636075,-0.00547121907858633,0.0147538779055478,0.36836545056612
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,COMMD9,COMM domain-containing protein 9,40450,-0.00349795704900556,0.00389349835600016,-0.0111292138267659,0.00413329972875476,0.368986334855835
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NFKB2,Nuclear factor NF-kappa-B p100 subunit,40301,0.00461174225119835,0.00513367362188123,-0.00545025804768887,0.0146737425500856,0.369028158283264
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GAD1,Glutamate decarboxylase 1,40079,-0.00230863690148466,0.002571411241249,-0.0073486029343327,0.00273132913136338,0.369307088429653
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MAPK13,Mitogen-activated protein kinase 13,40079,-0.00368551458417567,0.00410571667466094,-0.0117327192665111,0.00436169009815978,0.36938968797189
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ERCC1,DNA excision repair protein ERCC-1,40079,-0.00301088789509051,0.0033567044689155,-0.00959002865416489,0.00356825286398387,0.369750838350834
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PSMD9,26S proteasome non-ATPase regulatory subunit 9,42586,0.00478954649073969,0.00534103329848558,-0.00567887877429204,0.0152579717557714,0.369870963350098
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ADAMTSL5,ADAMTS-like protein 5,40510,-0.00346465614702429,0.00386529968565915,-0.0110406435309162,0.00411133123686764,0.370085651953795
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",40135,0.00499113578533708,0.00557965905104969,-0.00594499595472031,0.0159272675253945,0.371061573576599
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MAPT,Microtubule-associated protein tau,42310,0.00466637338126747,0.00522068072699748,-0.00556616084364759,0.0148989076061825,0.371432092084476
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL4R,Interleukin-4 receptor subunit alpha,42593,-0.00331384252407373,0.00371070794248152,-0.0105868300913375,0.00395914504319004,0.371847186959684
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CTSV,Cathepsin L2,42676,-0.00365942710665609,0.00410114979038765,-0.0116976806958159,0.0043788264825037,0.372251849284399
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BANK1,B-cell scaffold protein with ankyrin repeats,42593,0.00911063671589103,0.0103014570869958,-0.0110802191746207,0.0293014926064027,0.376494721801187
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",42593,0.0036739163710019,0.00415649820369567,-0.00447282010824162,0.0118206528502454,0.376767665870614
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DOCK9,Dedicator of cytokinesis protein 9,40135,0.0104004200634953,0.0118243674924648,-0.0127753402217356,0.0335761803487263,0.379108811973049
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LXN,Latexin,42460,0.00582134037771522,0.00662863743607678,-0.00717078899699526,0.0188134697524257,0.379845286987551
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MMP10,Stromelysin-2,42607,0.00504524821859194,0.00575026781661897,-0.00622527670198125,0.0163157731391651,0.380288599271349
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,40450,0.00401441875624158,0.0045816081848805,-0.0049655332861242,0.0129943707986074,0.380938393533902
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ALDH2,"Aldehyde dehydrogenase, mitochondrial",40450,0.0045524458716563,0.00519701822854962,-0.00563370985630095,0.0147386015996136,0.381063590648581
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CTRB1,Chymotrypsinogen B,42610,0.00494140834920049,0.00567485961688567,-0.00618131649989542,0.0160641331982964,0.38390390929196
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LRP2,Low-density lipoprotein receptor-related protein 2,40181,0.00314784929610028,0.00361661429300572,-0.00394071471819094,0.0102364133103915,0.384108684627519
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,OXT,Oxytocin-neurophysin 1,42710,-0.011716407692095,0.0135129097466896,-0.0382017107956066,0.0147688954114167,0.385928413544979
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,40301,0.00537843436856051,0.00621674033785703,-0.00680637669363927,0.0175632454307603,0.386973254812041
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KCNIP4,Kv channel-interacting protein 4,42310,0.00417857202306799,0.00483575917164311,-0.00529951595335251,0.0136566599994885,0.387549610190532
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SAFB2,Scaffold attachment factor B2,40481,0.00232456592203661,0.0026916911056998,-0.00295114864513499,0.00760028048920822,0.387821629084151
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RAD51,DNA repair protein RAD51 homolog 1,40301,0.00459799175772754,0.00532472656501847,-0.00583847230970865,0.0150344558251637,0.38787193840073
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SERPINA9,Serpin A9,42537,0.0060646557982458,0.00702640391613152,-0.00770709587737198,0.0198364074738636,0.388084968121773
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,40181,0.00346712038920923,0.00402195246918232,-0.00441590645038812,0.0113501472288066,0.388679329455413
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EPHA1,Ephrin type-A receptor 1,42657,0.00277465075289404,0.00322532502659178,-0.00354698629922586,0.00909628780501393,0.389655477827504
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SUMF1,Formylglycine-generating enzyme,40198,0.00541159445846652,0.00629364948464625,-0.00692395853144013,0.0177471474483732,0.38989046968981
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RALY,RNA-binding protein Raly,40450,0.00399037594981417,0.00464343934921909,-0.00511076517465524,0.0130915170742836,0.390161430249075
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD2AP,CD2-associated protein,42635,0.00533165539019365,0.00621126422520696,-0.006842422491212,0.0175057332715993,0.390695272136385
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,REG4,Regenerating islet-derived protein 4,42637,0.00441183865043793,0.00515521438937156,-0.00569238155273034,0.0145160588536062,0.392123005590577
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PSMD5,26S proteasome non-ATPase regulatory subunit 5,40181,-0.00469536907453264,0.00549021772912553,-0.0154561958236187,0.00606545767455339,0.392445487535631
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ADAMTSL2,ADAMTS-like protein 2,40526,0.00285280936258475,0.00333776035334222,-0.00368920092996601,0.0093948196551355,0.392731074105318
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TSC1,Hamartin,40198,0.00612459763570196,0.00719891867991855,-0.00798528297693841,0.0202344782483423,0.394917679623971
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,40115,0.00424925327374869,0.00500083243366925,-0.00555237829624305,0.0140508848437404,0.395505414649233
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LYPD3,Ly6/PLAUR domain-containing protein 3,42571,0.00284679642427901,0.00335328290377342,-0.0037256380671169,0.00941923091567492,0.395919842294099
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FGF20,Fibroblast growth factor 20,40198,0.00374724828536011,0.0044264164721993,-0.00492852800015052,0.0124230245708707,0.397256161869746
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FCRLB,Fc receptor-like B,42345,0.00538730631407446,0.00636460557139703,-0.00708732060586371,0.0178619332340126,0.397318390303984
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SLC12A2,Solute carrier family 12 member 2,40115,-0.00226204309067878,0.00267599327684231,-0.00750698991328972,0.00298290373193215,0.397956461962775
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GFRA3,GDNF family receptor alpha-3,42473,-0.00237841593713201,0.00281863616677337,-0.00790294282400781,0.00314611094974379,0.398786314932122
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,C9orf40,Uncharacterized protein C9orf40,40448,-0.00671677455379754,0.00796022881969849,-0.0223188230404066,0.0088852739328115,0.398803780983458
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NEB,Nebulin,40115,0.00316769533326332,0.00377256690240931,-0.00422653579545892,0.0105619264619856,0.401114185756221
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,40254,-0.00397411003327377,0.00474679530516732,-0.0132778288314017,0.00532960876485419,0.402487236172856
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DDX53,Probable ATP-dependent RNA helicase DDX53,40181,-0.00298001021043518,0.00355964121434023,-0.00995690699054203,0.00399688656967168,0.402517535794185
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SERPINA12,Serpin A12,42248,-0.00845340279026674,0.0101134588325144,-0.028275782101995,0.0113689765214615,0.403250797056103
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TNXB,Tenascin-X,42610,-0.00211034218944246,0.00252858611717194,-0.00706637097909946,0.00284568660021454,0.40396133860442
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CHEK2,Serine/threonine-protein kinase Chk2,42356,-0.00272138952478501,0.00326137185448625,-0.00911367835957807,0.00367089931000804,0.404053342304219
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HTR1A,5-hydroxytryptamine receptor 1A,40135,0.00641316334153638,0.00768564150422008,-0.00865069400673498,0.0214770206898077,0.404054480718689
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PTX3,Pentraxin-related protein PTX3,42593,0.00398174593223147,0.00478274356272774,-0.00539243145071491,0.0133559233151778,0.40512841364384
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ACE,Angiotensin-converting enzyme,40531,-0.00219194692444311,0.00263536285083694,-0.00735725811208351,0.00297336426319728,0.405571044710127
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PNLIPRP2,Pancreatic lipase-related protein 2,42617,-0.0240057240012154,0.0290482560782118,-0.0809403059145105,0.0329288579120797,0.408587125995173
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ADGRV1,Adhesion G-protein coupled receptor V1,40135,0.00575414342488926,0.006975540123413,-0.00791791521700022,0.0194262020667787,0.409444691714458
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NPR1,Atrial natriuretic peptide receptor 1,40115,-0.00331214999454003,0.00403221469485371,-0.0112152907964533,0.00459099080737324,0.411423848356263
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ANKRD54,Ankyrin repeat domain-containing protein 54,42345,0.00465622381622585,0.00567340966558209,-0.00646365912831505,0.0157761067607667,0.411826372431149
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CRYBB2,Beta-crystallin B2,40482,0.00654320665413506,0.00799341128569155,-0.00912387946582038,0.0222102927740905,0.413046214545671
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SPRR3,Small proline-rich protein 3,40482,0.0055881390934318,0.00685545172104284,-0.00784854627981216,0.0190248244666758,0.415010529395687
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TDGF1,Teratocarcinoma-derived growth factor 1,42310,0.0118902704865187,0.0146360217143799,-0.0167963320736659,0.0405768730467033,0.416578205834609
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EPHX2,Bifunctional epoxide hydrolase 2,42356,-0.0049365042025066,0.00610084902463361,-0.0168941682907885,0.00702115988577527,0.418443288586203
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LYZL2,Lysozyme-like protein 2,40079,-0.0028580787567748,0.00353326148212618,-0.00978327126174212,0.00406711374819251,0.418586515574472
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AZU1,Azurocidin,42215,0.00601639107725558,0.00745838875956755,-0.00860205089149682,0.020634833046008,0.419876572023444
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL20RB,Interleukin-20 receptor subunit beta,40198,-0.00322976809872469,0.00402945910655971,-0.0111275079475817,0.00466797175013235,0.422837058291533
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SELE,E-selectin,42793,-0.00397212714423878,0.0049568321634011,-0.0136875181845049,0.00574326389602737,0.422946592344811
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SPINK1,Serine protease inhibitor Kazal-type 1,42610,0.00358124789569674,0.00447121655433179,-0.00518233655079356,0.012344832342187,0.423171280929939
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IGSF21,Immunoglobulin superfamily member 21,40222,-0.003106373146004,0.003878788240158,-0.0107087980967137,0.00449605180470568,0.423228937815887
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CARHSP1,Calcium-regulated heat-stable protein 1,42310,0.00407567275273846,0.00510212530821966,-0.00592449285137208,0.014075838356849,0.424410050282772
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,S100A3,Protein S100-A3,40450,-0.00339702681232528,0.00426944454501358,-0.0117651381205519,0.00497108449590133,0.426246383595268
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RAC3,Ras-related C3 botulinum toxin substrate 3,40181,0.00552864057851907,0.00699394059650059,-0.00817948299062208,0.0192367641476602,0.429258681827746
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PDGFRB,Platelet-derived growth factor receptor beta,42793,-0.00267033907272021,0.00338486861095174,-0.00930468155018562,0.0039640034047452,0.430181406747753
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PAPPA,Pappalysin-1,42369,-0.00361131091799979,0.00458073799401153,-0.0125895573862624,0.00536693555026281,0.430495199252254
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AFM,Afamin,40538,-0.00153418112539115,0.00194978440490852,-0.00535575855901185,0.00228739630822954,0.431388139316761
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,OSTN,Osteocrin,40181,0.00322672946410229,0.00410500687745863,-0.00481908401571662,0.0112725429439212,0.431856744177487
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NRN1,Neuritin,40481,-0.0027973382045603,0.00356571057390367,-0.0097861309294115,0.00419145452029089,0.432756952781897
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MUCL3,Mucin-like protein 3,40079,-0.00327819969167192,0.00418258263116542,-0.0114760616487562,0.00491966226541231,0.433189762219553
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",40135,-0.00342178143814147,0.00436949943139749,-0.0119860003236805,0.0051424374473976,0.433581789072532
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,THBS4,Thrombospondin-4,42651,0.00350882544016557,0.00448478442081451,-0.00528135202463088,0.012299002904962,0.434002456035513
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,THSD1,Thrombospondin type-1 domain-containing protein 1,40109,0.0026350720419756,0.00336965201818195,-0.00396944591366103,0.00923958999761222,0.434230810363579
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AOC1,Amiloride-sensitive amine oxidase [copper-containing],42369,0.00433716001514734,0.00557080370175921,-0.0065816152403007,0.0152559352705954,0.436257682689191
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ASAH2,Neutral ceramidase,42494,0.00405223673118754,0.00523009060117157,-0.00619874084710873,0.0143032143094838,0.438475856841072
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RAB37,Ras-related protein Rab-37,42369,0.00613152678717737,0.00792012654114288,-0.00939192123346267,0.0216549748078174,0.438843977383247
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HMMR,Hyaluronan mediated motility receptor,40058,-0.00377458701310108,0.0048822864336969,-0.013343868423147,0.00579469439694485,0.439468946627147
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BATF,Basic leucine zipper transcriptional factor ATF-like,40181,0.00637058417187052,0.00824704213789704,-0.00979361841840768,0.0225347867621487,0.439853332441842
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,40481,0.0024551444504794,0.00318393843362756,-0.00378537487943062,0.00869566378038941,0.440662029109109
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CBLN1,Cerebellin-1,40135,0.00713904691954036,0.00929643056015752,-0.0110819569783684,0.0253600508174491,0.442542853837259
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MYBPC2,"Myosin-binding protein C, fast-type",40222,0.00635115403181123,0.00830918812721612,-0.00993485469753236,0.0226371627611548,0.44467318009515
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EDDM3B,Epididymal secretory protein E3-beta,40450,0.0039321707740537,0.00516939197626618,-0.00619983749942802,0.0140641790475354,0.446873670276527
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LCN15,Lipocalin-15,40481,-0.00466507923495176,0.00613436760060419,-0.016688439732136,0.00735828126223245,0.446982108747639
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,OTOA,Otoancorin,40135,0.00404387150418701,0.00535322693610313,-0.00644845329057513,0.0145361962989491,0.450020358351994
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PKD1,Polycystin-1,40510,-0.00198363803629914,0.00262708283705969,-0.00713272039693613,0.00316544432433784,0.450221189970882
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,42345,-0.00938562165929691,0.0124314145268171,-0.0337511941318585,0.0149799508132647,0.450267150862021
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,40181,-0.003824241778994,0.0050824932069799,-0.0137859284646746,0.0061374449066866,0.451806097745551
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TTR,Transthyretin,40423,0.00185350700833194,0.00247012383811943,-0.00298793571438214,0.00669494973104602,0.453047571411374
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MKI67,Proliferation marker protein Ki-67,40198,0.00284833329363338,0.00379764424008574,-0.00459504941693467,0.0102917160042014,0.453254862960961
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,40198,0.00326620053845236,0.00435485244859531,-0.00526931026079445,0.0118017113376992,0.45326227550522
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CDC123,Cell division cycle protein 123 homolog,40079,-0.00464832255220266,0.00620329316623725,-0.0168067771580277,0.00751013205362235,0.453673660461975
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SCN3B,Sodium channel subunit beta-3,40135,0.00352985420859093,0.00471699775423661,-0.00571546138971282,0.0127751698068947,0.454279356330067
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MEGF10,Multiple epidermal growth factor-like domains protein 10,42617,-0.00278085447187316,0.00371650482317809,-0.0100652039253022,0.00450349498155591,0.454325774439488
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PRC1,Protein regulator of cytokinesis 1,40450,-0.00326482170879722,0.00436822992828529,-0.0118265523682364,0.00529690895064195,0.454836838032255
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TSPAN15,Tetraspanin-15,40115,0.00382058517525731,0.00511985008384216,-0.00621432098907333,0.0138554913395879,0.455544616301488
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",42593,0.00700232486441828,0.00939805705103478,-0.0114178669556099,0.0254225166844464,0.456235107828807
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CDH22,Cadherin-22,40301,0.00205232415219914,0.00275679374973104,-0.00335099159727369,0.00745563990167198,0.456613657774763
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,C19orf12,Protein C19orf12,42310,0.00460741668375485,0.00622151574846239,-0.00758675418323144,0.0168015875507411,0.458972454903948
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ATP2B4,Plasma membrane calcium-transporting ATPase 4,40115,0.00445293204666266,0.00602146166629682,-0.00734913281927911,0.0162549969126044,0.459613170858294
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AMFR,E3 ubiquitin-protein ligase AMFR,42310,0.00454361835706649,0.00614965706418801,-0.00750970948874201,0.016596946202875,0.460016814420896
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TNNI3,"Troponin I, cardiac muscle",42356,0.00610381635423229,0.0082699901620187,-0.0101053643633244,0.0223129970717889,0.460486194721093
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ITGAX,Integrin alpha-X,40301,0.00393353459657651,0.00533889783969757,-0.00653070516923073,0.0143977743623837,0.46127837969758
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RELB,Transcription factor RelB,40198,-0.00358800196888948,0.0048731470257036,-0.0131393701392685,0.00596336620148958,0.461575850691833
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SKIV2L,Helicase SKI2W,40115,-0.00287515012881635,0.00391117504472997,-0.0105410532164871,0.00479075295885439,0.462287317957096
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GRIK2,"Glutamate receptor ionotropic, kainate 2",40481,0.0032251927546652,0.00438890408228994,-0.00537705924662309,0.0118274447559535,0.462445204715003
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KRT8,"Keratin, type II cytoskeletal 8",40135,0.00582870632281905,0.00793921191912549,-0.00973214903866692,0.021389561684305,0.46286277848403
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GLYR1,Putative oxidoreductase GLYR1,40450,0.00423041654806287,0.00576866809486632,-0.00707617291787512,0.0155370060140009,0.463364085529005
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PRR5,Proline-rich protein 5,40198,-0.00343753146003319,0.00468796736839932,-0.0126259475020959,0.00575088458202946,0.463411258626716
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LRRC38,Leucine-rich repeat-containing protein 38,40181,-0.00347313401489242,0.00474279852848228,-0.0127690191307177,0.00582275110093285,0.464003331923595
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,40538,-0.00141635286200016,0.00193833422931143,-0.00521548795145055,0.00238278222745024,0.46497371133137
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PRSS22,Brain-specific serine protease 4,40198,0.00261606882650641,0.00358149721244351,-0.00440366570988287,0.00963580336289569,0.465136825744418
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ANKRA2,Ankyrin repeat family A protein 2,40079,0.00401576144474758,0.00564013790756426,-0.00703890885407837,0.0150704317435735,0.476481873931273
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MYL1,"Myosin light chain 1/3, skeletal muscle isoform",40115,0.00284018785484501,0.00400754404642302,-0.0050145984761441,0.0106949741858341,0.478519381738502
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,40115,-0.00262658129019234,0.00370725755281334,-0.00989280609370648,0.00463964351332179,0.478651723504668
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IGFBP2,Insulin-like growth factor-binding protein 2,42770,0.00429184863611961,0.00605777289049241,-0.00758138622924552,0.0161650835014847,0.478655529042943
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ARMCX2,Armadillo repeat-containing X-linked protein 2,40135,-0.00433051119823954,0.00613293286055279,-0.016351059604923,0.00769003720844393,0.480136190247326
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,OSBPL2,Oxysterol-binding protein-related protein 2,40482,0.00275511767900653,0.00390812905013821,-0.00490481525926437,0.0104150506172774,0.480842823488269
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PRDX2,Peroxiredoxin-2,40332,-0.00431063013898269,0.00613549676507516,-0.01633620379853,0.00771494352056462,0.482337006169525
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BEX3,Protein BEX3,40079,0.00329460170578305,0.00469722095521649,-0.00591195136644127,0.0125011547780074,0.483072278036423
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ITGB6,Integrin beta-6,42369,0.00214139177343615,0.00305956459152894,-0.00385535482596057,0.00813813837283287,0.484001601443163
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,APOBR,Apolipoprotein B receptor,40222,-0.00291657103856103,0.00417459419723221,-0.0110987756651362,0.0052656335880141,0.484786898020946
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MAPRE3,Microtubule-associated protein RP/EB family member 3,40079,0.00983351892107504,0.0140795739819672,-0.0177624460835807,0.0374294839257308,0.484926701528359
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RAP1A,Ras-related protein Rap-1A,40198,0.00485550081066319,0.00696408775615017,-0.00879411119139114,0.0185051128127175,0.485679894705522
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TERF1,Telomeric repeat-binding factor 1,40198,-0.0020184444650908,0.00290029029355454,-0.0077030134404577,0.00366612451027611,0.486477554142097
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PTK7,Inactive tyrosine-protein kinase 7,42310,0.0025939179185225,0.00374581762372266,-0.00474788462397392,0.00993572046101892,0.488645832965127
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DSG3,Desmoglein-3,42650,-0.00238210800232771,0.00344304576180337,-0.00913047769546231,0.0043662616908069,0.489036759046294
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PTPN9,Tyrosine-protein phosphatase non-receptor type 9,40176,0.00257546738659185,0.00372806963597545,-0.00473154909992004,0.00988248387310373,0.489686131652288
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ESPL1,Separin,40079,0.00390186958630177,0.00565158854037299,-0.00717524395282929,0.0149789831254328,0.489955966848678
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SERPINB5,Serpin B5,42356,0.00327396446842485,0.00477218243564443,-0.00607951310543823,0.0126274420422879,0.492692512671629
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ACTN4,Alpha-actinin-4,42369,0.00220046436930128,0.00321017249928227,-0.00409147372929196,0.00849240246789453,0.493061916325271
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SFTPD,Pulmonary surfactant-associated protein D,42635,-0.00453141403708274,0.00665233165081837,-0.0175699840726867,0.00850715599852126,0.495771356364562
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TF,Serotransferrin,40538,0.00141791736436389,0.002087863289048,-0.00267429468217019,0.00551012941089797,0.497073365815642
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SESTD1,SEC14 domain and spectrin repeat-containing protein 1,42310,0.00422714538638553,0.00622609926888084,-0.00797600918062091,0.016430299953392,0.497188108856183
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TXNL1,Thioredoxin-like protein 1,40123,-0.00654270342264931,0.00965534294027284,-0.0254671755855841,0.0123817687402854,0.498023725915902
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IFNL2,Interferon lambda-2,40135,0.00410471586481135,0.00606377350308614,-0.00778028020123748,0.0159897119308602,0.4984682725412
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,L1CAM,Neural cell adhesion molecule L1,42678,0.00193646400761014,0.00287050045835192,-0.00368971689075962,0.0075626449059799,0.499936097208822
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MEP1B,Meprin A subunit beta,42635,-0.00779770367279834,0.0115590706511159,-0.0304534821489854,0.0148580748033887,0.499944030969458
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",40482,0.00171528821108159,0.00255767221394489,-0.00329774932825039,0.00672832575041357,0.502460895061634
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LPO,Lactoperoxidase,42133,-0.00396636811016181,0.00594645090144853,-0.0156214118770009,0.00768867565667731,0.504774858687691
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AGR3,Anterior gradient protein 3,42325,0.00385057706001965,0.00584813278862067,-0.00761176320567686,0.0153129173257162,0.510274397249273
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FOS,Proto-oncogene c-Fos,40064,-0.00230854115753807,0.00351237074297013,-0.00919278781375953,0.00457570549868338,0.511027601208534
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,WFDC12,WAP four-disulfide core domain protein 12,42697,0.00420159001659603,0.00641260766889681,-0.00836712101444172,0.0167703010476338,0.512345189466217
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TGFBR3,Transforming growth factor beta receptor type 3,42793,-0.00201676325061242,0.00310303572598977,-0.00809871327355238,0.00406518677232754,0.515746909637215
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TP73,Tumor protein p73,40181,-0.00220412605261585,0.00339224257742386,-0.00885292150436663,0.00444466939913492,0.515864174174452
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,POLR2A,DNA-directed RNA polymerase II subunit RPB1,40198,0.00186736409598144,0.00287481711945785,-0.00376727745815593,0.00750200565011882,0.515990510719217
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DPP6,Dipeptidyl aminopeptidase-like protein 6,42586,0.00213765320047457,0.00332216087826217,-0.00437378212091928,0.00864908852186841,0.519941451434068
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GSTA3,Glutathione S-transferase A3,42345,0.00477458339058894,0.00745234089384431,-0.0098320047613459,0.0193811715425238,0.521740237113958
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,REN,Renin,42635,0.00536295298152731,0.00837947045295554,-0.0110608091062655,0.0217867150693202,0.52217637893357
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NAMPT,Nicotinamide phosphoribosyltransferase,42345,0.00327589821063539,0.00512183896490206,-0.00676290616057266,0.0133147025818434,0.522447631335867
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PALLD,Palladin,40198,0.00244246769435584,0.00382277012713549,-0.00505016175482971,0.00993509714354139,0.522884291785327
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,THOP1,Thimet oligopeptidase,42570,0.0019236105938404,0.00301560715532554,-0.00398697943059767,0.00783420061827846,0.523559457013986
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,40482,0.003996762904203,0.00627379169822119,-0.00829986882431053,0.0162933946327165,0.524100636980172
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CCDC28A,Coiled-coil domain-containing protein 28A,40181,0.00187430031075665,0.00295120059117788,-0.00391005284795199,0.00765865346946529,0.525378010297126
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DCDC2C,Doublecortin domain-containing protein 2C,40079,0.00391327086446383,0.00622183143605684,-0.00828151875020758,0.0161080604791352,0.529389729595123
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SMC3,Structural maintenance of chromosomes protein 3,40079,0.0034186250611247,0.00545808834039287,-0.00727922808604533,0.0141164782082947,0.531104367203381
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,UBQLN3,Ubiquilin-3,40115,-0.0033262073042423,0.00532982715620108,-0.0137726685303964,0.00712025392191182,0.53259193080196
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IDUA,Alpha-L-iduronidase,42720,0.00281937095922021,0.00452830772725273,-0.00605611218619515,0.0116948541046356,0.533551147619378
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EPB41L5,Band 4.1-like protein 5,40181,0.00370429413741809,0.00601312948112738,-0.00808143964559158,0.0154900279204278,0.537884630051656
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ROBO4,Roundabout homolog 4,40222,-0.00109870030470589,0.001783527522335,-0.00459441424848248,0.00239701363907071,0.537889711841279
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CTLA4,Cytotoxic T-lymphocyte protein 4,40526,0.00180050554612336,0.00294161214587677,-0.0039650542597951,0.00756606535204183,0.540496303612288
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,42369,0.00257211094785152,0.00422011388712489,-0.00569931227091327,0.0108435341666163,0.542211193073118
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,42171,-0.00397774032184629,0.00653694435480076,-0.0167901512572558,0.0088346706135632,0.542865574315239
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",40222,0.00338621226980656,0.00558203934796066,-0.00755458485219633,0.0143270093918094,0.54411138305156
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CTNNA1,Catenin alpha-1,40135,0.0020881794447922,0.00344578530838299,-0.00466555975963847,0.00884191864922287,0.54452085993067
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CCND2,G1/S-specific cyclin-D2,40301,0.00219110989784792,0.00362000433781366,-0.00490409860426684,0.00928631839996269,0.545006495622571
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MAGEA3,Melanoma-associated antigen 3,40301,0.00512870231269348,0.00851624733226085,-0.0115631424585378,0.0218205470839247,0.547036258753032
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BABAM1,BRISC and BRCA1-A complex member 1,40198,0.00171751863539785,0.00285295978950624,-0.00387428255203437,0.00730931982283007,0.547177944885388
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LAMP1,Lysosome-associated membrane glycoprotein 1,40185,-0.00162045877206323,0.00272111209041888,-0.00695383846928424,0.00371292092515778,0.551512591562775
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BRD3,Bromodomain-containing protein 3,40115,0.00289502923355953,0.00488568980284948,-0.00668092278002545,0.0124709812471445,0.553492735092799
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KLK15,Kallikrein-15,40428,0.00310023206618717,0.00523804822896856,-0.00716634246259121,0.0133668065949656,0.55395102994665
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CSPG4,Chondroitin sulfate proteoglycan 4,40526,0.00191806027294211,0.003242259733128,-0.00443676880398876,0.00827288934987298,0.554142790528949
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SATB1,DNA-binding protein SATB1,40481,0.00169488746097016,0.00286991056330868,-0.00393013724311486,0.00731991216505518,0.554819372170511
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NELL1,Protein kinase C-binding protein NELL1,42678,0.0025302454136915,0.00428892365320164,-0.00587604494658371,0.0109365357739667,0.555234853317767
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FMR1,Synaptic functional regulator FMR1,42345,0.00204494777272186,0.00347116257391997,-0.00475853087216129,0.008848426417605,0.555787713002852
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GLT8D2,Glycosyltransferase 8 domain-containing protein 2,42310,0.00263324740579885,0.00447224272412122,-0.00613234833347875,0.0113988431450765,0.556006952175877
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TEX101,Testis-expressed protein 101,40181,-0.00305571383148264,0.00519243608573905,-0.0132328885595312,0.00712146089656591,0.556213328839295
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SOX2,Transcription factor SOX-2,40460,0.0013768147820941,0.00234576004546697,-0.00322087490702115,0.00597450447120935,0.557257374039361
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MORF4L2,Mortality factor 4-like protein 2,40079,-0.00211616339771943,0.00361151118950083,-0.00919472532914105,0.0049623985337022,0.557921559152581
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,40135,0.00179140584950534,0.00310091894213255,-0.00428639527707446,0.00786920697608513,0.56347748376724
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AARSD1,Alanyl-tRNA editing protein Aarsd1,42586,0.00308332484288085,0.00536916887598187,-0.00744024615404361,0.0136068958398053,0.565798251122003
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,42793,-0.0039488017859814,0.00687993416205857,-0.0174334727436162,0.00953586917165341,0.56600487600152
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CDK1,Cyclin-dependent kinase 1,40079,0.00206853765084328,0.00362066403237834,-0.00502796385261828,0.00916503915430483,0.567798309394655
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",40181,0.00441170783214013,0.00773410168281182,-0.010747131466171,0.0195705471304513,0.568402643141672
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RAB44,Ras-related protein Rab-44,40450,0.00233126306067085,0.00411255913305127,-0.00572935284010964,0.0103918789614513,0.570817666295405
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CLEC2L,C-type lectin domain family 2 member L,40181,0.00270789424422607,0.00483430214490097,-0.00676733795977983,0.012183126448232,0.575394206250955
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TPT1,Translationally-controlled tumor protein,42369,0.00358767371782669,0.00640853266717617,-0.00897305030983861,0.016148397745492,0.575606526278892
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CNTN2,Contactin-2,42720,-0.00244434893290604,0.00436877412433344,-0.0110071462165996,0.0061184483507875,0.575826701679486
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SCGB2A2,Mammaglobin-A,40115,0.00174427314714024,0.00312315133740735,-0.00437710347417816,0.00786564976845865,0.576515957275536
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",42673,0.00391012931282636,0.00702135674656474,-0.00985172991044054,0.0176719885360933,0.577611254029147
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,40115,-0.00185644204581033,0.00333441328573584,-0.00839189208585257,0.00467900799423192,0.577708131813531
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GUCA2A,Guanylin,42562,-0.0019827568405524,0.00356701656491812,-0.00897410930779191,0.00500859562668712,0.578316823318427
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,THAP12,52 kDa repressor of the inhibitor of the protein kinase,40064,0.0047878739595168,0.00861864207253287,-0.0121046645026476,0.0216804124216812,0.57854682377077
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KIAA1549,UPF0606 protein KIAA1549,40301,-0.00384277051237991,0.00694338628222501,-0.0174518076255409,0.00976626660078111,0.579971046222675
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,42494,0.00157056338193401,0.00284071452303627,-0.00399723708321708,0.0071383638470851,0.580357494193988
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SEZ6,Seizure protein 6 homolog,40181,0.00169944146551405,0.00307862653577173,-0.00433466654459854,0.00773354947562663,0.580950764297977
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FHIP2A,FHF complex subunit HOOK interacting protein 2A,40115,-0.00258033974447543,0.00467464488765443,-0.0117426437242781,0.00658196423532726,0.580969062537244
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD34,Hematopoietic progenitor cell antigen CD34,42673,-0.00130442867721118,0.00237480123738068,-0.00595903910247731,0.00335018174805496,0.582823029976584
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,UBAC1,Ubiquitin-associated domain-containing protein 1,42586,-0.00184174791888812,0.0033636153628259,-0.00843443403002689,0.00475093819225065,0.584009987661071
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BMP4,Bone morphogenetic protein 4,42474,-0.00248783818529626,0.00455989257209989,-0.011425227626612,0.00644955125601952,0.585355998964182
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HRAS,GTPase Hras,40285,0.00532062300996088,0.00977797815732146,-0.0138442141783892,0.0244854601983109,0.586353684145283
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KHDC3L,KH domain-containing protein 3,40079,-0.00368764115354915,0.00678155070847593,-0.016979480542162,0.00960419823506367,0.586607104338825
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ANGPTL1,Angiopoietin-related protein 1,42438,-0.00154581182203638,0.00284754771349771,-0.00712700534049189,0.00403538169641912,0.587237251080097
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FZD10,Frizzled-10,40181,0.00321566852572958,0.00595416541782474,-0.00845449569320691,0.0148858327446661,0.589159426032402
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",42310,0.0028020048542605,0.00518875286395993,-0.00736795075910096,0.012971960467622,0.589195792917307
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL1R1,Interleukin-1 receptor type 1,42589,-0.00124525139493448,0.00230861032882259,-0.00577012763942675,0.00327962484955779,0.589623736003378
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RNF31,E3 ubiquitin-protein ligase RNF31,40198,0.0018749353429212,0.00347639434921558,-0.00493879758154132,0.00868866826738373,0.589667786323254
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KLK1,Kallikrein-1,42504,0.00680742963052235,0.0127235455672227,-0.0181307196812341,0.0317455789422788,0.592640711170373
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SLC39A14,Zinc transporter ZIP14,42310,-0.00180040156370617,0.00338495426760255,-0.00843491192820717,0.00483410880079483,0.594815645119001
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,COL2A1,Collagen alpha-1(II) chain,40222,0.00416753942999886,0.00790766589563179,-0.0113314857254395,0.0196665645854372,0.59818666952464
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD3G,T-cell surface glycoprotein CD3 gamma chain,40198,0.00465544489200276,0.00888348999326622,-0.012756195494799,0.0220670852788046,0.600250250398842
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LEG1,Protein LEG1 homolog,39925,0.00359037063224532,0.0068663021309006,-0.00986758154431985,0.0170483228088105,0.601056540878925
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IKZF2,Zinc finger protein Helios,42345,0.00449101915787589,0.00861944346225166,-0.0124030900281374,0.0213851283438891,0.602352178241698
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SCN3A,Sodium channel protein type 3 subunit alpha,40181,-0.00189288155072031,0.00364120789215174,-0.00902964901933772,0.00524388591789711,0.603178671284125
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL3,Interleukin-3,40079,-0.00311459774217761,0.00607101484663192,-0.0150137868415762,0.00878459135722096,0.607942475682227
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ADRA2A,Alpha-2A adrenergic receptor,40115,0.00349161177413322,0.0068335767407035,-0.00990219863764565,0.0168854221859121,0.609396833726807
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,UMOD,Uromodulin,42763,0.00275345729001248,0.00539950812261714,-0.00782957863031711,0.0133364932103421,0.610097624152618
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,40115,-0.00194320612226752,0.00381751837423323,-0.00942554213576465,0.00553912989122962,0.610746116888799
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PAIP2B,Polyadenylate-binding protein-interacting protein 2B,40064,0.00258995991189162,0.00511565176471045,-0.00743671754694085,0.0126166373707241,0.612669307431032
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TPPP2,Tubulin polymerization-promoting protein family member 2,40301,0.00402764004946223,0.00795790550540827,-0.011569854741138,0.0196251348400624,0.612783786789227
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,STOML2,"Stomatin-like protein 2, mitochondrial",40079,0.00458961890125041,0.00907819489437623,-0.013203643091727,0.0223828808942278,0.613172193529933
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CRH,Corticoliberin,42321,-0.00422218152945881,0.00840822538001717,-0.0207023032742925,0.0122579402153748,0.615571173631927
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PCDH1,Protocadherin-1,42720,0.00106475245726744,0.00212548758220439,-0.00310120320385317,0.00523070811838805,0.616417956223942
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CTAG1A_CTAG1B,Cancer/testis antigen 1,40286,0.0024581572209326,0.00492450750242739,-0.00719387748382507,0.0121101919256903,0.617670841341696
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CELA2A,Chymotrypsin-like elastase family member 2A,40526,-0.00309308754264706,0.00620653937405481,-0.0152579047157945,0.00907172963050037,0.618240385163266
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,COPE,Coatomer subunit epsilon,42310,0.00231467634862609,0.00465254648579227,-0.00680431476352676,0.0114336674607789,0.618839619428498
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RNF168,E3 ubiquitin-protein ligase RNF168,40198,0.0019460923002421,0.00393587197070467,-0.00576821676233906,0.00966040136282325,0.62099820785622
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MRPS16,"28S ribosomal protein S16, mitochondrial",40198,0.00137850303864632,0.00278895308260804,-0.00408784500326543,0.00684485108055807,0.621123553138633
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,COL5A1,Collagen alpha-1(V) chain,40282,-0.0020027407118988,0.00405478952235925,-0.00995012817572293,0.00594464675192534,0.621372624901598
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL1RL1,Interleukin-1 receptor-like 1,42759,-0.00220737728582572,0.00448192549503824,-0.0109919512561007,0.00657719668444924,0.622369323166944
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RNF43,E3 ubiquitin-protein ligase RNF43,40301,0.002766443412839,0.00561997229978305,-0.00824870229473577,0.0137815891204138,0.622550835736141
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,UPK3BL1,Uroplakin-3b-like protein 1,40280,0.00262732140885406,0.0053403577081178,-0.00783977969905682,0.013094422516765,0.622746900507606
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SCN4B,Sodium channel subunit beta-4,40222,0.00211849269618062,0.00431015492363907,-0.00632941095415196,0.0105663963465132,0.623074176887175
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PROCR,Endothelial protein C receptor,40115,-0.00167753531241322,0.00343227600066066,-0.00840479627370811,0.00504972564888168,0.625026365764389
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TMED1,Transmembrane emp24 domain-containing protein 1,40301,-0.00258944036611436,0.00530203722831463,-0.012981433333611,0.00780255260138231,0.625286149805071
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CLINT1,Clathrin interactor 1,40079,0.00221498848749397,0.00453830675806393,-0.00668009275831132,0.0111100697332993,0.625513663297668
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CLEC5A,C-type lectin domain family 5 member A,42602,0.00142304948935251,0.00295347155300075,-0.00436575475452896,0.00721185373323398,0.62993980217584
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CLEC10A,C-type lectin domain family 10 member A,42494,-0.00171434288856489,0.00356549989159536,-0.00870272267609179,0.00527403689896202,0.630656483884658
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ICOSLG,ICOS ligand,42586,0.000907230884212545,0.00189669358323727,-0.0028102885389325,0.00462475030735759,0.63242861725577
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MRPL28,"39S ribosomal protein L28, mitochondrial",40481,0.00173814272398896,0.00363814452279148,-0.00539262054068234,0.00886890598866026,0.632833651703859
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TAGLN3,Transgelin-3,40079,-0.00287560878992336,0.0060226248570896,-0.014679953509819,0.00892873592997225,0.633038708499423
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,42356,-0.0037687669772233,0.00794383703218692,-0.0193386875603097,0.0118011536058631,0.635203654260413
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MMP1,Interstitial collagenase,42135,0.00422354472673926,0.00894391484897387,-0.0133065283772495,0.021753617830728,0.636773797694283
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,METAP1,Methionine aminopeptidase 1,42310,0.00135017746092516,0.0028632049446297,-0.00426170423054906,0.00696205915239938,0.637247595979728
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HAO1,Hydroxyacid oxidase 1,42720,0.005737009085938,0.0122143439882121,-0.0182031051309577,0.0296771233028337,0.638580934338949
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ACTN2,Alpha-actinin-2,40115,0.00273788928926823,0.00584293045021271,-0.00871425439314867,0.0141900329716851,0.639378134453378
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PITHD1,PITH domain-containing protein 1,40064,-0.00371408151361892,0.00793592089409753,-0.0192684864660501,0.0118403234388122,0.639787616871981
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",42369,-0.00522022030922008,0.0111731628667576,-0.027119619528065,0.0166791789096248,0.640356925435656
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ITGA2,Integrin alpha-2,40282,0.00159475278319986,0.00342158934126563,-0.00511156232568078,0.0083010678920805,0.641163540209611
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RUVBL1,RuvB-like 1,42345,0.00479081310335737,0.010355465579205,-0.0155058994318844,0.0250875256385991,0.643632820519652
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AMOT,Angiomotin,40282,-0.00175353072829261,0.00379590384337524,-0.00919350226130807,0.00568644080472285,0.644123793918714
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TRPV3,Transient receptor potential cation channel subfamily V member 3,40115,-0.00220218351286411,0.00477729349882732,-0.0115656787705657,0.00716131174483743,0.644830129964689
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SUSD2,Sushi domain-containing protein 2,42610,0.00129797452543247,0.00282660519969207,-0.00424217166596398,0.00683812071682893,0.646098646328927
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DEFB104A_DEFB104B,Beta-defensin 104,40135,0.00240679739463251,0.00525013824470836,-0.00788347356499587,0.0126970683542609,0.646655860379131
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MCAM,Cell surface glycoprotein MUC18,42688,-0.00150380482290813,0.00328717395388546,-0.00794666577252363,0.00493905612670736,0.647335957523486
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,42656,0.00457513195776692,0.0100391007862195,-0.0151015055832233,0.0242517694987572,0.648590597501948
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,40115,-0.00217043894802818,0.00477817341194437,-0.0115356588354391,0.00719478093938278,0.649664903702377
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,42345,0.00160511868901673,0.00353660216257572,-0.00532662154963168,0.00853685892766513,0.649937810946401
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RPGR,X-linked retinitis pigmentosa GTPase regulator,40181,0.0018996990067565,0.00420072780456723,-0.00633372749019527,0.0101331255037083,0.651111562332092
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SLC34A3,Sodium-dependent phosphate transport protein 2C,40079,-0.00223444282134564,0.00496698203587887,-0.0119697276116682,0.00750084196897695,0.652820889100166
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LELP1,Late cornified envelope-like proline-rich protein 1,40135,0.00320626174968491,0.0071855401321014,-0.0108773969092338,0.0172899204086037,0.655454200768836
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL4,Interleukin-4,42369,-0.00409272796942895,0.00918408641692189,-0.0220935373465959,0.0139080814077379,0.65587000703026
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,40450,0.00278026684592875,0.00625150961187616,-0.00947269199334852,0.015033225685206,0.656519625139706
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PTGR1,Prostaglandin reductase 1,40510,0.00363999064688513,0.0081935504276021,-0.012419368191215,0.0196993494849852,0.656869823779441
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HIF1A,Hypoxia-inducible factor 1-alpha,40198,-0.00267783571232919,0.00609182167305742,-0.0146178061915217,0.00926213476686336,0.66025082415945
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ERBB4,Receptor tyrosine-protein kinase erbB-4,42678,-0.00102942046783588,0.00235290548088518,-0.00564111521037083,0.00358227427469908,0.661748288904966
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD109,CD109 antigen,42610,-0.00143373822471625,0.00329515766122679,-0.00789224724072075,0.00502477079128825,0.663493510527157
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CEP152,Centrosomal protein of 152 kDa,40079,0.00176827344330727,0.00409476069535471,-0.00625745751958797,0.00979400440620251,0.665867681351752
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CPB1,Carboxypeptidase B,42793,0.00255767025494417,0.00593017496028704,-0.00906547266721843,0.0141808131771068,0.666258828548536
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,42569,-0.00773275313542112,0.0179490922904595,-0.0429129740247217,0.0274474677538794,0.66660922907463
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FGF16,Fibroblast growth factor 16,40198,-0.00199428372339298,0.00464319706801716,-0.0110949499767066,0.00710638252992065,0.667563010944348
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GAMT,Guanidinoacetate N-methyltransferase,40115,0.00158554711663206,0.00372269012698074,-0.00571092553225019,0.00888201976551432,0.670178657191453
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IFNW1,Interferon omega-1,40115,-0.00153607506483583,0.00362155639449525,-0.00863432559804652,0.00556217546837486,0.671466404062429
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SH3GL3,Endophilin-A3,40249,0.00353680968426882,0.00837884983076368,-0.012885735984028,0.0199593553525656,0.672951771926606
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ENOX2,Ecto-NOX disulfide-thiol exchanger 2,40115,0.00117252942588464,0.00279124894579602,-0.00429831850787555,0.00664337735964483,0.674440100445667
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FGF9,Fibroblast growth factor 9,40064,-0.00167188478850862,0.00405039981337938,-0.00961066842273221,0.00626689884571497,0.679783046744939
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PPIE,Peptidyl-prolyl cis-trans isomerase E,40301,0.002566448734532,0.00624304098262234,-0.0096699115914078,0.0148028090604718,0.681014823704784
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CBX2,Chromobox protein homolog 2,40115,0.00161492942653744,0.00394354339853977,-0.00611441563460051,0.0093442744876754,0.682171792341276
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GATA3,Trans-acting T-cell-specific transcription factor GATA-3,40079,-0.00107255213098485,0.00264275829643083,-0.00625235839198927,0.00410725413001957,0.68486394381907
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CGN,Cingulin,40181,0.00163030008425878,0.00404399472195393,-0.00629592957077093,0.00955652973928849,0.686852343255757
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CALY,Neuron-specific vesicular protein calcyon,40115,0.00154351953639749,0.00384775916646409,-0.00599808842987213,0.00908512750266711,0.688319270896689
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,COL4A4,Collagen alpha-4(IV) chain,40283,0.00208228024410882,0.00524777331339959,-0.00820335545015437,0.012367915938372,0.691527674784906
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SLC1A4,Neutral amino acid transporter A,40181,-0.00201696056374992,0.00511361315603413,-0.0120396423495768,0.00800572122207697,0.693271524556814
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KCNC4,Potassium voltage-gated channel subfamily C member 4,40135,0.0021685448846435,0.00550517645428339,-0.00862160096575194,0.0129586907350389,0.693655052672193
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PGA4,Pepsin A-4,40531,-0.00311146011294644,0.00792143716579827,-0.0186374769579111,0.0124145567320182,0.694482087173358
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GAD2,Glutamate decarboxylase 2,40198,-0.00176109333232682,0.00452289992648853,-0.0106259771882443,0.0071037905235907,0.697008068138912
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,42494,0.00271626766024872,0.00701423466759442,-0.0110316322882363,0.0164641676087338,0.698576776055881
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SCLY,Selenocysteine lyase,42673,0.00176528802267276,0.004564024895719,-0.00718020077293649,0.010710776818282,0.698922842739054
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NGF,Beta-nerve growth factor,42494,-0.00045396990415359,0.00117524280877538,-0.00275744580935334,0.00184950600104616,0.699297309730738
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PGLYRP4,Peptidoglycan recognition protein 4,40115,-0.00224149243891205,0.00581625233140097,-0.0136413470084579,0.00915836213063384,0.69996020509038
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SPINT3,Kunitz-type protease inhibitor 3,40448,0.0055683122835557,0.0145600510047473,-0.022969387685749,0.0341060122528604,0.702143959918095
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SHC1,SHC-transforming protein 1,40079,0.00441704792748515,0.0116073236610882,-0.0183333064482477,0.027167402303218,0.703552228753822
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",42561,-0.00249025348067758,0.00660151784786429,-0.0154292284624916,0.0104487215011364,0.706012851870717
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PGR,Progesterone receptor,40198,0.00360244465794301,0.00959383147752382,-0.0152014650380037,0.0224063543538897,0.70729891156479
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ZP3,Zona pellucida sperm-binding protein 3,40222,0.00987957966871963,0.0265494519055741,-0.0421573460662057,0.061916505403645,0.709810722788488
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PTTG1,Securin,40301,0.00149485805604978,0.00401784039159576,-0.00638010911147791,0.00936982522357746,0.709858914536152
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TSPAN7,Tetraspanin-7,40135,0.00341760891166191,0.00923414525153994,-0.0146813157813564,0.0215165336046802,0.711310970195719
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ACP1,Low molecular weight phosphotyrosine protein phosphatase,40198,-0.00161207107211863,0.00437516042306835,-0.0101873855013326,0.00696324335709535,0.712537445265744
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,40448,-0.0012745085376913,0.00347835185273204,-0.00809207816904609,0.0055430610936635,0.714064838191117
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NAAA,N-acylethanolamine-hydrolyzing acid amidase,42438,-0.00214459085411145,0.0058622183727584,-0.0136345388647179,0.00934535715649502,0.714495801447073
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EIF5A,Eukaryotic translation initiation factor 5A-1,42369,0.00106295530601636,0.00291717200707443,-0.00465470182784953,0.00678061243988224,0.715581096140574
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HK2,Hexokinase-2,42356,-0.00098442721431319,0.00270613519482561,-0.00628845219617139,0.00431959776754501,0.716031079603551
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PFDN6,Prefoldin subunit 6,40181,-0.0023055271682443,0.00635695110414887,-0.0147651513323761,0.0101540969958875,0.716852311499517
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MMP13,Collagenase 3,42310,-0.00117896644121281,0.00327037041114615,-0.00758889244705927,0.00523095956463365,0.718479540160654
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CRHR1,Corticotropin-releasing factor receptor 1,42356,0.00211566327397671,0.00587246377331415,-0.00939436572171902,0.0136256922696724,0.718652190308611
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RICTOR,Rapamycin-insensitive companion of mTOR,40198,0.0017246035737104,0.00480177098228725,-0.00768686755157261,0.0111360746989934,0.71948236615968
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TRAF3,"TNF receptor-associated factor 3, Isoform 2",40198,-0.00127948270064136,0.00357035354831725,-0.00827737565534317,0.00571841025406044,0.720078532211087
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TMEM132A,Transmembrane protein 132A,40222,-0.00219810537293212,0.00614053094512966,-0.0142335460253863,0.00983733527952201,0.720375112608798
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PADI4,Protein-arginine deiminase type-4,42291,-0.00251678898208163,0.00704311061842859,-0.0163212857942017,0.0112877078300384,0.720842638624462
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SNAPIN,SNARE-associated protein Snapin,40481,-0.00200482828008753,0.00561786024278704,-0.0130158343559501,0.00900617779577506,0.721198133390247
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AREG,Amphiregulin,42586,-0.00148170575338498,0.00417226934796601,-0.00965935367539835,0.0066959421686284,0.722496405765715
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CHRM1,Muscarinic acetylcholine receptor M1,40181,-0.00128322585981128,0.00364884444224763,-0.00843496096661664,0.00586850924699409,0.725084954816474
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SAA4,Serum amyloid A-4 protein,40538,-0.0011152572977475,0.00317495595567729,-0.00733817097087499,0.00510765637537999,0.725394562777614
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CHGA,Chromogranin-A,40526,0.00334017433774128,0.00958059930860132,-0.0154378003071173,0.0221181489825999,0.727366525916245
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ZNF174,Zinc finger protein 174,40198,-0.00127719165292758,0.00367210110149726,-0.00847450981186221,0.00592012650600704,0.727989906238512
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SPINK6,Serine protease inhibitor Kazal-type 6,42720,0.00181291577922108,0.00523247464700775,-0.00844273452891412,0.0120685660873563,0.728992002185903
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RBM25,RNA-binding protein 25,40079,0.00161189037147979,0.0046639070775271,-0.00752936750047332,0.0107531482434329,0.729642919998728
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SLITRK6,SLIT and NTRK-like protein 6,42356,-0.00120311229997441,0.00348280702526174,-0.00802941406948742,0.0056231894695386,0.729766661305917
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NRXN3,Neurexin-3,40181,0.00119500486406431,0.00348828971367871,-0.00564204297474597,0.00803205270287459,0.731923899515506
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NPHS2,Podocin,40198,-0.00350539713885914,0.0103023454002321,-0.0236979941233141,0.0166871998455958,0.733672999382196
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BTNL10,Butyrophilin-like protein 10,40079,-0.00142400688819726,0.00419009451733641,-0.00963659214217663,0.0067885783657821,0.733975462124045
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IGLON5,IgLON family member 5,40079,0.00315618214529593,0.00931132648046483,-0.0150940177564151,0.021406382047007,0.734645194886205
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NPTN,Neuroplastin,42345,0.00261039871547684,0.00770655379992972,-0.0124944467323854,0.0177152441633391,0.734822677086554
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CBS,Cystathionine beta-synthase,40222,0.00170188510776967,0.00502549751301503,-0.0081480900177398,0.0115518602332791,0.734879802389925
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CCNE1,G1/S-specific cyclin-E1,40198,-0.00292245714384221,0.00869247063143308,-0.019959699581451,0.0141147852937666,0.736722254685419
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL33,Interleukin-33,42369,0.00127617757564544,0.00380006133059163,-0.00617194263231415,0.00872429778360504,0.737003822458568
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NTF3,Neurotrophin-3,42593,0.00117795499527232,0.00351059476585261,-0.0057028107457988,0.00805872073634344,0.737220875195555
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TP53BP1,TP53-binding protein 1,40198,-0.0028565966790767,0.00851465072316742,-0.0195453120964849,0.0138321187383314,0.737260420340021
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,40135,-0.00197072808802505,0.0059323127499484,-0.0135980610779239,0.00965660490187381,0.739742852126441
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ARG1,Arginase-1,42487,0.00167688538765696,0.00506439917302026,-0.00824933699146275,0.0116031077667767,0.740564801354516
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,40115,-0.00194732956541424,0.0058852209996661,-0.0134823627247598,0.00958770359393131,0.740737929748913
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FAM171A2,Protein FAM171A2,40481,0.00518679404018761,0.0156757358457332,-0.0255376482174494,0.0359112362978246,0.740740955325745
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,VIM,Vimentin,42356,0.0037433838279861,0.0113587822347557,-0.018519829352135,0.0260065970081072,0.741738789178926
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GJA8,Gap junction alpha-8 protein,40079,-0.0021122211111978,0.00641159800905559,-0.0146789532089468,0.0104545109865512,0.741831331569935
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RTKN2,Rhotekin-2,40115,0.00165976888473597,0.00506985384747862,-0.00827714465632213,0.0115966824257941,0.74338674666896
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EXTL1,Exostosin-like 1,40115,-0.0014986782097539,0.00464965657269792,-0.0106120050922418,0.00761464867273402,0.747216305736922
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CCAR2,Cell cycle and apoptosis regulator protein 2,40482,0.00170373805661494,0.00529251674097122,-0.00866959475568864,0.0120770708689185,0.747523403801534
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MYOC,Myocilin,42610,0.00139986326119017,0.00437794708312063,-0.00718091302172626,0.0099806395441066,0.749160290061966
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PRND,Prion-like protein doppel,40482,0.00163252058227011,0.00512412028948625,-0.00841075518512294,0.0116757963496632,0.750039321027996
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL20RA,Interleukin-20 receptor subunit alpha,42369,0.0013991842532494,0.00440841303807482,-0.00724130530137724,0.010039673807876,0.750953061110681
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GUCY2C,Heat-stable enterotoxin receptor,40301,-0.00248878574351659,0.00790394438645503,-0.0179805167409684,0.0130029452539353,0.752859476318563
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL1RAP,Interleukin-1 receptor accessory protein,42610,-0.00137160399253627,0.00439253282576079,-0.00998096833102741,0.00723776034595487,0.754849226712823
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TGM2,Protein-glutamine gamma-glutamyltransferase 2,42617,-0.00224317348145872,0.0073120798747851,-0.0165748500360375,0.0120885030731201,0.759018337414255
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,40181,-0.00152941699459231,0.00499884534589589,-0.0113271538725483,0.00826831988336363,0.759645426290862
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL12RB2,Interleukin-12 receptor subunit beta-2,40198,-0.00123839214308998,0.00408973086068857,-0.00925426463003957,0.00677748034385961,0.762043974734949
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RCC1,Regulator of chromosome condensation,40450,0.00155358052664817,0.0051477085883723,-0.00853592830656154,0.0116430893598579,0.762809799195724
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ICAM4,Intercellular adhesion molecule 4,42593,-0.00155184416951261,0.00515958591531487,-0.0116646325635297,0.00856094422450453,0.763595215985417
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LTO1,Protein LTO1 homolog,42369,-0.00123213125260013,0.00412773056966212,-0.00932248316913789,0.00685822066393763,0.765325603731568
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SCARF2,Scavenger receptor class F member 2,42710,-0.000884576194776798,0.00296630826054789,-0.00669854038545067,0.00492938799589707,0.765549169755159
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,WFDC1,WAP four-disulfide core domain protein 1,40228,0.0016395844327378,0.00552548519857871,-0.00919036655647647,0.0124695354219521,0.76667724021414
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MORN4,MORN repeat-containing protein 4,40079,-0.0022383555582845,0.00755456138427032,-0.0170452958714543,0.0125685847548853,0.767012802416212
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KRT17,"Keratin, type I cytoskeletal 17",40115,-0.00113517346563197,0.00387298680967903,-0.00872622761260287,0.00645588068133893,0.769451082027828
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SIRT1,NAD-dependent protein deacetylase sirtuin-1,40198,0.00236640097885393,0.00816577897620397,-0.0136385258145058,0.0183713277722137,0.771978621363882
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CA8,Carbonic anhydrase-related protein,40198,-0.000812038620070372,0.0028090277483354,-0.00631773300680775,0.00469365576666701,0.772524274903473
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,40198,-0.000967324674792102,0.0034111664881185,-0.00765321099150436,0.00571856164192016,0.776740727848958
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL10RA,Interleukin-10 receptor subunit alpha,42369,-0.00160259908617382,0.00568667679710218,-0.0127484856084941,0.00954328743614645,0.778088680394252
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",40115,-0.00193486316622734,0.00686830248919215,-0.015396736045044,0.0115270097125893,0.778171930163953
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ZCCHC8,Zinc finger CCHC domain-containing protein 8,40115,0.00166274865853605,0.00592646897414081,-0.00995313053077995,0.013278627847852,0.779050816438303
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HBZ,Hemoglobin subunit zeta,40510,0.00291926398674231,0.0104164193018966,-0.017496917844975,0.0233354458184596,0.779286230002236
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DCUN1D1,DCN1-like protein 1,40135,-0.00205267371058798,0.00734185392048534,-0.0164427073947392,0.0123373599735633,0.779801046685471
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,REST,RE1-silencing transcription factor,40079,0.000936363947402082,0.0033704774117037,-0.00566977177953718,0.00754249967434134,0.781160844536029
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PRDX1,Peroxiredoxin-1,42260,0.00241406500427516,0.00874117649678122,-0.014718640929416,0.0195467709379664,0.78242061026193
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TOP1MT,"DNA topoisomerase I, mitochondrial",40079,0.0013265220385977,0.00481031080309755,-0.00810168713547351,0.0107547312126689,0.782732735840673
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CYB5A,Cytochrome b5,40079,0.00196382257485405,0.00718153554837497,-0.0121119870999609,0.016039632249669,0.784509119982623
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NECTIN1,Nectin-1,40198,0.00087694027182251,0.00320748724532355,-0.00540973472901166,0.00716361527265667,0.784547706559907
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DIPK1C,Divergent protein kinase domain 1C,40181,-0.00107386121317546,0.00412362998588846,-0.00915617598551684,0.00700845355916591,0.794547410957763
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FH,"Fumarate hydratase, mitochondrial",40135,-0.00216676208219968,0.00838618532047415,-0.018603685310329,0.0142701611459296,0.796124075759413
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FOLH1,Glutamate carboxypeptidase 2,40198,0.00257368254546753,0.00996450013155804,-0.0169567377123862,0.0221041028033213,0.796191666143991
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,UHRF2,E3 ubiquitin-protein ligase UHRF2,40115,0.000917774012128747,0.00356189766725581,-0.00606354541569265,0.00789909343995015,0.796670824178297
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,APOE,Apolipoprotein E,40538,-0.0018169661365232,0.00712211490079089,-0.0157763113420733,0.012142379069027,0.798638058770219
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,COL28A1,Collagen alpha-1(XXVIII) chain,40181,0.00187525703023728,0.00746045773426026,-0.0127472401289128,0.0164977541893874,0.80154086705205
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ADM,Pro-adrenomedullin,42720,0.000655879359378695,0.00262638977690059,-0.00449184460334646,0.00580360332210385,0.802802587079536
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,H2AP,Huntingtin-interacting protein M,40079,0.00129109173423446,0.00517497224707644,-0.00885185387003536,0.0114340373385043,0.802988290070576
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LAMA1,Laminin subunit alpha-1,40115,0.0013200834048326,0.0052972103862833,-0.00906244895228267,0.0117026157619479,0.803208053393698
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,42356,0.000758542364553606,0.00304402983533789,-0.00520775611270866,0.00672484084181587,0.803217557876396
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SPESP1,Sperm equatorial segment protein 1,40510,0.000771432634909207,0.00311087915860893,-0.0053258905159643,0.00686875578578272,0.804155171366997
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,40079,0.00204776459965339,0.00830993712636157,-0.0142397121680153,0.0183352413673221,0.80535898807084
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL17C,Interleukin-17C,42369,0.00180140495431571,0.00732282610310917,-0.0125513342077783,0.0161541441164097,0.805687149917356
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SLK,STE20-like serine/threonine-protein kinase,40301,0.00191686426879161,0.00783772518724027,-0.0134450770981993,0.0172788056357825,0.806794721186062
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KIAA1549L,UPF0606 protein KIAA1549L,40301,0.000692118699485771,0.00284135528394773,-0.00487693765705178,0.00626117505602333,0.807554790063063
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RANGAP1,Ran GTPase-activating protein 1,42345,0.00115160520058206,0.00473256797800652,-0.00812422803631071,0.0104274384374748,0.807748743616577
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CTSC,Dipeptidyl peptidase 1,42615,-0.00104296693142979,0.00431077264428862,-0.00949208131423549,0.00740614745137591,0.808827008730077
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ITGB7,Integrin beta-7,42720,-0.00108834773687117,0.004515071688635,-0.00993788824659576,0.00776119277285342,0.809521784982532
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PPT1,Palmitoyl-protein thioesterase 1,40181,-0.00182015999988373,0.00756068270279536,-0.0166390980973626,0.0129987780975952,0.809760999135926
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,COMP,Cartilage oligomeric matrix protein,42510,0.000787001654733589,0.00330042125253888,-0.00568182400024262,0.0072558273097098,0.811531952147171
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CEP112,Centrosomal protein of 112 kDa,40115,0.00102661378144027,0.00440752351856727,-0.00761213231495157,0.00966535987783212,0.815825531337894
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MTSS1,Protein MTSS 1,40448,0.00253343030604531,0.0108971892612674,-0.0188250606460388,0.0238919212581294,0.816165759113866
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PSMC3,26S proteasome regulatory subunit 6A,40079,0.000695581435946668,0.00300906341198758,-0.00520218285154899,0.00659334572344233,0.817193212429214
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AMY2B,Alpha-amylase 2B,41778,-0.00112690577421808,0.00488883059577479,-0.0107090137419367,0.0084552021935005,0.81770219153088
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD164L2,CD164 sialomucin-like 2 protein,40181,-0.000823102403551029,0.00357640613022629,-0.00783285841879456,0.00618665361169251,0.817981120202552
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ALMS1,Alstrom syndrome protein 1,40301,-0.000995516182496644,0.00437469552363303,-0.00956991940881739,0.0075788870438241,0.819990647350197
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,40301,0.00139195502401872,0.0061731455881369,-0.0107074103287296,0.013491320376767,0.821605727033723
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AKR1C4,Aldo-keto reductase family 1 member C4,42356,-0.00118698403505987,0.00529066885994759,-0.0115566950005571,0.0091827269304374,0.822485150280138
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ACTA2,"Actin, aortic smooth muscle",42356,0.000946489648885523,0.00431003289450805,-0.00750117482435026,0.0093941541221213,0.826184935716239
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FEN1,Flap endonuclease 1,42345,-0.00135873056610072,0.00622423601163133,-0.0135582331488981,0.0108407720166967,0.827201284472088
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PNLIPRP1,Inactive pancreatic lipase-related protein 1,40482,-0.00174640416089692,0.00801787758888804,-0.0174614442351175,0.0139686359133236,0.827578150749844
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,42356,0.0012333872516229,0.00566977789575113,-0.00987937742404931,0.0123461519272951,0.827793140646816
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ESR1,Estrogen receptor,40198,-0.00117453666892643,0.0054251053575308,-0.0118077431696868,0.00945866983183394,0.828601843183962
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TMED4,Transmembrane emp24 domain-containing protein 4,40115,0.00120686512203138,0.00563010534922547,-0.00982814136245054,0.0122418716065133,0.830270924202522
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NGFR,Tumor necrosis factor receptor superfamily member 16,40510,-0.000619767779417422,0.00289715302640139,-0.00629818771116414,0.0050586521523293,0.83061092790044
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,VIT,Vitrin,40510,-0.00080424429763421,0.00377232260342047,-0.00819799660033832,0.00658950800506991,0.831177885681268
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD82,CD82 antigen,40301,-0.000854243433649252,0.00401819108925521,-0.00872989796858946,0.00702141110129096,0.831647530353086
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MNDA,Myeloid cell nuclear differentiation antigen,42610,0.00200750521508229,0.00950025082153142,-0.0166129863951193,0.0206279968252839,0.832647997330752
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TTN,Titin,40115,-0.00136047312109211,0.00644813760275334,-0.0139988228224887,0.0112778765803044,0.832901362645012
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FLT3LG,Fms-related tyrosine kinase 3 ligand,42753,-0.000713573166479934,0.00339111702598084,-0.00736016253740239,0.00593301620444252,0.833339750239773
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NTRK3,NT-3 growth factor receptor,42710,-0.000445442373678811,0.00213074472652944,-0.00462170203767652,0.0037308172903189,0.834408624137719
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CRTAC1,Cartilage acidic protein 1,42793,0.000609985652392746,0.00292494612670917,-0.00512290875595723,0.00634288006074272,0.834805835986657
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FGF3,Fibroblast growth factor 3,40198,0.000590393283973113,0.00285398264758946,-0.00500341270530222,0.00618419927324845,0.83611797938491
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BLVRB,Flavin reductase,42610,0.00132337200019632,0.00643533476986206,-0.0112898841487333,0.0139366281491259,0.837074065300594
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EDNRB,Endothelin receptor type B,40198,-0.00089546902772064,0.0043732199718813,-0.00946698017260799,0.00767604211716671,0.837761907521651
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LRP1,Prolow-density lipoprotein receptor-related protein 1,42586,0.000532622178237453,0.00260327673113284,-0.00456980021478292,0.00563504457125783,0.8378902380764
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,40181,-0.000913758467770095,0.00452248143226427,-0.00977782207500806,0.00795030513946787,0.839882916050768
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GAGE2A,G antigen 2A,40079,-0.00132272146992003,0.00654984453994806,-0.0141604167682182,0.0115149738283782,0.839961930404566
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TANK,TRAF family member-associated NF-kappa-B activator,42369,0.00136421321725629,0.00676921847595895,-0.0119034549956233,0.0146318814301358,0.840285827932148
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CCL2,C-C motif chemokine 2,42474,0.00102621887235598,0.005197611161704,-0.00916109900458385,0.0112135367492958,0.843485871835314
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MSLNL,Mesothelin-like protein,40181,0.000757151541855366,0.00386261040334928,-0.00681356484870922,0.00832786793241995,0.844597599996674
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PMCH,Pro-MCH,40115,-0.00161939372377922,0.00831905949478722,-0.0179247503335622,0.0146859628860037,0.845662221817909
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL36G,Interleukin-36 gamma,40153,0.0013117652638103,0.00674644256665168,-0.011911262166827,0.0145347926944476,0.845836488155239
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KLK13,Kallikrein-13,42380,0.000878060845880643,0.004516509495484,-0.00797429776526799,0.00973041945702928,0.845856774549955
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AMY2A,Pancreatic alpha-amylase,42113,-0.000921459537912676,0.00478102473563949,-0.0102922680197661,0.00844934894394073,0.847171386120392
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SNX18,Sorting nexin-18,40448,0.000806751339554585,0.0042930859308148,-0.00760769708484242,0.00922119976395159,0.850943732599956
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TAP1,Antigen peptide transporter 1,40301,0.00113484356805911,0.00604246020295921,-0.0107083784297409,0.0129780655658592,0.851027844338056
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TBC1D17,TBC1 domain family member 17,42310,0.000832800497261198,0.00444289461547659,-0.00787527294907292,0.00954087394359531,0.851314268970057
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HTR1B,5-hydroxytryptamine receptor 1B,40135,-0.000781153507370739,0.00423642375720558,-0.00908454407149367,0.0075222370567522,0.853711055453379
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FLT3,Receptor-type tyrosine-protein kinase FLT3,42345,-0.000553261226828658,0.00300883698683236,-0.00645058172102009,0.00534405926736278,0.854111399418816
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CNTN4,Contactin-4,42610,-0.000429015257406461,0.00235548635001405,-0.00504576850343399,0.00418773798862107,0.855479949951655
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL21R,Interleukin-21 receptor,40198,0.00099542527146444,0.00548867883753401,-0.00976238525010221,0.0117532357930311,0.856088571523097
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL34,Interleukin-34,42291,0.000643861790275523,0.00358524627073824,-0.00638322090037142,0.00767094448092247,0.857479990550796
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TCP11,T-complex protein 11 homolog,40301,0.00103292376558822,0.00580694061026162,-0.0103486798305245,0.012414527361701,0.858822467565014
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ARNT,Aryl hydrocarbon receptor nuclear translocator,42369,0.000629356233456816,0.00359094040164474,-0.00640888695376688,0.00766759942068051,0.86087627937562
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",40198,0.000720728207940366,0.00416458740126924,-0.00744186309854734,0.00888331951442808,0.86260655946016
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL13,Interleukin-13,42369,0.000792699232970507,0.00465581781479654,-0.0083327036840307,0.00991810214997172,0.864808333624885
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DPEP1,Dipeptidase 1,42475,0.000830214945146004,0.00488600480035952,-0.00874635446355866,0.0104067843538507,0.865078053044136
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",40115,0.000722750848504155,0.00425490784711996,-0.00761686853185096,0.00906237022885927,0.865121130293213
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,42710,0.000792069877164692,0.00466332120788952,-0.00834803969029877,0.00993217944462816,0.865129841452765
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,40115,0.00074269539535033,0.00439282496070184,-0.00786724152762527,0.00935263231832593,0.865744627130714
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DENND2B,DENN domain-containing protein 2B,40115,-0.00081763724718692,0.00490751289303461,-0.0104363625175348,0.00880108802316092,0.867680566596307
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FSTL1,Follistatin-related protein 1,40222,-0.000354373546585215,0.00221836026442389,-0.00470235966485605,0.00399361257168562,0.873084313481642
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,STEAP4,Metalloreductase STEAP4,40135,-0.00113724232080307,0.00713459886335962,-0.0151210560929879,0.0128465714513818,0.873358087718231
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BCL7A,B-cell CLL/lymphoma 7 protein family member A,40079,0.000997047442184826,0.00628931243612296,-0.0113300049326162,0.0133240998169858,0.874041780403941
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,42345,0.000895414692432328,0.00589418329458469,-0.0106571845649537,0.0124480139498183,0.879256329419302
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KRT19,"Keratin, type I cytoskeletal 19",42561,-0.00103676349824891,0.00690036443605866,-0.0145614777929239,0.0124879507964261,0.880571505080455
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,40115,-0.000302689385466947,0.00204115127852103,-0.00430334589136817,0.00369796712043428,0.882113914293059
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CSH1,Chorionic somatomammotropin hormone 1,40531,-0.000414197479896699,0.00279886123532541,-0.00589996550113451,0.00507157054134111,0.882354982224248
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SOX9,Transcription factor SOX-9,40181,0.000402021326480515,0.0027173455490013,-0.00492397594956203,0.00572801860252306,0.882387832013149
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IZUMO1,Izumo sperm-egg fusion protein 1,40079,-0.000689398324161451,0.00468331167071706,-0.00986868919876689,0.00848989255044399,0.882974384803999
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TGFBR1,TGF-beta receptor type-1,40198,-0.00031071276884152,0.00211936117910797,-0.00446466067989314,0.0038432351422101,0.883445068593997
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MYH4,Myosin-4,40115,0.000649453815071006,0.00445516224046848,-0.00808266417624722,0.00938157180638923,0.884101252560235
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MAN2B2,Epididymis-specific alpha-mannosidase,40510,-0.000848883788425182,0.0058817428550735,-0.0123770997843692,0.0106793322075189,0.88524624002631
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NPTX1,Neuronal pentraxin-1,42610,0.000562352208596874,0.00392556933534889,-0.00713176368868695,0.0082564681058807,0.886091996871306
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,40450,0.0010708497619164,0.00751771658205661,-0.0136638747389146,0.0158055742627474,0.886732264625703
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,STX5,Syntaxin-5,40198,0.000570696497743088,0.00402501006922178,-0.00731832323793161,0.00845971623341778,0.887250378414298
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SEMA6C,Semaphorin-6C,40198,-0.000364873801537973,0.00257426610151924,-0.00541043536051568,0.00468068775743974,0.887288794205706
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,XPNPEP2,Xaa-Pro aminopeptidase 2,42678,-0.00131493671365214,0.00954995333352352,-0.0200328452473582,0.017402971820054,0.890487177679566
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CA11,Carbonic anhydrase-related protein 11,42345,0.000417611430817767,0.00318222364451999,-0.0058195469124414,0.00665476977407694,0.895593328175192
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,42682,0.000386709513233259,0.00301654701241179,-0.00552572263109385,0.00629914165756036,0.897995710501841
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CDAN1,Codanin-1,40482,0.00028087202876347,0.0022142650859327,-0.00405908753966463,0.00462083159719157,0.899064060320353
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ECSCR,Endothelial cell-specific chemotaxis regulator,40135,0.000636804150567307,0.00505383699682124,-0.00926871636320232,0.0105423246643369,0.899730999330591
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",40198,0.000576341046729533,0.0046289880522444,-0.00849647553566949,0.00964915762912856,0.900916195589462
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KCNH2,Potassium voltage-gated channel subfamily H member 2,40181,-0.00095537177997745,0.00771045213027306,-0.0160678579553126,0.0141571143953577,0.901391917658275
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ARID3A,AT-rich interactive domain-containing protein 3A,40135,0.000485878052000449,0.00398027398708637,-0.00731545896268884,0.00828721506668974,0.902844627514217
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PRAME,Melanoma antigen preferentially expressed in tumors,40079,-0.000294608626348623,0.00247759120116815,-0.00515068738063819,0.00456147012794095,0.905349410874658
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FGF23,Fibroblast growth factor 23,42710,-0.000625626727676106,0.00532807408476221,-0.01106865193381,0.00981739847845783,0.906528345871223
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,40531,-0.000424156927651621,0.00370304841511222,-0.00768213182127158,0.00683381796596834,0.908809678351583
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RANBP2,E3 SUMO-protein ligase RanBP2,40135,-0.000360045459729405,0.00318045062548695,-0.00659372868568382,0.00587363776622502,0.909869473908331
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NPY,Pro-neuropeptide Y,42720,0.000703861569322844,0.0062928584169996,-0.0116301409279964,0.0130378640666421,0.910943326865038
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,40482,-0.000893211363311067,0.00835494588860004,-0.0172689053049671,0.015482482578345,0.914863789602789
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SAT1,Diamine acetyltransferase 1,40115,-0.000536985733823762,0.00504845668421968,-0.0104319608348943,0.00935798936724681,0.915293671826457
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CNTF,Ciliary neurotrophic factor,40135,0.000346162557378484,0.00336714408143906,-0.00625343984224207,0.00694576495699904,0.918118840753252
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GRP,Gastrin-releasing peptide,40222,-0.000558795610034828,0.00548041371973859,-0.0113004065007225,0.0101828152806528,0.91878844985564
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,40115,-0.000510558475862763,0.00524429291776367,-0.0107893725946796,0.00976825564295403,0.922446214924477
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SHPK,Sedoheptulokinase,40301,0.000386310228397514,0.00402890899420139,-0.00751035140023722,0.00828297185703224,0.923613974983133
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PHLDB2,Pleckstrin homology-like domain family B member 2,40079,-0.000876056507691395,0.00945936466657235,-0.0194164112541732,0.0176642982387904,0.926213025057948
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CPA1,Carboxypeptidase A1,42793,0.000552604684222421,0.00610456835001563,-0.0114123492818082,0.0125175586502531,0.927872841026945
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KIF20B,Kinesin-like protein KIF20B,40135,0.000691686047977623,0.00766532397385179,-0.0143323489407719,0.0157157210367271,0.928101549325192
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,VWA5A,von Willebrand factor A domain-containing protein 5A,40079,0.000684154704276921,0.00763563151363389,-0.0142816830624455,0.0156499924709993,0.92860651218449
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ZNF75D,Zinc finger protein 75D,40301,0.00053483205815349,0.00601834531225539,-0.0112611247538671,0.0123307888701741,0.92918924314802
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LYPD1,Ly6/PLAUR domain-containing protein 1,42310,-0.000531930800279217,0.00601520124745972,-0.0123217252453003,0.0112578636447418,0.929535402275149
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,40448,0.00151465862321595,0.0171651865007325,-0.0321291069182198,0.0351584241646517,0.929687377105855
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ENO3,Beta-enolase,40222,-0.000497974670261357,0.00575915158931463,-0.011785911785318,0.0107899624447953,0.931097018656165
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DHODH,Dihydroorotate dehydrogenase,40115,-0.000412873561988202,0.00477825239566053,-0.00977824825748284,0.00895250113350643,0.93114461512334
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SPINK4,Serine protease inhibitor Kazal-type 4,42593,0.000584649671505015,0.00678682780094384,-0.0127175328183449,0.0138868321613549,0.931352627394232
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,C1QA,Complement C1q subcomponent subunit A,42700,-0.00018423766827224,0.00215865262533731,-0.00441519681393336,0.00404672147738888,0.931985634916834
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,C7,Complement component C7,40250,0.000274632560395017,0.00323070471939306,-0.00605754868961538,0.00660681381040541,0.932257353937083
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CDA,Cytidine deaminase,40493,0.000384223884649465,0.0045844703516373,-0.00860133800455964,0.00936978577385856,0.933209081679896
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL25,Interleukin-25,40035,0.000287384572727995,0.0034360006964496,-0.00644717679231323,0.00702194593776921,0.933344791627628
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CTSO,Cathepsin O,42753,0.000239803336277383,0.00300360173838474,-0.00564725607095671,0.00612686274351147,0.936366807869237
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LEPR,Leptin receptor,42635,-0.000238195381134682,0.00304952455463196,-0.00621526350821333,0.00573887274594397,0.937742493132019
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KLK12,Kallikrein-12,42345,0.00104531534931052,0.0136795100338704,-0.0257665243170755,0.0278571550156965,0.939090355088993
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SAG,S-arrestin,40135,0.000385142085256436,0.00513358470343783,-0.00967668393348172,0.0104469681039946,0.94019698398127
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AKR1B10,Aldo-keto reductase family 1 member B10,40181,0.000466241922644171,0.00630710092394321,-0.0118956758882845,0.0128281597335729,0.941072735223562
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MUC2,Mucin-2,40526,0.000640127527666775,0.00909793336431978,-0.0171918218664,0.0184720769217335,0.943908637264101
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,VCPKMT,Protein-lysine methyltransferase METTL21D,40079,-0.000574037831697089,0.00850562554047186,-0.0172450638910219,0.0160969882276278,0.946193502079773
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CFC1,Cryptic protein,42345,-0.000306487956861681,0.00463766792939348,-0.0093963170984729,0.00878334118474954,0.947309840566556
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MMP3,Stromelysin-1,42610,-0.000320192301166137,0.00494268378492562,-0.0100078525196204,0.00936746791728808,0.948349285860385
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CEP164,Centrosomal protein of 164 kDa,42369,-0.000407617451227626,0.006469955016254,-0.0130887292830855,0.0122734943806302,0.949766194180795
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CXCL14,C-X-C motif chemokine 14,42369,0.000343563285212279,0.00552373274070605,-0.0104829528865716,0.0111700794569961,0.950406364479746
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RNF4,E3 ubiquitin-protein ligase RNF4,40301,-0.000377979621940311,0.0065755573668481,-0.0132660720609626,0.012510112817082,0.954161862416422
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NEO1,Neogenin,40481,0.000121408021621771,0.00217767180447673,-0.00414682871515262,0.00438964475839616,0.955540922874602
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KIAA2013,Uncharacterized protein KIAA2013,40450,0.000293354604859025,0.00526673621831296,-0.0100294483830344,0.0106161575927524,0.95558218174431
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IKBKG,NF-kappa-B essential modulator,42593,-0.000484433237218491,0.00886041317211153,-0.0178508430545571,0.0168819765801201,0.956399087749107
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PLB1,"Phospholipase B1, membrane-associated",40482,0.000315326674580122,0.00588254899189202,-0.0112144693495282,0.0118451226986885,0.957251818807605
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ISM2,Isthmin-2,40526,-0.000221980382787382,0.00424200185690649,-0.0085363040223241,0.00809234325674933,0.958267343276947
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NENF,Neudesin,40450,-0.000561481941395772,0.0107975919464026,-0.0217247621563448,0.0206017982735533,0.958529087784267
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,REG1B,Lithostathine-1-beta,42793,0.000297624463001261,0.00573415489859163,-0.0109413191382383,0.0115365680642409,0.958606104021204
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CORO6,Coronin-6,40135,0.00018274884862245,0.00364543750843935,-0.00696230866791867,0.00732780636516357,0.960019038050081
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PPM1B,Protein phosphatase 1B,40198,0.000297413614504886,0.00598344169223428,-0.0114301321022743,0.0120249593312841,0.960357489059477
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FGF6,Fibroblast growth factor 6,40198,-0.000199028149613712,0.00406800868482184,-0.00817232517186453,0.0077742688726371,0.960979791958467
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,40301,0.000223890440775207,0.00464413967156289,-0.00887862331548805,0.00932640419703847,0.96155035363994
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FRMD7,FERM domain-containing protein 7,40181,0.000153004782885322,0.00328445025789082,-0.00628451772258068,0.00659052728835132,0.962845157296549
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SHH,Sonic hedgehog protein,40198,-0.000187853671632913,0.00414347792362028,-0.00830907040192866,0.00793336305866284,0.96383936228346
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ENDOU,Poly(U)-specific endoribonuclease,39633,-0.000226384177672057,0.00535931350278701,-0.0107306386431346,0.0102778702877905,0.966307175681685
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TRIM5,Tripartite motif-containing protein 5,42593,0.000347840825276674,0.00831012939481472,-0.0159400127885602,0.0166356944391135,0.966612960335798
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL1A,Interleukin-1 alpha,42369,0.00022750481274138,0.00571638418755245,-0.0109766081948614,0.0114316178203442,0.968254194299023
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,40135,0.000203566996042877,0.0057286934325993,-0.0110246721318518,0.0114318061239375,0.971654082069459
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,40181,0.000105519362891761,0.00311112955485144,-0.00599229456461705,0.00620333329040058,0.972944162780586
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,40526,-7.91338567206631e-05,0.00247423374557644,-0.00492863199805049,0.00477036428460916,0.974486029818805
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DMP1,Dentin matrix acidic phosphoprotein 1,40222,-0.000182804702651202,0.00592821711116041,-0.0118021102405256,0.0114365008352232,0.975400592297587
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DCLRE1C,Protein artemis,40079,9.39519889308547e-05,0.00307028715442862,-0.00592381083374924,0.00611171481161095,0.975588790946499
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MYBPC1,"Myosin-binding protein C, slow-type",40510,0.000202769617014049,0.00702021296244432,-0.0135568477893768,0.0139623870234049,0.976957867348247
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CDKL5,Cyclin-dependent kinase-like 5,40135,-0.000148959571513316,0.00529233840506656,-0.0105219428454438,0.0102240237024171,0.977546006034239
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SMPD3,Sphingomyelin phosphodiesterase 3,40198,0.000151260434299119,0.00537701355483953,-0.0103876861331864,0.0106902070017846,0.977558229100619
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DUOX2,Dual oxidase 2,42356,0.000190520928101962,0.007012077816142,-0.0135531515915364,0.0139341934477403,0.978324239807644
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GNPDA1,Glucosamine-6-phosphate isomerase 1,40222,-8.29283043962255e-05,0.00328433020151151,-0.00652021549935879,0.00635435889056634,0.979856263188889
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AKAP12,A-kinase anchor protein 12,40282,-4.92926618074487e-05,0.00216444405719729,-0.00429160301391414,0.00419301769029925,0.981831100117043
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CCL11,Eotaxin,42753,-7.59045913541453e-05,0.00358686047126179,-0.00710615111502725,0.00695434193231896,0.983116860786734
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LRP2BP,LRP2-binding protein,40181,-0.000158033055690147,0.00846802355320355,-0.0167553592199691,0.0164392931085888,0.98511081765994
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CDH6,Cadherin-6,42635,6.95097508211489e-05,0.00379229486186688,-0.00736338817843793,0.00750240768008023,0.985376501029467
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ENG,Endoglin,42793,2.08317383437676e-05,0.00170254502818171,-0.00331615651689239,0.00335781999357992,0.990237790003042
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,42675,2.90215672629824e-05,0.00414119322641501,-0.00808771715651043,0.00814576029103639,0.994408558059986
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,40301,2.52298270415902e-05,0.00691605836620785,-0.0135302445707258,0.013580704224809,0.99708938377157
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,40115,-2.31657684320456e-05,0.00664081211272248,-0.0130391575093681,0.012992825972504,0.997216733729044
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RYR1,Ryanodine receptor 1,40115,7.26558975824328e-06,0.00338868900340526,-0.00663456485691606,0.00664909603643255,0.998289319338052
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",40115,-1.03947639044835e-05,0.00589120889609504,-0.0115571642002508,0.0115363746724418,0.998592202785925
